Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
ABT1	Esf2	ENSG00000146109	"Activator of basal transcription 1"	Q9ULW3	6	26596952-26600744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077039			Approved	Vesicles		NA	NA			Vesicles		"HPA077039: AB_2732328"	"unprognostic (1.32e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (3.80e-4)"	13.1	11.0	11.2	14.6	10.7	28.9	13.0	15.8	14.1	13.3	12.1	9.8	13.5	14.5	16.2	14.3	19.4	13.9	9.0	10.8	9.6	7.6	10.1	19.1	11.4	20.4	9.5	9.3	14.2	18.2	8.4	10.9	19.6	8.3	13.5	10.1	9.3	13.4	12.0	16.1	18.2	15.6	9.2	6.3	23.2	13.5	17.9	9.4	23.9	13.1	17.4	22.4	12.9	13.2	32.0	18.5	29.1	20.1	24.9	34.7	37.0	12.6	6.6	9.3	16.0	5.2	5.5	13.6	7.5	7.7	11.4	11.2	11.9	5.6	18.5	17.2	6.1	9.1	8.1	10.7	10.9	6.7	10.2	21.8	12.2	6.0	22.1	8.4	16.6	12.4	7.2	10.2	9.1	5.4	5.3	9.9	14.7	21.1	12.5	6.3	12.8	19.1	21.2	9.5	8.1	8.9	11.6	7.5	19.5	7.1	10.3	12.2	9.8	4.6	12.2	17.8	5.1	11.7	13.5	8.4	8.8	6.4	6.9	15.0	14.7	21.6	16.8	4.1	20.6	13.3	29.1	20.1	24.0	32.8	18.1	31.4	31.2	32.3	32.7	18.5	32.0	34.7	31.2	17.4	24.9	18.0	17.1	34.1	37.0	11.2	10.7	15.8	14.1	9.6	7.6	9.5	9.3	8.3	9.4	14.9	13.3	52.3	27.6	53.1	16.8	5.6	20.4	18.7	15.9	10.4	2.0	79.8	34.9	29.8	33.9	35.1	16.3	0.0	34.0	80.3	20.7	16.1	27.8	21.2	36.8	14.3	32.6	17.8	15.4	58.5	25.6	22.9	15.1	25.2	23.4	20.9	28.3	21.0	22.3	19.1	15.4	19.4	23.2	22.3	36.4	52.2	91.5	58.6	30.2	27.0
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 754.9;Proximal tubular cells: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	10.0	9.7	13.5	7.0	14.5	4.7	7.9	8.2	13.1	5.8	12.8	5.6	5.9	9.4	5.2	6.2	5.4	5.9	9.9	24.2	11.1	11.6	26.3	41.7	7.0	7.1	13.8	10.6	6.4	9.7	8.9	12.2	6.3	12.3	9.8	11.0	4.0	7.4	6.4	15.7	8.2	8.6	5.5	10.1	6.8	8.1	19.8	8.8	10.5	8.7	8.5	5.2	6.9	4.7	12.8	8.7	11.5	10.5	7.8	12.0	8.8	4.3	5.6	5.7	10.3	8.2	10.3	3.2	3.6	4.3	2.6	4.2	7.5	5.6	8.1	12.3	4.1	14.0	4.8	5.0	7.3	4.1	12.7	4.6	7.6	5.8	5.2	4.1	4.8	3.5	5.9	7.2	3.5	7.0	6.5	6.2	8.4	12.1	4.3	5.2	4.5	8.7	9.4	3.9	8.6	4.5	7.5	5.1	10.2	8.8	4.1	11.5	4.0	4.2	14.4	10.1	7.0	9.9	4.0	7.2	4.8	2.7	1.3	3.4	8.2	20.8	8.2	5.0	17.6	14.3	6.9	10.2	6.4	8.8	10.5	12.0	12.8	9.9	10.0	8.7	8.7	11.7	10.2	11.5	7.8	9.9	7.0	9.5	8.8	13.5	14.5	8.2	13.1	11.1	11.6	13.8	10.6	12.3	8.8	62.5	32.4	18.2	21.9	15.2	15.6	80.7	43.3	40.2	25.0	29.6	15.7	46.4	134.3	36.6	754.9	21.5	50.1	0.0	35.3	23.9	19.9	21.9	13.9	199.8	79.5	4.8	52.6	21.5	21.2	100.1	18.1	27.8	25.3	112.8	85.9	34.6	30.9	101.7	22.6	372.2	30.4	25.8	15.5	41.9	20.4	20.6	33.4	16.2	62.8	21.7
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6;ovary: 47.7;pancreas: 46.6"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 71.3;Ito cells: 98.8;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 18.3;T-cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HEL: 20.3;HMC-1: 85.9;K-562: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain					NA	NA					"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	2.1	1.8	0.3	3.7	1.0	3.4	18.6	0.4	0.4	10.9	7.0	0.5	4.3	1.7	10.4	5.3	2.9	11.2	5.0	4.0	0.3	0.3	33.1	58.6	6.4	3.7	0.4	0.3	47.7	46.6	5.1	1.0	1.8	0.7	9.6	7.2	1.4	3.6	6.5	1.0	2.0	3.1	3.2	0.5	1.3	10.9	14.7	0.3	1.5	1.5	1.6	1.8	3.9	6.6	2.2	1.9	18.3	2.9	1.9	7.4	2.3	0.2	2.8	0.5	0.1	0.8	0.5	0.3	0.0	0.3	0.0	0.2	0.2	4.0	0.3	4.5	0.1	0.1	0.3	0.0	0.4	0.3	0.9	1.4	20.3	0.0	1.5	0.3	2.2	85.9	0.8	0.4	0.1	0.4	0.4	0.0	0.1	60.5	3.4	0.0	0.3	0.1	0.7	0.1	3.0	0.7	0.6	0.0	4.3	4.1	0.2	0.1	0.1	0.0	1.2	0.0	0.1	1.3	0.1	0.3	0.2	0.2	0.2	0.1	4.9	3.8	0.2	0.3	1.6	0.1	2.3	1.6	18.3	3.3	1.0	3.8	1.4	4.1	3.0	0.2	2.2	6.5	7.4	0.5	1.9	2.9	1.9	4.6	2.3	0.3	1.0	0.4	0.4	0.3	0.3	0.4	0.3	0.7	0.3	3.0	25.3	23.1	29.1	2.5	0.0	3.2	17.8	2.7	2.3	12.2	0.0	14.9	71.3	44.7	11.7	0.5	3.9	0.0	11.1	1.0	1.5	14.6	0.0	34.1	3.2	0.0	2.4	98.8	6.9	9.1	25.6	1.5	0.0	1.0	9.1	0.0	14.1	11.5	12.0	77.8	0.0	0.0	3.1	2.7	1.0	1.6	16.0	5.7	22.5	4.3
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.0	0.0	13.2	3.0	11.6	3.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.2	0.1	6.3	0.0	0.1	0.0	0.0	12.5	4.4	0.1	22.3	0.5	0.0	20.7	1.5	10.3	0.0	0.0	0.4	0.0	3.2	0.0	3.9	5.9	0.1	0.0	0.1	0.0	10.6	0.0	5.9	1.4	0.0	0.1	0.1	0.0	12.8	1.1	0.7	0.1	21.0	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	28.1	20.5	5.2	0.0	0.4	6.6	2.3	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.0	4.7	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940823-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	26.8	24.8	20.4	16.4	25.9	65.7	29.6	18.1	29.0	22.2	19.3	33.2	17.1	16.2	18.0	33.7	49.1	24.8	18.5	39.6	19.8	19.5	30.5	56.8	41.5	33.6	20.7	14.3	22.6	66.2	30.4	21.6	63.1	20.2	23.1	21.6	38.3	39.7	17.9	43.5	46.1	24.4	18.2	30.2	36.9	24.8	24.9	18.3	21.9	26.6	28.6	32.1	25.0	29.3	21.6	28.8	112.6	49.9	16.0	23.4	63.8	24.9	23.8	14.6	16.0	30.5	23.5	74.4	28.0	32.7	29.1	27.0	23.7	30.3	16.7	20.8	31.7	23.3	31.0	21.7	38.4	26.4	31.5	24.7	12.8	30.2	18.8	30.1	26.5	19.5	27.8	62.6	31.6	32.3	29.1	28.6	29.5	33.0	35.5	29.3	27.2	21.9	19.5	32.0	22.5	27.3	17.5	35.4	32.3	28.2	30.0	24.0	24.8	29.6	44.2	34.4	40.8	32.1	25.7	25.5	21.5	17.0	10.5	30.8	37.5	50.8	18.9	30.8	15.3	25.1	39.6	49.9	59.9	19.7	33.5	20.4	21.6	21.0	19.3	28.8	21.4	21.0	18.4	112.6	16.0	32.3	19.9	23.4	63.8	20.4	25.9	18.1	29.0	19.8	19.5	20.7	14.3	20.2	18.3	32.8	48.6	40.6	78.1	208.7	24.6	48.9	30.6	50.9	36.4	50.6	27.5	96.5	58.0	65.0	51.8	53.4	41.2	210.2	76.0	142.7	52.5	96.6	35.9	53.5	89.9	11.1	47.2	52.8	115.1	42.9	26.4	67.3	81.0	74.9	43.5	23.3	91.5	45.6	23.0	46.9	35.3	38.8	45.3	11.6	29.6	200.0	169.6	42.7	43.1	136.7
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;HaCaT: 6.7;TIME: 11.1;U-2 OS: 9.3;U-251 MG: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074416			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.00e-5)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.3	0.0	13.2	3.9	5.2	6.7	0.0	0.6	0.3	0.0	0.3	0.0	1.7	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	2.3	0.1	0.0	11.1	0.1	9.3	0.0	7.1	0.0	0.0	0.0	3.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Cell line enhanced"	"Detected in all"		"MCF7: 115.3"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.4	30.8	25.5	37.9	19.7	20.5	28.5	28.4	34.6	42.0	33.7	20.2	18.7	18.7	21.9	38.9	21.4	20.1	18.0	26.4	18.3	42.6	7.3	14.1	18.4	21.7	21.9	23.0	36.9	29.3	22.3	21.0	14.0	20.2	31.4	18.4	12.3	20.8	26.9	115.3	28.9	29.4	6.6	30.3	22.1	27.3	23.6	12.7	19.4	38.4	29.3	24.3	23.7	31.0	17.8	11.9	40.6	34.3	25.0	28.2	13.5	40.1	28.5	22.6	10.9	16.1	23.8	19.5	33.9	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8	14.9	24.3	13.4	13.8	11.0	24.3	13.8	40.8	5.3	11.4	21.0	11.8	15.1	11.6	21.0	1.2	19.6	22.2	0.0	30.3	25.7	18.8	34.2	2.3	38.4	20.2	39.7	28.8	24.5	23.7	3.1	26.4	18.1	10.1	17.2	36.1	35.8	43.4	17.3	29.0	13.9	24.0	25.8	11.8	0.9	5.1	12.2	19.6	18.1	26.9	30.8
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
ALG1L2		ENSG00000251287	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 3.5"	"Cell type enhanced"	"Detected in some"	5	"Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 4.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9"									HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0		0.8		1.2	0.0		0.0	0.0	0.0			0.8	0.0	0.0	0.3	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.9	0.0	0.0		3.5	0.3	0.0			0.0		0.0	0.1		0.7	4.0	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.4	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.6	0.3	0.3	0.4	0.1	0.0	0.0	0.0	4.0	0.9	0.1											0.0	1.6	0.8	4.9	0.0	1.9	0.2	0.0	1.4	1.2	1.8	3.9	0.2	1.7	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.6	1.8	0.0	0.2	0.2	4.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.8	0.0	0.0	2.5	0.3	3.0	0.0	0.1	0.5	0.1	0.0	0.0	0.5	0.6	1.4
AMMECR1		ENSG00000101935	"Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1"	Q9Y4X0	X	110194186-110440233	"Disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	7.2	6.6	2.4	10.1	4.5	17.0	5.3	2.9	6.5	6.3	6.2	3.9	5.0	4.6	5.3	6.0	15.9	6.3	6.5	3.0	3.1	2.9	7.5	8.5	5.9	5.8	2.6	3.2	12.4	7.4	5.0	9.5	22.7	6.6	4.3	6.1	9.7	6.5	7.0	3.2	14.2	7.8	4.5	2.4	9.7	5.8	4.0	2.3	12.5	6.0	11.1	11.3	6.8	8.9	4.3	2.9	1.5	4.8	1.2	6.7	1.9	11.3	5.6	4.1	2.0	4.7	7.0	4.5	7.9	7.1	6.5	9.6	8.9	8.3	6.7	3.8	10.4	5.2	5.4	13.1	8.9	6.7	4.7	5.9	9.3	12.9	1.8	11.9	7.4	3.9	3.9	15.9	7.4	13.3	3.5	5.1	3.3	25.9	20.2	4.9	9.5	3.5	2.6	18.9	9.7	11.0	7.7	4.4	11.9	11.0	9.6	6.6	3.2	13.3	13.1	11.1	5.2	3.2	7.4	2.3	4.5	2.8	13.3	7.1	4.2	4.7	10.8	6.9	15.5	15.0	1.3	1.9	1.5	3.4	1.3	4.6	3.3	6.7	5.4	2.9	4.3	4.6	3.9	1.3	1.2	4.8	1.3	4.6	1.9	2.4	4.5	2.9	6.5	3.1	2.9	2.6	3.2	6.6	2.3	0.0	9.8	8.2	3.8	8.5	29.6	3.8	5.1	5.3	3.4	3.5	49.1	19.3	19.9	8.0	0.4	4.2	7.9	70.0	10.4	9.3	11.3	5.9	2.3	6.0	6.1	1.6	14.5	25.2	7.8	0.8	11.8	4.0	3.3	7.2	10.2	5.8	9.8	0.0	16.3	8.2	93.5	12.9	4.7	1.8	6.9	23.3	72.3	10.0	9.9	11.5
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	10.7	14.9	29.5	13.8	30.1	40.3	14.0	9.1	32.5	9.9	20.0	13.7	13.2	14.9	15.3	19.9	17.2	13.4	13.3	22.2	23.6	19.8	16.0	16.9	12.2	19.5	25.2	20.6	8.0	16.6	9.4	11.7	12.7	19.3	17.4	20.5	11.6	18.2	20.6	41.5	14.1	14.8	21.8	17.7	14.4	15.1	22.1	12.6	22.5	21.6	23.1	20.9	12.8	9.4	27.0	45.6	39.9	52.7	20.5	44.0	35.5	19.6	29.7	24.4	15.4	7.2	11.8	11.5	21.0	19.3	33.9	22.6	34.7	21.5	26.6	20.5	29.9	16.5	33.5	36.7	39.3	32.1	17.0	17.4	30.2	34.0	22.4	8.6	29.3	28.3	12.3	15.6	19.2	25.8	12.8	22.2	37.5	21.8	18.5	22.0	33.8	56.3	27.3	19.7	41.7	17.2	23.9	60.6	18.0	29.1	13.7	17.3	15.1	21.5	21.2	33.3	13.7	24.8	15.7	20.0	15.6	20.6	30.8	22.1	19.0	18.4	33.9	9.6	23.6	8.7	7.5	52.7	39.9	24.0	33.4	25.4	27.0	30.9	27.9	45.6	19.9	37.1	33.9	21.7	20.5	30.4	36.6	44.0	35.5	29.5	30.1	9.1	32.5	23.6	19.8	25.2	20.6	19.3	12.6	14.9	13.9	33.5	62.0	37.2	30.5	2.8	12.7	40.2	35.2	22.7	25.5	72.2	104.5	44.3	13.8	19.6	61.2	0.0	89.5	62.0	19.8	46.4	30.0	37.8	71.7	12.7	47.5	19.0	44.0	9.1	6.4	47.5	25.3	51.3	52.0	22.6	43.9	54.5	21.5	83.0	32.0	19.4	29.7	92.2	129.0	35.9	39.0	41.5	65.5	51.5
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell type enhanced"	"Detected in all"	8	"Hofbauer cells: 225.7;Kupffer cells: 390.4;Macrophages: 350.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 67.3;SK-MEL-30: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.4	2.9	32.5	16.0	6.2	4.1	1.1	10.2	4.8	7.9	10.2	2.1	3.6	5.8	45.5	14.9	14.3	4.0	9.0	2.8	13.3	8.3	14.4	3.5	5.1	3.2	5.4	12.9	3.9	2.4	2.9	7.5	7.7	11.2	15.9	4.7	3.2	67.3	14.3	1.8	3.4	6.8	43.3	1.8	10.7	7.3	23.7	11.8	8.9	0.8	4.0	15.8	4.5	1.4	89.0	23.4	15.2	13.3	8.4	13.6	5.1	18.9	9.5	7.8	17.6	12.3	7.2	5.8	32.9	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4	3.0	16.2	80.2	10.9	49.0	31.7	178.0	7.6	1.4	3.4	8.7	11.8	4.7	28.2	12.5	3.9	119.9	7.7	23.3	5.6	16.4	51.9	11.0	77.3	6.4	225.7	11.1	25.8	148.0	390.4	8.9	16.1	350.3	141.7	139.7	7.0	19.0	8.6	11.2	6.7	6.6	34.6	38.8	56.7	25.7	19.4	45.0	4.7	51.1	6.4	5.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.9	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.7	17.3	10.8	18.6	14.6	14.3	8.6	20.9	16.6	18.0	17.3	13.4	11.8	13.7	17.8	19.8	11.0	7.4	10.9	16.8	7.6	14.2	24.9	9.0	8.4	14.0	15.6	9.1	9.9	13.1	21.5	14.7	14.3	15.6	10.5	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	18.8	16.5	8.5	8.1	10.5	15.3	21.1	11.8	10.4	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9	3.0	16.9	15.2	10.8	11.4	3.2	4.7	10.2	12.0	9.1	10.4	0.0	43.2	13.3	21.7	0.2	7.7	13.7	70.0	13.2	28.4	7.0	7.8	8.1	10.2	21.2	6.4	5.8	8.6	8.6	0.8	5.5	13.5	0.0	29.7	11.1	5.8	15.0	14.8	8.1	15.8	2.1	19.4	4.4	1.0	10.8	11.0	39.8	15.8	11.3	10.0
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	46.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	21.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2	0.0	7.9	0.0	0.9	1.1	0.2	1.1	2.5	4.0	3.4	0.0	0.0	0.4	3.3	0.1	0.0	3.8	0.0	0.0	0.6	0.6	6.3	1.2	2.3	0.0	2.4	1.6	14.3	1.3	4.5	0.0	2.6	5.3	0.0	1.8	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.4	0.0	0.0	1.0	5.1	0.0	0.1	1.4
APOPT1	"APOP-1, C14orf153, MGC2562"	ENSG00000256053	"Apoptogenic 1, mitochondrial"	Q96IL0	14	103562962-103607523	"Predicted intracellular proteins"	Apoptosis		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 626.8;Late spermatids: 837.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.83e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.99e-1)"	14.2	10.2	26.0	7.9	21.8	7.0	32.0	10.1	22.8	12.9	12.2	8.1	11.9	11.7	12.5	12.9	13.3	9.5	10.4	26.5	22.2	18.4	14.1	14.2	10.0	16.7	21.4	13.9	10.8	32.5	6.4	9.0	10.2	12.0	11.1	12.5	7.1	16.7	11.6	53.8	12.5	10.1	16.4	19.2	8.0	10.0	30.5	9.6	6.2	17.2	19.8	10.6	13.0	15.4	24.5	24.7	30.8	27.5	26.1	25.2	22.4	12.6	10.3	9.7	16.5	20.9	22.0	14.4	15.4	15.3	16.6	20.9	8.4	21.2	11.8	18.9	16.8	17.2	16.8	7.8	15.6	22.3	17.9	5.8	6.6	7.9	11.0	26.0	10.0	9.2	17.1	25.8	11.3	26.5	20.6	20.7	11.9	9.0	16.2	19.5	14.7	10.5	12.4	9.9	33.3	26.2	7.4	9.7	9.7	24.3	11.8	14.3	7.8	10.1	12.0	24.8	13.6	19.4	11.1	14.8	13.8	9.4	24.2	18.0	10.0	16.8	16.0	21.3	10.6	14.2	28.3	27.5	30.8	20.1	23.0	17.7	24.5	19.7	21.6	24.7	22.5	16.5	19.9	13.6	26.1	19.4	18.9	25.2	22.4	26.0	21.8	10.1	22.8	22.2	18.4	21.4	13.9	12.0	9.6	41.7	12.5	36.8	34.5	47.3	20.6	54.9	22.9	16.0	31.8	38.4	19.6	64.7	102.8	69.7	626.8	40.5	52.9	0.0	37.9	45.9	40.9	31.7	29.9	46.0	75.3	14.3	45.5	27.0	41.2	837.9	37.7	44.1	40.5	47.7	51.0	22.6	68.7	40.3	38.2	97.7	29.0	25.8	33.0	66.9	39.6	52.9	58.0	35.5	57.0	41.3
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.0	3.3	1.4	2.2	3.2	0.8	1.4	1.7	0.8	1.6	0.7	7.8	1.6	1.6	0.8	0.7	12.3	1.0	0.5	0.1	0.8	4.8	1.3	1.3	1.1	13.0	1.0	2.7	1.5	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.8	1.0	1.8	1.6	1.0	1.8	1.4	7.5	3.0	1.4	3.5	0.6	0.9	1.2	1.4	1.0	2.1	0.4	0.8	1.1	1.6	0.4	0.9	1.3	4.1	2.5	1.1	1.1	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7	0.0	0.0	0.0	0.7	0.1	7.5	0.4	7.6	0.0	0.0	1.8	0.0	6.6	0.0	1.2	30.5	0.3	15.8	0.0	3.4	10.1	0.9	1.2	4.6	21.5	1.0	0.0	4.1	0.0	0.3	51.4	14.4	0.0	1.7	0.0	3.1	29.1	3.7	3.1	10.6	15.3	5.0	0.0	0.7	35.9	5.8	0.1	13.3	0.0	5.6	0.1
ARHGEF39	"C9orf100, FLJ14642"	ENSG00000137135	"Rho guanine nucleotide exchange factor 39"	Q8N4T4	9	35658875-35675866	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.7;Erythroid cells: 46.7;Late spermatids: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.4"	"Low region specificity"	"Detected in all"			HPA061299	Uncertain					NA	Yes					"HPA061299: AB_2684473"	"unprognostic (2.93e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (9.75e-2)"	"unprognostic (6.04e-9)"	"unprognostic (3.31e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.46e-1)"	1.6	1.4	0.6	10.0	0.6	3.3	1.3	1.7	0.6	1.4	3.7	0.3	0.7	4.1	2.1	1.6	5.6	0.5	3.6	0.9	1.0	0.6	0.9	1.0	1.4	3.7	0.6	0.0	0.8	1.6	0.0	0.6	2.8	0.6	0.8	2.1	0.4	1.4	0.7	0.6	2.0	5.5	1.4	0.6	2.0	2.7	2.9	0.1	18.0	0.5	1.7	7.1	0.9	1.7	1.8	0.9	1.4	1.2	1.7	3.6	0.7	5.3	8.3	7.9	3.9	0.1	0.3	5.3	4.0	1.5	3.5	3.1	9.2	4.3	3.3	2.4	0.6	4.8	4.2	3.9	2.3	1.4	9.8	6.2	5.4	10.7	3.3	0.0	4.5	8.1	0.3	0.2	1.7	1.0	1.2	1.3	4.9	3.7	3.1	1.5	2.7	1.1	2.5	5.0	3.8	2.7	4.5	6.1	2.0	1.3	2.3	5.6	2.2	2.0	4.4	1.2	3.3	6.5	2.6	0.8	2.6	8.3	2.9	2.8	3.1	3.7	1.5	1.5	2.4	5.5	1.2	1.0	0.8	2.4	0.7	3.6	0.9	1.7	2.4	0.9	1.8	0.6	1.6	1.4	1.7	1.2	0.8	1.9	0.7	0.6	0.6	1.7	0.6	1.0	0.6	0.6	0.0	0.6	0.1	0.0	0.0	2.7	1.4	2.4	1.7	1.0	2.5	1.4	1.2	1.8	0.0	1.4	0.0	0.8	86.7	1.1	1.0	46.7	0.7	16.7	1.9	0.9	0.0	0.6	4.4	0.0	3.4	1.8	3.1	30.7	0.9	2.5	5.0	0.0	2.4	1.9	0.6	0.0	0.4	0.3	1.8	0.0	1.7	2.6	3.3	1.8	1.6	1.9	3.6	0.7
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 18.3"	"Cell type enriched"	"Detected in some"	10	"Urothelial cells: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0"	"Region enriched"	"Detected in single"	9	"olfactory region: 4.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.0"						"Secreted in other tissues"	NA	NA						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2.0	5.1	2.0	0.6	1.6	6.2	0.4	2.1	0.5	1.0	0.1	2.4	14.4	18.3	8.0	10.4	4.8	10.0	2.5	0.7	5.3	12.4	1.0	1.2	1.1	2.0	2.0	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.8	0.7	0.5	0.4	0.1	0.1	0.1	1.2	0.2	1.2	1.2	0.1	0.7	0.3	0.1	0.4	0.3	31.5	0.0	28.0	0.2	0.1	0.9	0.4	3.0	0.0	0.0	0.1	0.6	0.0	11.8	0.5	9.0	5.4	0.0	0.4	0.3	0.9	0.1	2.1	0.1	1.7	2.6	0.0	1.1	0.5	0.0	0.4	0.1	0.5	0.6	0.2	0.1	0.0	0.6	0.5	5.0	4.5	0.3	0.5	0.2	0.2	1.2	3.0	2.2	0.3	4.0	1.4	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	4.3	1.7	0.6	1.6	1.0	0.1	4.8	0.7	0.0	0.0	0.0	2.6	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.1	5.6	0.0	0.8	0.0	0.2	0.0	0.2	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.8	4.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	56.7
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA		1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.6	23.7	13.9	13.2	10.5	11.5	16.6	20.5	10.2	17.6	17.3	22.8	33.5	32.3	30.9	12.4	6.6	27.9	15.9	20.4	13.9	24.1	53.6	27.6	102.7	30.7	11.4	21.0	28.0	13.3	33.9	15.6	12.6	17.2	16.8	38.6	48.8	29.5	12.5	30.3	31.2	38.9	46.3	17.2	29.3	29.9	15.4	45.6	34.2	30.4	28.2	20.3	25.4	26.5	26.1	14.2	39.3	23.3	17.3	5.7	15.7	22.2	24.1	76.4	46.0	44.6	27.0	57.7	6.6	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2	190.6	249.0	0.0	0.0	0.0	0.0	0.0	0.0	1141.6	276.4	518.2	0.0	390.3	877.0	342.1	0.0	0.0	0.0	0.0	585.4	173.6	0.0	0.0	159.3	0.0	316.5	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	214.6	0.0	0.0	472.8	0.0	0.0	988.7	0.0	0.0	0.0	0.0	0.0	0.0	210.5	0.0	0.0	0.0
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA058978: AB_2683867, HPA060520: AB_2684302"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	23.1	34.5	69.4	19.3	64.3	40.2	34.9	31.0	91.7	21.0	43.0	16.0	26.8	44.1	16.5	39.1	27.3	21.3	20.5	87.5	57.5	44.7	43.0	45.2	15.7	28.6	54.0	41.4	22.1	38.2	17.2	29.2	20.5	30.4	22.1	45.6	20.1	28.9	30.3	117.3	17.3	33.6	24.6	28.5	19.5	25.8	17.5	24.4	18.9	23.6	58.9	30.9	18.4	17.2	51.8	63.1	91.6	91.0	32.8	54.6	98.1	37.9	43.8	38.0	36.1	45.5	47.3	37.5	29.7	33.7	37.3	32.7	37.8	27.0	39.8	31.4	30.4	30.1	32.4	48.9	35.8	50.6	32.9	49.3	44.4	37.1	58.1	30.1	53.6	30.9	49.6	48.8	25.3	27.1	42.9	41.9	53.7	26.9	42.7	41.0	112.7	51.8	76.6	29.7	88.5	83.8	33.3	33.2	36.1	56.8	54.0	32.9	39.3	24.9	46.7	56.0	43.9	57.8	63.8	22.5	14.7	23.0	39.6	24.3	32.8	55.7	55.7	34.4	30.6	24.7	54.8	91.0	55.0	37.5	68.0	41.7	51.8	47.8	42.3	63.1	43.6	54.6	48.4	91.6	32.8	65.0	61.2	46.5	98.1	69.4	64.3	31.0	91.7	57.5	44.7	54.0	41.4	30.4	24.4	205.4	192.2	0.0	0.0	0.0	0.0	0.0	0.0	269.0	169.5	392.6	0.0	537.4	1357.9	448.4	0.0	0.0	0.0	0.0	495.8	570.0	0.0	0.0	86.0	0.0	793.2	0.0	0.0	0.0	0.0	0.0	0.0	158.5	0.0	585.3	0.0	0.0	512.8	0.0	0.0	1064.7	0.0	0.0	0.0	0.0	0.0	0.0	593.8	0.0	0.0	0.0
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987943-64997045	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 8.4;Mucus-secreting cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.6;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.6;monocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 11.4;BJ hTERT+ SV40 Large T+ RasG12V: 17.5;GAMG: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.8	5.3	2.4	8.3	3.3	0.4	3.2	1.0	3.4	2.0	8.9	1.9	7.2	8.8	2.1	2.8	2.3	2.9	9.3	2.2	1.9	1.7	10.0	5.4	7.8	2.7	2.2	2.4	3.2	17.3	0.7	3.1	3.0	5.9	7.9	6.7	4.2	14.0	5.1	4.8	0.5	14.0	2.7	2.1	18.7	5.1	0.9	1.7	0.9	16.5	1.0	3.4	3.9	1.2	1.3	0.3	9.6	6.6	0.1	0.1	0.9	1.2	0.8	0.1	0.0	0.1	0.5	0.0	0.4	5.4	11.4	17.5	1.5	4.7	0.0	2.2	0.7	15.6	0.1	0.0	1.3	0.8	0.1	0.3	1.6	0.0	3.9	4.3	0.0	1.0	0.3	0.4	1.5	1.9	0.4	2.7	0.1	3.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.5	0.0	1.1	0.4	1.4	0.1	0.1	0.0	0.4	0.3	5.4	0.1	0.5	0.8	2.0	0.6	0.6	1.0	0.0	0.0	0.1	0.4	0.9	0.5	0.5	0.0	2.6	1.1	0.0	6.6	0.0	1.3	0.0	0.1	0.3	0.4	0.0	0.0	9.6	0.1	3.1	0.0	0.0	0.9	2.4	3.3	1.0	3.4	1.9	1.7	2.2	2.4	5.9	1.7	3.0	1.3	3.7	0.6	0.0	0.0	0.5	5.1	4.0	2.3	1.8	0.0	0.0	1.7	4.6	0.9	1.5	8.4	0.0	5.8	0.2	0.9	0.2	0.0	0.8	3.8	0.0	2.4	5.5	2.7	1.7	0.0	1.0	0.0	1.0	8.0	0.8	4.6	7.0	0.7	3.3	0.1	0.0	1.5	0.1	0.6	0.0	0.0	0.0	6.3	1.1
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	19.3	7.1	14.7	13.9	7.8	9.1	22.0	14.6	11.3	19.4	20.0	9.9	8.0	17.2	20.2	9.4	13.1	9.4	17.0	14.4	27.0	15.6	15.3	9.0	14.1	14.3	14.2	22.7	9.8	8.3	15.9	20.0	24.8	9.1	12.6	18.8	17.2	12.9	15.9	118.8	20.2	16.9	25.5	11.9	16.2	14.5	26.0	12.0	13.6	17.0	19.2	12.8	18.2	14.1	22.4	12.7	12.4	18.0	11.1	11.9	15.9	23.8	27.4	14.1	14.5	27.9	23.2	19.0	44.8	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6	26.8	38.4	63.6	94.6	69.1	63.3	63.3	28.1	42.8	36.4	47.1	35.3	67.4	81.2	56.2	17.0	43.9	22.2	23.3	58.4	73.6	49.8	51.7	99.1	27.7	58.7	36.5	47.9	27.0	31.0	13.7	36.8	54.3	64.1	50.5	30.7	70.3	45.0	31.1	41.1	72.5	55.6	38.8	78.0	57.0	37.7	55.5	84.7	66.0	31.3	106.5
BLOC1S1	"BLOS1, BORCS1, GCN5L1"	ENSG00000135441	"Biogenesis of lysosomal organelles complex 1 subunit 1"	P78537	12	55716037-55720087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 663.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021381	Approved					NA	NA					"HPA021381: AB_2228026"	"unprognostic (1.27e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.83e-2)"	31.2	39.2	56.3	31.7	44.8	60.6	31.4	16.2	54.1	26.0	64.5	36.2	27.0	45.4	28.7	50.4	41.6	43.2	46.5	30.4	48.2	36.8	47.3	63.7	27.6	36.9	54.1	43.4	28.9	33.8	24.8	28.4	33.7	30.9	31.4	54.1	34.1	30.9	28.0	93.6	27.0	63.3	42.3	59.3	44.2	40.5	18.2	34.2	38.0	41.6	37.8	33.7	29.6	25.6	46.2	68.3	100.4	76.8	28.0	42.5	74.4	30.9	61.1	32.2	27.1	42.1	54.0	18.3	22.1	36.7	27.3	27.3	34.8	63.5	34.5	40.5	45.6	23.1	21.7	16.8	31.3	27.0	32.9	38.2	19.6	54.7	51.7	40.5	23.9	43.0	34.5	32.9	26.1	20.2	35.5	36.2	40.8	17.6	53.0	43.7	68.0	37.3	28.5	20.3	51.0	32.0	25.6	31.3	37.8	43.2	38.5	20.6	34.4	20.1	20.6	34.6	23.6	42.5	39.4	26.9	21.3	34.8	23.2	17.1	24.1	28.1	30.4	38.7	22.6	29.0	67.5	67.8	100.4	35.6	73.8	24.1	46.2	33.9	35.4	68.3	44.6	24.7	30.9	89.3	28.0	76.8	57.5	42.5	74.4	56.3	44.8	16.2	54.1	48.2	36.8	54.1	43.4	30.9	34.2	14.9	16.5	113.6	99.7	73.7	46.2	30.9	160.5	25.4	14.8	151.8	23.6	84.0	313.4	165.1	45.4	101.2	663.8	210.2	280.7	153.6	122.2	129.9	18.6	293.7	381.4	28.6	95.9	109.9	364.0	127.9	124.3	209.9	167.0	292.2	320.6	111.2	242.8	394.7	93.0	527.1	66.8	77.6	114.6	47.2	50.5	77.8	61.2	124.6	343.5	143.5
BOLA1	CGI-143	ENSG00000178096	"BolA family member 1"	Q9Y3E2	1	149887890-149900798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 24.1;MCF7: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007005	Approved				"Intracellular and membrane"	NA	NA					"HPA007005: AB_1078294"	"unprognostic (5.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.84e-2)"	"unprognostic (8.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.41e-4)"	"unprognostic (3.14e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.93e-3)"	13.9	24.5	14.5	14.3	16.4	8.2	10.9	10.2	15.4	11.9	15.0	12.0	21.2	30.1	15.3	11.5	13.6	10.7	14.2	13.4	13.6	11.3	13.7	17.6	9.3	12.5	14.2	14.9	16.1	24.6	10.9	13.3	9.9	12.5	16.6	5.6	11.2	36.8	18.7	35.5	16.5	23.6	12.0	12.0	15.5	17.8	8.3	14.0	22.6	16.7	13.4	12.3	13.6	9.4	12.7	15.6	9.7	8.0	6.9	16.9	7.6	8.5	11.8	1.2	2.6	0.4	2.2	2.3	3.6	0.9	2.8	2.2	7.6	13.4	1.3	9.3	1.4	1.4	9.0	0.0	2.2	0.1	11.0	3.4	0.4	2.7	1.0	3.8	0.0	8.9	2.0	2.9	0.9	0.3	0.6	3.4	24.1	4.9	3.4	1.4	27.6	11.2	2.7	0.8	7.9	3.0	8.8	0.7	2.4	1.2	1.1	7.5	8.2	5.2	8.2	8.4	0.7	15.2	2.5	1.4	3.8	6.1	8.1	0.1	14.1	11.5	0.1	4.9	2.4	3.7	6.1	8.0	9.7	12.8	6.7	13.4	12.7	11.8	10.2	8.2	11.4	16.9	16.1	4.0	6.9	4.1	15.6	15.0	7.6	14.5	16.4	10.2	15.4	13.6	11.3	14.2	14.9	12.5	14.0	3.0	7.4	13.7	13.8	3.9	7.0	15.3	22.9	14.7	5.7	22.7	3.9	16.7	58.0	20.0	5.5	11.9	13.5	23.3	17.4	21.1	10.8	17.5	4.7	30.8	14.6	9.5	12.1	20.3	11.0	1.8	14.7	8.4	5.0	10.0	18.2	16.6	15.4	15.3	19.4	34.9	8.9	38.8	11.4	18.5	16.2	5.8	11.7	13.8	19.6	7.9
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Cell type enhanced"	"Detected in many"	12	"Proximal tubular cells: 218.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		13000	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.9	11.0	18.0	16.0	11.3	10.6	8.6	7.1	12.0	15.9	14.0	13.0	15.0	16.6	14.3	11.7	14.8	13.8	16.2	16.5	37.0	19.7	10.5	8.1	8.3	16.8	3.6	10.0	4.4	8.5	7.6	15.6	23.1	9.8	23.3	13.3	7.2	8.5	24.5	20.5	12.2	6.0	13.4	14.7	24.7	12.8	20.2	16.5	12.8	15.8	17.3	13.6	10.6	5.7	27.5	23.1	17.4	4.9	8.2	19.9	16.5	11.8	13.2	7.1	21.6	13.7	4.3	5.8	22.4	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8	6.0	9.4	4.7	8.7	7.9	11.6	3.9	35.7	45.5	14.8	15.7	19.6	23.1	59.7	24.9	0.4	7.1	17.1	0.0	11.8	27.7	12.2	7.5	2.3	62.1	19.8	15.9	15.4	3.7	1.8	0.7	13.8	10.5	30.4	21.6	10.1	11.0	17.9	10.8	13.1	218.9	7.2	6.5	9.5	6.7	21.5	8.2	11.7	5.3	16.3	6.8
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.8	14.7	15.0	20.7	6.5	9.3	29.6	18.4	13.0	24.9	15.9	20.0	19.7	32.8	9.5	10.9	27.7	12.4	26.2	18.9	28.3	17.6	25.9	21.9	35.2	17.8	17.9	34.8	15.2	11.2	12.3	22.9	20.7	7.6	11.4	17.2	38.3	10.0	16.2	16.1	24.1	38.1	24.2	17.6	21.6	21.6	27.2	14.1	14.3	17.3	18.2	16.3	38.0	26.7	17.1	12.4	16.7	21.5	6.8	19.1	20.9	13.7	35.1	9.1	19.4	41.6	16.5	40.1	23.7	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9	26.8	30.7	36.9	76.5	96.6	20.2	18.6	15.3	46.8	48.9	22.7	11.8	108.4	41.4	38.0	10.5	32.1	8.4	23.3	37.3	80.2	49.4	31.2	18.6	11.5	37.1	20.6	20.2	16.5	12.9	6.8	36.5	20.6	30.4	33.3	17.8	15.1	37.9	10.5	27.3	26.6	34.1	6.5	35.4	54.6	70.7	83.7	105.5	31.6	29.0	66.5
BTN3A3	"BTF3, BTN3.3"	ENSG00000111801	"Butyrophilin subfamily 3 member A3"	O00478	6	26440472-26453415	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;T-cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.6;BJ hTERT+ SV40 Large T+ RasG12V: 21.5"									"HPA007904, HPA011871"	Enhanced					NA	NA					"HPA007904: AB_1078307, HPA011871: AB_1845496"	"unprognostic (1.18e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.13e-3)"	"unprognostic (8.08e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.54e-3)"	13.3	19.1	6.6	22.5	8.1	2.6	10.6	5.5	8.6	11.8	8.5	5.9	8.8	9.8	19.1	14.9	7.0	12.1	11.8	7.7	5.2	6.8	8.7	11.8	19.5	15.3	5.8	8.4	12.0	3.9	3.1	24.0	5.5	6.6	12.0	8.5	9.8	8.9	7.9	2.9	6.6	15.7	10.2	7.3	29.4	8.9	3.5	6.0	11.7	10.6	8.4	20.1	12.8	10.1	9.0	5.3	16.3	10.0	19.2	25.3	13.0	1.8	0.9	0.8	0.8	16.6	31.6	0.2	2.6	14.1	5.9	21.5	0.0	5.9	11.7	11.9	4.2	5.4	1.3	1.2	4.5	2.9	9.8	2.0	5.4	5.2	0.6	12.1	2.8	1.0	16.7	1.8	5.1	1.9	9.4	11.6	4.4	0.2	1.8	3.2	0.0	7.6	2.3	0.0	0.0	1.4	7.7	1.6	11.2	4.6	1.6	1.0	1.9	1.6	1.5	2.8	0.2	0.4	1.6	7.1	2.9	0.6	3.1	1.8	2.0	0.5	1.1	7.6	5.5	3.0	16.3	6.6	5.5	25.2	9.9	20.4	9.0	17.5	25.3	5.3	6.2	17.1	22.9	5.1	19.2	10.0	2.8	19.6	13.0	6.6	8.1	5.5	8.6	5.2	6.8	5.8	8.4	6.6	6.0	8.9	7.7	13.6	2.1	1.5	0.0	4.4	0.0	2.7	6.8	0.0	0.0	2.2	1.7	3.4	3.2	13.2	6.4	23.3	2.1	1.2	6.7	2.2	3.5	2.4	4.4	0.0	1.2	19.0	14.0	15.2	3.7	8.3	3.3	4.6	6.4	2.0	2.6	3.5	2.1	1.0	0.0	6.5	2.1	0.3	0.1	1.8	0.5	29.9	4.4	1.6
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	6.9	17.3	16.6	8.2	21.2	5.7	13.1	25.8	23.9	8.7	10.1	12.7	10.9	10.5	12.7	15.6	9.9	14.7	6.9	18.6	13.4	14.8	19.6	12.7	8.0	10.8	13.8	14.1	16.0	11.3	16.6	17.2	9.3	21.1	11.8	11.3	11.7	11.8	11.8	15.0	8.0	9.2	11.0	11.3	10.8	10.9	20.4	13.3	11.7	16.4	8.3	11.3	9.7	8.9	15.0	13.7	18.4	12.3	13.7	16.4	13.0	13.3	14.6	21.1	7.5	6.2	8.2	11.0	9.7	10.7	15.7	13.9	7.3	5.2	9.2	11.3	8.9	20.5	15.1	17.4	13.3	22.5	6.5	16.9	7.4	13.5	13.5	13.4	10.5	6.2	6.5	16.1	11.3	8.1	12.3	11.9	16.3	14.5	13.4	10.3	11.1	29.5	9.1	13.5	8.7	8.0	18.7	13.9	16.1	9.3	7.5	20.7	17.0	8.6	7.6	20.4	14.0	19.4	6.4	7.3	8.2	13.0	3.8	15.1	16.0	18.1	31.8	6.3	9.2	2.4	18.4	10.6	13.2	16.0	8.8	16.4	14.5	14.6	15.4	13.7	15.0	16.1	15.1	3.5	13.7	12.3	10.4	15.0	13.0	16.6	21.2	25.8	23.9	13.4	14.8	13.8	14.1	21.1	13.3	11.9	40.3	5.2	11.6	5.3	23.1	23.8	2.5	36.1	13.6	14.0	7.9	27.4	36.5	14.5	5.3	9.8	4.7	46.7	12.0	14.8	7.9	6.4	10.5	9.8	8.5	30.2	12.1	7.4	10.3	4.9	6.9	7.7	5.0	4.6	7.1	16.9	10.7	2.9	7.8	23.0	21.0	38.8	9.0	76.3	27.9	5.4	13.6	14.9	8.8	5.1
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972083-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 94.7;Spermatocytes: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	14.1	16.1	13.4	16.7	12.5	53.0	18.4	23.1	25.8	13.0	12.8	7.9	17.6	15.2	15.0	17.7	15.0	12.9	11.7	15.2	12.4	12.5	14.0	14.5	11.3	17.1	11.7	14.7	16.4	22.0	12.9	16.9	14.8	13.0	13.4	12.3	8.1	16.5	17.8	28.7	13.6	14.1	15.8	10.6	17.2	16.7	28.7	11.7	22.9	14.8	21.4	15.7	17.8	14.8	18.5	15.1	40.6	16.5	16.5	21.7	10.6	13.3	9.1	19.8	13.6	12.7	19.4	13.3	18.4	17.5	22.1	22.5	7.7	9.1	10.7	19.7	13.5	15.3	13.7	13.8	14.1	24.6	16.2	14.1	11.2	10.8	17.3	18.4	34.0	14.0	18.7	23.0	19.5	19.8	20.6	18.0	17.2	18.1	17.4	14.5	14.9	22.4	23.6	16.6	6.2	10.0	15.2	16.9	20.8	14.9	14.7	12.7	19.0	12.3	9.9	29.4	18.9	14.4	15.3	12.8	21.8	10.4	8.0	16.2	24.4	21.7	23.5	11.1	17.7	11.4	40.6	16.5	18.3	14.6	16.5	14.6	18.5	15.9	13.7	15.1	16.1	12.3	16.0	14.9	16.5	15.3	14.6	21.7	10.6	13.4	12.5	23.1	25.8	12.4	12.5	11.7	14.7	13.0	11.7	17.9	6.7	15.9	8.2	10.5	9.1	10.8	5.1	2.7	11.4	1.8	5.9	15.8	10.0	17.5	94.7	8.7	9.3	0.0	24.9	24.6	8.9	7.3	13.9	9.4	18.9	7.9	6.9	8.6	16.8	46.0	20.8	13.1	11.8	10.8	13.0	8.4	18.6	11.5	15.9	17.0	11.1	0.0	8.6	73.2	36.1	10.8	11.0	12.8	16.6	7.1
C1orf115	FLJ14146	ENSG00000162817	"Chromosome 1 open reading frame 115"	Q9H7X2	1	220689845-220699157	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;intestine: 32.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 168.2;Hepatocytes: 103.9;Syncytiotrophoblasts: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.6;HUVEC TERT2: 19.4;TIME: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.69e-3)"	"unprognostic (8.65e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.24e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.07e-1)"	12.4	1.6	16.2	3.2	27.0	0.0	8.9	3.1	32.9	3.9	8.1	2.1	2.4	30.6	3.1	5.8	2.9	3.8	4.6	4.7	9.6	2.9	14.4	27.6	6.2	1.7	2.5	17.8	4.9	3.9	8.5	6.2	19.0	5.7	8.6	6.2	3.3	20.2	2.8	3.3	2.6	32.1	3.2	1.1	12.7	5.5	2.8	3.7	1.0	5.5	1.1	2.2	2.1	2.3	3.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	2.8	0.1	4.0	0.0	0.0	11.5	0.8	3.1	1.6	7.3	2.8	2.9	0.0	1.2	0.2	3.4	0.1	6.6	1.3	1.5	0.0	6.6	0.1	0.6	23.6	3.8	0.0	0.1	0.5	2.2	0.1	0.8	0.0	19.4	0.0	1.7	0.0	0.1	2.5	0.0	0.1	4.8	7.8	2.0	0.0	0.0	0.2	3.5	3.7	2.1	2.9	0.0	4.8	11.6	7.3	7.9	0.1	36.2	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.8	0.0	0.3	1.9	0.9	0.2	0.2	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.2	27.0	3.1	32.9	9.6	2.9	2.5	17.8	5.7	3.7	3.0	7.0	9.9	3.4	3.1	11.4	12.2	10.2	1.4	5.7	29.6	5.9	57.1	33.2	10.0	1.1	33.7	168.2	0.0	14.6	51.0	2.4	13.3	0.0	103.9	5.6	0.0	8.1	11.1	4.7	1.9	2.8	1.1	8.5	7.2	22.1	5.6	13.2	46.0	18.0	52.2	3.9	0.0	3.1	0.3	3.9	1.5	153.8	0.5	13.3	2.1
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.6	10.7	6.9	4.1	3.7	3.8	16.1	7.4	3.4	6.6	4.9	9.7	9.2	9.4	16.2	2.6	4.6	10.8	6.5	7.2	2.5	10.7	34.4	5.8	7.5	9.5	6.3	13.0	7.4	3.4	8.6	6.3	6.1	3.9	7.3	10.9	14.8	5.2	4.9	11.3	17.3	16.7	13.5	12.2	25.0	12.3	10.9	15.6	5.8	7.2	12.1	11.4	7.0	11.2	9.6	2.1	13.3	12.3	6.3	5.3	7.7	13.8	15.7	9.7	5.0	8.7	6.4	7.7	8.2	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2	20.8	19.0	30.7	27.5	59.3	48.2	15.4	12.7	17.4	11.4	36.6	17.7	65.7	38.1	35.0	3.0	27.0	34.4	23.3	34.3	47.2	35.1	28.5	24.3	19.5	36.1	44.5	25.2	28.3	24.7	2.6	47.5	35.5	30.4	27.1	35.6	37.2	33.3	33.4	43.9	30.1	49.8	64.7	30.0	35.6	47.1	70.4	23.7	36.7	41.6	21.3
C2orf15	MGC29762	ENSG00000273045	"Chromosome 2 open reading frame 15"	Q8WU43	2	99141485-99151487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 12.0;Distal tubular cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.2;NK-cells: 6.5;T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"RT4: 11.0;SCLC-21H: 11.0"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.61e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.54e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (2.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.08e-1)"	"unprognostic (2.97e-2)"	1.0	1.7	4.2	1.2	7.7	1.6	5.4	9.3	4.9	3.9	4.9	0.9	5.4	5.9	1.8	9.3	2.5	6.1	3.9	0.7	7.4	4.5	12.1	1.2	2.1	6.3	3.4	2.9	2.0	6.0	8.0	22.2	1.6	3.7	2.2	3.5	2.1	5.8	4.6	0.7	2.7	4.5	0.3	3.5	2.6	5.5	3.4	2.3	2.4	9.5	0.8	2.1	3.7	1.4	3.2	0.5	1.3	0.4	6.5	7.4	2.2	8.6	1.4	0.3	1.1	0.1	0.0	6.5	0.0	0.7	0.4	0.3	9.2	6.2	3.7	2.8	0.0	0.7	5.4	1.3	1.2	0.0	0.7	3.9	0.3	1.4	5.6	0.1	1.2	1.6	0.1	2.0	0.0	0.7	0.3	0.0	4.9	0.3	0.7	0.3	7.6	1.1	1.6	2.0	4.7	2.0	0.6	0.1	4.2	8.9	11.0	11.0	1.4	0.7	8.8	0.3	1.6	7.1	0.4	0.0	0.4	0.4	0.3	0.3	2.5	4.1	1.2	0.2	1.1	0.1	0.2	0.4	0.3	3.2	0.2	7.4	3.2	4.9	4.0	0.3	3.2	6.8	3.3	1.3	6.5	0.2	0.5	2.6	2.2	4.2	7.7	9.3	4.9	7.4	4.5	3.4	2.9	3.7	2.3	3.0	1.9	1.3	1.9	0.2	5.3	0.3	2.5	12.0	2.3	7.0	5.9	5.0	13.3	4.7	1.6	0.2	0.0	0.0	2.6	0.6	0.2	1.7	0.0	0.0	0.6	6.4	1.2	0.0	0.0	0.0	0.6	0.7	0.0	0.0	2.7	4.3	2.9	3.2	0.4	6.3	8.4	0.0	0.2	3.0	2.4	0.3	1.7	0.5	2.7	1.1
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149743-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 252.0;Late spermatids: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	12.2	11.7	13.7	12.8	16.1	35.2	12.3	12.9	12.8	11.6	11.9	13.6	8.4	9.5	11.5	10.7	14.6	10.7	9.4	9.7	11.3	11.1	10.2	13.5	10.6	19.2	15.1	9.4	12.1	9.3	7.1	15.8	12.5	11.4	11.2	11.2	9.0	10.6	10.2	9.7	11.6	11.4	10.9	11.3	17.0	10.1	33.2	13.5	29.5	11.6	9.0	17.1	12.4	11.6	20.0	17.7	25.8	24.2	17.1	17.4	15.3	6.4	6.7	13.2	7.0	8.8	8.0	6.1	10.5	12.6	15.7	21.3	7.7	8.9	8.7	9.4	9.7	7.5	4.7	9.5	7.7	13.6	15.6	4.5	10.6	5.2	6.5	12.6	14.5	9.2	11.4	7.8	10.5	9.0	10.3	9.0	9.5	6.7	10.0	17.0	7.5	14.6	6.1	16.0	12.1	7.6	9.2	4.6	8.2	10.4	8.8	4.0	5.8	9.6	5.3	15.8	11.2	10.2	11.1	8.2	9.8	10.7	59.4	11.5	9.2	13.6	12.9	7.6	11.5	9.2	25.8	16.8	17.5	13.5	24.2	17.4	20.0	12.6	13.8	17.7	15.9	12.6	12.8	7.5	17.1	19.7	12.3	15.1	15.3	13.7	16.1	12.9	12.8	11.3	11.1	15.1	9.4	11.4	13.5	17.9	6.9	32.0	16.6	10.4	21.8	5.6	0.0	14.7	11.4	5.2	21.6	19.3	16.6	14.7	252.0	8.7	11.8	0.0	12.0	18.8	15.4	14.2	13.9	7.4	23.4	6.4	15.5	8.6	17.2	238.1	15.3	21.8	15.1	27.1	10.7	22.8	11.6	13.3	14.2	9.8	21.7	12.9	12.2	25.9	12.0	12.3	21.4	28.7	9.0	18.6
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24720836	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	38.9	38.3	46.0	42.8	49.9	37.8	52.0	34.3	50.1	30.7	35.4	31.4	49.9	30.8	31.0	42.6	33.1	32.0	41.9	27.8	38.2	40.5	35.1	49.0	54.6	67.6	50.0	36.7	37.8	52.9	35.6	33.6	37.9	33.9	33.6	31.3	33.8	47.4	52.6	31.1	33.7	38.6	28.8	36.4	58.3	38.9	46.0	38.1	75.2	41.5	28.1	56.5	35.6	34.2	48.4	48.7	64.0	62.3	52.7	65.3	103.5	23.0	14.3	17.6	29.8	22.2	28.7	19.3	27.4	35.8	41.3	44.2	17.9	20.8	26.6	43.2	32.1	40.8	19.3	20.1	26.8	45.8	44.8	9.7	27.9	23.3	24.0	37.9	33.9	33.4	22.3	54.1	27.9	37.2	27.6	31.9	16.6	24.5	19.9	38.7	19.1	26.0	51.0	19.4	14.1	14.5	20.9	19.1	26.7	24.6	34.9	29.8	16.8	32.8	37.4	49.7	20.6	32.8	27.2	28.3	37.4	18.1	14.1	37.2	46.8	73.7	33.1	13.4	46.9	36.1	47.7	62.1	64.0	55.7	62.0	58.6	48.4	57.4	60.6	47.7	41.8	57.6	65.3	44.2	52.7	62.3	48.7	53.4	103.5	46.0	49.9	34.3	50.1	38.2	40.5	50.0	36.7	33.9	38.1	77.4	66.5	104.0	40.4	51.1	48.9	29.1	107.0	54.9	46.6	89.0	47.1	43.9	31.5	55.4	110.4	61.6	88.0	93.5	64.0	46.9	51.8	87.1	54.3	110.1	83.6	39.7	92.1	86.5	306.8	40.0	50.0	84.3	47.2	83.8	78.0	40.4	70.7	77.0	44.6	54.9	60.4	51.8	42.8	83.7	91.8	48.9	62.9	96.5	75.2	51.5
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892804	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	9.5	26.3	10.5	14.3	11.7	10.0	11.6	12.9	12.9	10.1	16.9	9.1	16.4	14.9	13.6	19.5	14.3	9.1	12.3	9.1	10.2	10.6	25.6	30.1	7.9	12.7	9.7	7.2	8.1	20.7	17.7	20.0	9.1	10.7	10.8	19.1	14.2	17.5	15.5	9.9	10.6	17.6	10.0	8.8	14.1	10.8	19.4	9.6	25.6	27.1	10.6	16.7	10.1	9.8	16.2	15.0	12.7	14.5	15.1	17.6	12.7	13.0	8.2	14.0	14.6	9.4	8.0	10.2	9.0	9.8	9.5	11.7	2.5	8.6	16.4	9.0	8.7	5.5	6.7	14.3	9.7	13.4	19.6	7.2	27.6	13.7	15.4	16.0	11.4	13.0	8.0	12.5	7.2	18.0	10.7	15.8	10.4	7.3	12.1	10.8	7.2	18.1	4.9	18.3	13.0	5.3	12.7	6.5	10.1	24.6	9.9	10.8	22.4	8.6	10.3	8.7	13.3	8.8	14.4	8.6	0.0	14.3	5.8	9.2	5.3	9.9	17.9	4.7	12.4	5.8	12.7	9.4	6.4	14.1	14.5	17.6	16.2	15.6	16.3	15.0	14.1	13.0	13.6	1.2	15.1	12.1	13.8	15.1	12.7	10.5	11.7	12.9	12.9	10.2	10.6	9.7	7.2	10.7	9.6	20.8	16.3	15.2	9.8	8.9	10.2	6.7	15.3	24.1	33.0	29.6	7.9	15.8	49.7	17.2	7.9	10.4	15.3	0.0	17.2	12.3	9.8	13.5	17.4	27.2	10.8	7.9	14.9	11.6	10.7	2.7	7.8	10.6	8.5	16.2	22.0	20.7	17.9	21.0	6.0	19.9	11.6	12.9	9.1	39.5	18.8	12.8	9.0	8.7	26.8	10.5
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.3	21.0	30.9	13.2	10.3	11.6	19.9	23.3	13.8	30.2	22.1	21.6	19.0	32.0	24.3	16.5	21.7	16.6	38.5	17.0	31.3	16.9	23.5	24.0	20.7	23.1	7.8	32.2	15.1	7.8	10.5	24.8	15.0	15.6	21.2	28.8	48.0	18.0	21.7	11.3	49.5	29.5	29.4	45.8	9.8	22.4	22.0	36.9	21.5	24.3	21.3	20.5	15.8	27.7	24.0	43.6	21.5	28.2	10.9	17.2	18.4	24.0	37.3	17.4	50.0	71.0	14.4	28.3	19.9	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5	80.4	34.1	105.0	107.7	103.9	56.2	89.6	38.2	80.3	52.4	33.2	58.9	184.6	129.3	83.6	75.6	64.3	63.7	23.3	82.6	245.4	120.8	92.6	91.1	35.8	172.4	28.6	114.6	40.5	47.3	21.9	79.7	120.6	102.9	341.8	42.9	55.2	88.9	53.2	69.3	119.5	79.1	32.3	106.6	100.9	149.2	74.9	120.0	115.4	82.3	81.3
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 1318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		450000000	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	67.5	55.5	31.9	58.9	36.1	86.4	64.6	20.9	38.9	50.2	52.3	42.5	65.7	44.1	61.6	108.4	65.2	49.1	67.5	62.5	31.6	35.2	81.9	302.6	61.8	83.6	33.5	33.4	59.6	124.3	56.4	60.3	98.0	35.7	53.1	60.0	43.2	121.0	68.6	25.1	34.2	53.8	56.9	42.1	66.6	49.7	65.0	32.7	61.6	250.6	55.0	65.2	39.4	68.0	25.1	57.2	16.1	38.6	26.3	48.4	16.2	118.3	46.8	64.3	140.1	81.3	73.4	58.9	158.3	130.0	95.4	139.0	71.5	95.3	76.0	146.2	183.6	85.6	47.2	70.3	100.9	96.7	56.5	40.1	63.3	57.0	108.7	192.1	254.0	85.9	68.0	46.8	88.4	74.9	126.5	114.8	52.2	54.1	38.6	77.4	81.7	70.4	166.1	57.2	66.7	66.4	54.6	54.5	92.0	83.8	67.8	24.5	52.3	98.1	54.0	32.3	79.5	72.2	105.4	99.3	79.7	50.2	113.4	70.7	48.2	42.9	76.4	112.3	110.8	87.6	16.1	19.5	10.1	48.4	38.6	34.3	25.1	29.2	36.7	20.4	22.4	21.6	39.2	6.6	26.3	30.8	57.2	21.5	16.2	31.9	36.1	20.9	38.9	31.6	35.2	33.5	33.4	35.7	32.7	137.0	125.9	216.1	284.2	232.4	67.7	39.5	168.2	151.3	164.9	211.1	119.8	557.7	54.7	494.3	20.8	202.2	487.4	140.2	249.9	1318.6	319.8	346.7	204.2	513.5	724.5	33.4	339.2	328.4	165.0	18.8	295.1	261.1	202.4	256.1	263.3	298.5	397.7	287.1	292.4	139.9	115.0	200.5	213.6	255.0	394.6	186.7	806.5	193.7	294.0	285.1
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785324-7769706	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA036342: AB_2675072, HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	18.4	24.3	31.6	12.2	30.7	12.1	21.7	24.4	37.1	16.5	30.2	19.9	13.2	28.3	20.0	46.7	22.7	16.8	17.7	58.1	26.4	27.6	36.7	37.2	16.5	13.3	31.2	26.5	17.1	18.6	22.0	17.6	14.3	47.5	22.2	27.1	25.0	27.1	29.6	48.0	12.9	30.4	38.4	23.9	15.7	21.5	23.0	19.4	14.7	30.8	20.5	17.5	31.3	18.7	19.8	32.3	28.3	32.4	10.3	18.1	18.9	22.0	12.4	34.6	17.5	17.9	27.4	9.7	23.9	18.4	25.8	21.9	15.0	28.0	18.3	18.8	25.0	17.3	13.7	18.0	24.7	36.9	13.7	19.6	20.6	29.4	29.2	29.1	15.6	15.0	18.3	17.2	18.6	28.7	22.3	28.7	26.1	14.4	24.9	29.7	21.3	20.7	42.9	23.9	28.1	14.6	13.9	30.8	40.5	34.8	12.9	35.8	28.9	16.9	25.2	36.8	26.0	13.6	19.6	16.7	18.4	15.6	18.9	14.8	19.0	23.5	49.2	27.5	35.2	10.3	27.5	32.4	28.3	11.5	19.4	12.5	19.8	18.0	14.2	30.6	16.2	14.7	12.8	6.6	10.3	14.7	32.3	18.1	18.9	31.6	30.7	24.4	37.1	26.4	27.6	31.2	26.5	47.5	19.4	50.6	45.6	87.6	306.4	275.2	103.9	495.7	107.0	68.3	46.6	181.5	237.6	60.6	354.8	147.0	138.1	160.0	190.4	46.7	180.4	116.8	142.3	320.6	54.3	215.1	94.9	149.4	125.6	81.6	94.6	111.6	70.8	142.3	226.0	196.6	153.7	60.0	175.4	166.1	120.9	611.1	144.7	135.8	271.7	133.0	213.0	247.2	73.7	58.9	164.9	354.7
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.9	10.3	11.6	20.5	6.5	7.7	6.2	11.2	5.1	10.3	11.3	10.2	12.4	20.8	10.7	7.1	7.9	10.8	11.6	8.9	13.8	18.2	8.9	12.3	16.2	7.0	3.5	23.9	15.4	5.3	7.3	12.5	4.4	4.7	8.8	16.4	10.2	13.3	10.9	10.8	41.6	25.2	14.6	10.7	10.5	30.6	6.0	12.7	6.1	9.3	12.7	14.3	22.3	9.7	7.1	8.3	10.6	9.2	9.8	9.2	6.4	16.5	11.2	11.1	10.9	24.2	10.3	28.5	16.7	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9	8.9	8.8	17.9	5.4	13.5	4.7	5.3	25.5	2.7	3.4	7.0	7.9	16.2	3.3	7.7	35.5	13.9	6.5	0.0	6.6	12.8	8.7	5.5	9.3	4.4	8.8	6.4	10.3	14.7	15.4	38.5	10.9	12.1	20.3	11.8	10.3	4.0	7.6	3.5	7.8	3.3	14.0	0.0	8.4	10.1	29.4	12.0	4.8	20.8	13.3	6.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.5	12.4	3.6	10.1	10.1	14.8	5.6	6.4	6.3	7.6	12.6	16.6	25.4	1.6	14.1	4.9	13.7	7.4	7.9	7.6	15.1	9.4	7.2	14.2	10.1	15.8	8.2	11.0	15.4	12.8	18.8	14.4	11.3	6.4	7.2	12.3	12.7	31.6	6.9	6.0	14.3	11.6	5.9	8.0	11.1	10.8	7.5	25.9	14.3	16.2	1.1	0.5	8.3	13.8	8.2	3.5	3.6	8.6	9.0	8.2	8.6	4.3	5.0	28.7	12.8	9.9	12.3	14.8	7.7	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7	23.8	26.1	34.1	10.1	6.6	1.5	1.6	7.6	16.0	18.2	5.2	9.8	7.5	13.3	9.0	5.6	7.1	19.8	0.0	7.3	10.3	3.8	8.1	23.2	10.4	11.2	0.0	4.1	5.5	25.6	0.7	2.3	21.7	6.8	19.8	13.0	0.1	9.6	12.7	0.7	20.0	0.4	0.0	1.4	0.7	0.4	6.8	2.9	55.4	12.1	12.7
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	24.2	28.0	22.6	38.7	27.9	27.8	24.6	36.9	31.7	26.0	28.7	21.5	24.7	22.7	23.9	23.7	26.5	19.7	23.2	21.6	21.3	20.5	27.4	22.3	23.4	37.5	31.7	17.9	32.1	22.9	28.6	44.3	29.2	23.6	25.0	31.1	26.0	26.7	37.9	47.0	32.3	25.4	24.5	30.4	28.6	23.5	18.9	29.9	42.1	28.5	20.6	37.4	28.8	25.0	12.4	18.6	12.3	12.8	8.8	16.0	9.1	26.5	27.9	32.1	21.5	13.9	13.5	25.0	23.8	20.5	26.0	17.8	36.7	21.7	31.3	13.1	16.4	13.0	21.0	33.5	18.9	28.5	21.4	21.1	25.1	19.2	22.7	15.9	39.6	29.5	13.5	23.5	21.9	27.0	16.0	20.8	15.9	34.1	20.3	25.0	19.1	26.4	25.1	32.1	20.7	26.0	30.9	19.2	18.7	22.7	20.2	18.6	16.2	23.4	38.6	23.4	26.3	26.1	24.3	20.3	16.2	20.4	17.4	25.6	14.1	18.4	33.6	13.6	26.7	15.3	4.9	12.8	12.3	15.5	11.5	13.8	12.3	11.0	14.9	18.6	12.4	13.3	14.0	3.1	8.8	12.8	11.8	16.0	9.1	22.6	27.9	36.9	31.7	21.3	20.5	31.7	17.9	23.6	29.9	32.8	82.3	47.7	44.3	32.7	48.9	60.4	50.9	49.5	43.3	43.6	55.0	60.8	19.9	54.9	17.6	45.3	37.7	23.3	68.1	73.7	49.1	41.9	65.8	38.5	43.1	52.4	44.3	42.4	40.5	9.5	49.8	41.4	20.3	55.1	49.6	36.7	64.1	24.6	47.4	16.5	65.5	64.7	40.1	90.4	82.9	32.6	91.5	44.7	56.2	39.6
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 270.6;Late spermatids: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.8"	"Low region specificity"	"Detected in all"							"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	7.9	24.6	21.0	13.4	35.1	22.2	10.9	15.5	28.6	14.8	12.9	30.6	28.3	17.8	13.9	21.1	11.8	14.2	19.0	13.6	22.8	11.9	13.4	18.9	12.8	14.7	38.5	22.9	19.2	15.1	34.3	20.8	7.3	28.0	24.7	9.5	17.7	14.5	17.4	6.3	14.6	14.3	12.5	24.2	24.1	16.1	28.2	43.5	7.5	17.8	8.5	11.2	13.7	12.6	9.9	16.5	21.2	28.0	15.7	15.2	11.8	2.2	2.0	1.7	5.2	6.8	9.9	1.7	3.7	3.9	4.4	5.9	0.6	2.4	1.9	9.6	7.0	1.3	1.9	1.0	5.9	2.7	9.2	1.4	4.5	1.6	2.4	12.0	1.7	6.8	11.8	15.6	3.2	4.3	4.6	12.3	3.4	4.0	21.8	2.2	2.8	2.7	3.6	0.9	3.1	7.4	3.0	0.0	12.2	4.0	3.2	0.7	2.8	3.7	4.3	6.8	3.2	6.3	7.5	8.1	3.5	1.0	6.0	3.4	20.0	4.8	3.8	4.7	9.2	5.0	21.2	28.0	19.1	12.1	23.6	11.7	8.1	8.2	11.0	16.5	9.9	7.5	5.9	13.2	15.7	16.4	4.3	15.2	11.8	21.0	35.1	15.5	28.6	22.8	11.9	38.5	22.9	28.0	43.5	14.9	9.9	9.0	13.1	6.6	11.2	9.8	12.7	21.4	14.8	17.4	39.3	4.9	21.6	7.6	270.6	9.1	14.8	0.0	8.4	4.4	8.4	23.8	33.5	9.6	20.4	6.4	10.4	12.9	26.0	182.1	10.6	15.7	11.8	13.6	10.6	14.8	7.5	23.0	12.7	31.6	28.9	0.0	8.2	4.8	3.8	7.0	5.0	21.5	8.1	17.5
CCDC160		ENSG00000203952	"Coiled-coil domain containing 160"	A6NGH7	X	134237047-134246207	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.9"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 32.1;Distal tubular cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 25.7;RPTEC TERT1: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.45e-3)"	"unprognostic (2.79e-2)"		"prognostic favorable (2.31e-4)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-4)"		"unprognostic (4.22e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (7.62e-6)"	"unprognostic (3.32e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.44e-3)"	0.5	0.3	4.2	0.5	3.5	0.5	6.0	2.8	3.6	4.6	0.5	2.5	7.1	0.4	1.3	4.2	0.8	5.0	1.9	0.4	5.1	5.2	9.6	0.3	3.1	0.8	7.7	3.0	2.2	2.0	8.0	1.2	0.5	7.5	3.5	0.4	0.9	21.9	11.7	1.5	0.6	0.3	0.4	5.8	0.8	1.6	3.0	6.5	0.0	0.6	0.5	0.4	1.4	0.6	0.3	0.2	0.2	0.1	0.1	0.5	0.0	0.0	0.0	25.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	7.1	2.0	0.0	0.1	0.0	0.3	0.3	2.6	3.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.4	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	4.2	3.5	2.8	3.6	5.1	5.2	7.7	3.0	7.5	6.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	2.5	32.1	10.3	8.7	0.0	0.0	38.1	2.0	10.7	0.0	0.0	0.0	0.0	0.1	0.6	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.6	0.0	1.7	0.0	0.0	2.9	0.3	0.0	0.4	5.7	0.4	0.0	0.0	5.9	8.7	0.0	0.0	0.0	0.0	1.4
CCDC34	"L15, NY-REN-41, RAMA3"	ENSG00000109881	"Coiled-coil domain containing 34"	Q96HJ3	11	27330827-27363868	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.5"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 280.3;Spermatocytes: 327.2;Spermatogonia: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 37.6;U-266/70: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037574	Uncertain		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Nuclear membrane, Nucleoli fibrillar center"		"HPA037574: AB_10795136"	"unprognostic (8.23e-3)"	"unprognostic (1.09e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.32e-7)"	"unprognostic (9.09e-2)"	"unprognostic (1.34e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.11e-2)"	2.7	4.7	9.3	6.8	17.1	8.3	8.4	3.8	11.7	4.2	6.6	2.1	3.8	7.9	4.1	8.6	5.9	9.7	4.0	3.2	9.0	7.5	4.1	3.4	2.8	4.3	5.6	6.2	7.7	4.8	7.2	12.5	3.9	11.1	5.4	7.4	3.3	3.6	3.8	2.8	4.7	6.3	2.8	4.5	3.3	6.9	31.5	4.4	14.8	6.7	5.3	6.0	3.3	3.9	4.8	2.4	0.4	3.6	4.1	7.1	1.3	10.2	11.8	10.1	10.1	1.9	4.1	7.2	6.5	2.6	7.5	7.3	6.6	2.0	11.5	4.7	3.7	10.5	9.5	9.8	4.3	13.4	4.4	14.2	9.0	15.0	16.5	0.9	8.9	3.5	1.4	3.1	6.2	2.8	3.1	5.3	16.4	9.1	3.8	7.5	7.4	17.2	14.2	10.6	7.0	10.8	17.5	37.6	1.6	2.8	3.3	7.7	10.2	10.4	4.6	4.5	5.7	12.3	4.8	2.6	11.3	10.6	21.4	15.5	37.5	34.0	8.1	10.5	0.4	9.6	0.0	0.2	0.4	3.6	1.0	4.5	3.5	4.5	4.8	1.0	4.8	5.4	3.3	0.0	4.1	3.6	2.4	7.1	1.3	9.3	17.1	3.8	11.7	9.0	7.5	5.6	6.2	11.1	4.4	0.0	1.7	5.2	22.4	20.3	10.0	8.1	35.7	119.1	23.9	22.7	11.8	26.0	16.6	12.7	280.3	10.6	8.9	93.5	10.8	18.1	15.8	12.5	6.9	14.9	18.8	3.2	20.7	8.0	10.5	39.6	19.8	8.4	13.5	6.4	32.6	21.5	5.5	7.0	19.4	11.2	19.5	6.5	4.7	327.2	197.3	18.1	13.5	8.7	69.8	7.8
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754385-116769228	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 101.7;lymphoid tissue: 164.4"	"Cell type enriched"	"Detected in many"	11	"T-cells: 299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3"	"Group enriched"	"Detected in many"	9	"NK-cells: 101.7;T-cells: 74.2"	"Group enriched"	"Detected in some"	24	"HDLM-2: 58.9;JURKAT: 39.9;MOLT-4: 43.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in some"			"CAB002430, HPA003883"	Enhanced					NA	NA					"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	3.0	1.1	0.6	14.5	0.5	2.4	1.7	0.5	0.6	2.9	6.0	0.6	0.6	4.8	1.7	2.1	3.8	3.1	4.8	1.4	0.6	0.6	3.3	2.5	8.1	33.0	1.2	0.6	1.9	1.6	0.0	1.0	1.0	1.0	2.9	4.7	2.3	4.1	1.3	1.0	1.2	18.8	0.9	1.8	28.8	6.5	1.1	0.8	164.4	3.5	3.4	30.8	7.7	2.7	0.3	9.3	1.4	0.5	101.7	74.2	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	0.0	0.1	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.1	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.5	0.1	44.4	0.3	42.5	0.3	65.3	74.2	9.3	0.2	34.2	52.4	1.4	101.7	0.2	2.0	62.3	45.9	0.6	0.5	0.5	0.6	0.6	0.6	1.2	0.6	1.0	0.8	3.0	27.0	1.5	0.4	4.4	0.0	0.8	0.0	0.0	4.5	3.5	0.0	0.0	0.0	0.0	13.2	2.4	0.0	0.0	0.0	0.0	2.1	0.1	4.7	0.9	0.7	0.0	2.9	9.8	7.0	4.0	0.6	8.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	4.7	0.2	0.2	3.1	0.0	299.5	0.1	0.1
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189548-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.8;testis: 37.3"	"Cell type enhanced"	"Detected in many"	15	"Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.0	1.9	2.9	15.2	3.1	19.1	5.5	2.1	3.0	3.9	4.7	1.2	0.7	4.2	2.9	3.1	7.7	2.5	2.8	4.4	2.7	2.1	1.9	2.2	3.6	11.1	2.6	3.7	3.6	1.6	1.6	2.7	6.8	1.8	2.4	5.5	1.6	3.0	1.5	3.6	6.0	4.0	2.4	2.6	6.2	2.5	37.3	1.8	31.8	1.8	10.2	12.2	3.1	4.3	12.1	6.1	2.5	3.6	7.5	9.8	4.2	18.4	5.7	26.8	20.9	1.7	5.6	14.3	9.1	9.7	20.3	22.0	7.8	23.5	39.7	10.9	5.3	11.8	13.8	17.5	21.0	26.0	12.0	12.0	9.2	9.8	7.7	0.6	13.3	9.5	2.2	4.3	13.2	14.6	5.8	6.8	21.7	16.3	15.8	15.6	10.3	42.8	19.1	23.2	6.0	4.9	26.7	35.3	30.6	6.4	6.8	18.5	24.7	10.0	6.8	8.0	15.2	9.5	9.0	3.3	10.1	17.0	13.4	22.6	19.5	29.5	31.8	15.6	27.0	19.1	0.6	1.8	2.5	4.5	3.0	7.3	11.8	7.6	5.7	2.8	12.1	9.8	8.3	0.4	7.5	3.6	6.1	8.7	4.2	2.9	3.1	2.1	3.0	2.7	2.1	2.6	3.7	1.8	1.8	0.0	1.6	22.3	12.1	32.5	3.6	2.2	5.1	13.4	6.8	0.0	0.0	23.0	0.0	5.8	21.9	5.7	1.2	70.0	7.9	41.3	7.8	4.5	4.7	0.8	15.0	0.0	1.2	5.5	5.6	22.4	3.4	11.0	8.5	5.4	7.2	5.2	5.5	2.9	4.6	2.9	3.0	19.4	6.6	122.1	250.2	16.8	8.4	13.1	13.0	6.2
CENPL	"C1orf155, dJ383J4.3, FLJ31044"	ENSG00000120334	"Centromere protein L"	Q8N0S6	1	173799550-173824720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.5"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 70.0;Spermatocytes: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044520	Uncertain					NA	Yes					"HPA044520: AB_10794500"	"unprognostic (8.72e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.88e-3)"	"unprognostic (6.43e-6)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.60e-4)"	"unprognostic (1.78e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.46e-10)"	"unprognostic (2.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.09e-1)"	4.0	2.7	3.1	3.8	3.7	10.9	3.1	5.0	3.8	3.6	3.0	2.8	1.7	3.0	2.5	1.5	4.2	1.8	2.0	2.2	3.0	2.5	2.1	1.4	2.6	7.8	3.9	1.7	2.6	1.4	1.5	2.3	3.8	4.0	2.3	3.9	1.8	2.9	1.8	2.8	3.2	2.9	3.0	2.9	6.6	2.6	13.7	4.5	29.5	2.3	1.9	7.2	3.2	3.7	6.0	5.3	4.2	1.4	10.6	8.4	3.2	16.3	4.4	8.4	11.1	2.5	4.3	6.2	14.7	8.6	15.0	10.6	5.7	8.7	11.7	7.0	7.5	6.1	10.8	8.7	6.9	16.8	10.7	4.3	9.0	4.9	3.3	1.3	13.4	9.1	2.1	2.3	10.6	8.6	2.9	8.7	9.3	15.1	17.7	13.8	3.8	10.8	5.9	8.7	11.3	24.7	11.5	10.5	10.1	5.3	4.6	8.4	7.1	11.4	14.2	9.5	7.1	10.1	10.8	5.4	18.5	12.5	9.3	16.7	9.8	16.9	19.3	6.0	9.8	16.4	4.2	1.3	2.7	6.1	1.4	6.9	4.3	5.6	6.8	1.2	6.0	7.1	7.6	1.0	10.6	0.9	5.3	8.4	3.2	3.1	3.7	5.0	3.8	3.0	2.5	3.9	1.7	4.0	4.5	8.9	3.0	10.5	4.2	4.1	4.9	3.6	2.5	1.4	2.3	1.8	13.7	6.0	0.0	2.2	1.7	3.8	2.8	70.0	3.2	13.3	5.0	5.5	4.6	0.0	5.5	1.6	1.7	1.3	2.7	2.2	4.4	4.3	5.0	4.6	4.1	2.8	2.5	2.9	1.8	0.8	3.8	0.0	6.2	34.3	11.5	5.3	4.9	10.8	3.0	3.1
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463378-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	7.2	7.6	10.4	11.2	15.4	6.4	8.7	10.9	11.4	6.6	5.8	6.4	5.8	4.2	7.5	7.1	12.1	6.4	5.4	10.0	11.5	9.3	7.6	6.8	5.8	10.0	19.8	7.7	10.4	4.8	4.6	8.9	9.1	15.3	7.4	7.5	2.7	5.5	5.4	6.9	6.1	5.1	7.0	18.7	8.8	5.6	8.8	18.3	15.1	6.0	9.1	12.7	9.5	6.4	7.8	5.0	7.2	3.1	4.4	5.6	2.3	16.4	4.6	14.7	9.1	4.0	6.3	13.0	21.4	12.3	20.6	29.0	5.6	6.7	11.2	10.7	6.0	16.1	6.0	7.6	7.7	30.5	12.1	10.7	8.2	7.4	9.0	1.7	17.4	10.4	2.8	4.3	25.2	8.8	5.3	7.5	9.8	12.6	11.2	15.2	4.7	12.2	8.2	9.1	14.4	4.2	8.8	17.4	12.1	6.0	6.8	7.9	7.9	10.0	6.0	11.2	15.2	7.7	16.0	4.4	16.0	12.4	12.5	19.0	5.1	13.2	10.0	10.8	13.1	15.4	4.1	2.2	7.2	4.0	2.7	4.2	7.6	4.3	4.6	2.5	7.8	4.7	4.5	1.6	4.4	3.1	5.0	5.6	2.3	10.4	15.4	10.9	11.4	11.5	9.3	19.8	7.7	15.3	18.3	0.0	2.4	6.7	8.9	7.7	5.4	5.1	7.6	10.7	3.4	7.0	2.0	12.0	6.6	7.0	1.0	6.3	1.6	0.0	6.9	23.5	8.4	4.8	4.6	2.8	8.8	6.4	2.4	13.5	10.8	1.9	8.1	5.5	3.3	7.2	2.7	12.4	6.0	3.6	10.3	3.1	5.0	6.5	5.1	16.8	28.6	6.0	10.4	6.4	4.5	5.4
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826973-152830777	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 97.3"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 902.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028956	Approved					NA	NA					"HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favorable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	11.7	17.1	26.6	7.8	26.4	9.1	16.7	7.5	25.3	27.3	16.7	11.4	23.8	6.3	27.5	48.3	16.6	97.3	13.0	13.5	30.0	30.8	29.4	12.6	15.9	6.7	21.2	24.0	24.2	8.6	14.8	26.7	11.1	54.2	21.1	10.9	9.9	10.4	33.0	10.2	7.3	7.0	22.1	19.8	8.0	10.5	11.2	10.3	9.9	34.6	11.7	8.6	17.9	12.4	9.1	15.4	26.2	10.1	8.8	11.5	8.7	39.6	18.1	22.6	16.9	30.0	32.6	9.0	17.3	20.8	22.9	17.6	8.2	21.4	14.2	45.6	23.1	37.1	15.6	15.6	21.5	27.3	6.3	11.3	3.1	9.8	23.7	11.3	13.2	3.6	19.6	28.4	21.2	11.3	27.6	18.0	11.3	8.3	5.9	22.1	18.5	9.8	14.5	7.8	33.1	23.4	8.7	16.4	14.6	41.5	9.8	11.1	14.4	11.5	12.0	10.1	21.3	12.9	10.2	16.8	16.2	13.1	32.0	19.2	6.0	7.9	22.4	34.3	8.0	7.9	12.9	8.8	26.2	9.6	10.1	11.5	9.1	9.4	10.5	10.3	7.8	10.2	10.3	8.4	8.8	10.0	15.4	8.0	8.7	26.6	26.4	7.5	25.3	30.0	30.8	21.2	24.0	54.2	10.3	47.6	33.1	28.2	43.9	20.0	12.7	33.0	63.7	902.0	128.5	160.5	5.9	57.1	202.2	81.0	41.5	28.7	10.1	0.0	36.1	56.2	42.6	31.4	23.2	48.9	44.6	12.7	35.6	49.7	20.1	61.7	62.7	25.9	35.4	28.9	26.5	78.1	33.5	8.6	105.0	253.7	23.4	19.4	49.9	46.0	63.6	26.7	34.7	31.6	26.1	42.6
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.5	21.7	24.1	11.2	15.4	13.3	13.6	13.2	15.2	20.1	20.1	18.8	14.4	27.4	8.3	17.6	15.9	20.3	29.4	18.5	25.4	20.9	13.4	24.0	14.5	22.8	14.3	33.2	22.9	17.9	15.1	22.5	16.2	15.6	17.8	21.7	16.7	14.7	15.1	17.8	23.8	13.6	18.4	16.1	18.4	22.4	18.2	9.2	14.9	30.6	17.6	16.9	20.6	16.1	11.4	22.7	11.3	16.1	20.9	16.7	12.8	9.8	15.6	16.7	19.9	27.4	6.7	12.3	16.6	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1	35.7	52.5	15.1	10.4	11.2	32.4	18.1	20.4	36.1	43.3	31.4	25.5	12.2	1.7	19.0	1.6	18.0	11.3	23.3	20.2	10.1	9.9	12.1	26.7	12.4	15.0	22.3	26.0	14.1	20.9	2.5	15.0	13.0	10.1	19.8	16.3	19.2	21.3	14.0	16.6	6.3	22.9	0.0	13.3	26.2	22.4	14.4	10.3	22.3	14.7	11.1
CHRAC1	"CHRAC15, YCL1"	ENSG00000104472	"Chromatin accessibility complex 1"	Q9NRG0	8	140511298-140517137	"Predicted intracellular proteins"		"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059008			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059008: AB_2683878"	"unprognostic (6.34e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (4.19e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.49e-1)"	24.3	14.7	12.1	15.9	16.0	23.3	18.0	10.1	14.2	17.3	20.9	23.8	11.9	15.5	20.4	12.7	24.1	16.1	19.8	18.7	13.7	10.4	21.4	24.3	16.5	21.6	19.2	7.7	18.2	17.7	15.5	13.1	21.0	13.6	17.8	16.2	17.2	17.6	20.1	28.4	19.1	24.3	21.2	20.8	22.2	18.2	26.1	21.6	36.4	27.5	19.3	24.9	19.3	15.8	19.6	19.5	21.4	23.5	16.1	16.0	12.5	22.4	10.9	10.3	9.7	10.3	17.5	7.8	9.6	14.1	14.1	17.2	14.0	16.3	23.3	14.4	11.8	11.2	14.1	12.2	9.9	19.6	17.8	12.8	33.0	15.2	15.7	9.7	10.9	17.5	8.7	14.5	10.4	20.3	7.6	13.5	14.4	24.3	22.3	12.5	26.4	38.2	11.8	7.5	19.8	18.4	23.1	10.8	18.5	14.1	9.4	14.1	11.7	13.5	9.2	17.0	5.8	17.8	12.6	12.7	16.8	29.3	20.6	20.3	10.7	13.9	28.3	20.2	26.1	13.0	8.7	17.0	20.3	16.0	22.4	15.7	17.3	14.4	15.8	18.7	19.6	15.2	12.6	21.4	16.1	23.5	19.5	12.7	12.5	12.1	16.0	10.1	14.2	13.7	10.4	19.2	7.7	13.6	21.6	14.9	25.1	31.5	36.8	34.1	6.9	11.6	20.4	16.0	29.6	14.0	2.0	19.7	36.5	19.4	15.6	29.5	21.9	0.0	31.3	42.0	24.9	26.9	32.3	18.4	21.6	6.4	20.7	30.1	29.5	26.2	27.0	33.4	18.6	31.5	20.5	25.3	27.4	18.6	23.7	24.5	10.7	71.1	38.1	72.7	63.0	42.4	20.1	29.9	19.3	30.6
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, 1"	Q86X95	2	174348022-174395715	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 56.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favorable (2.04e-5)"	24.1	20.8	27.0	21.9	38.1	48.4	31.0	41.0	34.8	33.6	22.8	19.8	27.2	21.4	23.9	38.6	23.8	24.7	19.8	23.1	25.1	24.7	28.4	22.3	22.2	23.4	26.2	28.3	30.0	24.4	22.5	54.0	36.9	32.3	31.6	22.8	14.0	21.2	23.5	30.8	27.5	34.3	20.3	27.6	32.4	21.0	26.9	30.7	35.8	35.8	21.4	23.7	37.8	22.2	12.0	11.9	56.9	10.1	13.3	10.9	7.6	10.2	5.8	13.9	11.0	19.4	27.3	20.6	16.9	24.0	17.0	21.0	10.9	15.8	7.1	16.0	16.5	14.9	12.4	11.4	12.0	20.5	13.1	15.1	14.8	9.2	17.5	18.9	17.5	13.7	22.4	22.0	18.6	14.0	29.4	16.8	12.9	15.2	16.0	16.1	9.7	21.8	27.8	12.8	16.8	16.5	12.4	20.0	21.0	20.0	16.3	16.2	19.0	11.6	15.0	25.7	25.2	11.2	26.1	17.2	13.8	10.1	13.0	8.7	18.2	15.5	2.6	19.8	9.2	12.0	17.8	10.1	15.8	9.1	9.2	9.0	12.0	10.3	9.6	6.4	11.8	10.9	10.0	56.9	13.3	9.4	11.9	10.5	7.6	27.0	38.1	41.0	34.8	25.1	24.7	26.2	28.3	32.3	30.7	110.2	65.6	68.2	50.4	25.3	52.0	53.3	79.0	231.6	86.4	40.1	29.5	63.6	101.2	53.5	115.6	59.6	61.4	46.7	68.9	48.3	50.4	36.2	77.6	47.4	56.2	42.9	49.3	70.6	74.2	20.4	99.2	90.2	32.1	71.3	77.3	66.2	52.8	66.2	77.4	70.5	52.0	71.1	42.4	112.8	47.6	28.0	97.0	87.3	52.5	41.4
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10308026	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 182.4;Enterocytes: 265.0;Hepatocytes: 151.5;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.9;HSkMC: 30.8;K-562: 31.3;PC-3: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					NA	NA		590000			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	5.7	13.9	8.1	6.1	7.7	2.0	13.1	4.1	7.8	5.6	38.3	2.9	5.2	47.0	4.3	6.1	3.0	5.1	21.6	11.4	7.8	5.1	81.7	83.7	5.5	2.1	5.8	7.6	10.6	6.5	13.9	6.0	1.3	5.1	8.6	17.8	4.8	3.5	8.4	70.6	1.4	71.4	5.0	7.0	1.4	14.4	3.9	4.1	1.3	7.3	10.5	1.6	6.4	4.8	0.8	0.6	3.0	1.2	0.7	2.1	0.8	3.7	4.3	5.1	12.8	20.5	23.5	27.9	6.3	6.8	2.0	2.9	1.8	19.1	0.1	10.6	4.6	9.4	0.1	12.0	8.1	2.5	0.2	9.0	16.7	20.1	14.3	6.3	0.1	0.1	30.8	5.3	4.2	3.8	7.6	6.1	0.0	31.3	0.2	7.1	0.7	0.1	0.6	7.8	0.0	30.2	3.7	0.0	0.4	18.8	2.4	4.1	6.3	15.1	1.4	0.4	6.4	10.5	0.6	1.8	3.0	4.0	4.8	0.0	0.1	0.0	0.0	5.0	0.0	0.0	2.1	1.2	0.5	1.5	0.5	2.1	0.3	1.7	0.7	0.6	0.8	0.8	1.6	3.0	0.7	0.3	0.5	0.2	0.8	8.1	7.7	4.1	7.8	7.8	5.1	5.8	7.6	5.1	4.1	23.8	12.1	3.2	13.6	3.3	2.0	76.4	50.9	18.7	22.7	22.7	3.9	12.7	182.4	9.2	2.2	11.3	265.0	23.3	13.7	8.1	16.4	25.4	12.7	151.5	10.5	0.0	18.5	12.3	5.4	2.2	44.3	3.5	1.7	0.0	82.6	15.4	13.3	100.8	38.9	326.1	2.8	0.0	8.6	0.7	6.4	3.3	4.1	2.5	128.4	10.7
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA					"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	19.4	14.3	19.8	12.0	23.3	11.1	13.8	31.6	24.6	18.7	15.0	21.9	7.0	11.3	21.1	15.2	15.8	16.7	13.8	18.7	19.2	18.0	16.0	16.0	13.6	14.4	18.5	15.1	24.7	14.1	22.6	28.6	16.1	21.1	15.3	13.4	16.4	16.8	15.6	35.0	15.6	12.3	17.1	22.6	13.7	12.3	25.8	18.5	18.5	21.1	12.3	18.1	16.2	15.7	12.0	10.0	21.5	12.7	16.7	15.5	9.1	13.6	12.9	13.3	17.7	22.1	17.6	9.6	15.4	16.8	13.1	16.4	11.1	14.1	13.7	13.4	13.9	18.6	13.0	16.7	11.6	18.8	15.4	12.9	11.3	11.2	9.9	12.3	12.6	13.5	13.5	14.9	16.8	10.5	15.1	13.4	9.8	19.6	10.9	19.2	17.1	17.3	20.5	17.4	12.6	11.0	11.3	13.1	14.8	15.5	12.6	14.1	16.5	17.9	20.2	11.2	12.9	12.4	14.3	18.1	16.0	9.5	14.8	16.6	16.8	15.8	19.5	16.1	14.9	21.2	21.5	11.5	14.9	14.1	11.5	15.5	11.0	12.0	11.7	10.0	12.0	13.1	12.1	10.7	16.7	12.7	8.0	10.1	9.1	19.8	23.3	31.6	24.6	19.2	18.0	18.5	15.1	21.1	18.5	20.8	41.3	39.1	72.1	60.1	49.7	39.2	25.5	29.4	34.2	34.9	100.1	25.2	59.7	27.4	14.2	43.4	27.3	0.0	18.1	19.0	52.1	62.8	60.2	23.3	22.5	52.4	39.0	36.2	21.4	15.3	60.4	32.6	40.5	50.5	23.7	70.1	25.3	25.9	65.0	41.4	66.1	19.4	57.9	120.0	69.4	66.1	37.3	43.1	24.7	86.4
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876988	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	19.0	46.2	18.9	17.0	17.3	10.8	18.1	12.2	20.2	17.5	23.9	25.7	27.0	24.7	18.0	22.4	24.9	20.1	31.5	35.3	17.7	17.0	33.2	74.7	14.7	20.2	20.5	16.3	23.2	37.1	17.6	17.2	18.3	19.4	21.5	21.1	17.6	21.2	28.0	33.2	14.4	31.2	16.2	21.5	20.1	19.2	13.5	19.4	16.3	38.7	27.6	18.2	21.5	18.9	23.4	32.3	5.3	20.6	16.7	21.2	15.0	20.9	39.1	16.1	23.5	14.3	17.8	16.3	21.4	14.9	25.4	21.5	28.5	26.1	17.8	43.4	17.6	20.5	21.1	24.6	28.6	19.8	23.3	22.4	29.9	24.3	26.7	27.2	20.3	23.5	22.6	27.4	42.4	27.7	14.5	23.3	17.7	25.7	17.6	22.7	39.9	16.0	31.8	21.2	82.8	40.5	18.7	34.7	47.1	26.9	19.4	14.6	24.5	19.8	22.7	57.5	16.5	31.8	20.6	15.9	21.0	18.7	42.2	27.9	21.8	23.6	60.5	11.5	25.4	23.7	5.3	20.5	4.7	15.9	20.6	20.2	23.4	18.7	16.5	24.6	20.4	20.1	21.2	1.4	16.7	19.1	32.3	19.0	15.0	18.9	17.3	12.2	20.2	17.7	17.0	20.5	16.3	19.4	19.4	32.8	29.0	44.7	53.9	47.6	19.8	62.1	89.2	49.5	36.4	52.4	21.6	140.3	109.5	72.0	22.0	43.6	113.7	46.7	82.4	84.7	46.3	77.6	61.1	154.9	85.2	17.5	69.7	28.8	37.8	8.2	50.9	50.0	27.0	51.3	90.6	41.3	87.3	73.7	36.0	190.6	16.4	6.5	34.3	51.0	36.1	44.8	102.3	34.8	108.4	86.3
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.9	25.4	28.0	15.8	25.4	32.6	18.5	18.1	36.9	14.3	15.0	26.5	9.5	16.2	12.4	20.4	18.4	16.2	15.8	23.1	25.4	25.7	34.5	28.0	20.4	24.8	27.7	23.8	15.8	23.3	19.4	18.9	18.9	22.8	12.6	19.1	16.0	16.7	11.1	43.6	19.6	16.4	17.0	28.4	26.0	14.8	14.6	17.2	24.7	19.8	21.1	23.6	16.6	12.2	22.5	66.3	28.8	66.2	14.8	18.9	46.4	10.8	13.0	14.3	15.0	22.1	15.5	7.9	13.0	16.9	29.7	28.0	10.5	9.3	12.6	13.0	25.9	23.0	16.1	25.1	17.5	28.1	15.1	29.5	6.9	24.3	18.3	20.8	26.9	20.8	19.5	19.7	16.2	10.0	15.4	24.3	17.0	17.0	13.6	23.3	14.0	17.9	18.7	15.2	21.4	27.6	19.8	32.4	14.9	30.9	10.2	17.5	19.6	18.6	18.5	16.6	12.2	40.4	10.3	16.2	18.0	13.8	42.7	19.0	9.6	19.5	14.2	20.7	25.4	17.2	12.2	66.2	28.8	16.8	59.6	15.7	21.8	16.2	16.1	66.3	22.5	18.7	15.7	7.4	14.8	47.5	25.0	18.9	46.4	28.0	25.4	18.1	36.9	25.4	25.7	27.7	23.8	22.8	17.2	20.8	21.9	17.1	14.2	13.6	18.7	25.5	10.2	6.7	7.9	17.4	9.8	36.2	66.3	59.6	7.5	21.8	19.7	0.0	40.5	47.0	19.1	4.8	18.5	15.5	95.4	4.8	24.6	15.4	46.2	23.1	16.4	57.6	23.6	52.3	18.1	27.7	40.4	17.5	11.0	51.2	20.1	12.9	11.8	28.8	29.3	18.9	20.8	27.7	23.0	8.8
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.7	9.2	9.3	29.0	6.4	4.8	21.9	15.5	10.3	8.9	8.0	26.2	25.7	5.6	19.7	10.4	17.3	9.6	4.9	12.4	12.0	15.6	3.4	10.8	13.5	24.1	8.6	26.4	16.6	4.3	6.0	13.1	9.2	12.8	10.1	6.3	22.2	23.3	18.3	9.1	14.2	11.8	24.6	26.6	19.2	10.5	11.5	34.0	16.5	8.7	5.4	14.9	19.4	10.2	20.1	9.8	18.9	7.6	19.6	19.8	26.0	17.2	33.2	37.0	50.7	11.9	25.2	29.5	18.9	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0	17.9	46.2	77.5	98.6	75.7	105.2	57.3	178.3	52.2	58.0	181.5	43.2	203.1	351.5	126.1	26.1	56.2	109.3	93.5	164.5	133.4	54.1	70.8	70.6	249.2	109.9	84.2	59.4	39.3	60.1	57.2	64.5	84.0	69.2	129.8	72.2	94.2	142.7	87.5	75.3	253.1	99.4	64.7	95.9	66.9	97.5	66.0	221.2	70.2	105.2	80.4
CREB3	"Luman, LZIP, sLZIP"	ENSG00000107175	"CAMP responsive element binding protein 3"	O43889	9	35732335-35737004	"Predicted membrane proteins, Transcription factors"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030978			Supported	Cytosol		NA	NA			Cytosol		"HPA030978: AB_2673683"	"unprognostic (1.73e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.77e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	15.7	25.1	23.7	12.0	27.6	5.6	19.4	18.5	30.2	25.4	20.3	17.6	28.2	12.8	20.9	22.5	15.0	23.9	25.2	16.3	19.4	21.3	21.3	42.3	15.9	15.3	23.1	17.1	20.2	26.3	22.1	23.1	19.5	17.3	32.9	16.7	17.4	31.7	37.6	12.6	9.9	14.6	26.0	19.6	13.0	20.5	23.0	14.0	9.1	24.4	9.4	14.9	22.0	17.6	17.7	19.4	14.8	16.9	15.9	21.8	15.7	12.3	11.5	12.1	9.1	25.6	16.7	8.0	22.5	36.1	24.1	25.0	12.8	6.0	4.4	9.9	32.9	26.7	4.8	7.8	18.6	15.9	16.5	6.5	3.4	10.2	5.8	32.6	5.7	6.8	14.6	15.3	23.4	22.9	19.7	14.7	8.5	4.9	7.5	24.7	6.1	5.8	2.0	7.6	9.0	15.1	6.5	5.3	5.6	19.4	6.0	5.7	7.8	9.0	8.0	5.3	10.3	12.2	2.4	15.7	16.0	9.0	11.5	13.8	4.3	5.3	5.3	16.7	2.0	17.3	14.8	16.9	6.3	19.2	16.0	20.7	17.7	16.8	21.8	17.9	12.3	13.7	13.4	7.7	15.9	12.8	19.4	18.5	15.7	23.7	27.6	18.5	30.2	19.4	21.3	23.1	17.1	17.3	14.0	26.8	16.2	9.0	41.3	31.8	28.3	10.1	38.2	41.5	27.3	15.7	11.8	41.9	28.2	83.0	124.3	32.4	52.9	0.0	61.5	45.7	42.8	65.2	31.2	20.3	32.9	4.8	25.3	19.0	14.8	350.3	27.9	22.7	47.2	58.7	42.1	33.3	62.6	30.3	39.6	55.4	13.8	32.3	53.6	60.7	24.6	19.8	51.0	26.6	24.2	39.6
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;HEK 293: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.8	4.7	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.1	0.0	2.0	0.4	2.2	0.2	0.2	0.0	7.4	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.7	0.0	0.9	5.2	0.2	0.1	1.2	0.2	0.3	2.6	1.9	2.7	0.4	0.2	0.6	1.1	0.9	2.8	1.3	1.7	3.4	0.1	0.7	1.3	2.4	0.2	0.0	5.6	0.1	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1	3.0	1.3	0.0	0.1	0.7	28.1	1.2	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.5	0.2	6.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	86.9	0.2	0.0	0.0	0.0	19.5	0.0	0.2	17.2	1.0	0.5	0.1	0.0	0.2	0.1
CWC15	"AD002, C11orf5, Cwf15, HSPC148"	ENSG00000150316	"CWC15 spliceosome associated protein homolog"	Q9P013	11	94962622-94973612	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 683.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039878	Supported		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles, Mitochondria"		"HPA039878: AB_2676722"	"unprognostic (1.97e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.81e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.84e-3)"	"prognostic favorable (9.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (5.23e-2)"	9.5	9.6	9.9	7.9	12.0	10.6	13.5	12.4	11.9	10.1	9.2	7.2	7.7	5.8	8.6	14.9	10.0	9.2	5.5	14.1	9.8	9.6	14.0	15.6	8.8	8.7	10.3	10.1	11.8	8.6	7.5	12.1	11.1	12.6	9.5	8.1	6.4	10.2	9.1	24.4	9.0	10.1	7.3	11.7	10.7	9.5	17.2	12.4	11.2	11.2	14.7	9.6	9.8	10.6	31.8	31.3	36.8	33.0	26.1	35.8	25.7	10.8	8.8	26.3	12.5	25.0	22.8	13.7	16.3	23.0	27.4	22.7	39.3	24.8	16.8	33.1	23.1	20.3	11.4	15.9	20.6	29.4	21.3	14.0	21.1	10.5	17.7	21.5	26.3	13.1	22.6	23.7	18.3	24.5	22.8	26.6	20.5	24.8	14.6	24.6	14.3	25.3	35.6	12.6	30.5	22.2	17.2	16.0	17.7	27.2	13.1	14.9	11.6	18.0	17.8	14.1	25.5	28.6	21.3	14.6	18.0	14.4	25.0	16.2	6.9	17.6	23.2	10.1	30.4	17.5	36.8	25.1	34.5	26.8	27.3	35.8	31.8	34.6	32.8	31.3	27.6	34.4	34.7	29.5	26.1	33.0	29.7	35.4	25.7	9.9	12.0	12.4	11.9	9.8	9.6	10.3	10.1	12.6	12.4	68.5	52.8	80.4	76.4	52.7	51.9	156.1	96.8	103.1	97.8	48.8	13.7	121.9	187.3	96.3	683.1	78.7	55.1	140.2	125.1	102.3	82.2	67.4	99.6	99.5	111.8	38.1	27.3	83.4	57.4	99.0	104.4	88.5	67.4	94.6	54.4	99.4	104.3	80.6	87.4	170.4	46.4	135.8	50.5	192.5	186.1	55.8	99.8	69.1	59.8	59.2
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	253000					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.2	3.4	3.4	0.3	0.1	3.0	0.3	0.0	7.9	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	6.3	0.1	3.6	0.0	0.0	0.0	0.7	2.0	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9	0.0	2.1	0.5	9.7	0.8	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.8	10.1	1.1	0.0	18.2	0.0	0.0	0.0	5.6	3.5	0.3	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3"					"Not detected"	"Not detected"			CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000				"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.3	8.3	8.8	0.0	0.2	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5	3.0	0.0	0.0	2.5	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	3.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.6	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell type enriched"	"Detected in some"	6	"monocytes: 67.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.4"									HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700				"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.3	0.0	10.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	2.8	1.1	8.6	10.5	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	2.8
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell type enhanced"	"Detected in some"	15	"Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	902000					"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	6.6	0.0	0.0	0.0	11.9	1.4	0.6	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.7	0.3	0.1	0.0	0.0	0.1
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118165	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 149.9;lymphoid tissue: 186.3"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 772.9;Macrophages: 299.5;monocytes: 255.1;T-cells: 588.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 76.4;JURKAT: 43.5;Karpas-707: 41.0;MOLT-4: 69.2;REH: 36.7;U-266/70: 88.9;U-698: 89.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	15.4	26.5	3.0	39.1	3.4	149.9	9.7	0.8	2.1	7.7	8.7	6.8	1.5	1.6	8.3	3.8	16.4	9.1	12.0	5.4	4.1	4.7	8.2	7.1	29.3	94.5	6.5	1.3	6.3	3.1	0.7	8.1	7.8	6.1	6.8	7.0	10.0	10.6	2.2	3.2	2.3	57.8	3.8	22.9	82.4	8.0	7.2	3.4	186.3	9.2	4.6	97.5	50.0	6.6	47.3	16.8	37.8	7.2	4.0	32.0	11.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	76.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.9	4.6	12.1	0.0	0.0	10.5	8.3	0.0	0.0	0.0	0.0	0.0	7.3	43.5	0.1	41.0	0.0	0.2	69.2	9.4	1.2	5.9	0.4	36.7	8.5	13.3	0.6	0.0	4.2	3.5	0.0	0.2	0.0	0.4	0.0	20.7	1.0	0.0	0.2	0.0	0.0	88.9	15.0	89.4	0.0	17.4	0.0	17.9	7.2	29.6	22.9	3.8	18.7	30.1	21.1	21.7	6.6	47.3	32.0	30.1	37.8	4.0	2.1	16.8	18.9	11.9	3.0	3.4	0.8	2.1	4.1	4.7	6.5	1.3	6.1	3.4	14.9	64.2	772.9	4.0	36.5	4.4	3.6	2.5	4.0	6.8	3.5	0.0	1.4	11.6	3.6	0.9	19.0	0.0	46.7	0.8	2.2	30.2	4.8	11.6	5.5	168.4	0.0	1.7	22.7	175.5	1.7	1.4	299.5	108.0	255.1	0.1	1.0	1.6	0.0	2.5	2.1	0.6	45.3	16.3	0.5	5.5	31.1	5.3	588.4	0.4	3.2
DCAF12	"CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A"	ENSG00000198876	"DDB1 and CUL4 associated factor 12"	Q5T6F0	9	34086387-34127399	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062279	Uncertain					NA	NA					"HPA062279: AB_2684734"	"unprognostic (9.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (2.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	14.4	32.9	9.7	22.3	9.3	17.3	25.9	9.6	22.9	13.6	16.4	11.5	11.3	10.3	12.8	15.9	28.6	11.6	14.4	13.5	8.7	8.6	11.9	16.0	22.0	22.4	8.6	6.6	15.3	21.0	13.5	11.1	30.6	9.3	11.7	16.3	11.7	15.7	17.9	28.2	13.4	10.8	10.8	11.0	15.5	10.9	49.7	10.1	29.2	13.5	13.1	24.9	13.4	16.3	0.8	15.5	19.3	17.1	9.7	13.7	11.5	15.9	10.7	21.5	9.5	9.4	8.2	12.2	8.9	11.7	16.3	14.1	9.1	7.8	31.6	7.7	10.1	5.7	7.1	23.7	10.4	14.2	14.2	12.7	24.9	22.9	12.7	13.8	30.3	15.6	8.2	20.3	10.5	19.9	12.6	13.0	17.8	24.5	11.1	10.4	6.5	19.2	30.3	11.0	10.5	10.3	18.4	11.7	13.9	17.0	11.8	21.1	18.2	18.0	15.4	7.2	11.9	8.6	48.0	9.2	7.8	9.5	6.6	11.9	7.3	13.4	24.5	7.4	23.3	18.7	19.3	17.1	16.7	8.1	14.7	11.9	0.8	8.1	9.1	15.5	0.3	6.6	7.6	17.2	9.7	12.0	12.6	13.7	11.5	9.7	9.3	9.6	22.9	8.7	8.6	8.6	6.6	9.3	10.1	6.0	21.9	6.7	13.2	34.2	6.0	6.3	7.6	12.0	7.9	5.2	5.9	18.8	21.6	13.8	131.8	16.9	13.4	70.0	15.9	21.0	13.1	21.1	17.3	19.1	26.4	9.5	24.2	14.1	53.3	37.6	18.7	14.7	16.9	1.0	21.8	8.1	16.1	17.5	19.8	17.0	6.7	12.9	10.8	32.4	27.9	33.8	18.8	16.6	19.1	30.1
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA					"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.6	2.9	0.0	0.9	0.3	8.4	19.4	2.8	0.6	0.1	0.0	0.0	0.3	8.5	2.8	0.0	2.7	0.0	3.5	3.8	1.6	0.0	4.9	0.0	4.0	0.5	0.5	0.5	0.0	1.7	0.2	1.7	0.9	0.5	0.0	0.0	1.9	0.1	0.3	0.0	0.4	0.2	1.0	0.0	2.1	0.7	0.0	0.8	7.1	6.8	3.5	2.6	0.8	1.6	0.0	0.0	1.6	2.6	1.0	1.7	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9	0.0	0.0	0.0	0.1	0.5	18.2	9.1	2.5	0.0	1.2	3.5	15.7	0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.6	0.0	2.2	0.9	4.6	0.0	1.3	33.4	2.9	8.6	0.0	0.0	1.7	1.0	5.0	0.0	0.2	39.2	0.2	0.0	3.5	0.3	8.9	12.9	4.1	0.1	0.2	0.5	0.2	0.0	1.3	0.1
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	7.0	5.1	4.8	13.8	9.9	15.2	6.9	6.8	5.9	6.2	6.0	6.0	6.2	6.0	5.7	4.8	9.5	5.8	4.6	4.8	5.4	3.5	5.9	3.3	5.9	14.8	6.9	3.4	6.1	4.4	5.3	7.2	5.0	6.3	7.0	6.2	5.0	6.8	9.2	3.7	7.8	7.8	8.2	8.2	13.3	6.9	2.8	8.3	23.3	7.1	5.6	16.5	9.7	8.0	23.5	17.2	19.3	14.5	8.0	12.2	6.7	12.0	5.9	4.9	10.6	5.1	6.6	5.2	7.5	4.0	10.3	10.4	6.5	10.1	16.2	3.0	5.8	7.2	10.1	5.6	3.9	8.5	9.5	5.9	12.1	5.3	4.3	4.0	7.5	14.2	5.3	3.7	9.9	4.1	6.3	5.6	10.6	7.8	13.7	6.2	5.5	11.0	7.3	3.5	10.6	2.7	12.5	6.9	9.1	5.3	4.7	2.7	5.2	8.0	8.4	20.9	4.4	9.8	13.8	4.7	6.3	9.3	13.0	7.9	7.8	13.7	16.6	6.4	8.0	8.8	19.3	11.1	14.9	10.1	14.5	12.1	19.3	11.7	12.2	16.2	23.5	10.2	11.3	10.7	8.0	12.7	17.2	9.0	6.7	4.8	9.9	6.8	5.9	5.4	3.5	6.9	3.4	6.3	8.3	3.0	5.8	22.9	17.0	15.3	24.2	4.1	12.7	8.1	6.8	14.0	58.9	12.5	3.3	7.6	20.7	9.5	9.5	0.0	9.7	17.7	11.3	16.9	5.8	1.0	9.0	30.2	6.4	6.7	17.4	1.5	11.5	16.7	18.6	11.8	5.4	7.2	10.6	11.8	10.6	2.2	42.0	19.4	13.9	10.0	18.4	18.4	4.2	20.2	5.6	35.5
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.2	28.8	26.8	28.0	23.8	33.3	11.0	29.3	27.4	40.9	32.2	18.4	12.9	15.8	18.4	38.5	14.3	13.7	24.3	30.7	26.2	49.5	30.5	10.5	51.0	15.8	25.8	27.6	32.1	29.3	26.6	28.2	18.5	20.0	26.9	29.8	12.5	32.8	35.6	28.2	34.7	74.5	8.1	14.4	46.5	17.5	14.5	21.7	19.7	12.2	8.9	22.9	21.7	20.0	11.2	8.2	26.8	31.7	24.4	25.8	20.9	29.2	28.4	22.2	28.7	10.5	40.5	16.1	52.4	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0	29.8	31.8	49.9	82.5	90.2	76.0	72.8	63.7	57.6	43.3	76.8	23.6	100.4	175.8	103.7	8.3	78.7	68.5	210.2	135.3	93.0	101.4	62.7	86.5	74.9	115.9	69.9	71.7	73.1	79.5	15.7	95.8	80.9	141.7	86.6	53.8	145.8	101.0	66.0	115.2	170.3	63.4	58.2	101.0	73.5	71.3	124.6	83.4	96.6	55.1	72.9
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103062076-103092215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	20.9	18.3	18.9	17.2	24.5	13.4	19.1	22.5	28.8	12.9	13.5	15.9	11.5	11.4	15.9	13.7	26.5	12.9	10.6	24.2	20.3	16.6	14.4	19.0	13.9	21.5	15.6	21.0	12.2	17.7	14.5	17.0	17.3	23.6	15.4	13.9	9.9	15.6	13.5	38.7	14.0	11.3	18.4	17.5	15.7	16.0	24.0	21.0	19.4	13.2	24.2	21.3	14.4	14.7	14.4	17.3	11.8	13.1	20.5	17.0	13.4	22.3	12.4	13.7	21.0	11.2	14.2	15.2	22.2	12.1	18.3	18.9	47.5	26.2	10.8	39.3	15.8	19.0	21.3	28.8	28.1	18.9	19.0	19.4	28.9	10.7	18.4	19.0	41.4	15.0	12.4	25.0	24.5	25.4	9.6	22.7	26.4	47.2	0.0	17.3	20.2	27.3	32.4	26.7	19.5	31.7	11.6	21.9	27.4	13.9	23.0	18.6	19.7	20.7	21.2	18.4	14.7	24.8	17.4	18.4	14.9	18.1	26.4	19.8	9.1	14.4	36.0	10.6	40.7	15.4	11.8	11.1	10.2	13.8	13.1	16.3	14.4	16.3	14.2	13.7	14.1	14.0	16.3	4.0	20.5	10.0	17.3	17.0	13.4	18.9	24.5	22.5	28.8	20.3	16.6	15.6	21.0	23.6	21.0	14.9	8.3	25.2	44.6	70.6	11.0	26.6	15.3	14.7	14.8	8.7	7.9	51.2	41.4	60.4	3.0	19.7	6.9	23.3	48.3	76.2	37.5	35.6	15.1	21.3	40.1	6.4	13.8	20.9	29.7	5.9	13.3	22.6	28.7	25.2	16.1	14.8	51.7	14.0	18.4	31.1	12.3	25.8	31.1	118.2	114.7	73.1	36.6	24.5	23.4	57.0
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Collecting duct cells: 27.9;Cytotrophoblasts: 25.8;Hofbauer cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA041423: AB_10795540, HPA052932: AB_2681991"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favorable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	12.5	18.7	23.4	15.9	23.1	10.7	9.3	27.3	22.6	14.6	16.7	18.1	16.0	13.8	16.8	13.1	16.0	21.9	12.5	63.9	18.8	16.6	20.1	13.1	13.7	11.2	20.1	19.2	13.4	9.3	29.3	14.2	9.2	19.0	13.3	17.0	11.3	17.4	22.3	82.9	13.9	12.3	20.0	18.5	17.3	18.9	12.2	21.6	11.2	16.8	29.1	14.1	19.4	11.4	9.4	19.8	57.9	19.3	5.6	12.0	7.0	2.7	7.5	3.8	9.2	15.7	14.9	10.0	2.9	8.1	9.0	9.3	4.8	21.6	18.7	21.7	8.6	11.8	8.3	10.5	11.4	3.7	10.3	4.4	12.5	3.8	6.2	23.0	12.8	18.3	22.9	4.9	4.9	1.9	11.9	16.0	10.5	6.2	25.5	8.5	0.7	10.0	12.1	7.7	0.3	0.7	17.2	7.4	13.6	15.3	11.8	10.6	5.4	4.8	8.4	3.5	4.1	14.9	10.8	11.4	2.7	2.4	8.0	2.7	14.7	10.4	6.3	14.0	16.7	1.8	13.7	13.6	8.1	8.8	19.3	9.0	9.4	5.9	7.2	19.8	7.0	4.9	6.0	57.9	5.6	15.5	6.2	12.0	7.0	23.4	23.1	27.3	22.6	18.8	16.6	20.1	19.2	19.0	21.6	26.8	16.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.3	27.9	0.0	25.8	18.3	11.9	0.0	0.0	0.0	0.0	5.1	13.7	0.0	0.0	7.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	12.6	0.0	0.0	7.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 186.0;Proximal tubular cells: 502.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.9	2.2	11.0	21.4	22.4	0.2	7.7	15.3	11.3	8.4	3.7	10.1	5.6	5.3	15.5	7.3	9.3	9.9	12.9	9.4	18.2	6.0	1.3	11.2	23.0	15.8	7.1	22.2	23.1	16.4	7.3	10.8	7.8	13.2	17.3	4.3	19.9	12.1	26.9	17.7	7.4	4.4	20.1	14.3	28.0	9.1	17.4	16.2	11.3	12.0	7.2	10.6	9.8	6.4	4.9	11.8	10.7	9.3	6.0	6.2	7.0	3.9	11.6	9.2	1.6	5.2	10.3	8.5	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5	14.9	23.5	21.4	38.6	24.6	9.7	15.1	17.8	32.1	23.9	24.4	2.0	16.3	107.8	33.6	16.0	33.7	49.1	23.3	48.9	6.2	41.2	29.1	17.3	186.0	120.7	11.1	35.8	45.4	59.2	31.0	40.6	42.6	49.0	45.9	56.0	58.7	33.6	63.1	35.0	502.2	6.9	32.3	38.1	8.9	1.4	35.1	10.9	27.3	69.8	32.0
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025211-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 189.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	29.0	46.7	46.5	26.1	47.2	42.7	57.2	31.6	53.3	30.4	18.7	20.7	25.5	14.4	27.6	27.9	17.1	34.8	28.2	22.2	42.5	51.7	36.0	71.9	30.7	23.8	56.5	30.8	30.7	19.5	47.3	40.2	35.0	49.6	29.8	21.7	9.0	18.9	23.0	14.5	13.1	15.9	29.0	42.4	22.3	20.8	42.2	51.5	24.1	47.0	15.3	28.1	27.9	189.5	36.6	60.0	50.0	69.0	31.6	37.2	49.5	38.7	69.6	56.4	19.5	39.2	25.5	32.3	40.1	32.4	72.2	56.2	46.1	18.0	39.8	30.8	27.2	40.9	17.7	81.1	24.1	62.3	56.0	23.6	31.9	85.7	58.4	18.8	36.6	37.5	15.6	24.9	27.1	8.7	35.1	43.0	17.4	49.6	17.4	41.3	31.7	61.1	80.7	54.8	39.1	48.6	45.0	20.2	20.4	40.4	23.0	35.8	39.1	53.9	34.9	17.9	44.0	16.3	35.6	36.8	25.8	44.1	29.3	53.2	11.2	34.7	42.1	33.8	32.0	22.1	33.3	40.1	43.3	28.5	56.0	33.3	36.6	35.6	31.4	35.7	32.7	37.2	34.7	50.0	31.6	69.0	60.0	30.1	49.5	46.5	47.2	31.6	53.3	42.5	51.7	56.5	30.8	49.6	51.5	199.5	144.3	123.6	875.9	235.0	170.2	172.5	48.4	514.0	273.0	78.5	196.3	237.2	145.9	218.2	352.5	305.0	136.1	70.0	158.2	280.3	289.7	362.1	422.8	118.0	203.3	114.4	374.9	98.8	133.8	169.3	91.7	282.9	269.9	316.6	116.6	133.1	170.5	185.9	89.1	138.6	144.4	103.5	321.4	400.4	214.4	232.0	388.8	169.6	115.9	335.9
DNAJC19	"Pam18, Tim14, TIMM14"	ENSG00000205981	"DnaJ heat shock protein family (Hsp40) member C19"	Q96DA6	3	180983709-180989774	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	Cardiomyopathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA037782	Approved					NA	NA					"HPA037782: AB_10672611"	"unprognostic (4.52e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (8.53e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-3)"	14.6	32.0	24.5	11.0	23.1	8.5	23.8	12.0	25.8	17.1	17.0	14.0	15.6	18.9	13.9	30.9	15.8	17.2	15.7	53.2	21.4	23.3	44.1	38.1	11.8	13.4	22.3	17.9	24.6	22.0	22.2	24.7	12.8	19.9	19.4	16.4	15.1	23.3	17.7	45.5	11.5	16.9	19.2	17.9	14.0	17.2	9.8	14.5	13.3	22.9	30.9	13.5	18.4	12.6	20.6	19.6	16.8	14.1	13.6	24.9	16.4	21.0	5.5	15.9	12.1	19.1	11.6	14.3	12.1	7.4	12.1	10.6	19.6	10.6	8.9	25.6	10.3	29.4	10.7	15.3	14.7	15.1	14.2	19.6	10.6	9.5	19.2	20.5	25.4	11.3	10.8	12.3	10.0	18.0	15.9	13.9	22.0	16.3	14.6	9.4	17.4	18.8	21.2	21.0	30.0	17.8	11.9	10.9	26.8	17.7	9.9	15.9	8.4	12.5	30.9	30.5	19.1	34.3	17.5	6.6	7.6	11.3	10.5	21.4	19.3	23.0	30.9	7.7	19.6	9.1	13.2	11.5	16.8	20.0	11.4	23.6	20.6	23.3	20.7	15.8	17.2	24.9	24.8	2.4	13.6	14.1	19.6	18.6	16.4	24.5	23.1	12.0	25.8	21.4	23.3	22.3	17.9	19.9	14.5	35.7	48.6	66.8	59.9	50.4	31.2	138.0	79.0	53.5	51.2	73.3	13.7	99.1	399.6	71.6	5.8	54.0	53.5	0.0	94.7	95.3	70.0	81.0	105.4	133.3	59.2	46.1	43.5	49.7	30.2	7.9	78.9	50.7	70.9	62.3	81.2	47.0	73.4	66.6	68.2	169.2	52.1	84.1	69.7	70.5	59.6	52.6	57.4	61.8	84.7	48.6
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"Downstream neighbor of SON"	Q9NYP3	21	33559542-33588708	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 44.4;Spermatocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	6.4	3.5	4.1	9.2	8.0	9.4	10.2	7.8	5.6	6.8	7.1	3.3	3.5	6.1	6.7	5.8	8.3	6.3	5.9	7.5	5.5	4.4	5.6	16.2	5.2	11.1	4.7	4.0	13.5	5.7	11.7	6.9	12.2	8.1	5.7	7.4	4.4	4.8	4.3	5.9	9.1	9.3	5.4	5.2	8.2	5.8	24.0	3.0	26.4	5.0	8.1	10.7	4.5	9.7	0.7	0.5	0.1	0.9	0.4	1.4	0.3	27.4	6.4	13.5	11.8	4.2	7.8	10.5	21.9	9.5	16.8	19.1	18.0	7.5	14.9	5.7	10.9	12.7	8.2	18.2	7.8	18.5	14.9	15.7	27.9	14.1	16.3	3.1	14.8	6.8	5.5	2.5	19.0	4.6	5.0	10.7	7.8	26.6	26.0	14.4	5.6	13.5	5.3	14.0	13.1	7.9	12.1	27.9	15.9	7.5	7.4	14.7	6.1	32.9	10.5	9.6	7.0	13.8	7.5	6.2	16.0	11.2	11.7	15.4	23.6	23.2	24.5	8.9	19.8	18.0	0.0	0.3	0.1	1.4	0.9	0.7	0.2	1.4	0.6	0.2	0.7	0.8	0.1	0.0	0.4	0.0	0.5	0.6	0.3	4.1	8.0	7.8	5.6	5.5	4.4	4.7	4.0	8.1	3.0	3.0	3.4	0.8	7.7	7.2	3.5	3.4	7.6	0.0	1.2	3.5	9.8	8.0	1.7	3.0	44.4	4.5	2.7	0.0	4.0	22.1	6.4	4.6	8.1	5.5	7.6	6.4	1.2	8.6	2.7	16.6	9.5	5.1	6.8	3.6	3.8	2.4	3.7	2.9	13.1	4.2	2.7	0.0	8.1	53.1	21.1	8.5	13.8	5.7	5.1	8.1
DPM3	"MGC125904, MGC125905, MGC34275"	ENSG00000179085	"Dolichyl-phosphate mannosyltransferase subunit 3"	Q9P2X0	1	155139891-155140595	"Disease related genes, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014667	Approved					NA	NA		160000			"HPA014667: AB_1847848"	"unprognostic (6.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.83e-3)"	"unprognostic (4.71e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (1.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.64e-4)"	21.6	32.2	18.8	14.6	21.3	21.8	28.4	13.0	20.7	25.9	36.1	14.6	43.4	31.0	23.4	42.9	19.6	25.1	31.7	26.1	17.4	18.0	23.9	42.5	19.2	17.9	18.1	15.3	19.9	62.6	9.2	32.7	12.4	14.3	22.3	9.9	23.7	42.1	44.8	29.6	13.4	23.4	23.3	15.1	20.0	24.2	21.5	12.2	13.1	47.0	22.2	11.9	17.3	18.1	43.3	49.6	40.4	45.2	36.4	42.1	37.6	22.6	25.3	7.9	18.6	14.6	13.6	8.5	7.5	9.5	10.1	10.6	8.0	26.8	7.3	23.0	6.1	3.4	16.3	3.0	8.7	1.2	10.4	52.3	8.1	37.6	27.1	13.8	7.2	10.8	13.4	16.1	7.3	3.1	4.9	11.7	18.5	9.0	39.4	7.5	54.9	15.9	16.6	19.6	26.6	19.7	13.8	9.0	43.7	12.1	15.7	13.9	28.7	17.0	20.3	27.0	3.0	14.0	35.2	9.3	6.3	15.2	8.9	10.8	33.5	16.9	21.9	16.5	15.7	4.7	20.3	45.2	40.4	38.8	27.8	42.1	43.3	41.4	37.9	43.7	41.8	39.7	37.9	25.0	36.4	27.6	49.6	32.6	37.6	18.8	21.3	13.0	20.7	17.4	18.0	18.1	15.3	14.3	12.2	47.6	64.3	56.3	56.1	24.4	27.7	97.4	104.4	92.3	59.1	167.5	9.8	59.1	56.3	50.1	36.1	63.7	136.5	0.0	141.2	58.3	64.6	65.2	69.3	221.9	77.0	12.7	95.4	77.3	64.8	9.5	85.7	58.5	92.8	28.9	187.9	74.4	61.4	155.6	91.9	122.9	22.5	38.8	60.8	23.6	10.6	29.5	34.1	44.9	139.7	53.3
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 56.4"	"Cell type enriched"	"Detected in some"	9	"Ciliated cells: 337.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4"					"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced					NA	NA					"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3.0	0.1	0.3	1.3	10.0	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0.0	0.2	0.1	4.4	0.1	0.5	0.0	0.1	0.0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	1.0	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0.0	0.0	0.4	0.2	1.1	0.0	0.1	0.0	0.0	1.4	0.2	0.3	0.3	0.3	0.7	0.0	7.0	0.0	0.0	1.8	0.5	1.6	0.0	0.1	6.0	4.0	0.2	0.0	0.7	1.7	0.0	2.7	0.1	0.1	0.3	4.4	0.0	0.1	0.1	0.3	0.4	0.0	0.0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0.0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0.0	0.0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	337.3	30.7	0.0	0.0	0.0	1.7	0.4	35.5	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	24.4	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	1.9	2.2	0.0	0.0	0.0	0.0	0.1
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.8	5.6	16.1	17.3	5.4	6.0	11.2	9.3	8.1	8.9	9.9	6.9	4.3	15.4	18.0	8.6	8.3	7.2	18.4	8.3	15.0	6.0	13.0	27.9	9.3	7.7	5.8	18.3	16.8	4.8	6.2	8.7	10.7	9.2	6.1	14.7	30.9	9.5	10.1	7.1	20.7	20.5	12.1	5.3	5.8	22.6	14.2	17.7	10.6	11.9	11.6	21.3	8.6	11.9	12.2	10.3	6.1	11.1	8.2	14.4	9.0	7.1	14.7	6.0	19.0	19.3	3.5	11.3	20.4	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1	0.0	1.6	8.2	10.8	8.1	35.1	8.9	7.6	0.0	12.5	7.0	21.6	6.3	8.3	7.0	10.2	5.2	7.9	0.0	5.9	11.3	10.4	18.4	19.7	5.0	14.5	30.2	11.5	19.0	49.7	5.0	2.6	18.9	5.0	8.2	11.3	2.1	11.2	11.6	2.8	20.5	9.2	0.0	8.2	2.7	3.2	7.9	2.6	9.6	12.7	14.2
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102578	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	10.5	21.8	20.1	14.2	26.9	34.0	18.5	20.0	24.6	10.8	12.2	13.5	12.3	8.2	13.6	19.2	15.9	10.3	9.5	12.5	19.4	27.0	34.9	19.2	9.9	19.7	26.9	16.2	10.8	26.6	19.8	28.6	11.7	41.2	12.5	15.2	9.6	13.5	13.4	14.4	8.4	8.4	13.3	21.3	11.8	14.8	36.3	19.4	9.9	13.9	15.8	20.3	11.6	9.3	20.9	29.6	6.8	15.0	14.0	21.3	13.5	28.1	14.9	24.0	16.5	7.9	13.3	14.6	23.7	15.0	21.4	22.1	24.3	11.8	30.9	52.3	15.4	39.2	11.7	27.1	27.3	36.1	17.3	35.3	24.9	19.7	42.2	14.7	49.3	18.4	11.1	25.8	25.5	26.5	15.0	30.2	25.5	59.5	8.6	20.4	11.8	21.1	40.1	21.6	27.5	24.0	25.9	14.1	48.5	35.0	21.7	35.7	11.1	10.1	22.8	28.2	33.9	18.1	17.0	15.6	17.9	17.7	16.2	34.3	13.5	61.1	43.9	10.0	20.9	28.4	6.2	11.0	6.8	13.5	15.0	19.1	20.9	18.1	17.8	29.6	20.5	20.3	20.6	1.1	14.0	11.2	13.0	21.3	13.5	20.1	26.9	20.0	24.6	19.4	27.0	26.9	16.2	41.2	19.4	14.9	28.8	28.9	35.2	58.5	35.8	20.7	15.3	33.5	37.5	57.6	9.8	71.1	119.3	54.7	233.2	31.6	7.7	23.3	76.4	54.8	31.5	42.5	15.1	26.4	44.1	28.6	38.5	23.4	30.6	155.8	24.5	35.1	40.5	22.6	35.3	32.1	63.6	7.0	22.3	129.8	16.8	12.9	36.0	118.9	83.7	66.6	27.0	27.3	39.8	36.5
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Cell type enhanced"	"Detected in some"	10	"Ciliated cells: 17.4;Cytotrophoblasts: 12.5;Fibroblasts: 9.4;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.6;NTERA-2: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA001838: AB_2666457"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0	0.0	1.3	0.0	1.3	0.9	4.9	0.3	0.0	17.4	6.8	0.0	0.0	12.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	8.1	9.4	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	7.3	0.0	0.2	0.4	22.1	0.0	0.0	3.8
EIF3G	"eIF3-delta, eIF3-p44, eIF3g, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115017-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 1028.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 177.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol		NA	NA		12000	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	41.6	29.0	20.2	34.2	21.5	34.1	36.1	18.1	28.4	41.1	41.2	27.0	30.3	29.8	40.2	34.6	37.7	34.1	47.0	52.3	19.0	18.4	30.5	45.0	28.2	40.1	22.6	18.5	63.6	88.6	30.9	24.8	34.9	19.3	41.9	17.6	25.6	57.1	35.5	141.1	40.2	30.1	39.1	24.3	36.7	38.9	51.0	23.4	46.4	42.3	49.7	40.3	46.2	48.7	47.1	58.4	31.4	60.6	80.3	70.8	74.7	25.5	21.7	16.7	22.0	22.2	28.5	21.4	21.9	30.7	34.5	32.1	35.5	13.8	26.3	31.4	26.1	15.7	19.7	20.2	32.9	14.3	23.7	61.5	46.6	21.9	35.5	37.0	36.6	24.6	34.1	24.3	24.3	23.4	22.3	24.6	33.1	41.8	31.3	20.7	34.3	39.8	177.9	40.8	16.3	46.8	32.2	16.4	34.7	21.9	22.4	21.6	42.0	14.5	19.1	34.3	9.9	16.8	32.4	24.2	29.9	16.9	32.4	41.5	92.6	67.3	29.3	22.5	40.2	28.5	31.4	60.6	25.3	54.6	44.4	70.8	46.7	59.0	59.1	58.4	47.1	60.3	54.1	11.7	80.3	35.6	45.9	64.9	74.7	20.2	21.5	18.1	28.4	19.0	18.4	22.6	18.5	19.3	23.4	41.7	79.8	229.1	225.9	202.7	38.3	40.8	122.3	78.9	77.3	102.9	17.7	402.8	159.2	159.9	356.5	161.9	178.9	23.3	266.1	265.8	177.6	154.0	126.9	95.5	198.8	20.6	124.7	129.5	241.3	1028.3	220.4	229.7	138.3	284.1	165.6	56.1	195.2	164.9	166.6	222.1	38.4	161.7	224.0	181.2	151.2	208.6	440.9	257.6	191.5	210.8
EIF4E3	MGC39820	ENSG00000163412	"Eukaryotic translation initiation factor 4E family member 3"	Q8N5X7	3	71675416-71754773	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.8;monocytes: 4.2;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.0;U-937: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058649, HPA076465"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA058649: AB_2683785, HPA076465: "	"unprognostic (3.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.31e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (3.10e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.16e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (6.99e-5)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.83e-2)"	18.8	9.4	17.2	11.8	22.6	17.7	25.6	13.9	19.4	9.6	16.3	11.5	3.7	10.4	11.0	8.5	16.0	12.2	11.9	30.3	18.6	14.6	10.5	8.8	13.7	11.7	15.2	12.4	17.9	19.4	26.7	14.6	4.7	12.8	14.8	13.0	10.8	12.9	14.5	40.4	7.2	17.6	25.6	19.4	15.3	9.9	5.9	6.7	7.8	19.7	14.5	7.8	17.6	21.8	0.2	0.9	14.8	4.2	1.0	5.4	1.6	0.3	1.3	1.3	4.3	1.3	3.4	1.7	1.1	1.2	1.1	0.6	0.7	0.6	0.0	2.9	1.1	7.4	1.6	4.7	6.5	0.9	14.9	1.4	0.0	0.1	0.1	4.6	2.3	2.6	3.0	4.2	0.3	3.6	0.6	3.6	2.7	0.5	20.0	0.2	5.0	2.0	0.5	10.5	0.5	2.3	1.1	5.2	0.6	14.3	7.2	2.7	7.2	7.8	1.7	0.2	4.3	7.5	0.1	0.9	0.6	3.4	9.2	1.0	14.1	13.1	0.0	0.5	27.1	2.6	1.2	4.2	5.9	2.2	1.8	3.4	0.2	3.1	3.6	0.9	0.1	2.3	2.7	14.8	1.0	2.3	0.0	5.4	1.6	17.2	22.6	13.9	19.4	18.6	14.6	15.2	12.4	12.8	6.7	26.8	12.6	0.0	8.5	9.0	10.3	35.1	7.6	2.7	10.3	10.4	0.0	3.3	3.3	4.9	0.9	9.3	27.6	0.0	4.9	2.3	8.4	10.8	6.9	4.9	4.0	1.6	8.7	14.7	15.7	1.1	11.8	5.8	3.3	1.0	11.1	13.5	8.0	14.4	8.9	11.4	0.5	0.0	17.5	0.2	0.4	11.8	1.3	13.8	6.4	7.6
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	34.1	17.1	19.5	25.4	23.7	28.1	32.4	30.2	19.0	20.1	20.1	39.3	24.4	39.2	26.2	22.4	23.9	19.6	34.1	29.2	35.6	23.6	20.4	47.1	17.5	51.7	18.8	46.0	29.1	18.9	20.6	27.9	28.6	17.3	29.2	24.1	51.9	19.6	28.9	27.7	29.1	42.7	30.4	22.5	25.2	25.5	29.1	31.9	41.2	28.7	16.6	15.7	16.4	37.8	24.3	38.8	15.3	30.4	32.0	31.3	30.7	16.3	26.8	14.6	20.6	32.0	22.7	51.1	23.0	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8	101.3	209.4	134.1	138.3	285.5	99.2	532.6	145.2	179.3	205.9	326.2	47.1	126.1	122.7	191.6	558.1	145.8	91.2	116.8	202.2	178.1	139.3	179.5	165.5	428.2	118.4	73.1	151.6	136.2	112.7	88.6	115.3	122.6	135.0	171.3	133.7	81.8	227.8	86.3	165.2	160.8	108.6	271.7	161.7	293.6	551.3	283.8	151.7	127.0	125.6	200.5
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	36.1	24.0	40.3	30.3	15.8	15.9	22.7	27.0	22.7	40.2	31.5	34.7	21.1	43.6	38.0	29.6	22.6	25.3	44.9	30.9	34.1	38.9	41.7	38.2	17.7	32.3	23.2	36.2	30.6	19.7	18.6	28.0	17.1	19.1	30.7	33.3	39.2	32.7	27.7	26.8	60.5	29.2	35.9	27.2	30.6	68.1	26.3	28.7	25.5	26.7	29.0	21.2	25.6	25.9	20.4	25.4	29.5	28.6	23.0	37.7	26.4	34.9	46.4	33.4	32.3	45.8	21.1	43.6	32.5	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5	23.8	23.9	31.2	59.2	64.3	42.6	27.2	30.6	14.7	13.6	45.4	53.0	76.4	56.3	31.1	188.6	49.4	29.5	0.0	29.2	87.0	49.8	55.0	20.7	78.0	55.5	57.2	40.4	43.0	50.2	108.9	46.6	53.3	49.0	30.7	47.6	43.8	29.8	48.6	53.4	49.4	54.8	51.8	58.0	132.2	59.8	62.0	62.6	49.8	53.0	69.3
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141588	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054715, HPA078254"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA054715: AB_2682582, HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	5.0	15.4	10.6	5.2	11.7	10.0	8.5	18.4	16.0	6.1	11.4	5.7	13.1	17.8	5.9	9.8	7.9	6.7	7.3	9.6	9.9	11.1	9.9	17.1	5.1	7.4	8.6	9.7	6.8	15.1	8.8	17.0	6.1	12.8	9.8	6.9	16.8	15.5	12.7	35.6	9.0	11.4	6.3	5.2	8.4	6.5	10.3	4.2	11.8	10.1	12.9	9.3	7.5	5.5	5.3	12.3	4.0	5.2	3.8	8.9	4.3	7.6	18.1	5.1	14.2	2.7	1.4	4.7	4.9	4.0	7.1	7.2	7.8	5.9	6.4	4.3	3.9	5.5	7.0	4.2	7.7	4.2	5.0	10.1	1.5	7.0	34.4	3.4	5.5	3.3	2.0	3.2	3.8	6.8	5.8	8.0	9.2	1.4	8.4	5.6	18.0	5.5	4.8	5.9	7.8	13.4	3.5	12.7	6.6	5.5	9.2	9.0	7.2	9.1	16.4	4.2	2.6	9.1	2.9	4.0	3.1	8.8	4.6	8.0	10.7	9.3	7.2	4.8	2.4	4.9	1.0	5.2	4.0	5.0	2.6	5.5	5.3	6.8	6.5	5.3	4.9	3.4	4.5	0.5	3.8	2.5	12.3	8.9	4.3	10.6	11.7	18.4	16.0	9.9	11.1	8.6	9.7	12.8	4.2	0.0	6.5	18.6	8.4	16.1	47.5	16.3	22.9	10.7	10.3	22.7	17.7	24.4	48.0	15.0	62.5	9.3	25.7	23.3	10.3	21.5	21.2	14.4	4.7	22.2	25.9	11.1	20.2	6.7	12.7	115.8	10.6	13.2	15.1	19.0	14.6	13.8	10.4	10.5	20.5	44.8	44.0	12.9	21.2	9.7	5.5	20.8	20.5	17.0	26.2	7.2
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 303.2"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 1952.6;Mucus-secreting cells: 1256.8;Paneth cells: 2168.3;Undifferentiated cells: 1330.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"A-431: 55.5;CACO-2: 71.9;CAPAN-2: 101.2;OE19: 96.3;RPTEC TERT1: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	0.4	2.1	1.8	49.8	3.0	0.2	8.9	0.6	1.0	10.8	155.8	0.7	31.5	66.8	4.4	35.2	2.8	10.2	41.6	0.4	1.7	2.7	60.2	1.2	22.6	0.4	1.2	0.4	3.8	54.1	19.8	38.7	2.2	0.9	9.0	70.5	0.7	47.2	25.0	0.5	2.0	303.2	1.7	1.4	0.5	15.3	5.5	0.9	1.7	83.6	4.2	4.1	4.1	2.1	0.2	1.9	0.4	0.2	0.0	0.0	0.6	55.5	0.6	0.0	0.1	0.0	0.0	35.2	0.0	0.0	0.0	0.0	71.9	101.2	0.0	15.6	0.1	0.0	26.2	0.5	6.6	0.2	0.0	6.4	0.0	0.3	28.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	16.6	0.0	0.0	28.3	0.0	2.6	18.2	96.3	3.6	0.0	0.0	14.1	43.2	24.5	39.1	0.3	0.4	20.7	0.0	15.5	17.4	0.1	0.0	0.0	0.7	0.2	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.6	1.8	3.0	0.6	1.0	1.7	2.7	1.2	0.4	0.9	0.9	288.8	113.7	7.2	161.4	8.2	0.1	1.7	236.9	180.7	188.8	425.7	0.0	14.0	64.6	814.0	5.0	2.3	1952.6	0.0	356.0	2.6	1.9	182.8	33.3	0.4	2.4	0.0	478.4	0.0	0.0	3.2	19.0	5.0	33.7	19.8	1256.8	11.8	505.0	2168.3	17.7	160.0	0.7	12.9	0.4	67.3	135.0	9.2	5.0	2.5	1330.8	202.8
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 351.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.5	22.5	18.5	12.4	26.8	31.5	45.1	40.0	33.7	25.1	27.1	29.7	41.4	13.5	39.8	31.7	45.3	25.7	17.6	26.4	40.1	28.9	18.9	22.0	32.3	17.2	15.7	30.5	18.6	22.2	21.3	31.6	32.0	46.6	19.4	18.5	17.9	38.5	33.3	13.2	15.2	33.1	26.1	26.1	63.8	14.1	51.0	27.4	21.2	35.9	7.1	11.6	20.3	23.1	23.6	41.1	44.7	25.1	21.4	34.1	29.1	45.1	43.0	28.3	35.8	27.0	28.5	22.9	27.6	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7	26.8	22.9	45.6	61.3	51.4	54.1	50.9	35.7	38.8	36.4	50.6	51.1	98.6	41.4	61.1	351.1	42.1	17.7	46.7	54.6	97.9	61.2	75.0	54.3	44.3	50.6	46.1	40.1	33.7	17.2	29.1	48.6	35.9	59.1	46.9	30.8	66.0	56.1	21.0	56.3	38.6	50.8	32.3	70.7	51.7	35.3	58.1	130.7	44.8	32.4	68.7
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.2"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.9;Cytotrophoblasts: 25.0;Exocrine glandular cells: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;BJ hTERT+ SV40 Large T+: 8.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;HDLM-2: 33.3"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	2.3	2.5	1.7	7.9	1.7	0.9	1.8	0.9	1.5	2.3	15.1	0.9	2.1	14.4	2.0	2.1	4.7	1.9	7.5	0.9	0.9	1.0	3.0	3.6	7.5	4.2	1.1	1.7	3.7	2.4	3.1	9.9	7.2	3.0	5.3	2.2	3.0	8.1	1.5	0.8	15.1	22.2	4.5	1.5	3.3	5.5	1.1	1.3	3.7	5.3	5.5	8.0	4.3	9.8	2.8	0.7	15.4	4.4	0.4	12.0	1.8	2.1	0.3	0.5	1.3	0.0	0.1	16.1	0.2	5.3	8.4	16.0	1.1	4.7	0.7	0.8	0.1	1.4	2.7	0.2	0.9	0.4	33.3	0.6	1.1	0.3	1.2	1.1	0.5	0.6	0.7	1.4	0.4	0.1	0.4	0.2	0.4	0.3	1.0	0.2	0.4	0.7	0.6	1.2	0.7	0.1	3.5	0.3	0.3	0.1	1.3	0.8	0.5	0.8	1.8	0.5	0.8	2.9	1.0	0.7	0.8	0.9	0.4	0.5	0.3	0.5	0.7	0.3	1.9	0.9	0.0	2.9	0.2	1.4	4.4	3.3	2.8	4.5	1.8	0.7	1.1	0.9	1.2	15.4	0.4	1.4	0.0	12.0	1.8	1.7	1.7	0.9	1.5	0.9	1.0	1.1	1.7	3.0	1.3	17.9	17.9	0.0	1.9	1.8	0.2	0.3	0.0	1.4	7.9	0.0	0.0	25.0	0.0	12.2	0.4	0.7	9.3	0.0	20.9	4.3	2.4	3.4	2.3	0.2	2.5	0.0	3.5	0.0	0.8	0.0	1.4	0.5	3.3	10.0	4.6	2.2	12.8	5.8	1.1	0.8	0.6	0.0	8.2	0.9	16.6	3.1	7.1	0.0	4.5	4.3
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.2;U-138 MG: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.4	9.9	0.1	0.4	0.0	2.0	27.2	17.8	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.4	0.7	0.0	0.0	5.0	2.7	23.9	11.0	19.5	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	0.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.6	0.7	0.0	0.1	9.8	36.5	15.3	0.6	22.6	0.2	0.0	0.0	20.7	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3	38.7	30.7	2.7	9.2	2.5	0.8	0.2	0.0	1.4	36.4	10.4	0.0	33.7	23.2	27.0	11.0	1.3	0.0	0.0	14.2	17.5	2.1	5.2	0.0	71.0	3.2	0.0	1.7	3.7	0.6	8.2	0.3	0.8	27.0	0.0	0.0	0.0	15.1	0.0	0.7	53.7	0.0	0.0	1.0	1.7	0.4	0.6	104.4	0.0	0.0	10.0
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078626-144080647	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 251.1;Late spermatids: 557.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024792, HPA065103"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA024792: AB_1848325, HPA065103: "	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	12.3	16.7	12.8	11.4	17.6	13.8	8.9	13.9	20.6	8.1	12.0	10.5	13.6	15.8	9.8	10.4	14.5	10.0	9.3	16.5	11.4	11.2	14.9	21.5	8.7	11.4	11.5	13.0	10.3	15.0	8.0	10.2	11.5	12.0	12.1	6.5	11.6	28.0	14.7	12.1	12.7	11.1	6.7	9.3	13.4	13.9	45.0	9.7	14.8	10.8	10.4	11.1	8.7	7.8	24.7	38.2	19.0	31.8	17.1	16.1	18.8	10.3	22.9	4.1	9.8	3.5	2.7	11.2	8.2	3.4	6.4	6.5	16.0	7.3	6.3	12.0	3.4	4.6	8.6	7.5	8.9	1.9	8.3	25.5	9.0	17.1	17.7	5.9	6.7	10.8	3.8	9.2	7.4	5.9	2.5	3.3	6.9	14.1	4.3	5.2	37.9	10.4	13.3	10.6	11.0	91.9	4.6	6.7	16.3	6.1	10.6	12.9	17.0	10.2	13.2	18.8	2.2	15.0	10.2	3.2	6.6	14.5	15.8	13.8	11.4	13.6	7.9	9.5	10.8	10.3	19.0	31.8	12.5	15.9	29.4	16.1	22.0	12.4	15.4	29.8	24.7	15.9	15.4	9.2	17.1	16.1	38.2	13.7	18.8	12.8	17.6	13.9	20.6	11.4	11.2	11.5	13.0	12.0	9.7	8.9	24.2	15.2	27.4	83.9	8.8	18.2	20.4	18.7	12.5	26.2	7.9	39.9	104.5	49.6	251.1	24.8	32.9	0.0	40.1	34.1	31.5	24.7	13.9	52.3	40.4	6.4	24.9	20.9	31.4	557.6	17.3	24.1	33.7	54.1	29.8	14.1	51.1	45.6	19.8	81.3	6.8	12.9	40.6	52.4	33.8	76.9	40.3	13.8	40.1	33.2
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3"															NA	NA						"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.5	0.2	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.0	0.0	1.8	10.7	0.1	3.1	0.0	0.0	0.4	0.8	1.9	0.0	9.6	5.2	0.3	2.5	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.1	0.0	1.0	1.2	4.8	0.0	1.0	0.5	0.0	1.8	2.2	0.0	0.0	1.8	19.4	6.3	3.4	1.8	0.1	0.1	3.0	0.0	4.6	3.0	0.0	0.0	0.0	0.2	0.0	0.1	16.3	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3	3.0	5.6	0.0	11.2	2.4	3.1	0.3	2.5	24.1	6.8	5.2	17.7	4.4	8.3	8.3	0.0	0.0	3.9	0.0	12.2	2.1	0.5	10.4	0.0	9.0	0.6	1.6	12.7	0.6	0.0	0.0	0.6	0.0	3.3	1.0	5.6	1.2	11.6	3.4	0.4	4.5	12.2	0.0	0.1	0.0	0.0	5.8	4.7	2.5	4.7	9.0
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 26.8;Club cells: 6.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;Hep G2: 5.6"					"Low region specificity"	"Detected in many"			HPA045540	Enhanced					NA	NA					"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	2.8	77.3	0.9	0.7	1.2	0.0	0.7	0.1	0.5	1.3	0.6	3.1	0.3	0.0	0.5	9.4	0.8	26.1	0.9	0.1	1.3	1.5	0.4	0.1	2.7	0.1	0.1	0.2	2.5	0.1	0.0	0.2	0.1	3.8	0.1	0.0	0.7	0.6	0.6	102.9	0.2	0.3	0.3	0.4	0.2	0.0	0.5	0.6	0.1	0.3	1.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	2.5	0.7	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	1.3	0.2	1.4	0.5	0.9	0.0	0.3	0.0	0.0	5.6	0.0	0.4	0.4	0.0	0.5	0.0	0.5	0.2	0.4	1.9	0.0	0.6	0.0	0.1	0.0	0.4	0.5	0.5	0.6	0.0	0.2	0.0	2.0	0.3	0.8	0.0	0.0	0.0	0.0	1.8	0.6	0.0	1.1	0.7	0.4	0.8	0.0	1.3	0.8	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.2	0.1	0.5	1.3	1.5	0.1	0.2	3.8	0.6	0.0	0.3	0.0	1.1	4.1	0.0	0.2	0.0	26.8	6.8	0.0	2.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	1.3	0.1	0.0	0.2	0.2	0.0	1.8	0.0	0.0	0.0	0.3
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		180000	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	20.8	25.6	29.5	17.5	29.2	24.9	20.6	14.1	25.9	27.2	45.8	29.2	19.6	32.6	16.3	17.9	22.2	12.7	22.0	44.2	31.6	35.3	35.5	49.1	36.0	10.4	41.1	24.2	14.4	21.5	14.2	43.8	17.7	39.6	37.9	41.6	13.6	19.5	22.3	33.8	17.4	34.0	25.5	45.4	15.7	24.1	42.6	22.2	13.3	31.0	19.0	12.8	27.6	18.2	14.1	16.8	56.7	15.1	9.4	18.5	9.7	20.3	16.5	12.6	10.1	21.8	21.9	17.0	33.3	18.1	17.3	19.0	16.8	27.0	8.5	23.8	31.6	23.6	21.4	15.2	18.8	22.2	23.8	11.6	6.5	20.9	56.8	26.9	9.9	15.1	19.6	24.8	20.9	16.5	25.5	19.8	15.4	15.4	26.2	33.3	29.2	12.2	9.2	10.3	32.1	23.5	7.0	17.8	11.8	31.3	22.1	17.6	15.8	39.3	30.9	25.6	26.0	28.6	7.6	23.2	22.7	20.1	25.2	17.0	20.4	24.4	10.0	14.0	6.6	22.1	20.9	15.1	24.9	10.7	11.4	12.6	14.1	14.2	12.2	10.9	11.3	11.3	11.0	56.7	9.4	9.7	16.8	18.5	9.7	29.5	29.2	14.1	25.9	31.6	35.3	41.1	24.2	39.6	22.2	223.4	156.1	82.9	157.1	142.8	34.3	125.5	66.2	148.5	129.7	99.5	25.5	63.2	101.2	106.7	472.3	134.1	241.2	46.7	217.0	95.5	80.8	234.3	79.8	184.5	67.0	22.3	128.5	82.9	53.3	400.3	50.0	70.6	141.7	179.5	172.8	36.1	275.5	227.7	49.8	271.4	43.2	45.3	134.8	116.8	87.3	149.8	103.1	90.6	196.2	201.3
FAM89B	"LRAP25, MTVR1"	ENSG00000176973	"Family with sequence similarity 89 member B"	Q8N5H3	11	65572349-65574198	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046895	Approved					NA	NA					"HPA046895: AB_2679858"	"unprognostic (1.16e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.09e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.07e-3)"	"prognostic unfavorable (9.48e-5)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.12e-2)"	19.3	10.4	19.7	13.4	18.4	13.5	17.7	17.4	23.5	23.5	21.7	9.6	12.0	9.9	17.1	14.4	23.6	14.5	19.5	18.2	19.4	9.8	12.5	15.0	17.4	15.8	11.5	11.0	21.5	36.1	17.4	7.8	13.4	9.2	24.2	8.2	13.7	32.0	18.7	69.2	17.7	11.8	18.0	8.3	20.2	14.7	11.9	6.6	27.2	17.8	28.2	16.9	21.7	14.4	3.1	6.1	11.6	14.5	6.1	10.2	3.8	6.5	10.5	15.7	19.5	19.2	22.2	5.2	12.0	10.6	8.8	5.2	6.3	7.4	4.5	16.3	18.3	9.7	11.4	6.6	7.0	2.0	15.1	17.9	8.4	7.3	3.5	11.7	4.1	16.0	17.3	14.2	7.3	5.0	28.2	23.3	10.6	9.4	29.9	12.4	9.7	18.7	14.6	7.1	6.3	25.1	23.5	2.4	19.5	9.7	6.1	18.0	23.7	8.6	12.6	19.0	5.0	12.7	6.2	15.2	19.0	10.1	18.3	6.2	15.3	23.6	2.9	16.6	6.2	13.5	7.1	6.4	11.6	5.9	11.2	8.0	3.1	7.4	7.3	5.4	2.9	6.3	6.3	9.4	6.1	14.5	6.1	10.2	3.8	19.7	18.4	17.4	23.5	19.4	9.8	11.5	11.0	9.2	6.6	8.9	4.6	24.6	30.0	42.1	10.4	9.1	12.7	4.0	4.5	22.7	2.0	23.5	11.6	13.5	8.2	33.8	15.4	0.0	23.4	16.7	30.2	37.7	4.6	23.6	29.6	15.9	27.9	27.0	24.6	19.2	24.5	33.7	42.2	13.6	16.0	22.0	26.7	20.1	28.3	12.6	7.4	45.3	52.8	2.3	10.4	50.2	18.7	39.2	15.6	49.0
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Cell line enhanced"	"Detected in many"		"AF22: 15.7;Karpas-707: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.3	2.6	15.7	6.1	0.4	0.0	0.4	0.1	0.6	2.4	4.6	2.4	3.6	4.7	5.7	0.1	6.5	4.1	1.7	2.5	2.4	1.9	2.9	2.2	0.2	1.3	0.3	2.7	1.6	0.2	8.4	0.6	2.6	1.1	0.0	4.0	0.8	18.1	1.0	4.1	0.3	3.7	3.4	1.6	3.6	0.1	3.7	7.2	3.3	2.1	10.2	4.3	0.4	2.5	6.8	2.9	10.9	4.6	0.5	1.3	4.8	2.8	2.2	4.0	3.5	3.9	5.3	0.6	2.8	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4	3.0	2.6	0.0	2.3	0.1	7.9	2.0	5.1	26.8	6.8	3.5	33.4	0.5	6.6	4.5	8.6	0.0	0.0	0.0	3.9	0.2	0.9	2.7	0.0	2.4	2.0	4.8	9.8	0.6	1.0	8.4	1.1	0.0	0.0	0.0	1.9	7.8	2.9	0.0	0.7	4.0	42.0	0.0	1.2	7.4	3.4	0.0	0.0	0.0	0.8	1.0
FBXO6	"FBG2, FBS2, FBX6, Fbx6b"	ENSG00000116663	"F-box protein 6"	Q9NRD1	1	11664124-11674354	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 55.4;Late spermatids: 93.4;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051175	Approved					NA	NA					"HPA051175: AB_2681372"	"unprognostic (3.23e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (2.65e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (5.90e-4)"	9.1	11.8	10.8	12.2	17.4	19.7	13.2	9.5	11.6	7.6	11.6	4.4	9.8	14.6	5.4	9.1	14.1	15.7	11.1	14.4	9.5	12.6	8.9	17.5	12.2	17.5	9.4	12.2	6.8	25.9	10.4	6.8	5.0	9.1	11.4	7.5	8.9	13.8	9.9	16.8	9.3	9.9	10.6	6.6	14.9	9.8	9.9	8.5	5.8	13.0	13.2	12.1	10.5	6.9	6.0	25.1	23.5	31.0	14.4	18.7	12.2	6.2	4.7	0.5	0.2	1.4	4.6	3.0	2.7	4.2	13.2	6.1	4.7	5.5	0.2	12.4	4.5	3.7	0.1	4.4	4.8	1.0	16.6	0.7	0.1	0.6	4.8	10.3	5.8	0.0	5.3	10.3	1.6	4.2	2.9	1.8	6.7	14.0	12.3	1.2	12.0	2.1	5.0	0.5	6.4	6.3	1.5	0.1	0.5	4.4	0.9	1.1	1.3	5.9	7.1	8.9	1.2	6.8	6.6	1.3	0.7	0.5	1.8	0.2	6.7	4.5	2.4	0.8	13.7	1.2	5.6	19.1	23.5	18.7	28.0	10.3	6.0	5.0	12.5	25.1	5.2	3.0	10.0	15.6	14.4	31.0	9.9	4.7	12.2	10.8	17.4	9.5	11.6	9.5	12.6	9.4	12.2	9.1	8.5	6.0	5.8	8.5	6.2	6.3	4.6	5.6	5.1	37.5	9.1	8.7	2.0	0.8	0.0	13.8	55.4	3.6	9.8	0.0	33.3	7.8	5.8	8.6	3.5	15.3	24.1	4.8	4.7	7.4	14.5	93.4	7.5	27.2	6.8	52.3	7.8	6.7	12.1	10.7	10.6	9.3	6.7	0.0	3.9	2.8	11.7	8.5	1.5	13.8	6.3	6.7
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome		NA	NA			Centrosome		"HPA064246: AB_2685225"	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favorable (1.51e-4)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	22.6	77.8	19.0	25.2	22.3	47.2	22.8	33.5	42.6	19.4	22.3	15.2	37.2	17.4	21.3	26.6	25.1	20.6	22.6	28.7	20.0	23.8	27.3	38.0	40.5	28.9	22.7	30.5	20.6	32.9	32.7	22.5	28.9	30.4	21.3	18.0	21.8	35.3	43.7	32.0	20.9	19.9	26.9	13.8	22.2	27.0	18.2	17.1	13.8	24.8	29.9	18.3	20.7	18.6	16.0	15.6	14.6	24.2	14.8	14.6	8.4	28.0	11.5	10.8	32.0	22.2	18.0	24.9	27.2	27.7	25.1	25.1	22.3	12.2	14.4	18.6	26.8	15.8	17.2	23.3	21.7	32.3	17.8	23.3	34.4	21.2	31.6	18.6	32.6	21.8	23.3	24.0	17.3	17.9	25.4	21.2	14.9	34.0	22.5	26.3	18.5	14.1	21.4	9.5	27.1	16.7	16.4	29.0	17.4	27.5	21.1	38.8	14.8	27.3	20.0	35.8	22.7	30.8	31.9	17.2	36.1	24.8	39.3	30.8	23.8	29.9	22.2	17.4	22.6	19.8	14.6	24.2	13.4	12.8	12.6	14.4	14.4	13.1	12.6	15.6	16.0	14.6	11.1	14.4	14.8	12.2	12.3	13.5	8.4	19.0	22.3	33.5	42.6	20.0	23.8	22.7	30.5	30.4	17.1	71.5	78.7	19.3	17.6	12.6	77.5	35.4	38.2	46.8	60.3	19.2	62.8	34.4	33.2	58.3	113.4	26.9	23.7	116.8	66.7	35.9	19.3	26.9	30.2	57.2	22.4	73.1	28.7	25.2	35.1	96.7	35.6	31.6	18.6	22.6	22.4	61.2	54.3	17.8	30.4	47.7	75.8	19.4	25.5	24.7	22.2	14.2	63.0	28.0	21.1	14.8
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.7;Spermatogonia: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.2	28.8	31.6	17.0	3.1	3.9	20.1	27.7	15.8	33.9	38.6	25.1	23.6	45.1	21.6	11.7	32.0	33.1	44.4	24.2	34.8	23.7	24.5	23.8	39.3	25.6	2.4	37.0	24.7	2.7	3.3	31.3	8.3	5.0	13.2	25.5	36.0	32.7	28.1	39.4	51.6	33.3	34.7	24.6	28.2	35.4	36.6	46.6	13.5	29.6	36.0	29.9	18.5	24.2	15.9	15.5	35.1	26.0	8.8	30.2	38.2	38.4	27.8	25.9	40.2	46.9	21.1	24.8	26.0	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9	0.0	2.1	12.6	4.8	9.2	21.1	4.0	5.1	6.7	3.4	0.0	11.8	28.6	6.6	11.6	16.8	2.7	3.1	23.3	10.5	61.7	7.6	4.4	0.0	6.8	21.8	14.3	4.6	1.3	5.1	9.8	5.2	7.1	5.0	19.0	5.3	29.9	9.3	6.0	6.7	4.7	20.5	0.0	4.2	33.0	63.4	5.4	25.9	14.1	13.0	3.7
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FK506 binding protein like"	Q9UIM3	6	32128707-32130291	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.6	5.6	4.1	2.7	4.7	4.6	7.1	12.1	6.2	4.4	4.5	3.9	8.9	6.0	4.1	8.7	12.7	7.0	4.5	6.0	4.1	3.5	5.9	6.7	4.5	7.7	7.1	2.4	7.0	13.2	6.2	5.0	6.9	5.8	3.8	4.9	3.7	8.0	3.6	5.1	11.5	4.4	5.1	3.6	7.8	6.6	7.6	6.8	10.5	11.6	2.8	6.8	4.7	6.3	3.4	3.7	8.3	4.8	3.3	4.6	1.5	0.0	2.0	4.4	11.9	6.6	4.7	3.8	2.9	3.3	5.5	5.3	9.5	4.0	3.3	3.4	5.1	7.4	2.2	6.2	5.7	3.8	5.9	7.6	0.0	6.6	5.3	3.7	0.0	3.6	4.6	5.8	10.7	6.7	4.1	5.8	8.7	11.1	8.3	5.6	3.2	3.6	4.1	3.3	8.6	1.7	3.0	5.8	7.3	5.7	0.7	8.5	2.0	2.9	5.3	6.4	2.3	9.2	6.4	2.5	8.0	6.6	4.1	7.0	4.4	7.7	3.0	3.1	5.4	4.9	4.9	3.4	2.3	4.6	4.8	4.4	2.8	2.6	3.3	3.7	3.4	3.0	2.9	8.3	3.3	2.5	2.9	1.1	1.5	4.1	4.7	12.1	6.2	4.1	3.5	7.1	2.4	5.8	6.8	6.0	5.1	4.7	3.2	10.0	2.9	2.0	5.1	0.0	4.5	1.8	0.0	8.3	5.0	6.7	2.2	4.5	8.1	0.0	5.9	10.6	7.4	3.3	2.3	2.8	4.5	9.5	5.8	3.7	3.2	4.0	2.6	4.4	6.8	4.6	4.9	6.4	5.4	3.7	3.2	7.7	4.0	0.0	6.2	8.9	8.3	8.9	11.8	6.5	5.0	4.1
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
FMC1	"C7orf55, HSPC268"	ENSG00000164898	"Formation of mitochondrial complex V assembly factor 1 homolog"	Q96HJ9	7	139339457-139346319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 68.3;Collecting duct cells: 80.3;Distal tubular cells: 169.1;Proximal tubular cells: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045663, HPA050553"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045663: AB_2679410, HPA050553: AB_2681173"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.19e-1)"	"prognostic favorable (5.63e-6)"	"unprognostic (1.04e-3)"	"unprognostic (2.39e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (1.50e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.02e-2)"	9.2	9.7	11.2	6.0	16.9	7.0	10.2	6.2	18.6	8.4	8.8	7.2	15.1	8.4	7.1	13.6	6.5	11.5	9.7	26.7	10.3	10.0	12.2	17.5	7.2	7.9	12.8	10.2	10.6	22.1	5.5	10.7	4.4	12.2	12.9	6.2	7.1	14.2	13.2	28.3	5.2	6.0	8.1	9.2	6.0	8.7	6.4	11.9	5.3	15.4	18.7	4.0	7.9	10.9	15.9	15.0	7.4	7.7	10.4	12.1	5.3	2.4	9.1	5.4	5.6	2.9	2.5	2.2	0.8	2.3	6.3	4.6	3.0	3.3	5.9	5.5	2.7	5.8	2.0	5.1	2.2	1.4	2.9	30.8	3.0	9.3	12.7	6.1	2.4	4.0	6.3	4.4	2.0	1.7	2.4	4.8	3.9	5.6	8.6	3.5	17.6	5.8	14.6	5.1	4.2	13.1	3.5	2.7	7.6	4.9	2.3	10.2	6.8	2.8	2.3	3.8	0.9	1.1	1.8	2.3	2.2	2.1	2.7	2.3	3.0	2.9	6.5	5.4	5.3	3.6	7.4	7.7	7.4	8.3	4.6	7.4	15.9	10.3	8.3	8.4	14.6	12.1	8.7	3.5	10.4	5.0	15.0	11.3	5.3	11.2	16.9	6.2	18.6	10.3	10.0	12.8	10.2	12.2	11.9	41.7	34.6	0.0	0.0	0.0	0.0	0.0	0.0	68.3	36.4	80.3	0.0	54.8	169.1	29.3	0.0	0.0	0.0	0.0	30.9	18.2	0.0	0.0	11.6	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	22.6	0.0	0.0	24.3	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2"	"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2	89.3	60.1	0.0	1.0	0.0	0.0	0.3	48.4	17.4	22.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	4.9	0.0	31.8	0.0	0.0	0.6	4.6	51.3	0.0	0.0	27.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	82.6	0.0	24.8	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	33.6	0.0
FZD3		ENSG00000104290	"Frizzled class receptor 3"	Q9NPG1	8	28494205-28574268	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 92.3;Rod photoreceptor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.8;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AF22: 31.1;Karpas-707: 16.0;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024995, HPA042320"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB024995: , HPA042320: AB_2677948"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.69e-2)"	"unprognostic (4.26e-4)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.09e-3)"	2.2	6.4	13.3	3.4	21.1	3.2	5.4	14.4	20.9	5.3	4.4	5.2	8.7	3.2	7.5	15.6	4.4	7.8	3.2	3.0	9.1	7.8	5.7	1.9	2.6	4.3	4.4	14.4	15.0	7.1	8.2	12.5	3.1	9.6	9.6	3.1	4.3	7.0	12.4	2.7	3.3	2.5	5.8	5.4	1.8	5.1	9.9	4.3	1.3	7.4	0.3	3.3	5.2	3.7	1.6	11.8	0.9	0.3	1.1	3.1	0.9	8.2	1.7	31.1	5.8	0.0	0.4	4.8	0.3	0.6	1.7	0.8	1.7	1.7	4.1	1.5	0.2	3.8	2.9	4.7	4.9	1.2	5.1	3.6	2.6	0.6	1.1	0.0	1.4	4.6	0.3	2.6	0.1	1.3	0.3	0.3	4.1	1.9	16.0	0.1	2.0	0.1	3.2	7.8	3.5	2.6	1.8	4.6	3.7	2.4	2.4	22.9	6.2	1.6	4.3	4.8	4.2	4.2	2.2	0.0	0.0	8.4	1.1	2.1	2.9	3.3	3.7	2.4	0.0	1.5	0.9	0.3	0.0	2.2	0.2	2.8	1.6	1.6	3.1	1.2	0.9	2.2	2.3	0.2	1.1	0.0	11.8	0.0	0.9	13.3	21.1	14.4	20.9	9.1	7.8	4.4	14.4	9.6	4.3	8.9	8.1	7.8	6.9	6.0	26.0	5.2	2.5	12.0	15.9	8.7	92.3	9.6	1.7	10.9	12.8	3.0	1.0	0.0	12.8	7.4	7.3	12.2	5.7	2.4	3.3	20.6	27.5	11.6	1.8	11.0	44.5	2.9	32.1	0.0	4.2	15.3	14.2	3.5	48.1	10.2	82.4	25.8	13.9	23.2	29.3	4.1	4.0	2.5	5.5	6.4
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell type enhanced"	"Detected in single"	28	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.5	0.0	0.0	30.5	0.0	10.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 35.4"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 164.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	3.1	1.8	4.0	4.1	9.5	4.4	10.6	1.0	5.1	19.5	13.4	15.4	0.5	11.8	0.9	14.4	2.8	3.7	6.8	0.8	7.1	3.6	2.5	0.8	4.1	4.0	14.4	3.6	1.4	6.3	0.4	1.6	9.9	5.8	1.3	3.9	0.9	23.8	6.3	0.6	5.5	16.9	0.8	8.3	5.5	35.4	0.8	9.7	6.6	1.8	2.3	6.6	2.2	2.2	2.9	3.7	23.8	6.5	10.8	3.4	2.8	11.5	1.2	0.2	0.0	0.0	0.1	18.5	19.3	33.6	8.3	5.6	33.2	6.1	0.1	1.8	10.9	0.0	11.1	0.6	8.4	5.2	2.6	1.2	7.3	0.2	0.2	0.3	3.9	26.1	0.7	7.8	7.4	7.1	0.0	20.3	4.2	1.6	0.3	0.0	22.6	12.4	2.9	1.6	28.5	20.9	0.0	0.0	3.3	6.5	0.8	0.1	7.4	0.1	33.8	0.0	3.9	18.8	1.7	23.9	0.0	4.2	0.0	0.0	0.6	0.1	1.0	2.3	8.7	0.1	4.5	4.4	23.8	3.4	3.7	1.4	0.8	1.7	2.6	3.7	2.9	2.7	2.3	0.8	10.8	6.5	3.1	1.1	2.8	4.0	9.5	1.0	5.1	7.1	3.6	14.4	3.6	5.8	9.7	3.0	3.7	15.2	2.7	2.6	0.4	0.8	2.5	10.7	14.8	1.8	0.0	11.3	3.3	2.7	1.6	1.4	20.4	0.0	9.8	40.7	1.7	5.0	164.7	0.0	13.2	0.0	0.0	2.5	12.0	1.0	0.0	11.8	1.7	1.0	14.2	0.0	15.6	26.2	0.4	1.8	0.0	0.0	0.9	0.2	1.2	8.2	4.0	8.7	9.2	5.4
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89052319-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 125.8;monocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.7;BJ hTERT+ SV40 Large T+ RasG12V: 48.7;GAMG: 38.4"									CAB015450	Approved				"Intracellular and membrane"	NA	NA					"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	32.2	4.9	4.2	30.8	8.8	2.1	12.5	3.1	4.3	18.3	14.7	5.9	4.8	7.3	17.3	11.5	9.4	11.0	19.7	7.1	4.2	4.6	15.5	35.4	38.6	21.6	6.7	3.0	16.5	2.3	8.4	4.2	20.9	20.1	21.4	7.2	5.4	5.9	9.3	17.0	6.3	21.4	18.0	9.0	32.3	9.4	4.6	4.5	12.5	51.3	7.7	12.6	19.2	9.8	4.0	10.8	26.0	30.6	14.1	39.1	18.7	3.5	0.0	0.0	0.0	3.4	6.2	10.6	9.8	19.6	35.7	48.7	1.0	2.5	3.4	6.1	11.5	38.4	0.8	0.0	4.5	16.5	10.6	0.0	0.7	3.3	0.1	21.2	0.0	0.5	15.0	1.8	15.7	2.8	9.7	8.7	5.1	0.0	3.2	11.9	0.0	8.1	0.0	0.1	0.0	0.4	12.0	11.3	0.2	2.3	5.9	0.2	0.0	10.7	2.6	0.9	0.0	0.3	0.0	11.4	10.6	0.4	3.2	7.9	0.1	0.0	0.0	4.1	0.0	1.1	0.1	9.3	1.2	23.4	30.6	22.3	4.0	23.7	24.9	10.8	2.7	18.1	20.8	26.0	14.1	29.3	0.0	39.1	18.7	4.2	8.8	3.1	4.3	4.2	4.6	6.7	3.0	20.1	4.5	68.5	20.8	5.4	125.8	35.1	0.2	2.0	15.3	73.6	33.0	8.7	0.0	34.9	0.0	35.8	0.0	44.3	10.7	0.0	63.6	65.0	39.3	13.4	13.9	65.5	33.4	0.0	8.6	20.9	30.1	0.2	9.2	52.4	5.0	99.2	3.4	9.1	33.3	7.0	24.1	12.8	0.0	12.9	17.0	0.0	0.0	18.7	29.2	17.5	6.1	24.5
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181148-89198932	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 56.2;Endothelial cells: 79.8;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.0;HDLM-2: 8.0;HEL: 10.7;REH: 9.0;RT4: 15.1;U-266/70: 13.6"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	25.4	4.4	3.9	18.4	5.9	3.6	9.4	2.1	5.0	7.8	5.8	4.4	2.9	8.0	10.5	7.4	7.9	6.3	5.7	9.2	4.6	4.4	8.5	9.8	34.7	20.5	5.8	4.4	12.8	2.4	9.3	4.8	9.1	6.9	12.7	4.8	17.4	4.8	4.8	12.0	3.2	11.0	5.1	7.4	23.4	7.4	2.6	2.7	8.1	23.3	5.7	15.2	9.3	7.7	3.3	2.0	5.1	12.6	12.2	7.6	4.4	0.7	0.0	0.1	0.3	0.1	0.1	0.6	1.5	6.4	6.8	6.2	0.1	10.0	0.5	0.9	1.9	0.6	0.8	0.0	0.3	0.3	8.0	0.1	10.7	0.3	0.3	0.9	0.2	0.3	0.3	0.0	0.1	0.0	1.0	1.6	0.2	0.3	2.0	0.0	0.1	5.3	0.3	0.4	0.0	0.1	9.0	0.2	0.3	0.1	15.1	0.2	0.5	0.2	0.5	0.3	0.7	0.5	1.1	0.4	0.2	1.4	0.2	0.1	13.6	0.2	0.3	0.3	0.1	1.9	0.4	3.8	0.4	6.6	12.6	5.8	2.3	7.3	7.3	2.0	3.3	5.5	5.1	5.1	12.2	11.5	0.7	7.6	4.4	3.9	5.9	2.1	5.0	4.6	4.4	5.8	4.4	6.9	2.7	29.8	44.9	10.0	7.8	4.0	2.1	2.8	10.2	56.2	37.5	5.2	7.9	0.7	0.0	1.9	1.5	79.8	2.5	23.3	2.9	1.1	5.6	14.8	20.8	6.4	8.7	0.0	0.0	89.0	20.0	0.5	3.4	22.5	5.0	29.7	2.8	16.2	21.4	1.9	1.8	0.7	10.6	0.0	5.7	2.6	4.5	2.6	1.3	21.3	0.5	12.5
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	13	"granulocytes: 10.4;Kupffer cells: 15.1;Macrophages: 11.7;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;NB-4: 7.5;U-266/70: 16.3;U-937: 23.9"	"Low region specificity"	"Detected in all"							HPA028656	Supported					NA	NA					"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.3	1.5	1.0	29.1	1.5	12.1	1.7	0.7	0.8	2.3	4.4	0.7	0.2	2.0	2.4	3.0	2.6	3.3	4.5	1.5	1.0	1.0	2.6	4.0	14.0	26.2	2.8	0.8	3.4	1.3	0.0	1.5	2.6	1.9	3.8	3.0	3.3	2.4	1.2	0.9	1.2	7.6	2.0	2.9	27.6	3.2	4.5	1.0	7.8	3.6	1.3	24.9	6.8	1.7	1.5	1.5	23.0	9.4	11.6	54.6	7.3	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.9	1.0	0.0	0.1	0.1	5.1	4.1	2.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.4	2.4	0.2	0.0	0.0	7.5	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.5	1.5	0.1	0.0	0.0	3.0	0.1	0.4	0.4	0.0	1.7	16.3	0.3	0.1	0.2	23.9	0.0	0.1	3.5	0.2	23.5	8.7	36.8	1.1	15.5	21.4	1.5	1.5	5.8	9.0	23.0	11.6	9.4	0.1	54.6	7.3	1.0	1.5	0.7	0.8	1.0	1.0	2.8	0.8	1.9	1.0	6.0	6.1	3.7	0.1	0.0	0.0	0.6	2.5	8.1	6.8	0.0	3.9	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.0	0.0	0.4	0.2	10.4	0.6	4.2	0.0	0.0	4.3	15.1	0.0	0.0	11.7	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.1	1.5	0.0	0.1	33.2	0.0	0.1
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 82.5;Intestinal endocrine cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.8	0.0	1.2	0.8	2.2	0.9	0.6	13.3	3.3	0.1	1.8	2.0	5.7	0.9	0.0	5.2	5.0	0.3	0.2	1.9	5.7	0.0	1.2	1.4	1.6	1.9	0.0	0.0	0.4	9.1	0.8	0.0	0.0	6.8	7.2	0.2	1.1	2.9	4.5	5.9	1.4	0.0	1.7	2.8	5.9	29.7	2.5	1.5	0.7	0.3	5.7	1.6	0.2	0.1	2.0	3.7	2.3	5.7	4.3	3.2	2.5	4.6	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1	3.0	4.5	8.1	28.1	66.2	0.0	3.3	5.1	2.7	7.9	5.2	2.0	1.8	6.6	8.3	0.4	11.7	16.0	23.3	8.1	40.5	8.2	17.3	0.0	82.5	5.6	0.0	203.8	6.2	24.0	0.6	0.3	13.3	10.1	6.4	15.2	0.3	9.8	14.0	4.6	38.4	0.2	0.0	15.5	1.1	4.7	66.6	3.5	22.3	8.9	32.9
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GLRX5	"C14orf87, GRX5, PR01238"	ENSG00000182512	"Glutaredoxin 5"	Q86SX6	14	95533503-95544724	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 439.3;Erythroid cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042465, HPA063716"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042465: AB_10794048, HPA063716: AB_2685102"	"unprognostic (2.57e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.83e-10)"	"unprognostic (1.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	13.7	24.1	19.3	11.2	16.9	54.8	9.7	10.5	17.3	7.4	16.6	7.7	8.1	17.6	9.1	10.8	10.7	8.4	12.6	45.3	16.1	14.5	22.5	43.3	7.7	8.4	15.5	9.5	15.8	19.1	8.3	9.4	27.3	10.4	9.9	9.9	13.3	11.6	11.0	68.8	7.9	15.7	12.6	8.3	9.1	12.8	24.2	7.1	19.9	14.8	25.6	9.7	10.0	10.8	6.0	9.9	5.5	4.5	4.8	8.7	3.0	14.0	18.9	8.7	11.5	8.5	6.3	39.3	10.4	6.8	9.0	8.6	24.7	15.4	20.3	15.4	5.2	5.5	14.2	12.9	10.4	7.5	13.3	19.5	17.4	12.1	36.8	9.7	27.7	18.6	7.7	8.6	6.4	9.0	4.1	9.0	15.0	20.6	16.0	6.3	39.5	21.8	28.2	14.8	11.1	21.1	39.8	30.9	12.1	9.9	17.0	23.1	14.4	9.9	12.6	14.2	7.7	19.4	11.9	10.7	5.7	12.7	13.9	14.6	8.7	10.3	15.4	12.5	16.8	13.2	1.0	3.5	5.5	5.2	4.5	6.1	6.0	6.4	7.7	5.4	5.8	5.9	5.8	2.2	4.8	2.7	9.9	8.7	3.0	19.3	16.9	10.5	17.3	16.1	14.5	15.5	9.5	10.4	7.1	26.8	28.8	35.7	48.6	96.4	37.5	144.4	68.8	8.1	12.5	90.7	31.4	78.3	439.3	9.8	246.8	42.7	50.7	490.6	13.4	138.0	62.7	73.1	14.9	132.8	51.0	47.7	51.9	30.7	26.9	69.9	50.3	48.4	82.7	7.2	63.3	72.3	13.6	31.6	69.3	215.3	32.2	58.2	72.1	35.6	88.2	109.2	45.0	39.2	74.7	69.4
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 272.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.9	14.8	37.6	15.5	5.3	5.7	25.1	24.5	13.0	29.5	32.4	28.7	9.0	25.1	31.3	7.9	21.7	14.7	32.5	18.1	31.8	9.3	34.0	34.4	26.4	47.0	5.0	26.7	12.6	4.6	5.9	17.9	7.0	6.1	14.5	19.6	43.2	13.4	20.8	19.5	50.1	28.9	20.5	20.4	11.7	29.2	29.4	32.2	12.4	21.8	30.2	18.6	11.0	18.2	21.6	22.1	19.1	16.4	7.1	18.1	18.3	20.8	41.5	14.9	45.7	47.1	5.5	50.4	25.9	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9	6.0	14.1	15.7	25.3	29.3	8.9	9.4	15.3	33.5	52.4	41.8	2.0	52.0	8.3	78.3	58.9	14.3	21.2	0.0	100.1	110.5	15.8	27.7	12.7	15.3	45.0	11.1	24.9	9.8	9.2	17.5	8.9	12.4	21.9	19.8	24.9	29.4	43.9	272.7	10.3	14.6	12.1	19.4	12.3	132.2	59.4	55.6	40.7	17.5	87.0	19.7
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238580-16295549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 72.9;Erythroid cells: 186.9;Glandular cells: 74.5;Melanocytes: 87.7;Peritubular cells: 76.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8;NK-cell: 8.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEL: 46.2;HMC-1: 78.9;SK-MEL-30: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		3800000			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	2.8	7.3	14.6	1.4	11.0	9.6	6.5	3.8	6.9	2.7	3.7	9.1	2.0	1.5	4.2	7.9	2.5	22.4	1.9	31.5	13.3	11.5	10.3	2.7	3.7	2.5	14.0	5.7	15.7	7.4	4.4	6.8	3.4	21.3	25.5	1.8	22.0	5.2	4.2	103.3	4.3	1.5	4.3	11.8	3.3	8.3	25.1	10.9	1.4	2.7	16.2	1.5	2.0	1.2	0.7	1.3	7.8	4.2	8.3	1.0	14.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.9	3.8	6.8	13.9	0.3	0.1	0.0	2.2	1.4	4.8	0.0	1.6	0.2	1.1	0.0	1.2	46.2	0.0	0.0	3.0	0.2	78.9	0.9	0.7	2.1	0.0	5.6	12.2	0.1	10.3	0.0	1.2	0.9	0.0	0.9	0.4	0.0	1.8	0.0	10.4	0.0	9.0	1.3	2.3	0.3	0.4	0.8	17.6	3.1	0.7	0.3	3.0	0.1	0.0	0.3	1.8	0.5	0.0	0.0	0.2	4.9	5.3	7.8	2.9	0.4	0.6	4.2	1.0	0.2	0.1	0.4	1.3	0.7	0.0	0.2	3.0	8.3	1.3	1.2	0.0	14.1	14.6	11.0	3.8	6.9	13.3	11.5	14.0	5.7	21.3	10.9	0.0	0.0	0.5	29.7	4.5	0.9	50.8	22.9	8.1	2.3	19.2	0.0	23.1	72.9	10.6	10.2	5.8	0.8	186.9	4.4	2.8	6.1	74.5	56.3	2.9	8.0	0.0	7.5	11.1	2.2	8.5	31.9	4.3	87.7	10.8	2.3	7.3	3.2	0.3	76.0	10.4	0.4	0.0	8.5	4.7	17.0	1.6	5.7	1.3	2.5	5.8
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	14.1	5.0	9.6	5.6	9.2	11.1	7.9	10.7	8.6	10.9	10.9	7.6	4.9	7.6	7.1	11.4	6.7	7.5	9.0	10.9	15.3	8.5	5.5	6.6	8.6	6.5	7.9	10.3	6.1	8.2	9.3	12.6	8.7	7.6	13.1	5.8	8.6	7.5	10.8	9.6	7.9	8.4	9.6	6.8	5.8	5.7	22.6	4.9	12.1	10.8	6.2	10.8	7.5	8.5	11.7	7.8	6.5	9.1	11.8	9.2	12.7	13.8	12.1	8.0	9.0	8.8	15.3	10.2	14.3	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0	41.7	29.8	72.9	89.8	134.3	27.1	11.7	28.1	46.8	34.2	55.8	329.9	74.3	54.7	94.8	7.0	65.3	47.7	23.3	88.0	115.2	72.4	62.2	45.1	49.5	96.4	23.8	80.9	47.9	103.4	6.0	45.1	89.9	70.9	77.5	58.1	44.4	82.3	52.6	44.6	40.9	23.4	51.8	82.4	64.2	49.4	164.6	89.4	82.8	47.9	147.8
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 1781.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.7	32.8	55.4	25.8	94.2	43.0	49.8	56.4	51.6	64.5	46.3	95.8	50.6	32.0	87.9	73.2	46.2	42.3	50.8	75.1	43.7	21.1	30.6	35.6	49.9	62.7	43.5	20.7	22.4	51.3	38.2	31.3	42.2	51.2	48.9	39.5	31.2	43.7	42.5	133.6	105.4	50.6	17.6	6.4	34.7	64.9	48.5	56.5	51.7	38.7	68.7	157.4	78.4	77.9	62.9	50.7	59.5	56.7	53.7	85.7	77.0	30.8	53.1	76.8	49.5	67.6	37.6	10.1	43.7	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4	205.4	224.1	189.5	151.9	115.9	363.0	884.0	242.0	250.3	255.9	247.7	53.0	672.6	376.4	220.5	577.5	343.9	323.7	303.7	196.1	292.5	221.9	260.9	133.0	165.2	333.8	1781.3	444.7	335.7	327.9	1338.6	245.7	276.8	210.9	147.9	250.3	861.2	313.5	239.3	185.3	130.9	175.1	207.0	226.4	48.2	25.4	103.0	1013.3	142.4	268.2	212.5
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.7	15.4	18.3	31.7	24.0	37.7	18.0	24.8	31.9	20.1	21.9	20.9	41.8	22.9	11.3	22.1	37.2	44.6	13.0	19.6	13.9	42.3	22.9	26.4	17.1	22.5	25.3	50.9	14.0	19.6	24.1	35.3	36.1	22.8	21.2	23.8	21.9	22.3	22.5	21.9	30.2	16.1	24.4	15.7	18.5	26.1	39.1	40.9	21.5	19.3	55.3	21.3	33.7	23.5	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2	14.9	47.4	26.7	52.5	56.2	7.6	18.2	5.1	73.6	79.6	7.0	9.8	32.5	23.2	37.6	45.3	20.2	13.4	0.0	54.2	43.6	26.3	29.5	46.2	16.2	28.9	6.4	16.6	11.6	17.1	7.8	22.2	29.8	8.5	36.1	16.0	19.1	39.6	17.8	18.0	12.9	8.6	0.0	33.0	50.5	54.9	46.2	38.6	26.7	19.7	42.6
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13771031-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 219.5"	"Cell type enriched"	"Detected in many"	6	"Muller glia cells: 1904.1"	"Group enriched"	"Detected in many"	14	"glioma: 192.5;melanoma: 41.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	222	"plasmacytoid DC: 33.4"	"Lineage enriched"	"Detected in single"	240	"dendritic cells: 33.4"	"Cell line enhanced"	"Detected in some"		"AF22: 42.8;AN3-CA: 42.4;ASC TERT1: 21.8;HSkMC: 32.1;SK-MEL-30: 42.1"	"Low region specificity"	"Detected in all"							HPA002913	Approved					NA	NA					"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	4.6	5.5	68.4	3.9	55.1	2.0	12.4	24.1	219.5	10.2	5.7	68.7	1.1	3.6	4.3	6.7	6.4	4.2	3.9	5.9	62.6	33.1	4.5	2.0	6.7	2.6	68.9	47.3	3.1	2.9	1.9	2.6	2.1	44.1	9.9	4.9	3.2	7.4	16.9	2.1	7.1	4.3	3.8	109.4	7.2	3.3	3.0	64.8	0.0	3.5	0.0	2.3	3.3	2.7	0.1	33.4	0.1	0.0	0.1	0.1	0.2	0.1	0.1	42.8	42.4	12.1	21.8	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.3	2.1	0.2	0.0	0.1	7.0	0.1	2.8	0.1	0.4	0.1	0.2	32.1	0.2	0.0	0.5	0.1	0.0	0.8	0.1	1.9	0.4	0.1	0.9	0.1	13.4	0.0	0.7	0.5	3.8	6.5	0.0	0.1	2.1	1.2	0.2	1.2	42.1	12.3	0.2	0.9	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.4	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	33.4	0.0	0.2	68.4	55.1	24.1	43.1	62.6	33.1	68.9	47.3	44.1	64.8	0.0	3.2	20.4	22.0	29.3	74.8	1.1	0.0	13.4	5.7	21.0	82.5	3.8	0.0	3.2	0.4	6.3	3.8	0.0	3.3	2.8	24.2	20.1	4.6	0.4	1.0	25.4	1.2	16.5	1.0	1.5	22.5	1.8	339.1	2.8	2.6	1904.1	1.9	3.2	30.1	0.6	143.8	45.3	22.6	4.3	9.4	14.9	11.4	15.2	2.9	12.6
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 11.0;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	13.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	12.5	0.7	0.0	2.2	0.0	0.9	0.0	0.0	2.7	0.0	0.0	0.0	10.8	0.9	0.2	21.5	0.0	0.0	0.0	0.0	0.0	10.4	5.8	2.3	8.2	2.8	0.0	0.0	2.9	7.5	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6	0.0	1.4	0.0	4.0	1.6	11.0	2.8	5.1	2.7	2.3	12.2	3.9	1.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	1.1	0.9	4.5	0.0	0.0	1.0	0.0	1.2	0.0	5.1	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.4	0.0	1.1	0.0	0.3	0.0	0.4	0.2	0.9	1.5	0.2	0.0	0.0	1.8
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell type enriched"	"Detected in many"	36	"Muller glia cells: 779.4"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		48000	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	22.0	0.3	0.2	2.8	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.8	0.0	0.1	0.0	4.5	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.4	0.0	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	10.6	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0.0	0.0	0.0	0.3	4.0	21.7	0.4	2.5	0.0	0.0	1.8	5.9	7.1	0.0	4.3	0.2	0.5	0.0	0.0	0.5	15.1	2.7	2.1	0.0	21.5	1.0	17.5	0.0	0.0	0.3	0.9	2.6	0.0	3.3	1.0	0.4	779.4	0.4	0.0	0.7	0.0	12.5	0.0	0.9	0.6	0.7	8.9	2.5	0.0	0.0	0.1
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	27.1	50.8	18.9	24.7	13.4	12.9	26.8	18.3	14.7	29.1	24.1	44.4	17.0	13.5	16.5	18.3	21.2	20.7	18.0	23.4	9.9	8.9	64.3	22.8	28.5	49.2	22.3	24.8	22.1	18.5	17.2	25.7	15.4	11.7	30.3	23.4	21.3	15.6	16.1	53.7	42.2	28.2	24.0	26.2	38.0	26.0	26.0	21.9	17.9	28.4	32.5	50.9	18.6	34.5	27.0	15.1	39.1	22.5	17.2	29.1	34.5	22.4	29.3	28.7	12.0	14.2	22.7	16.0	26.1	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2	11.9	21.9	21.6	19.7	22.2	28.4	50.0	28.1	32.1	18.2	19.2	23.6	60.9	51.4	48.6	24.6	27.5	66.9	23.3	60.4	58.8	33.4	21.0	24.3	47.8	53.5	46.1	39.6	30.7	32.4	58.5	27.9	36.5	32.1	45.9	33.5	36.5	43.4	45.6	29.7	84.8	24.9	6.5	35.6	48.3	48.5	26.2	45.2	25.8	42.2	17.0
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
GUCD1	"C22orf13, LLN4, MGC1842"	ENSG00000138867	"Guanylyl cyclase domain containing 1"	Q96NT3	22	24540423-24555935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022786			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022786: AB_1845711"	"unprognostic (1.58e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (2.83e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.01e-2)"	16.7	12.8	7.6	13.6	7.2	25.8	19.0	5.1	7.5	9.0	37.4	8.7	9.7	23.3	7.8	9.8	14.3	7.4	19.7	35.7	7.0	5.6	29.3	73.3	12.2	11.9	8.0	5.3	10.2	30.0	7.0	6.7	11.3	6.8	11.7	12.8	9.0	8.7	8.7	28.9	8.8	59.9	13.5	8.0	14.9	15.8	9.1	5.7	13.4	10.6	14.5	13.8	14.3	8.0	23.3	6.5	23.7	7.0	3.3	4.4	5.5	13.9	13.1	11.7	14.3	24.6	23.1	9.3	13.9	22.4	24.4	23.9	19.9	10.9	26.5	9.1	18.9	15.1	18.6	13.4	16.2	13.1	25.4	16.2	11.3	13.0	18.1	19.9	29.3	22.4	23.3	13.0	24.3	11.2	15.0	25.7	13.3	11.3	26.6	18.3	16.5	16.9	12.6	11.0	35.2	11.3	19.5	19.0	26.0	19.1	15.5	12.2	12.0	16.7	22.8	11.9	9.5	18.0	20.9	17.1	52.6	21.7	16.3	11.7	25.9	17.7	18.6	21.6	16.5	17.7	7.8	7.0	23.7	3.8	7.0	4.4	18.6	3.6	3.9	6.5	23.3	3.5	3.9	7.4	3.3	6.6	4.7	3.4	5.5	7.6	7.2	5.1	7.5	7.0	5.6	8.0	5.3	6.8	5.7	14.9	23.9	38.4	10.3	11.0	4.9	45.6	94.3	2.7	10.3	5.2	5.9	15.8	44.7	22.0	10.3	15.4	117.4	46.7	56.9	16.4	16.6	31.1	15.0	103.6	23.7	3.2	19.0	20.9	20.4	5.8	17.5	13.3	16.9	33.3	46.5	13.7	39.7	66.2	15.2	65.8	12.4	25.8	17.9	20.5	32.8	9.7	13.6	9.5	37.7	15.7
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999515-21031636	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 44.7;Ciliated cells: 89.7;Hofbauer cells: 50.9;Kupffer cells: 90.6;Macrophages: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.8;HDLM-2: 9.6;TIME: 7.9;U-937: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA					"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	4.3	7.9	4.9	9.2	7.1	16.3	10.3	3.3	3.1	8.9	10.1	2.6	1.2	3.2	6.9	5.6	10.7	6.5	7.6	7.5	4.1	3.2	3.3	1.8	24.1	18.2	5.2	1.8	6.5	1.9	4.0	2.3	9.9	3.7	5.9	5.0	6.3	3.6	3.8	1.5	4.7	7.5	11.5	9.6	10.1	5.4	1.8	5.5	19.9	4.1	6.2	7.9	5.1	5.6	1.2	8.4	13.6	8.8	3.0	3.0	3.9	3.7	1.1	0.4	0.1	0.0	0.1	0.1	3.4	15.8	2.8	3.2	0.0	0.0	3.4	1.9	6.7	0.0	1.0	0.2	1.4	3.5	9.6	0.1	0.0	1.2	0.0	2.2	2.8	3.0	6.4	6.2	2.5	0.0	0.0	0.9	3.9	0.0	2.0	0.5	0.1	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.8	0.3	0.0	2.3	2.8	5.3	7.9	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	12.1	0.1	13.6	7.1	11.4	2.2	8.8	2.0	1.2	2.4	2.5	8.4	1.2	1.7	2.4	10.2	3.0	8.5	0.9	3.0	3.9	4.9	7.1	3.3	3.1	4.1	3.2	5.2	1.8	3.7	5.5	44.7	6.7	16.7	9.5	0.0	1.4	1.6	0.0	89.7	20.5	12.2	0.0	10.0	5.0	0.5	0.4	3.3	0.0	0.0	0.4	30.5	7.8	3.2	3.5	1.3	50.9	0.0	0.0	9.8	90.6	0.0	3.4	52.2	0.0	14.4	0.0	6.7	0.1	0.0	1.1	5.1	1.5	12.9	7.3	0.3	1.3	0.0	4.2	28.8	0.1	3.8
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favorable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.7	11.3	43.1	23.2	11.1	17.2	11.6	18.3	18.3	29.4	29.2	11.1	10.6	35.8	11.1	13.1	13.6	20.0	25.8	15.6	32.4	20.1	17.3	26.3	12.2	20.9	9.3	47.9	16.2	8.3	6.2	18.1	9.3	13.0	32.0	25.8	18.7	10.2	26.1	10.9	37.9	23.0	27.5	9.0	6.7	38.1	30.9	25.6	23.2	13.2	20.3	21.1	17.0	5.9	13.8	17.8	8.6	23.3	18.0	17.2	11.7	7.4	19.1	12.0	18.2	33.2	11.0	40.7	19.6	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4	11.9	12.6	27.6	18.2	15.5	4.5	8.7	15.3	30.8	33.0	14.0	3.9	42.3	14.9	32.5	5.8	26.6	9.0	0.0	37.0	91.5	29.6	7.0	28.9	7.7	44.3	11.1	11.6	17.8	38.3	8.6	21.0	31.9	20.3	43.3	22.2	18.1	25.9	10.5	24.4	18.9	8.0	19.4	16.5	51.9	57.7	13.6	19.8	25.9	26.4	6.7
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742107-156766925	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm		NA	NA		300000	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	27.6	24.0	24.4	26.4	24.6	78.7	51.5	26.7	22.1	29.7	57.9	22.4	23.9	40.6	22.1	22.9	53.0	34.9	38.1	41.7	23.5	18.3	64.5	92.6	38.0	32.6	23.7	12.9	29.0	35.3	25.6	19.0	49.1	20.4	21.3	37.5	15.9	26.5	30.6	57.2	39.2	83.1	21.7	25.5	30.0	25.6	11.8	22.4	79.0	38.3	64.8	44.0	30.9	29.6	7.5	14.5	10.4	12.3	6.1	9.7	7.8	72.9	36.2	41.6	19.8	24.1	33.2	46.0	24.2	61.9	56.8	37.2	40.9	78.0	49.4	47.9	48.2	25.3	51.7	61.9	54.4	56.6	40.0	43.9	42.2	52.6	35.7	32.1	61.8	35.7	23.8	52.2	44.4	86.8	45.3	41.8	39.1	55.2	41.4	46.2	53.7	50.9	68.5	73.5	117.0	51.4	57.5	24.9	65.9	62.4	24.7	62.2	67.6	57.8	76.5	29.1	53.8	61.1	96.1	36.9	28.8	44.7	36.4	61.4	55.9	69.4	86.0	38.3	49.2	36.6	6.0	12.3	10.4	8.5	10.4	6.3	6.7	7.3	7.5	14.1	7.5	6.6	6.2	7.1	6.1	11.4	14.5	9.7	7.8	24.4	24.6	26.7	22.1	23.5	18.3	23.7	12.9	20.4	22.4	65.5	86.4	36.5	146.2	130.9	60.7	81.8	79.0	123.1	80.8	68.0	25.5	38.8	68.0	89.5	37.7	46.6	109.5	70.0	112.1	90.8	73.3	173.1	30.0	144.0	46.2	50.9	119.7	27.6	33.2	33.1	37.7	55.8	37.1	37.9	83.0	56.2	134.0	51.8	43.2	94.2	31.4	19.4	48.5	28.7	24.6	139.4	45.9	41.5	82.1	206.9
HEXIM2	FLJ32384	ENSG00000168517	"Hexamethylene bisacetamide inducible 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 121.3;Late spermatids: 208.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.0	7.7	8.3	4.2	8.0	3.6	3.4	9.0	11.8	4.3	4.8	5.0	6.5	8.8	4.3	5.6	4.2	5.1	7.9	6.3	6.7	6.2	9.3	9.6	4.1	5.6	7.8	6.7	5.7	9.3	7.5	6.1	3.0	6.6	5.1	2.5	6.9	9.9	5.5	36.4	5.6	6.4	4.3	5.4	5.2	6.9	27.7	6.4	6.4	9.1	6.6	3.0	4.7	4.7	9.7	13.2	10.0	12.2	7.3	8.6	13.3	5.0	18.2	4.0	8.9	4.5	7.4	7.7	2.8	3.4	4.6	5.1	6.9	13.5	3.1	14.8	2.0	2.3	8.4	3.9	3.4	1.4	7.2	6.3	2.3	17.0	30.9	3.2	2.0	5.2	6.4	3.3	4.0	1.4	8.9	2.2	6.5	2.5	7.8	2.1	8.7	3.2	4.3	4.4	7.1	8.0	4.3	6.1	9.5	5.8	5.0	4.8	4.2	2.5	5.1	11.7	3.0	13.6	3.4	2.2	8.3	4.4	5.5	6.6	12.2	12.9	2.9	6.5	3.7	6.2	8.4	12.2	10.0	5.4	9.7	8.6	9.7	3.8	6.1	10.3	6.5	3.0	5.3	8.3	7.3	3.0	13.2	4.6	13.3	8.3	8.0	9.0	11.8	6.7	6.2	7.8	6.7	6.6	6.4	0.0	1.0	4.7	3.5	1.8	12.7	0.2	5.1	0.0	1.2	1.8	3.9	10.7	16.6	3.9	121.3	4.0	4.0	0.0	1.4	4.5	3.4	1.8	6.9	6.2	6.3	3.2	4.6	2.5	7.0	208.9	5.5	2.8	3.3	4.6	4.3	8.0	2.1	3.5	6.7	26.1	10.6	0.0	3.4	18.2	12.0	2.6	5.1	1.3	4.1	1.6
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140455-43202855	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029578	Approved					NA	NA					"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	24.8	16.9	21.4	16.0	18.8	16.0	29.6	18.5	20.6	28.5	17.8	20.3	24.5	15.4	27.5	29.7	20.4	24.0	22.1	18.7	18.0	16.5	16.9	19.9	21.8	14.9	12.9	19.8	31.1	28.8	26.5	24.8	25.6	15.7	21.6	14.7	20.9	20.7	20.7	11.9	29.5	18.1	25.3	18.2	14.9	18.6	8.5	11.7	9.1	21.9	18.4	18.2	21.1	23.2	2.3	14.5	8.3	8.0	8.2	3.1	4.0	11.7	15.9	4.0	8.0	32.8	24.8	6.0	13.4	16.0	9.8	8.7	2.2	17.3	7.1	9.3	18.6	7.0	6.8	1.7	8.1	5.7	2.8	3.2	7.0	10.1	3.9	10.5	1.5	1.1	16.6	11.7	5.4	11.2	15.7	17.3	3.1	3.2	10.0	17.8	5.3	6.3	3.1	3.8	7.0	2.4	0.7	7.3	3.5	16.1	9.9	2.1	6.3	17.5	5.6	7.7	8.9	19.4	9.0	20.2	15.1	2.5	9.3	5.5	8.1	7.6	2.6	12.1	2.8	9.2	0.2	8.0	8.3	2.8	5.0	3.1	1.8	2.3	2.8	14.5	2.3	1.7	1.9	3.0	8.2	7.2	1.9	1.5	4.0	21.4	18.8	18.5	20.6	18.0	16.5	12.9	19.8	15.7	11.7	14.9	32.2	9.1	18.6	16.0	43.5	9.6	22.9	14.7	6.8	48.8	47.1	30.0	3.3	25.0	0.4	30.9	25.7	0.0	24.4	35.2	27.7	19.3	8.1	19.2	26.1	23.8	23.2	42.4	29.7	1.4	32.5	31.5	18.6	19.0	24.3	19.7	25.8	17.5	29.7	9.7	37.8	25.8	22.6	1.2	1.9	18.4	25.2	15.2	18.7	14.3
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	10.9	9.2	13.8	15.1	16.7	17.5	10.8	12.7	10.6	8.8	21.6	9.8	7.6	14.3	16.0	27.6	13.8	13.8	23.3	15.7	24.8	7.7	14.0	10.0	13.2	14.3	23.4	6.0	11.7	31.3	8.1	41.4	12.0	20.8	19.5	9.8	7.4	24.0	46.1	19.6	11.1	17.5	21.5	7.6	13.3	15.9	12.0	14.9	16.0	10.4	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.0	40.0	18.3	17.9	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2	20.8	10.8	63.0	60.5	40.3	34.2	96.4	124.9	53.5	13.6	76.8	19.6	143.0	537.2	101.9	54.3	49.6	142.5	46.7	149.8	55.2	58.2	44.3	18.4	366.2	96.3	19.1	92.3	63.3	58.2	111.5	37.4	47.7	114.7	71.3	106.7	69.3	83.1	158.4	42.1	463.5	36.6	45.3	71.8	32.1	82.2	40.1	47.5	67.1	120.6	54.5
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 50.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	9.9	9.8	14.8	10.0	13.6	19.9	7.4	16.7	16.3	8.0	11.7	10.9	9.4	12.4	11.9	8.4	9.7	11.5	10.0	9.2	13.4	11.6	12.8	15.0	9.1	11.4	11.3	10.0	10.8	11.3	25.6	11.4	7.6	9.8	7.6	9.4	8.9	8.6	8.7	15.3	10.8	12.1	10.3	8.3	10.2	10.1	10.5	10.6	20.3	50.0	4.6	10.0	8.9	18.2	8.2	2.9	6.1	1.2	3.6	2.4	1.2	8.1	7.1	10.1	10.4	9.9	6.5	7.1	6.8	7.9	11.3	11.2	16.2	4.7	15.7	3.4	8.8	6.8	9.6	14.3	8.6	7.3	9.8	16.6	14.6	7.7	14.8	10.8	33.7	10.8	7.9	8.4	8.8	8.7	6.1	8.1	15.9	74.9	8.4	6.4	10.0	16.5	12.0	9.2	19.2	7.2	13.2	14.4	4.6	6.5	9.0	14.8	9.9	7.8	7.9	9.4	5.3	5.0	11.8	9.4	7.8	11.6	7.9	8.0	9.0	8.9	16.5	9.0	10.9	6.4	6.1	1.2	5.0	2.3	1.2	2.4	3.7	1.3	2.3	1.5	8.2	0.6	1.7	2.2	3.6	0.6	2.9	0.6	1.2	14.8	13.6	16.7	16.3	13.4	11.6	11.3	10.0	9.8	10.6	6.0	0.3	6.9	1.9	8.1	8.5	2.0	5.1	0.0	0.0	5.2	2.0	3.2	5.0	5.3	5.7	3.6	7.0	0.0	7.7	3.0	4.1	3.8	0.0	18.1	5.6	15.9	2.4	7.4	10.8	1.6	4.6	2.5	10.1	3.6	8.5	4.5	6.6	10.8	6.3	9.3	4.0	6.5	4.2	7.1	7.5	9.3	2.5	3.3	13.3	1.8
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P04439, P13746, P16188"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 4504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	158.0	4.0	0.0	0.0	25.5	24.1	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.0	42.3	21.5	3.9	0.0	43.4	0.0	0.3	1.6	27.6	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	21.2	0.0	0.1	0.0	0.0	0.1	2.5	0.3	0.0	0.4	3.3	0.3	41.2	29.6	32.5	0.0	1.4	3.5	0.0	1.4	10.4	0.2	3.7	0.6	2.4	0.1	0.7	0.5	42.1	10.7	8.9	0.0	23.3	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3	345.4	508.3	1064.2	718.5	760.7	31.3	128.4	937.6	317.2	366.3	478.1	5.9	16.7	74.6	2692.4	38.8	1227.5	2851.3	186.9	1168.0	15.8	685.4	823.3	585.8	217.5	1814.8	35.0	917.5	1170.5	1323.9	66.9	652.4	1239.0	602.3	4504.1	1496.2	150.9	1505.1	2283.0	455.0	258.2	20.0	549.7	859.0	132.4	24.5	828.4	26.5	2218.3	1070.6	1059.3
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32817048	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.1;lymphoid tissue: 33.0"	"Group enriched"	"Detected in some"	6	"B-cells: 90.0;monocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 42.0;naive B-cell: 51.1"	"Lineage enriched"	"Detected in many"	19	"B-cells: 51.1"	"Group enriched"	"Detected in some"	5	"Daudi: 33.5;U-698: 11.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013846	Enhanced					NA	NA					"HPA013846: AB_1853928"	"prognostic favorable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	0.7	0.4	0.3	28.8	0.3	2.7	1.4	0.7	0.3	1.2	2.7	0.4	0.0	1.7	0.7	0.5	1.3	0.5	1.4	2.2	0.2	0.4	1.8	0.7	3.3	33.0	0.4	0.2	0.5	0.2	0.0	1.8	0.5	0.8	0.7	2.4	0.7	3.8	0.9	0.4	1.0	12.2	0.2	0.7	28.5	1.4	1.7	0.1	5.8	1.1	0.9	29.8	5.5	0.8	51.1	2.6	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	1.7	33.5	0.1	0.1	0.0	0.2	1.0	1.8	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.6	0.3	11.8	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	2.6	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.3	0.3	0.7	0.3	0.2	0.4	0.4	0.2	0.8	0.1	0.0	4.5	90.0	0.1	0.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	1.0	0.5	0.0	0.0	0.2	0.3	0.4	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.0	3.9	13.5	75.7	0.0	0.6	0.2	0.0	0.0	0.0	0.7	6.5	0.3	0.0	0.2	1.4	0.0	1.0	0.0	0.3
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 108.8;U-698: 98.0"									HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062583: AB_2684800"	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.7	16.7	52.8	27.5	2.2	6.6	65.8	16.6	10.9	19.3	10.0	13.2	15.7	26.5	53.5	12.7	10.9	18.2	48.1	108.8	21.8	18.0	14.0	23.0	16.2	20.8	3.3	34.6	11.7	5.2	25.8	7.9	20.0	4.9	24.9	16.3	11.9	15.7	22.9	29.0	38.1	26.6	31.3	24.8	20.5	46.8	43.0	15.0	14.2	18.1	38.1	24.9	24.7	26.6	8.2	31.5	23.5	22.9	18.7	8.0	19.0	25.5	36.5	14.3	17.8	98.0	9.6	17.7	16.3	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2	35.7	27.4	16.2	16.0	21.1	0.5	13.2	10.2	145.9	134.2	29.6	2.0	337.0	31.5	72.8	184.3	11.3	24.9	186.9	75.5	539.5	20.8	18.7	8.1	72.9	88.3	0.0	63.0	10.4	18.3	46.6	3.4	26.0	20.3	35.1	29.3	3.1	76.6	25.9	3.2	39.4	1.4	0.0	8.3	19.9	49.6	17.8	1171.0	14.0	52.8	17.0
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell type enhanced"	"Detected in many"	24	"Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 35.4;RT4: 63.6"	"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		NA	NA		820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.2	0.2	0.0	63.6	0.0	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3	3.0	6.7	7.5	3.6	0.1	0.0	4.5	68.8	0.0	0.0	29.6	0.0	0.2	0.0	0.0	1.5	0.0	76.1	0.0	0.0	0.1	0.0	10.3	4.6	901.4	0.2	0.0	70.2	16.0	17.8	2.7	1.4	0.0	5.0	0.0	249.3	0.0	0.1	126.7	0.0	0.3	0.0	6.5	0.0	0.5	0.4	0.3	7.9	0.0	248.3	15.4
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.0;Karpas-707: 66.4"					"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.9	28.8	5.0	1.6	1.2	1.6	2.5	0.4	0.7	0.7	10.9	45.0	5.1	0.7	0.4	1.9	34.8	4.1	1.1	26.3	13.9	18.8	21.2	0.3	0.5	31.2	18.6	1.3	1.1	1.8	1.7	1.6	2.3	29.0	24.8	66.4	2.9	1.0	28.4	11.1	26.2	6.3	7.6	1.1	24.6	21.2	7.1	0.8	0.2	0.7	0.2	0.6	1.9	5.3	3.6	7.4	2.6	0.9	7.7	4.5	6.1	4.6	1.9	7.2	2.8	12.3	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6	8.9	13.1	10.4	21.3	14.2	2.8	11.3	17.8	72.3	14.8	43.6	0.0	0.5	58.0	9.9	14.1	16.1	17.1	70.0	16.2	0.4	10.2	18.1	12.7	74.1	13.2	1.6	16.7	19.0	13.3	43.8	27.3	13.9	8.5	1.0	22.4	20.4	6.7	17.5	38.5	60.3	1.5	45.3	19.4	7.2	8.4	13.0	0.3	7.5	39.1	17.4
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204507-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		380000	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	34.9	41.7	16.5	47.8	18.4	44.6	32.5	17.9	19.1	30.0	54.0	20.4	24.9	37.0	33.9	23.0	50.9	27.3	38.6	44.4	15.4	17.8	50.0	72.4	29.8	36.5	20.6	12.4	39.1	39.1	25.5	20.5	36.7	16.8	26.8	47.1	19.4	31.3	26.7	53.3	43.4	55.0	38.7	18.9	53.5	31.9	26.5	15.9	75.6	34.6	46.3	41.3	38.7	36.8	5.9	11.4	15.1	7.2	5.7	6.6	2.2	46.1	38.5	59.4	57.4	22.0	19.4	85.9	52.0	24.1	41.6	44.9	70.9	34.7	74.8	48.0	27.8	50.8	30.6	51.4	70.6	51.7	115.6	60.6	47.0	31.0	43.3	22.0	59.4	40.1	19.1	33.4	37.3	37.6	17.2	37.2	30.0	38.3	34.2	41.7	124.3	71.6	57.4	54.4	47.6	55.5	58.5	35.8	44.3	35.1	49.5	54.7	42.6	40.5	56.6	36.6	38.8	33.9	36.4	33.3	50.9	43.0	35.8	71.0	40.1	46.8	88.0	20.6	65.8	41.2	2.8	4.8	15.1	5.5	7.2	6.2	5.9	4.6	6.6	4.6	5.0	4.5	5.3	0.9	5.7	7.1	11.4	4.8	2.2	16.5	18.4	17.9	19.1	15.4	17.8	20.6	12.4	16.8	15.9	29.8	43.7	80.2	123.5	250.0	24.2	39.9	48.4	25.4	44.3	47.1	17.7	71.8	43.1	103.9	4.5	77.1	177.1	93.5	130.6	169.9	80.3	113.7	44.9	96.2	90.6	15.9	114.3	57.1	60.6	7.9	68.4	88.9	64.1	41.5	155.2	31.3	147.7	149.7	82.7	85.7	26.4	77.6	138.6	57.6	139.0	297.1	95.7	42.1	166.2	201.2
HNRNPC	"hnRNPC, HNRPC"	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C (C1/C2)"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1400000	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	41.1	53.9	51.8	51.1	64.0	71.6	55.1	72.1	65.5	49.6	41.9	45.3	47.3	35.3	51.0	51.1	53.4	54.3	38.0	41.1	47.9	45.1	50.0	51.9	43.0	76.7	54.8	42.1	72.8	57.8	38.3	63.3	54.7	43.7	45.2	47.8	43.9	36.0	44.5	44.5	39.8	39.5	57.6	54.8	55.8	37.4	62.4	52.4	49.3	53.0	37.9	75.6	45.3	45.9	78.3	104.6	119.0	73.3	64.8	89.1	142.9	94.7	79.3	119.5	68.1	79.4	73.5	84.2	60.5	73.6	102.2	87.3	74.7	72.0	168.5	38.5	76.1	66.5	71.7	164.3	102.5	139.5	109.7	87.7	84.5	62.6	111.4	90.3	129.2	70.6	76.1	83.8	75.4	180.2	89.4	107.3	95.6	129.7	72.0	80.8	91.1	154.1	122.9	124.3	95.0	73.9	123.6	95.3	83.0	109.0	86.1	66.3	61.6	73.5	71.0	67.0	110.2	66.7	116.1	69.4	36.8	66.4	43.6	86.9	65.3	97.8	164.4	34.3	105.3	72.0	57.8	73.3	71.2	65.9	63.5	86.1	78.3	78.0	70.2	104.6	68.7	89.1	75.0	119.0	64.8	59.7	67.5	80.3	142.9	51.8	64.0	72.1	65.5	47.9	45.1	54.8	42.1	43.7	52.4	142.9	216.7	293.4	537.0	476.4	166.6	113.3	191.1	426.9	343.5	261.7	186.5	541.0	240.4	270.5	104.5	231.5	115.2	93.5	187.7	622.0	348.5	363.8	401.3	193.0	344.7	109.7	214.8	160.2	259.6	47.1	249.9	333.4	197.4	316.6	194.2	147.6	213.3	119.3	217.1	276.6	280.5	148.8	296.7	355.3	259.1	471.9	731.7	329.0	278.1	447.5
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.4	8.5	8.2	13.4	5.9	9.5	4.8	6.2	4.5	5.6	1.8	9.5	9.5	3.9	4.4	10.7	14.6	11.4	11.6	5.6	5.1	3.9	3.3	3.6	8.8	16.8	4.8	2.8	9.2	11.9	3.4	7.7	10.2	8.6	11.0	9.2	4.0	7.9	9.8	3.7	3.4	3.4	13.8	2.6	5.8	6.4	4.1	8.6	18.3	2.7	3.5	4.5	12.9	5.1	13.9	7.8	5.9	9.1	3.2	1.4	3.9	2.1	16.0	6.8	3.3	1.7	3.5	4.6	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4	6.0	6.5	6.9	14.8	2.5	4.7	6.5	10.2	6.7	9.1	22.7	5.9	6.0	11.6	9.6	220.5	3.5	6.3	0.0	9.5	5.4	4.6	9.3	3.5	4.4	7.6	9.5	3.5	5.5	2.9	54.5	6.4	5.5	3.3	20.8	9.8	6.8	8.8	3.5	7.1	15.1	3.4	6.5	3.8	5.7	4.5	4.4	7.8	2.9	9.3	27.4
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	35	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	47.2	0.6	0.0	0.8	0.2	11.7	3.1	2.4	0.1	0.6	0.0	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.0	0.3	13.3	0.3	0.5	0.1	0.5	0.0	0.0	0.9	0.0	0.0	2.2	0.1	5.8	8.6	16.6	0.2	9.1	0.0	2.6	0.0	7.7	0.1	0.1	9.3	0.6	6.0	29.8	4.6	0.6	0.0	2.5	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.3	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6	0.0	0.0	1.9	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.6	3.3	0.5	0.1	0.3	0.7	0.0	0.0	1.7	0.4	0.9	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	2.1	1.0	4.2	0.0	6.6	1.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729465-169757953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 58.5;Distal tubular cells: 77.9;Extravillous trophoblasts: 50.1;Hofbauer cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	16.5	18.6	27.3	14.9	26.3	13.7	20.9	22.9	31.7	17.6	17.5	17.6	10.0	11.5	23.2	25.2	17.2	16.9	12.7	20.9	27.3	24.0	17.5	20.8	13.5	18.0	24.9	22.6	23.1	13.1	13.9	22.9	16.0	33.4	17.4	17.6	15.1	12.2	16.0	17.4	18.6	11.3	24.2	23.8	16.4	14.0	12.9	19.8	20.8	18.5	14.9	19.3	19.0	14.8	13.6	15.6	12.8	14.1	14.9	22.2	13.3	12.6	8.0	28.0	14.7	17.1	21.3	11.9	23.1	22.9	28.8	30.6	5.4	13.7	6.6	6.2	15.0	21.1	5.7	19.2	16.8	30.6	20.7	13.1	21.6	11.8	7.7	12.1	18.2	7.9	13.7	17.1	18.5	5.7	17.5	24.9	22.9	16.2	26.0	25.0	10.2	38.1	15.9	11.4	12.2	10.5	16.8	13.3	7.9	16.4	8.4	6.7	25.0	15.3	6.7	20.8	20.3	13.3	16.4	12.0	9.8	15.6	23.0	20.5	12.4	18.4	19.7	27.2	17.8	15.6	8.9	12.3	12.8	18.5	14.1	21.9	13.6	21.5	22.2	15.6	11.1	21.2	21.7	3.3	14.9	13.1	10.7	22.0	13.3	27.3	26.3	22.9	31.7	27.3	24.0	24.9	22.6	33.4	19.8	41.7	23.7	0.0	0.0	0.0	0.0	0.0	0.0	28.1	31.8	26.2	0.0	58.5	77.9	38.2	0.0	0.0	0.0	0.0	40.0	50.1	0.0	0.0	16.3	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	6.4	0.0	0.0	27.9	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
HSBP1		ENSG00000230989	"Heat shock factor binding protein 1"	O75506	16	83807843-83819737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (3.27e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (1.85e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.70e-2)"	22.9	45.6	41.1	25.2	31.7	14.8	25.3	26.4	47.7	21.5	26.5	25.8	16.2	31.7	19.2	24.1	29.2	25.9	19.4	32.8	36.1	44.3	34.6	25.5	23.1	16.5	40.9	29.5	28.3	24.5	17.1	21.5	24.2	38.1	22.3	20.4	14.9	25.8	16.0	45.9	13.4	28.1	17.4	46.9	21.0	27.6	40.8	31.0	11.3	34.9	39.6	18.9	14.4	28.0	15.6	24.3	40.2	38.9	7.4	10.3	27.5	19.5	26.7	37.0	16.9	15.3	13.7	17.3	28.4	13.9	20.2	9.5	22.3	19.2	13.3	29.0	23.2	19.6	19.3	25.9	18.7	18.2	4.7	29.8	10.2	20.9	30.0	12.7	15.3	17.3	13.6	14.1	21.4	11.9	17.4	12.7	10.2	24.6	4.0	15.3	49.3	12.4	18.5	30.8	22.0	19.9	17.0	28.0	6.4	30.5	18.0	25.6	23.8	48.5	10.2	12.9	19.9	35.2	18.0	22.0	25.9	21.0	16.3	20.2	13.3	14.6	54.5	20.3	18.5	28.2	12.7	30.3	38.4	6.3	38.9	6.8	15.6	7.8	7.1	24.3	11.0	7.1	6.9	40.2	7.4	37.2	18.1	10.3	27.5	41.1	31.7	26.4	31.5	36.1	44.3	40.9	29.5	38.1	31.0	145.9	108.1	114.7	198.9	172.9	90.8	644.4	145.2	425.6	213.9	239.0	19.6	343.4	558.7	359.0	202.2	157.4	212.8	46.7	291.9	400.1	239.2	247.5	68.0	137.6	368.1	103.3	229.4	139.3	191.2	179.6	203.4	160.5	288.5	142.5	189.3	134.6	359.9	210.5	134.4	428.8	67.9	116.4	127.1	492.9	244.1	181.5	238.7	69.8	180.3	290.2
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 3438.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	135.6	87.0	77.3	95.0	53.1	55.6	81.0	61.3	60.1	113.6	80.0	130.1	41.6	173.8	66.5	63.8	115.6	79.1	188.1	91.3	140.6	57.5	76.1	135.2	49.3	170.0	38.5	135.0	93.7	51.4	61.8	89.2	77.1	99.7	108.6	89.9	180.5	64.9	77.2	137.0	112.4	81.4	90.2	251.8	66.7	108.5	79.1	95.4	76.8	82.5	113.3	69.2	47.6	69.1	86.0	109.7	89.8	67.6	68.1	67.8	113.5	55.4	140.0	75.2	117.8	313.9	73.7	99.3	77.2	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2	833.7	606.4	539.1	3438.1	940.9	289.3	1217.7	456.0	1493.6	1074.9	347.2	214.0	960.1	618.4	836.0	145.7	761.3	375.2	163.5	596.7	897.4	930.6	1319.6	967.8	307.7	711.8	321.0	544.1	275.6	256.9	156.5	635.1	727.9	698.5	738.6	374.5	296.6	721.4	313.4	574.6	560.9	223.5	342.8	894.3	197.9	740.6	807.2	939.3	460.3	567.6	2341.3
HSPA14	"HSP70-4, HSP70L1"	ENSG00000187522	"Heat shock protein family A (Hsp70) member 14"	Q0VDF9	10	14838164-14871741	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	320	"Cardiomyocytes: 15.4;Cytotrophoblasts: 29.7;Extravillous trophoblasts: 54.3;Hofbauer cells: 19.8;Syncytiotrophoblasts: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046180	Approved					NA	NA					"HPA046180: AB_2679571"	"unprognostic (5.84e-3)"	"unprognostic (5.85e-3)"	"unprognostic (5.73e-2)"	"unprognostic (6.40e-3)"	"unprognostic (7.98e-3)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (3.70e-8)"	"unprognostic (2.20e-1)"	"unprognostic (9.60e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.90e-1)"	9.8	12.0	10.8	13.9	14.8	35.2	13.4	20.6	13.4	9.2	14.1	9.0	8.3	12.8	10.0	11.5	14.3	9.4	11.5	13.0	12.2	11.6	10.9	12.9	10.5	18.4	11.2	7.8	10.3	11.7	8.9	13.3	13.0	14.0	9.8	17.9	8.6	11.9	11.3	28.1	13.0	16.1	12.1	11.7	14.7	11.8	31.6	13.0	29.2	10.8	18.1	18.1	9.7	9.9	14.5	15.2	13.0	18.1	17.0	19.9	11.1	20.6	15.3	13.4	12.1	6.4	9.0	17.5	11.0	5.7	19.0	15.4	20.2	15.3	25.6	8.8	9.9	9.5	17.0	21.7	12.8	20.0	10.8	22.2	23.9	13.4	11.6	5.4	16.6	16.2	6.6	6.1	15.5	4.7	4.7	9.5	21.3	20.4	21.5	14.0	14.6	25.0	11.7	13.9	21.4	8.1	19.3	17.5	20.8	9.8	10.6	7.6	9.4	12.5	17.3	13.6	13.4	19.5	22.1	5.3	8.0	11.2	31.4	17.4	14.8	32.2	26.2	16.0	21.7	4.5	11.6	12.8	13.0	14.8	18.1	16.1	14.5	15.5	18.5	13.6	14.4	13.3	16.2	6.4	17.0	14.7	15.2	19.9	11.1	10.8	14.8	20.6	13.4	12.2	11.6	11.2	7.8	14.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.0
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Group enriched"	"Detected in many"	19	"Early spermatids: 201.6;Late spermatids: 418.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	1.0	0.0	0.0	6.8	0.0	0.0	0.2	0.2	1.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2	0.0	0.6	0.0	0.6	0.8	2.1	3.6	0.0	1.4	1.2	0.0	7.9	0.4	0.0	0.7	201.6	1.0	0.5	0.0	0.2	0.4	0.5	1.1	0.0	0.9	1.1	3.2	1.7	3.1	2.4	418.3	4.6	1.5	5.0	1.8	0.6	3.3	0.3	0.8	2.1	0.3	2.8	0.0	1.4	16.4	7.7	0.1	0.3	2.5	1.0	0.3
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176374	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Diabetes mellitus, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 322.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	16.9	21.7	13.1	13.7	12.9	15.0	33.1	22.4	21.4	15.7	17.7	7.3	18.4	20.3	15.6	19.6	19.2	12.8	17.9	40.2	12.3	15.3	38.1	45.7	28.3	25.7	12.5	9.1	15.7	30.6	16.3	30.5	29.7	13.9	17.7	16.4	13.3	29.8	17.9	33.8	16.7	27.7	17.7	11.3	22.7	19.0	17.0	7.6	16.4	19.7	24.8	17.6	17.9	15.9	14.2	24.5	10.7	12.4	11.5	18.6	11.8	12.8	7.4	11.3	10.0	15.4	17.3	7.9	30.5	14.9	15.2	16.1	6.0	11.0	12.6	9.6	13.5	12.4	15.7	10.6	10.7	16.7	20.6	9.5	11.0	11.6	18.1	16.5	33.1	16.5	13.6	13.7	13.7	10.3	14.4	13.0	11.5	9.0	19.5	16.1	7.1	11.7	15.9	5.7	5.5	9.0	11.7	17.8	17.9	15.3	12.5	13.1	14.6	10.4	8.9	17.9	8.5	8.8	19.1	18.7	22.7	11.6	10.9	16.6	28.4	30.9	13.4	17.6	21.2	18.1	8.3	12.4	10.7	18.6	11.2	16.6	13.2	16.0	16.0	11.7	14.2	15.3	15.9	1.3	11.5	11.6	24.5	15.8	11.8	13.1	12.9	22.4	21.4	12.3	15.3	12.5	9.1	13.9	7.6	80.4	47.5	40.4	52.1	0.0	44.4	56.7	71.4	48.2	35.2	48.8	7.9	93.8	119.3	98.9	15.0	64.4	58.4	46.7	121.4	103.0	48.3	96.8	12.8	120.7	96.4	38.1	36.3	71.2	54.7	10.5	78.6	44.2	0.0	84.8	96.6	50.4	129.9	66.6	45.6	322.7	34.3	51.8	36.5	70.2	134.6	0.0	148.2	59.8	85.7	73.1
IFI27	"FAM14D, ISG12, P27"	ENSG00000165949	"Interferon alpha inducible protein 27"		14	94104836-94116698	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"	8	"Endothelial cells: 1184.0;Enterocytes: 2302.2;Exocrine glandular cells: 1468.8;Mucus-secreting cells: 1260.0;Paneth cells: 1956.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.4"	"Group enriched"	"Detected in many"	5	"monocytes: 9.4;T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 184.7;BJ hTERT+ SV40 Large T+ RasG12V: 163.5;EFO-21: 49.9;Karpas-707: 45.4;SK-MEL-30: 51.1"									HPA028875	Uncertain					NA	NA					"HPA028875: AB_10601434"	"unprognostic (1.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.78e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.65e-1)"	37.0	13.5	9.7	21.1	12.7	14.8	22.8	5.7	8.4	14.0	38.1	6.6	10.2	12.7	18.9	24.7	31.9	17.1	53.5	25.9	11.2	8.9	12.8	12.1	61.3	4.6	12.5	9.7	8.1	4.8	0.3	5.5	39.7	12.7	9.0	23.2	9.7	15.5	7.1	15.0	12.6	14.2	12.0	12.0	64.0	72.0	20.9	7.3	7.9	8.9	28.4	18.5	9.2	11.4	0.1	1.2	0.6	9.4	0.4	4.1	2.5	15.6	0.0	0.1	0.0	0.0	2.0	0.1	0.2	0.7	184.7	163.5	0.3	13.1	0.1	49.9	10.1	3.0	0.5	0.0	0.0	7.3	0.1	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.1	32.1	0.0	0.1	25.4	0.1	0.0	45.4	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	51.1	0.1	0.0	0.2	0.0	0.0	0.2	29.5	0.0	0.8	1.2	0.3	0.0	0.0	0.1	0.0	1.9	0.6	0.5	9.4	0.5	0.0	4.1	1.1	1.2	0.1	0.0	0.7	0.1	0.4	2.8	0.2	3.4	2.5	9.7	12.7	5.7	8.4	11.2	8.9	12.5	9.7	12.7	7.3	363.3	101.8	51.4	3.9	152.0	4.1	23.8	259.9	317.2	80.8	12.2	7.9	2.6	1.7	62.4	12.0	1184.0	2302.2	23.3	1468.8	175.5	190.4	8.2	44.9	3.0	127.4	4.8	257.4	658.0	97.1	17.7	159.3	46.5	332.3	44.1	1260.0	5.6	981.1	1956.9	392.4	11.8	17.1	271.7	155.5	14.6	10.5	122.7	4.3	20.3	464.4	79.9
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.1	15.7	14.8	26.9	17.5	14.6	14.9	14.3	19.3	17.4	16.7	12.7	7.3	28.5	7.7	38.4	9.0	10.9	12.6	26.4	12.4	15.5	8.2	18.8	16.0	30.8	11.1	6.5	13.3	27.0	20.4	23.4	15.5	8.0	12.6	25.0	16.5	7.8	13.6	14.1	18.7	35.8	14.0	17.8	12.3	6.3	13.6	5.8	4.2	25.3	13.1	17.0	14.5	48.1	29.7	5.6	12.0	6.9	32.9	7.0	25.6	44.9	14.8	17.5	20.0	8.9	30.9	37.6	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0	29.8	31.8	25.5	140.2	175.3	48.0	49.5	22.9	13.4	33.0	17.4	84.4	63.5	14.9	41.7	32.2	54.5	231.2	23.3	49.6	52.8	71.4	123.0	75.8	18.7	104.1	20.6	132.5	47.9	76.5	7.5	33.9	78.9	97.8	73.1	82.8	22.6	50.8	210.5	38.5	11.0	72.9	38.8	197.8	13.7	11.5	110.2	126.9	55.4	87.9	126.0
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.3	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	12.2	7.5	6.2	9.6	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.1	13.5	9.5	3.7	3.3	3.8	9.7	10.4	5.0	13.7	7.5	1.4	11.6	3.2	6.3	3.6	17.4	6.8	11.7	8.1	8.6	2.8	5.2	4.1	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6	437.7	206.1	73.5	89.1	36.5	19.9	27.8	48.4	679.9	320.8	48.8	64.8	19.7	99.5	136.8	1393.1	36.5	31.6	23.3	116.3	16.0	63.9	111.6	42.8	4.9	12.7	27.0	54.9	30.7	7.3	2088.2	60.4	26.4	43.9	5.4	28.2	42.9	82.4	31.7	60.5	97.1	66.9	51.8	57.7	146.9	42.2	32.5	12.5	26.6	47.6	75.8
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 121.2;liver: 46.2;lymphoid tissue: 40.7"	"Cell type enriched"	"Detected in many"	5	"monocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 121.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 121.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.3;Karpas-707: 17.1;U-266/70: 22.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012369	Uncertain		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA			"Focal adhesion sites"		"HPA012369: AB_1858095"	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	5.3	7.3	4.5	17.8	7.6	10.1	4.1	2.0	5.3	3.1	5.0	3.8	0.0	5.6	2.6	4.7	3.4	4.5	5.9	5.8	4.5	3.1	17.0	46.2	8.5	40.7	7.7	1.6	4.5	6.9	1.1	3.4	3.8	5.6	4.0	5.4	2.2	7.4	1.8	3.9	4.6	8.4	3.5	5.4	20.2	6.3	3.5	4.5	14.6	10.0	3.2	19.3	8.0	4.9	22.3	121.2	28.6	26.5	18.1	17.4	16.3	1.3	6.5	2.3	5.4	0.8	1.2	1.3	1.5	0.7	1.2	3.1	1.9	1.6	2.8	2.1	0.4	0.4	1.0	1.3	1.3	0.6	2.1	3.3	10.0	2.7	6.8	1.9	1.3	22.3	1.8	0.8	2.3	0.5	0.9	1.2	5.0	3.0	17.1	0.3	5.5	3.1	10.5	1.6	5.9	1.7	3.8	2.2	5.2	1.1	2.4	1.6	3.1	2.1	1.5	1.1	1.1	2.4	5.4	0.3	2.8	1.3	1.7	2.5	22.5	4.7	1.7	3.3	3.8	2.1	16.2	26.5	23.6	13.3	22.2	15.2	22.3	15.4	12.6	33.9	21.8	13.9	11.1	28.6	18.1	15.5	121.2	17.4	16.3	4.5	7.6	2.0	5.3	4.5	3.1	7.7	1.6	5.6	4.5	0.0	15.7	9.9	0.3	0.6	0.2	0.6	2.5	6.7	9.1	0.0	0.0	0.4	1.7	1.6	0.0	0.5	0.8	0.0	3.6	1.5	0.7	0.3	38.1	16.4	13.3	0.0	2.9	2.5	14.3	0.2	0.0	28.0	5.0	187.6	1.7	1.2	1.5	0.0	0.0	4.4	0.1	0.0	0.9	0.5	0.5	0.6	0.2	8.5	1.2	0.0
ISG20	"CD25, HEM45"	ENSG00000172183	"Interferon stimulated exonuclease gene 20"	Q96AZ6	15	88636153-88656483	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 116.8;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 305.7;monocytes: 313.8;Urothelial cells: 376.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.6;Karpas-707: 21.7;SK-MEL-30: 121.9;U-698: 21.8"					"Not detected"	"Not detected"									NA	NA						"unprognostic (2.55e-3)"	"unprognostic (1.19e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.85e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.86e-8)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.58e-2)"	8.4	2.4	2.2	39.6	3.6	12.1	7.3	0.8	3.1	4.1	18.3	1.9	8.3	25.9	2.7	8.2	9.9	3.9	36.6	4.9	2.4	2.6	6.1	9.9	26.0	56.6	3.2	1.8	6.8	6.4	0.2	10.1	4.6	3.2	6.0	3.0	2.2	13.2	8.1	4.1	3.4	39.4	1.2	3.6	53.8	21.9	2.5	1.8	29.1	14.5	6.1	41.4	10.7	4.2	99.2	12.3	116.8	5.1	31.0	104.4	29.7	1.6	2.5	0.0	0.0	0.0	0.0	0.4	0.0	1.1	7.5	10.4	0.8	3.6	36.6	1.9	0.1	3.5	0.5	0.1	0.8	0.2	11.5	0.1	0.1	1.2	1.5	5.0	0.0	0.0	0.7	1.4	2.6	1.7	0.1	1.2	2.6	0.1	21.7	0.0	2.6	0.1	0.2	0.3	5.8	5.5	1.4	0.1	6.8	0.6	0.3	0.1	0.1	0.3	14.5	121.9	0.0	0.4	0.8	1.5	0.2	0.8	0.0	0.5	15.4	4.1	21.8	0.3	0.5	1.5	8.4	3.0	6.2	27.7	5.1	36.6	94.6	47.9	39.7	2.6	99.2	35.5	37.2	116.8	31.0	3.8	12.3	104.4	29.7	2.2	3.6	0.8	3.1	2.4	2.6	3.2	1.8	3.2	1.8	44.7	47.2	305.7	100.8	158.8	0.0	1.2	50.9	65.6	50.0	3.5	0.0	1.5	1.7	54.2	12.1	28.6	92.1	116.8	133.1	66.9	47.5	249.9	7.0	10.4	8.0	0.0	36.0	14.1	25.6	3.3	2.0	43.4	214.2	313.8	83.6	0.0	202.6	80.7	1.8	5.5	0.1	25.8	27.8	0.9	2.1	250.9	43.5	278.6	6.2	376.0
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Cell type enhanced"	"Detected in many"	13	"Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	92.5	92.3	48.6	48.2	10.3	10.6	38.8	48.7	14.5	47.9	36.9	75.5	55.6	26.1	31.3	39.0	50.4	55.4	45.3	60.7	36.2	26.0	57.0	41.9	36.7	74.7	24.2	31.4	40.5	16.2	29.1	39.0	40.1	14.1	87.1	49.7	23.6	53.7	43.8	67.0	100.7	30.7	28.3	76.6	121.7	64.4	58.0	40.4	51.2	58.2	60.4	49.1	69.8	37.0	25.9	53.6	99.1	19.3	50.1	27.5	77.6	38.5	56.6	21.0	33.9	39.0	23.9	29.5	31.3	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9	23.8	17.8	0.0	0.0	0.0	0.0	0.0	0.0	30.8	33.0	233.8	0.0	95.9	84.6	365.7	0.0	0.0	0.0	0.0	382.5	1210.3	0.0	0.0	7.0	0.0	299.4	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	655.6	0.0	0.0	967.6	0.0	0.0	121.9	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977688	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006514	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	23.9	30.2	28.5	23.0	32.7	43.2	32.6	30.7	32.3	31.8	36.0	23.6	51.3	35.9	25.1	41.0	30.4	26.1	37.1	36.2	25.4	23.9	34.2	81.1	27.7	34.7	27.7	19.8	26.9	106.8	24.8	49.8	30.0	24.4	33.4	36.0	24.9	100.6	45.9	42.1	23.4	45.6	21.6	20.5	35.9	42.4	15.3	25.2	30.5	58.5	32.0	34.0	25.2	33.0	47.4	54.1	60.7	43.0	30.4	46.4	30.2	38.4	26.6	11.5	21.0	37.7	23.5	32.4	28.1	27.4	18.8	18.9	25.6	32.0	36.8	39.9	32.5	11.6	35.2	29.0	21.6	15.4	34.7	58.0	21.4	31.7	25.9	39.7	41.0	32.9	22.2	40.9	19.8	23.5	26.0	22.2	42.9	31.6	27.1	13.2	67.0	29.6	52.8	24.6	75.6	47.0	31.3	15.6	73.9	23.8	21.1	31.5	31.9	22.2	64.8	37.6	22.0	40.6	59.7	17.3	9.3	16.1	28.1	35.8	40.4	45.0	39.9	22.9	39.5	20.0	32.6	43.0	60.7	29.4	30.3	35.5	47.4	41.1	46.4	33.4	45.2	42.4	33.7	39.9	30.4	33.4	54.1	33.6	30.2	28.5	32.7	30.7	32.3	25.4	23.9	27.7	19.8	24.4	25.2	74.5	93.5	143.8	144.8	139.2	56.2	87.0	188.5	84.3	73.9	94.2	21.6	271.1	218.8	215.2	5.3	130.2	265.0	46.7	360.4	333.7	188.8	298.2	81.8	277.1	261.0	54.0	203.5	111.1	203.5	13.6	140.4	174.8	161.9	144.3	351.4	98.5	241.9	276.3	116.0	209.1	47.9	103.5	125.2	54.7	68.8	166.2	242.1	188.1	283.1	216.6
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4"									"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.1	0.3	0.3	0.8	0.5	2.1	1.1	1.0	2.1	5.1	8.0	5.2	0.0	5.7	0.6	0.2	0.6	0.3	15.4	5.4	0.2	7.8	0.0	1.8	16.8	3.1	0.1	0.1	2.4	0.4	8.4	6.6	1.5	0.5	0.1	0.1	0.0	0.8	0.1	0.2	0.4	3.9	0.2	0.3	0.2	0.0	0.0	27.3	2.0	1.4	0.1	0.0	0.1	2.5	0.5	0.8	0.6	0.4	0.1	12.4	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8	3.0	9.6	0.0	9.5	0.3	0.0	0.0	2.5	0.0	5.7	5.2	0.0	0.6	3.3	2.0	0.1	0.0	2.5	0.0	14.8	1.2	0.8	10.5	1.1	4.0	0.2	0.0	4.6	0.0	0.0	0.0	3.1	0.0	1.7	0.0	15.2	1.7	12.8	7.0	4.9	11.3	0.0	0.0	1.9	0.2	0.2	0.1	0.6	0.0	8.5	5.8
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	14.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	9.3	0.2	0.0	11.3	0.0	0.0	38.6	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1	14.9	43.1	0.0	6.2	0.5	5.1	1.5	0.0	34.8	62.6	0.0	3.9	0.5	0.0	0.9	32.7	0.5	13.1	0.0	33.1	0.6	1.6	98.1	22.1	0.0	0.9	1.6	156.4	1.3	1.6	12.3	4.0	2.3	3.3	0.0	151.0	1.4	16.5	24.6	2.1	0.0	2.6	0.0	1.4	13.7	1.7	1.4	0.5	4.4	73.4	8.3
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032058, HPA043197"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA032058: AB_10601439, HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	1.0	3.7	4.0	1.0	8.4	0.9	1.4	3.1	9.5	1.8	2.4	2.3	5.6	1.6	2.4	3.9	1.1	5.7	2.4	1.7	3.3	4.9	5.9	2.6	1.7	1.0	3.6	7.4	2.5	3.6	4.1	4.8	1.0	5.6	3.2	1.6	3.5	2.9	2.4	2.5	0.8	1.6	1.1	1.6	1.1	2.4	24.3	2.2	0.0	5.0	0.0	1.1	1.5	0.6	0.9	0.1	0.0	0.2	0.0	1.1	0.1	0.4	2.7	1.0	2.9	0.0	0.3	0.3	0.0	0.7	0.1	0.0	0.0	0.2	0.0	5.0	0.0	0.0	1.6	0.0	0.0	0.0	3.5	3.7	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.5	0.0	1.5	0.5	2.4	2.6	0.0	1.9	0.6	0.0	2.5	1.1	0.0	1.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	4.0	8.4	3.1	9.5	3.3	4.9	3.6	7.4	5.6	2.2	0.0	4.1	0.0	11.1	0.8	13.0	8.5	7.6	53.5	9.1	27.9	2.0	2.3	48.0	6.8	336.6	3.3	3.2	0.0	4.9	2.8	3.5	10.5	1.1	7.3	0.5	3.2	5.2	1.8	0.3	352.6	7.5	0.3	6.8	1.0	12.5	27.9	4.2	7.0	7.8	29.8	16.9	12.9	1.9	259.8	11.1	0.6	0.7	0.0	7.6	5.6
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.8	4.4	21.4	7.1	7.7	21.5	18.6	12.8	24.2	16.5	21.5	6.4	7.3	13.8	9.8	9.5	11.0	5.9	6.0	9.9	25.2	8.1	8.6	12.3	4.2	10.5	25.1	17.2	3.4	18.1	10.0	11.3	20.4	10.5	15.9	16.2	15.9	7.3	15.5	6.9	18.4	8.4	12.7	16.1	3.8	18.8	15.0	7.3	34.6	21.3	15.6	19.1	17.0	22.8	11.1	14.3	12.6	4.2	10.6	6.9	4.6	22.1	9.3	9.9	4.9	9.2	3.4	7.7	5.9	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.8	12.2	0.0	59.0	21.6	29.8	0.0	0.0	0.0	0.0	33.6	33.1	0.0	0.0	4.7	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	55.9	0.0	0.0	21.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122213-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 123.9"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 2: 374.8;monocytes: 592.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 7.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		47000	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.5	0.7	0.4	14.1	0.4	0.0	0.5	0.3	0.4	1.0	0.6	0.1	0.6	0.4	0.4	1.0	2.5	0.5	0.8	0.4	0.4	0.4	0.8	0.6	123.9	11.2	0.4	0.1	0.4	8.3	0.0	0.6	1.0	0.6	1.0	1.7	0.2	6.8	1.9	0.4	1.9	1.4	0.8	0.5	2.0	0.8	8.4	0.0	21.3	8.3	3.1	11.3	3.3	0.9	0.4	0.0	7.6	0.1	0.8	6.6	1.1	3.5	0.1	0.0	0.5	0.0	0.0	2.8	0.0	0.9	0.6	0.1	0.8	1.8	0.0	57.7	0.3	6.5	0.5	1.2	2.2	0.1	14.6	1.7	0.0	0.1	0.1	21.4	0.0	0.5	0.3	19.5	0.0	2.6	0.0	2.6	17.7	0.1	3.4	0.1	0.0	0.8	0.1	0.1	0.3	0.8	0.0	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.1	1.5	0.7	1.1	0.1	2.7	0.0	1.0	0.1	0.0	1.2	4.3	0.1	0.0	0.0	0.0	0.4	0.1	7.6	0.4	0.0	3.2	0.1	2.7	1.7	0.0	0.4	3.5	2.0	1.9	0.8	0.1	0.0	6.6	1.1	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.6	0.0	59.6	374.8	0.5	3.2	5.4	0.0	1.2	2.5	9.4	15.9	1.8	0.0	1.9	0.0	0.6	26.0	0.5	0.0	0.0	5.3	0.2	0.2	1.2	17.4	0.0	1.3	0.0	0.0	0.0	0.0	69.6	0.6	3.1	1.7	592.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	5.0	1.0	0.5	0.3	2.0
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 1943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006812	Approved		Supported	Cytosol		NA	NA		270000	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (6.66e-2)"	29.0	32.1	38.9	21.0	35.2	60.9	30.1	25.2	35.8	23.6	29.8	24.4	28.9	23.7	21.6	47.3	30.4	26.7	31.0	63.8	33.2	34.8	118.7	54.3	26.7	28.1	41.5	28.5	29.7	34.8	28.9	35.2	46.3	35.8	28.0	31.6	31.0	32.9	29.6	64.0	21.5	34.2	22.9	36.4	30.7	28.6	24.0	29.5	22.6	37.8	56.7	32.3	27.8	24.7	62.0	59.0	86.1	42.6	25.4	32.4	42.1	47.1	39.5	35.9	21.4	60.2	45.9	35.8	40.2	31.7	34.0	32.4	34.4	23.3	37.6	42.9	38.8	41.8	19.2	36.3	33.5	42.0	40.3	40.8	27.5	47.6	69.5	46.0	39.4	34.3	40.0	52.0	35.1	22.4	43.3	40.7	28.1	32.4	35.5	49.3	76.8	35.7	47.7	25.4	26.6	65.8	24.8	64.8	28.5	78.4	53.1	26.5	34.6	35.6	52.1	86.8	32.4	20.1	56.0	38.6	25.8	33.5	64.8	37.6	37.4	41.7	47.9	84.5	39.5	59.2	47.1	42.6	86.1	25.2	41.2	22.1	62.0	29.5	27.0	34.7	54.6	25.9	27.3	65.6	25.4	39.0	59.0	32.4	42.1	38.9	35.2	25.2	35.8	33.2	34.8	41.5	28.5	35.8	29.5	148.9	152.7	204.3	232.1	273.4	108.4	553.2	219.1	164.6	125.1	422.2	23.6	369.9	943.3	353.9	46.9	202.1	225.2	116.8	288.3	319.7	236.7	264.3	143.1	274.5	366.0	84.2	213.4	124.6	149.1	80.3	245.1	172.6	332.3	321.0	240.5	175.3	354.9	273.5	224.9	1943.6	111.9	168.1	174.7	196.9	336.9	281.9	418.5	125.0	192.7	332.5
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365448-55433742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.4;Late spermatids: 42.1"	"Cancer enhanced"	"Detected in all"		"glioma: 52.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"A-431: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.1	4.9	20.4	2.3	17.0	3.1	5.9	9.9	28.5	6.1	4.6	19.8	1.8	5.0	9.6	5.3	3.5	5.6	3.8	3.9	17.2	11.3	6.0	4.8	3.0	4.0	12.9	21.1	9.6	3.4	10.4	4.2	3.9	10.1	5.9	4.7	2.4	3.3	6.9	5.7	5.3	4.2	7.0	10.8	2.8	3.5	5.7	13.1	3.3	6.6	0.3	2.7	2.8	2.7	2.7	4.7	0.7	4.5	3.6	6.0	2.6	58.4	2.0	4.1	2.7	1.2	2.2	2.3	2.7	3.2	4.1	3.5	2.0	1.7	4.1	2.5	3.8	4.1	2.6	2.2	1.5	2.5	1.8	4.3	1.4	1.6	2.0	2.2	4.5	2.7	3.9	1.6	3.1	1.0	2.1	2.0	1.9	2.5	2.7	3.8	1.7	1.1	2.1	7.9	1.6	2.5	1.7	1.9	2.0	2.7	4.7	7.2	6.8	3.8	5.7	1.5	1.6	2.3	4.8	3.3	2.6	3.5	4.9	5.1	2.6	3.1	4.4	2.0	1.0	4.9	0.4	3.6	0.7	2.6	4.5	4.5	2.7	3.4	3.9	4.7	2.6	3.1	2.7	0.5	3.6	3.0	3.7	6.0	2.6	20.4	17.0	9.9	28.5	17.2	11.3	12.9	21.1	10.1	13.1	3.0	6.2	7.6	5.5	3.5	8.0	7.5	7.6	8.1	4.5	10.4	5.9	10.6	5.0	6.7	38.4	4.8	6.6	23.3	10.4	11.1	9.3	4.3	11.5	7.3	6.6	14.3	12.1	9.2	6.3	42.1	8.3	5.0	0.0	9.0	8.6	10.6	6.7	7.0	7.1	19.5	8.2	0.0	3.1	12.0	10.9	3.3	15.9	4.4	10.3	4.7
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74491712-74493733	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 47.3;Late spermatids: 20.4;Spermatocytes: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040249	Approved					NA	NA					"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	2.0	4.1	2.6	2.6	3.0	2.1	5.8	2.3	4.3	3.1	4.0	3.4	6.5	5.8	3.4	6.5	3.6	5.8	8.8	2.9	3.3	2.6	8.1	5.3	4.0	8.4	3.5	1.0	6.2	10.8	6.2	4.3	8.3	2.9	4.6	3.6	3.8	5.9	6.9	11.3	2.4	6.3	3.1	2.9	4.2	5.6	19.0	0.8	8.7	6.4	5.5	4.3	4.6	3.8	11.2	7.2	6.6	4.9	8.1	14.8	5.4	2.3	3.0	6.6	3.2	2.7	0.5	9.4	0.9	1.6	4.2	2.6	9.9	3.3	14.7	5.7	0.6	8.4	3.5	3.0	2.3	1.6	3.4	3.1	4.2	2.7	2.7	3.1	4.9	5.9	1.5	2.4	2.0	2.7	2.1	0.2	13.4	3.3	4.2	1.3	3.7	6.5	7.5	5.9	12.4	3.9	5.3	7.3	4.1	2.8	8.3	6.7	4.3	6.2	1.9	8.9	6.6	6.0	3.7	1.1	1.0	2.4	1.4	2.1	6.9	6.1	10.0	0.8	2.9	3.3	0.0	4.9	6.6	5.9	3.0	8.8	11.2	7.9	7.2	5.3	11.0	14.8	11.2	1.1	8.1	3.7	7.2	3.7	5.4	2.6	3.0	2.3	4.3	3.3	2.6	3.5	1.0	2.9	0.8	0.0	0.0	1.7	0.7	0.7	0.7	0.8	5.1	0.0	0.0	3.5	0.0	10.8	5.0	2.2	47.3	0.4	1.4	0.0	4.0	11.2	0.8	0.9	0.0	3.2	4.5	3.2	0.0	1.3	0.0	20.4	1.7	0.5	1.7	0.0	2.0	9.1	2.7	0.0	1.1	11.3	0.9	0.0	0.5	28.6	7.6	0.5	6.8	1.3	3.4	0.3
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328468-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 105.3;T-47d: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	19.3	7.5	39.8	11.7	36.4	8.0	13.9	10.3	102.4	22.7	16.2	9.8	10.9	11.5	19.4	18.1	22.2	13.7	21.0	17.2	62.3	18.0	12.8	14.5	16.6	11.5	21.0	50.9	18.4	10.4	11.6	13.3	27.5	13.0	26.0	14.3	11.2	36.2	37.9	18.4	17.1	21.1	15.3	16.5	15.8	38.6	12.0	11.0	4.4	14.2	12.5	36.3	15.4	21.4	7.8	7.2	18.9	8.2	15.3	6.9	3.6	9.4	7.4	5.8	105.3	17.9	21.3	14.8	8.6	6.8	8.1	9.1	18.2	6.0	22.2	11.0	10.0	13.2	7.9	2.3	6.0	8.1	11.8	5.8	20.2	16.2	5.6	17.2	10.9	27.5	11.1	13.9	12.6	7.2	14.7	5.5	8.6	4.5	19.7	4.3	3.8	0.3	7.1	21.3	10.2	7.0	12.6	8.1	4.8	10.0	36.4	4.8	0.3	34.6	5.1	25.5	11.6	67.0	30.0	3.5	38.2	7.2	9.1	28.1	18.1	11.9	5.0	4.7	2.4	5.4	18.9	6.8	13.0	6.0	8.2	6.9	7.8	5.4	6.1	5.0	4.4	1.4	3.5	10.9	15.3	7.7	7.2	1.4	3.6	39.8	36.4	10.3	102.4	62.3	18.0	21.0	50.9	13.0	11.0	41.7	27.4	50.6	46.8	87.3	192.0	49.2	163.1	29.4	48.9	34.9	68.7	270.0	53.0	48.7	1.6	54.7	57.7	23.3	112.7	251.2	186.2	38.4	292.9	75.1	64.5	104.9	29.9	81.6	115.9	4.5	88.1	61.6	62.4	25.2	66.7	78.4	77.9	34.8	221.3	42.6	34.0	32.3	148.3	3.9	34.7	81.2	214.1	67.1	38.3	32.9
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893213	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 32.0"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6"	"Region enhanced"	"Detected in some"		"olfactory region: 3.5"	"Low region specificity"	"Detected in some"			HPA013421			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.2	2.4	0.5	1.9	0.3	0.7	0.2	3.5	8.8	0.4	2.2	2.9	0.1	2.4	11.8	7.2	32.0	0.5	12.4	3.7	0.9	0.0	0.1	4.2	0.1	0.1	2.6	5.1	8.6	0.3	0.4	1.1	6.8	11.5	0.5	0.7	5.0	4.7	0.3	4.0	0.5	0.5	0.3	0.1	0.2	14.7	0.2	0.7	0.2	3.3	4.3	4.8	6.9	0.6	0.4	1.1	0.1	1.8	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	1.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	13.3	16.3	1.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	17.6	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	16.6	0.0	0.0	0.0	0.0	3.8	0.9	0.7	0.0	0.3	15.6	1.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.2	0.3	0.0	0.2	0.4	0.5	0.5	0.3	0.6	0.4	0.3	1.1	1.8	0.1	0.4	0.1	0.1	2.4	1.9	0.2	3.5	3.7	0.9	0.1	2.6	6.8	0.2	0.0	0.3	0.0	13.1	3.1	0.0	24.9	0.0	25.4	7.9	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	15.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.6	0.6	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.4	8.0	0.1	0.0	0.0	10.8
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947185-110964079	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	9.0	11.2	13.7	15.4	15.5	5.9	20.7	15.6	14.7	7.9	7.5	6.6	7.8	7.0	8.1	23.9	8.1	9.6	6.7	16.1	12.7	13.3	9.6	16.7	11.9	17.6	10.5	7.5	18.4	6.9	5.8	17.5	25.1	10.3	9.9	7.6	7.3	8.6	9.2	20.5	10.6	8.4	6.0	12.4	14.0	8.1	27.7	10.1	16.8	12.6	10.2	19.0	10.0	28.5	21.0	11.4	21.4	8.2	18.0	19.4	8.4	12.0	5.3	10.2	6.9	4.7	7.7	11.5	7.4	8.6	13.1	10.6	13.4	15.3	9.2	10.7	5.6	14.0	7.9	4.8	4.4	15.9	16.7	5.7	10.2	5.4	13.8	14.0	19.2	12.5	4.8	12.4	9.0	15.9	5.5	7.0	9.9	31.8	42.6	8.7	4.0	1.9	15.3	15.3	7.4	12.3	12.8	16.7	11.2	3.4	6.3	8.5	9.4	0.0	12.9	21.6	6.5	10.6	31.3	4.9	11.6	0.4	13.6	6.0	19.8	6.8	17.4	6.6	22.0	20.0	13.0	5.7	12.3	15.3	6.3	19.4	21.0	12.1	15.8	11.4	15.5	13.5	18.5	21.4	18.0	8.2	10.3	11.1	8.4	13.7	15.5	15.6	14.7	12.7	13.3	10.5	7.5	10.3	10.1	11.9	6.7	21.2	56.0	12.8	19.8	20.2	10.2	21.4	10.3	8.7	17.7	16.2	13.3	13.9	9.9	18.0	11.4	0.0	17.5	26.9	16.6	45.6	8.1	25.1	12.1	14.3	10.9	13.5	8.5	8.9	14.7	18.8	30.4	19.0	10.4	26.9	17.0	13.9	13.1	7.9	30.3	12.9	23.0	32.1	49.1	15.4	31.6	28.7	9.8	43.3
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 131.5;Late spermatids: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	9.1	9.5	7.5	5.3	12.7	7.4	7.3	12.7	15.4	7.7	10.4	8.1	6.1	15.8	6.9	7.6	9.9	5.0	8.8	10.8	7.5	6.5	17.7	42.3	6.2	6.3	6.9	8.4	5.8	18.1	9.1	10.8	5.9	9.8	6.3	9.5	9.3	8.6	6.9	18.0	12.1	18.2	7.8	6.7	6.3	9.1	24.1	5.2	17.7	7.4	8.2	8.6	7.9	7.3	4.8	6.0	21.8	6.9	3.4	7.0	4.2	2.9	7.1	7.1	9.1	10.2	14.4	3.0	3.1	8.7	5.3	6.3	5.5	6.3	5.9	5.7	7.3	6.6	6.5	5.1	9.8	7.8	3.6	7.5	4.0	3.3	5.5	9.0	3.9	6.5	8.5	13.6	5.0	10.0	12.0	16.7	9.5	3.5	5.9	11.0	5.6	10.6	6.5	2.9	22.4	2.5	6.5	6.0	5.3	11.3	9.3	3.2	4.1	7.3	4.0	11.4	11.2	6.2	7.4	6.0	5.2	3.6	4.0	6.0	12.1	16.7	3.6	6.7	3.8	9.7	15.6	6.9	21.8	5.5	5.5	4.3	4.8	5.2	5.7	6.0	4.1	4.8	4.1	3.6	3.4	5.3	5.0	7.0	4.2	7.5	12.7	12.7	15.4	7.5	6.5	6.9	8.4	9.8	5.2	14.9	2.6	9.7	11.4	12.2	20.0	13.3	10.2	10.7	6.8	10.4	21.6	15.0	23.2	11.2	131.5	10.5	25.7	23.3	25.7	18.2	9.3	9.5	2.3	32.1	16.9	20.6	8.7	11.1	19.8	330.3	11.8	8.6	13.5	17.2	15.4	14.3	13.6	20.1	8.1	54.9	19.0	0.0	12.0	42.3	35.8	13.8	10.9	15.0	13.6	11.9
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	"Q8WZ04, Q96E66"	11	72080331-72110782	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 49.8;testis: 47.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 522.5;Late spermatids: 1781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 27.7"									HPA039949	Approved		Uncertain	Microtubules		NA	NA			Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	3.5	3.7	10.6	2.0	11.1	2.1	7.1	3.7	8.9	7.1	4.2	14.0	6.1	3.2	6.0	13.6	3.5	49.8	5.3	2.6	8.8	7.6	9.0	6.2	6.2	2.6	7.7	8.5	8.5	7.0	7.1	8.9	4.4	10.6	7.5	6.2	7.3	4.3	4.7	5.2	4.5	2.5	4.8	7.7	3.2	3.6	47.8	8.9	3.1	9.3	2.4	3.5	3.5	2.6	4.3	4.2	9.2	2.9	10.1	6.2	2.0	2.6	9.8	6.2	5.0	5.4	4.8	1.5	3.1	2.5	2.8	2.5	4.7	14.3	3.4	4.7	5.3	6.9	5.3	4.4	7.4	3.2	6.4	4.3	2.5	4.5	3.3	0.9	2.0	2.7	2.1	3.8	4.3	3.3	4.6	1.0	7.2	2.7	5.3	4.1	9.3	6.0	4.0	3.1	15.4	2.6	7.3	6.3	5.2	11.0	3.2	5.8	4.5	6.1	14.0	7.5	4.5	27.7	2.4	4.6	3.0	4.2	8.0	2.1	5.7	6.2	3.9	2.9	1.7	3.3	2.3	2.9	5.0	3.1	2.8	3.2	4.2	3.3	2.6	1.7	4.3	3.0	3.0	9.2	10.1	1.8	4.2	6.2	2.0	10.6	11.1	3.7	8.9	8.8	7.6	7.7	8.5	10.6	8.9	0.0	1.0	6.1	6.6	2.1	3.7	1.7	5.1	115.1	9.1	3.5	11.8	11.0	10.0	6.1	522.5	4.5	3.1	0.0	2.1	6.7	4.1	11.4	0.0	5.6	2.7	6.4	1.2	3.1	1.0	1781.2	13.8	2.2	1.7	1.8	8.8	12.6	1.8	2.9	9.6	14.6	12.6	6.5	7.1	69.5	22.8	2.0	11.0	2.6	4.3	4.7
LSM4	YER112W	ENSG00000130520	"LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Z0	19	18306230-18323274	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 551.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040932	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040932: AB_10795529"	"unprognostic (2.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.34e-1)"	19.0	41.0	42.7	22.3	37.8	35.8	31.5	23.9	40.7	25.0	41.2	16.4	29.6	38.6	17.9	26.5	31.4	26.6	28.2	33.3	35.1	35.4	37.9	37.9	22.2	41.0	38.6	34.0	20.1	34.2	18.4	25.2	29.4	25.5	21.0	31.9	25.3	21.3	29.7	55.5	21.1	35.6	21.9	24.1	24.3	34.2	50.9	19.2	40.3	27.4	37.5	25.3	18.2	18.6	35.4	77.8	34.5	54.2	42.3	40.6	52.0	47.8	25.5	43.8	39.2	17.4	16.4	49.7	22.1	20.0	29.3	28.1	22.8	51.8	28.3	47.2	23.8	26.5	32.4	48.6	46.8	22.5	32.9	85.0	25.5	40.7	27.2	17.1	24.2	15.3	14.9	28.5	27.2	32.4	17.0	24.2	42.3	53.4	29.9	30.7	78.6	66.4	52.4	56.2	70.2	79.9	37.6	19.1	52.6	36.9	17.1	48.9	45.2	18.9	24.2	32.6	32.5	23.9	26.3	13.4	17.1	19.6	41.9	41.2	27.6	23.3	32.8	23.0	47.8	29.1	27.8	49.7	34.5	33.8	54.2	40.6	34.6	36.4	34.8	54.8	35.4	39.2	39.2	4.1	42.3	41.8	77.8	34.3	52.0	42.7	37.8	23.9	40.7	35.1	35.4	38.6	34.0	25.5	19.2	26.8	35.0	96.1	78.8	59.9	70.0	43.9	81.5	57.6	35.2	109.9	13.7	223.3	253.7	181.2	231.0	66.1	189.6	0.0	160.4	388.0	70.2	118.7	116.4	95.1	248.7	55.6	119.5	44.2	87.6	551.5	57.8	137.7	99.5	329.2	138.8	71.0	136.3	192.9	44.6	260.5	52.1	45.3	61.8	169.2	334.8	62.9	142.6	79.8	214.2	95.3
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.3	7.0	6.3	9.2	5.5	6.3	10.8	12.2	4.2	12.7	8.8	22.0	17.6	35.9	8.8	5.2	20.5	8.5	23.5	12.7	16.7	6.4	17.3	36.0	6.7	24.6	9.4	41.5	9.8	4.9	8.1	14.6	24.9	3.3	10.9	20.5	48.1	12.0	8.8	13.5	14.1	53.5	31.3	14.2	23.0	21.7	11.5	17.3	5.7	9.3	15.0	6.4	6.6	7.3	12.4	8.4	7.5	12.4	10.2	12.7	10.1	16.5	38.4	8.5	12.8	57.4	8.6	35.1	10.2	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0	14.9	30.0	19.7	34.4	106.7	9.4	21.6	12.7	26.8	36.4	1.8	7.9	43.0	8.3	15.1	74.2	29.5	2.8	0.0	17.0	43.6	29.4	25.4	20.8	10.6	32.5	14.3	10.3	8.6	30.8	61.9	31.7	32.1	20.3	19.0	16.0	9.6	22.6	13.9	25.1	5.1	28.7	38.8	35.0	435.9	39.2	101.3	16.9	130.7	24.0	62.3
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Group enriched"	"Detected in many"	33	"Early spermatids: 54.3;Late spermatids: 174.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	18.6	0.0	0.0	0.2	7.6	3.3	9.6	6.1	0.1	1.5	0.0	0.4	23.9	4.7	1.9	2.7	0.0	13.1	0.0	0.9	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.8	0.1	0.1	0.0	0.0	0.0	23.7	3.0	0.0	1.7	2.7	1.6	2.2	0.0	10.3	0.0	1.2	19.5	0.7	3.4	5.1	5.8	0.6	6.3	0.7	0.3	0.0	0.2	3.0	0.2	4.1	0.0	0.0	0.0	1.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6	0.0	0.0	0.0	0.5	0.1	1.9	0.3	2.5	1.4	3.4	0.0	0.0	0.0	3.3	2.2	54.3	0.2	1.0	0.0	0.7	0.2	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	174.5	2.8	0.0	0.0	0.0	2.5	3.5	3.3	0.0	0.4	0.0	3.2	0.0	0.1	0.7	1.1	0.0	0.2	0.0	1.9	1.1
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.4	10.0	60.2	18.3	28.7	39.1	11.1	22.5	40.2	17.9	31.8	10.0	13.9	7.6	59.1	45.3	14.7	7.4	17.1	17.0	12.9	13.5	14.2	15.7	11.9	19.5	24.6	4.0	12.1	51.1	7.1	18.1	9.2	36.9	33.9	8.9	3.8	9.3	34.1	15.0	8.9	6.7	22.2	9.5	12.0	5.9	21.6	10.8	24.5	4.1	9.5	24.5	8.9	10.4	52.0	73.5	42.9	6.8	29.2	15.3	23.8	22.7	6.3	6.0	5.0	5.4	22.3	10.6	77.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3	41.7	33.9	29.8	80.0	37.7	72.3	51.6	53.5	66.9	30.7	73.3	27.5	185.2	208.9	88.2	2.4	76.6	14.7	0.0	47.8	117.1	94.0	95.1	100.4	13.2	60.7	130.3	56.0	66.9	12.9	8.5	216.0	36.3	150.1	64.9	42.6	178.6	48.5	32.3	301.2	111.7	49.9	155.2	150.8	13.5	12.4	30.6	141.5	45.4	24.9	55.9
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390749-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 50.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 247.1;Bipolar cells: 91.7;Club cells: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008444			Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	4.4	4.3	9.5	9.0	6.2	0.4	11.6	11.3	11.9	4.9	15.3	1.3	1.7	7.4	6.2	8.7	10.0	4.8	6.3	4.2	6.6	9.5	9.6	8.0	50.7	2.6	8.0	7.9	8.0	13.3	7.1	8.2	9.2	5.2	5.5	10.5	5.9	7.8	3.6	2.4	3.1	25.1	5.9	5.4	3.6	14.6	4.9	3.9	3.9	16.5	9.1	9.0	4.5	9.8	0.1	0.7	1.1	0.2	0.8	1.8	0.2	8.1	9.4	9.0	4.0	4.2	6.1	2.7	5.8	2.7	4.4	5.0	8.3	2.4	0.3	4.3	5.1	3.7	3.6	8.1	4.3	5.5	8.8	8.7	3.5	8.2	3.8	1.0	2.8	5.3	3.2	2.2	4.6	10.3	5.3	6.0	3.7	4.4	7.8	5.9	5.3	4.6	0.7	3.3	13.8	5.9	6.6	14.4	1.0	5.2	3.6	8.3	8.6	6.7	11.3	2.0	11.9	5.8	1.5	10.6	7.3	9.2	6.6	7.9	3.1	2.5	0.0	3.8	1.4	5.8	0.4	0.2	0.0	0.5	0.0	0.5	0.0	1.3	0.2	0.7	0.1	1.8	0.1	1.1	0.8	0.2	0.2	0.0	0.2	9.5	6.2	11.3	11.9	6.6	9.5	8.0	7.9	5.2	3.9	247.1	72.0	0.0	7.8	9.6	91.7	7.5	15.3	21.4	97.8	12.2	47.1	12.8	6.6	8.8	20.1	12.0	41.6	0.0	9.3	1.7	11.3	11.7	5.8	12.2	3.3	38.1	13.2	9.8	1.8	21.6	9.5	2.8	11.8	0.0	19.0	36.6	11.9	26.6	10.6	4.3	46.3	12.9	6.9	15.9	10.1	6.6	4.6	1.8	25.9	8.9
MAGOHB	"FLJ10292, MGN2"	ENSG00000111196	"Mago homolog B, exon junction complex core component"	Q96A72	12	10604190-10613623	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043036, HPA047754"	Uncertain					NA	NA					"HPA043036: AB_2678279, HPA047754: AB_2680148"	"unprognostic (1.16e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.27e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (5.56e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.04e-8)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-2)"	13.9	15.6	14.3	13.5	24.6	11.3	17.3	13.5	14.6	15.1	15.7	11.8	11.4	9.8	16.0	22.3	16.3	11.0	10.6	13.0	12.5	11.1	15.5	25.4	11.2	16.5	16.2	14.1	11.3	15.7	12.6	24.2	13.5	11.4	13.1	16.6	11.9	13.0	16.9	7.6	10.3	11.5	21.4	13.9	13.3	12.3	9.2	12.6	20.0	12.0	13.4	20.8	12.4	11.5	8.5	21.7	1.8	8.6	13.1	13.7	6.2	12.2	17.0	18.2	12.5	4.3	5.9	18.0	17.9	5.4	15.1	11.0	22.0	12.0	20.3	2.8	12.1	13.8	6.8	16.2	10.6	19.5	12.3	22.6	16.8	17.6	14.9	5.6	34.1	9.5	4.2	4.0	12.0	7.5	4.2	9.3	24.6	16.2	3.2	13.6	17.8	22.1	22.5	37.1	12.8	15.3	19.7	30.3	12.3	11.8	14.8	4.9	10.3	12.5	13.9	12.0	36.7	6.7	30.2	5.2	8.6	28.9	12.5	25.8	4.6	12.9	39.7	20.3	18.0	23.2	0.3	5.3	1.8	10.3	8.6	10.7	8.0	9.9	11.1	7.7	8.5	11.5	13.7	0.9	13.1	8.4	21.7	8.6	6.2	14.3	24.6	13.5	14.6	12.5	11.1	16.2	14.1	11.4	12.6	17.9	16.8	27.4	25.0	12.6	11.1	22.2	20.4	17.4	12.5	21.0	7.9	51.6	59.7	36.9	7.0	20.2	11.7	0.0	29.6	100.5	30.1	27.4	23.1	37.7	43.4	0.0	21.8	16.0	17.1	4.5	16.7	21.0	28.7	33.3	19.4	16.1	26.3	10.5	14.5	38.4	11.0	25.8	19.4	25.5	60.0	11.5	39.1	20.8	20.3	23.0
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.4	6.3	10.8	9.3	14.2	17.1	34.6	12.0	18.8	5.4	5.1	4.8	8.3	10.8	22.3	15.4	5.1	8.6	5.0	10.2	12.2	13.5	7.6	6.4	8.9	5.3	8.6	10.0	14.8	11.5	11.0	8.3	7.3	10.0	16.1	7.6	10.3	16.7	11.3	28.1	6.1	3.2	5.5	7.3	6.6	5.5	23.5	7.4	7.5	19.7	5.9	8.6	11.9	12.8	9.4	14.7	6.3	6.4	15.3	12.2	10.1	8.6	12.2	11.4	7.7	7.3	16.2	8.0	29.0	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4	35.7	30.2	42.7	29.6	27.5	59.3	85.6	35.7	42.8	40.9	41.8	21.6	40.9	14.9	26.4	27.9	33.3	25.6	23.3	52.0	201.3	31.7	37.6	15.1	78.0	25.6	41.3	20.8	34.4	30.7	15.9	49.8	22.8	38.8	12.6	32.4	40.2	36.9	21.0	61.5	21.5	39.0	38.8	29.1	63.9	52.5	30.2	318.2	30.5	26.4	37.2
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
MARCH9	"FLJ36578, RNF179"	ENSG00000139266	"Membrane associated ring-CH-type finger 9"	Q86YJ5	12	57755098-57760407	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.9;Cone photoreceptor cells: 119.8;Horizontal cells: 54.0;Muller glia cells: 63.3;Rod photoreceptor cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	12	"RH-30: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (3.07e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.15e-3)"	"prognostic favorable (1.54e-5)"	"unprognostic (7.76e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	5.9	11.8	11.0	10.7	14.1	6.1	8.8	25.0	16.6	9.5	9.3	7.8	17.5	10.1	6.8	11.9	8.3	9.6	14.3	12.2	10.8	9.9	16.9	5.6	16.5	16.6	7.7	11.0	6.4	14.4	26.3	24.6	10.3	7.4	11.0	9.0	16.8	12.3	17.6	10.5	13.4	12.7	7.0	6.1	19.4	11.6	5.2	6.8	37.6	20.2	6.2	17.8	9.2	7.7	6.8	11.0	2.2	0.7	3.0	6.1	1.3	3.1	1.5	2.4	2.6	0.2	0.0	3.2	0.4	3.3	1.9	1.8	2.0	2.5	7.6	2.6	0.0	3.2	2.8	4.0	3.4	1.2	4.5	4.4	1.0	1.1	1.0	2.3	0.9	1.6	0.4	3.5	0.5	1.9	5.6	0.8	7.7	1.4	7.9	0.5	2.9	4.8	1.1	1.6	2.2	3.4	4.0	110.2	8.2	3.7	2.7	5.6	3.6	0.2	0.2	2.0	1.2	5.6	1.8	0.0	2.4	2.0	1.3	1.5	8.9	4.0	4.7	2.7	0.2	2.4	2.2	0.5	0.1	4.0	0.7	5.9	5.3	6.0	5.2	1.5	6.8	6.1	4.6	0.2	3.0	0.2	11.0	3.6	1.3	11.0	14.1	25.0	16.6	10.8	9.9	7.7	11.0	7.4	6.8	20.8	12.3	17.1	0.0	9.2	72.9	9.4	12.7	1.4	5.7	8.7	119.8	1.6	5.0	0.0	0.3	7.3	5.3	0.0	0.0	0.7	3.1	0.0	2.3	3.9	6.6	54.0	14.6	12.3	1.2	0.8	9.2	3.3	6.8	0.0	8.0	63.3	0.0	2.9	10.6	7.0	188.1	6.5	4.7	2.3	3.4	8.3	0.9	10.1	11.0	0.0
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.6	8.7	18.7	18.8	18.8	18.2	14.1	14.3	17.8	19.0	20.0	17.8	16.8	15.8	21.9	18.4	10.0	12.8	19.6	13.2	23.4	22.8	14.7	9.2	8.7	30.3	20.5	18.8	10.3	18.6	20.4	12.4	16.1	19.7	11.8	22.2	15.8	19.8	14.0	16.0	18.0	15.3	15.8	14.3	26.0	8.7	16.3	11.0	21.4	12.9	28.0	11.1	11.8	11.4	18.9	16.7	18.6	12.3	9.2	21.2	13.8	15.5	14.7	16.4	18.9	24.8	8.1	9.7	14.6	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8	202.5	218.5	10.4	31.7	80.1	24.3	9.4	2.5	50.9	169.5	24.4	2.0	20.7	49.7	17.7	2.7	17.7	14.6	0.0	16.6	17.7	24.9	20.7	12.7	21.2	15.9	87.4	30.2	15.4	9.9	2.5	29.7	14.5	20.3	9.0	12.1	23.6	16.8	17.5	25.5	38.3	22.5	12.9	21.2	42.9	36.4	57.2	16.6	14.9	17.7	12.9
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Proximal tubular cells: 205.7;Rod photoreceptor cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA					"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	11.2	7.3	19.9	8.6	16.2	7.6	18.8	11.3	19.4	10.4	15.3	10.3	19.1	22.7	9.1	17.1	12.2	6.3	7.1	12.0	17.2	20.9	27.8	21.4	10.7	8.2	22.1	14.5	5.6	21.9	4.5	9.5	11.7	14.1	8.5	12.4	15.2	13.4	15.6	20.7	22.3	29.5	6.6	16.5	10.6	7.9	6.1	10.1	9.1	20.2	14.3	11.1	6.6	9.0	4.4	7.0	6.0	3.4	4.0	5.2	6.3	10.4	3.2	15.6	16.1	9.4	8.2	9.9	9.4	9.2	10.4	11.0	10.9	5.1	14.1	19.4	6.8	16.4	4.6	9.8	7.8	11.8	9.5	6.0	14.4	5.7	10.7	9.1	14.4	5.7	5.6	7.8	13.3	9.7	7.7	3.6	17.5	10.7	7.7	7.2	4.4	17.4	21.8	10.3	26.9	4.2	12.9	14.0	20.3	12.5	6.4	10.2	11.6	6.3	16.3	24.4	26.1	6.0	6.6	5.0	15.7	8.8	11.2	13.1	9.4	31.3	20.6	7.2	8.5	21.2	6.0	2.9	0.8	3.5	2.5	4.2	4.4	5.0	5.2	7.0	3.9	3.8	3.6	2.1	4.0	3.4	4.6	2.8	6.3	19.9	16.2	11.3	19.4	17.2	20.9	22.1	14.5	14.1	10.1	14.9	23.5	19.3	19.0	39.8	34.3	40.3	25.5	5.3	10.3	54.1	113.9	37.7	117.7	23.3	39.1	29.3	86.7	70.0	27.5	51.7	37.7	49.1	6.9	60.4	75.5	25.4	15.0	25.2	24.4	3.6	20.4	39.2	49.0	45.9	44.1	30.8	28.8	77.7	25.5	205.7	250.4	19.4	35.8	3.5	39.8	50.2	72.1	13.8	33.6	27.1
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 615.5;Late spermatids: 1508.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	38.7	22.4	33.6	26.6	30.8	20.6	13.4	26.0	27.7	32.5	35.7	33.3	10.2	20.3	27.3	31.7	47.5	19.7	25.9	35.3	30.6	23.2	35.1	37.7	24.5	35.9	15.9	27.4	19.8	16.4	17.6	43.1	28.2	33.1	19.5	33.3	25.4	22.8	35.5	74.3	36.7	31.8	15.8	110.3	19.8	18.0	20.0	20.2	22.4	36.8	32.5	22.8	20.0	17.2	29.5	28.3	26.2	30.0	14.4	35.9	28.9	23.2	44.8	26.0	21.5	33.9	18.0	20.6	29.1	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7	23.8	11.8	43.2	62.1	58.8	20.2	24.9	43.3	58.9	39.8	52.4	3.9	94.6	142.6	74.9	615.5	56.2	55.4	0.0	80.2	87.3	55.2	61.8	46.1	39.4	95.1	15.9	28.7	41.7	31.9	1508.8	58.7	50.6	64.1	93.8	42.8	52.2	71.4	49.1	56.3	121.5	14.8	116.4	68.9	194.8	94.1	60.9	71.1	58.2	45.3	74.3
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	12.7	19.6	18.2	12.1	26.5	9.3	15.2	15.5	22.8	13.8	13.1	11.4	19.0	15.0	13.3	22.2	16.0	13.7	10.4	10.8	16.8	15.6	15.0	17.7	11.5	10.6	12.9	22.9	11.7	12.4	13.4	17.9	22.3	12.2	14.1	12.8	14.4	14.6	15.9	12.8	17.6	10.3	13.1	9.9	11.9	11.8	23.1	12.5	10.5	21.2	9.7	16.3	11.8	15.5	31.1	25.8	20.8	24.8	15.3	25.9	17.7	16.6	10.8	13.1	12.1	14.0	12.6	15.6	14.4	11.3	13.9	14.1	7.6	13.1	9.3	22.5	13.7	12.2	12.8	9.7	9.1	12.4	12.1	10.6	7.9	6.8	7.0	21.1	8.6	9.5	10.3	16.8	13.8	27.3	9.7	17.8	7.6	8.6	9.2	16.6	8.0	12.1	16.1	11.4	11.9	21.7	11.7	18.6	11.2	9.2	7.1	10.2	14.3	11.6	11.9	25.3	11.6	25.1	8.9	14.5	12.1	14.5	28.4	12.6	11.5	11.0	8.7	16.5	6.4	12.6	16.9	18.8	20.8	21.7	24.6	23.3	31.1	24.4	23.1	17.8	26.7	25.9	24.2	11.7	15.3	24.8	25.8	22.6	17.7	18.2	26.5	15.5	22.8	16.8	15.6	12.9	22.9	12.2	12.5	8.9	21.9	25.5	55.2	77.8	32.7	14.6	30.6	33.5	17.0	48.8	33.4	51.2	33.2	41.6	8.2	35.1	30.4	23.3	39.5	39.8	40.9	37.0	21.9	22.9	25.9	35.0	22.3	30.7	19.0	13.4	26.2	18.0	35.4	29.7	23.5	33.2	33.5	24.6	28.0	32.0	55.2	19.4	28.8	97.7	85.4	72.0	61.1	32.6	27.1	49.9
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989878	"Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 294.4;Extravillous trophoblasts: 237.4;monocytes: 150.5;Syncytiotrophoblasts: 364.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		690000	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	15.5	19.5	15.5	19.7	17.6	5.7	23.5	15.6	14.4	21.1	15.8	15.3	31.3	14.0	14.5	48.3	17.1	14.3	16.2	15.5	14.0	17.6	16.4	28.2	17.6	23.8	20.9	13.4	22.2	34.7	12.8	23.4	32.1	17.0	20.8	16.4	15.0	20.4	37.6	14.2	12.3	13.7	13.9	22.4	16.2	16.5	13.6	17.8	13.0	37.1	12.7	14.3	13.7	17.1	19.0	25.6	17.7	15.0	24.7	25.1	16.0	12.3	18.7	16.7	10.7	28.3	16.1	25.9	18.9	22.6	20.7	25.3	16.7	34.7	10.4	21.9	15.2	22.0	20.8	25.8	19.4	19.7	22.9	16.5	13.1	16.2	28.4	21.7	15.5	14.5	16.7	22.5	17.4	20.8	17.4	19.6	12.8	15.7	26.7	17.5	15.5	9.5	13.0	20.1	18.3	7.7	14.7	10.3	27.7	17.1	17.0	14.5	8.5	20.7	14.1	30.9	31.7	16.3	12.4	15.2	20.0	19.0	10.7	24.2	16.9	21.5	14.3	18.8	27.8	20.8	17.7	15.0	10.3	21.6	13.8	25.1	19.0	22.8	21.1	15.3	18.1	21.5	21.6	4.5	24.7	11.6	25.6	22.8	16.0	15.5	17.6	15.6	14.4	14.0	17.6	20.9	13.4	17.0	17.8	74.5	55.2	0.0	0.0	0.0	0.0	0.0	0.0	78.9	51.2	55.8	0.0	294.4	11.6	87.8	0.0	0.0	0.0	0.0	97.3	237.4	0.0	0.0	33.7	0.0	108.4	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	150.5	0.0	0.0	77.9	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	364.7	0.0	0.0	0.0
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29.0	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24.0	9.0	13.2	10.0	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22.0	15.6	19.7	17.4	9.6	15.6	6.5	11.0	12.0	10.4	10.6	13.2	12.1	8.0	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16.0	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9.0	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.6	10.7	24.1	11.7	11.7	16.6	13.3	21.2	25.5	18.5	9.0	17.3	11.5	16.2	12.9	11.6	13.7	20.7	22.9	22.0	24.9	12.0	15.0	13.0	9.0	31.1	11.7	32.3	20.2	10.4	19.8	11.0	31.7	9.4	21.2	22.7	30.5	4.6	28.1	15.9	24.8	38.2	22.0	24.5	14.9	30.8	11.1	10.7	16.7	20.7	16.5	7.1	35.7	15.9	15.2	10.3	27.9	20.1	16.6	17.4	17.3	15.3	15.0	6.8	16.4	64.4	15.7	26.6	22.0	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9	17.9	37.6	25.3	34.6	34.5	13.8	29.0	12.7	34.8	35.2	19.2	9.8	52.1	43.1	41.7	4.8	14.3	15.1	46.7	24.5	35.8	39.3	21.5	17.4	13.0	43.1	19.1	8.6	19.0	33.6	7.6	10.3	56.9	30.4	71.3	17.4	31.2	42.3	28.1	9.6	33.9	22.5	19.4	25.8	30.3	54.8	47.2	27.5	22.9	28.6	40.1
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113454-44127457	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 116.6"	"Low region specificity"	"Detected in all"							"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	10.1	16.1	12.5	9.6	12.8	7.9	11.7	10.5	12.7	10.5	16.4	9.6	8.4	16.2	12.1	12.3	15.7	10.4	14.8	18.5	10.0	8.4	12.4	35.5	25.9	10.4	10.9	11.5	7.1	17.5	4.9	9.6	11.8	10.6	9.7	16.3	13.7	14.0	9.4	61.4	16.0	14.0	12.7	7.9	10.2	12.7	19.0	10.4	13.1	26.3	27.8	12.4	12.3	10.0	33.2	36.4	9.0	36.1	46.7	32.5	30.3	39.8	17.1	12.1	16.7	10.5	10.3	15.5	14.9	14.9	19.9	20.0	35.6	14.1	17.4	16.9	12.7	19.2	16.3	13.6	24.3	15.9	20.6	37.1	17.9	15.1	43.5	13.0	17.0	12.6	9.5	13.2	18.8	11.2	15.4	16.4	15.0	37.6	11.2	17.6	40.3	20.3	26.8	10.6	116.6	16.4	14.6	13.6	23.6	32.8	19.8	27.1	10.5	9.6	18.8	18.5	11.0	17.2	17.5	13.1	17.8	26.6	12.7	25.8	14.0	12.3	40.8	20.1	16.9	12.9	9.0	36.1	7.5	25.4	32.7	29.9	33.2	32.5	28.6	32.4	30.2	25.8	26.5	2.0	46.7	21.9	36.4	21.9	30.3	12.5	12.8	10.5	12.7	10.0	8.4	10.9	11.5	10.6	10.4	348.4	202.5	87.1	148.9	205.3	26.8	126.7	117.2	72.3	125.1	54.1	29.5	154.6	172.5	198.2	197.3	76.8	185.2	23.3	191.9	163.1	85.4	198.8	43.8	284.0	228.8	31.8	89.7	48.5	40.9	90.3	69.0	86.6	65.8	216.4	126.1	48.1	252.2	194.7	50.2	212.2	55.1	45.3	85.8	91.7	125.6	245.9	133.9	72.7	153.8	317.1
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059806	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	16.9	19.9	17.4	13.1	22.5	16.0	14.2	13.6	21.8	13.0	15.6	13.3	16.4	20.3	14.1	16.9	13.6	16.2	15.5	31.7	16.0	16.8	20.9	55.0	12.9	16.2	18.8	20.3	15.7	17.4	25.8	17.8	11.7	15.3	12.9	15.0	12.6	21.1	19.6	53.2	13.8	15.2	13.4	12.4	11.5	13.4	21.0	13.2	17.5	15.7	25.5	12.3	12.4	11.9	21.0	26.9	14.3	18.5	17.5	16.9	13.6	10.9	12.6	6.3	11.0	7.7	6.2	9.8	4.9	7.0	12.8	11.5	24.1	3.8	15.5	12.3	6.8	9.5	11.6	13.6	13.1	8.0	9.0	28.2	12.5	10.2	29.1	15.2	10.4	6.1	8.1	13.9	14.8	20.1	6.7	9.0	19.8	20.9	10.4	6.8	21.3	13.4	37.0	5.7	42.2	14.9	15.6	6.3	19.8	9.6	6.9	15.2	7.9	4.8	8.5	15.0	5.6	9.6	18.7	8.1	7.5	10.1	9.9	13.6	12.1	11.0	32.0	5.5	16.8	7.3	6.8	18.5	14.3	13.5	17.2	16.9	20.4	15.6	16.0	25.2	21.0	15.9	16.1	5.5	17.5	13.4	26.9	16.6	13.6	17.4	22.5	13.6	21.8	16.0	16.8	18.8	20.3	15.3	13.2	20.8	15.2	33.7	27.7	21.6	18.7	34.1	35.7	29.4	27.3	57.6	25.5	66.2	157.5	45.9	72.1	31.5	50.7	46.7	46.7	41.8	35.6	25.5	27.7	68.6	44.0	4.8	29.4	30.1	23.0	24.4	50.9	27.0	50.6	45.1	37.0	29.6	38.4	49.5	48.4	109.4	17.2	25.8	39.1	33.4	34.3	23.7	53.1	27.7	57.2	21.0
MRPL3	"MRL3, RPML3"	ENSG00000114686	"Mitochondrial ribosomal protein L3"	P09001	3	131462212-131502983	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043665, HPA060132"	Approved					NA	NA					"HPA043665: AB_2678606, HPA060132: AB_2684209"	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.61e-3)"	"unprognostic (7.83e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.33e-7)"	"unprognostic (1.54e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (1.36e-4)"	"prognostic unfavorable (3.51e-6)"	"unprognostic (2.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-1)"	30.8	32.6	23.3	23.4	25.9	13.8	34.7	20.4	29.6	27.1	31.1	17.8	32.8	25.1	26.8	39.7	36.0	31.7	22.9	46.3	23.6	26.3	48.9	53.5	20.2	36.5	23.0	20.1	38.7	44.8	33.7	31.7	23.5	27.0	32.1	35.7	19.9	29.4	27.2	51.6	21.5	30.7	26.6	21.4	28.7	26.9	34.9	17.2	42.3	47.5	37.5	30.3	35.5	23.8	23.8	46.1	5.8	32.3	28.3	30.3	33.7	54.7	23.2	26.1	29.3	24.7	32.1	47.4	30.0	26.4	38.8	34.7	51.2	32.0	44.7	40.7	29.9	30.5	36.1	44.3	43.0	59.7	29.0	34.6	41.4	25.7	42.9	29.0	82.8	26.7	25.2	35.8	29.8	53.3	21.2	25.0	34.4	37.8	24.5	32.0	41.8	41.4	41.6	55.5	58.7	41.9	16.6	33.6	68.5	38.2	38.7	42.6	28.7	26.8	30.7	42.0	22.9	35.9	44.6	22.6	28.1	29.2	39.6	41.3	23.5	23.6	80.1	30.0	40.0	38.5	3.4	24.7	5.8	19.5	32.3	30.3	23.8	24.2	23.2	46.1	22.0	28.1	25.0	1.4	28.3	23.3	16.1	23.4	33.7	23.3	25.9	20.4	29.6	23.6	26.3	23.0	20.1	27.0	17.2	23.8	21.1	52.2	74.7	40.8	27.8	31.9	38.2	34.8	38.7	29.6	7.9	83.1	129.3	84.1	64.2	20.3	35.7	0.0	88.7	110.1	51.3	58.9	28.8	45.2	60.4	28.6	28.9	35.6	49.5	14.8	51.5	54.1	40.5	45.9	68.9	30.1	77.5	21.0	48.4	133.1	17.3	32.3	35.4	148.5	76.8	41.5	53.4	32.4	73.7	68.6
MRPL55		ENSG00000162910	"Mitochondrial ribosomal protein L55"	Q7Z7F7	1	228106679-228109312	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027641	Supported				"Intracellular and membrane"	NA	NA					"HPA027641: AB_10600825"	"unprognostic (4.84e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.03e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.15e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (5.54e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	20.1	27.1	31.9	13.5	30.9	39.7	18.7	20.7	37.4	16.1	19.9	16.8	24.2	22.7	17.6	27.4	15.8	17.1	21.3	32.8	27.3	26.5	20.1	31.4	14.4	18.1	27.8	23.0	15.1	27.9	13.8	20.6	13.6	20.5	19.4	8.0	17.7	40.8	25.0	42.2	18.5	23.7	17.3	20.6	16.7	18.2	21.3	14.8	13.6	21.2	18.2	16.0	17.6	12.3	52.6	57.0	30.5	42.7	33.2	47.2	38.1	15.4	23.7	5.1	9.1	5.9	6.6	20.6	10.6	5.8	11.9	10.0	23.9	15.0	12.1	22.6	7.3	6.1	13.3	4.9	11.6	2.8	10.3	54.2	5.4	18.1	26.3	10.0	14.5	6.4	7.3	9.6	10.6	5.9	4.9	9.5	18.8	13.9	13.1	5.5	18.0	17.0	22.0	17.0	15.3	67.2	15.2	10.0	32.4	7.1	8.3	13.4	13.4	8.6	27.1	19.5	1.8	22.8	13.2	8.1	10.0	11.2	18.9	20.3	11.7	14.5	14.6	16.6	12.5	19.7	22.7	42.7	30.5	36.1	41.9	42.6	46.4	41.3	39.1	41.3	52.6	42.9	45.3	26.6	33.2	34.3	57.0	47.2	38.1	31.9	30.9	20.7	37.4	27.3	26.5	27.8	23.0	20.5	14.8	41.7	60.2	77.3	63.7	67.9	32.6	75.4	96.8	46.8	36.4	89.0	7.9	121.4	200.6	58.3	98.7	63.7	105.7	46.7	81.6	108.7	77.9	59.1	46.2	224.7	108.5	22.3	75.2	62.6	57.2	160.4	71.9	70.8	69.2	99.2	65.7	50.2	69.0	62.0	65.7	189.7	36.7	77.6	100.9	66.9	81.3	84.8	92.5	52.4	77.6	56.7
MRPS11	"FLJ22512, FLJ23406, HCC-2"	ENSG00000181991	"Mitochondrial ribosomal protein S11"	P82912	15	88467453-88480773	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043752, HPA050345"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043752: AB_2678653, HPA050345: AB_2681100"	"unprognostic (2.66e-1)"	"prognostic favorable (3.60e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.45e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.44e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	12.4	19.1	19.5	9.0	18.3	6.1	13.5	11.2	19.6	7.0	13.4	8.0	11.0	17.6	7.3	9.3	15.1	11.4	10.3	31.0	19.1	17.3	16.5	28.5	8.2	10.5	18.3	15.0	6.0	22.5	9.6	9.3	9.0	15.8	8.9	8.6	8.0	11.4	10.4	44.3	11.5	13.1	10.0	13.7	9.5	10.7	9.9	10.4	12.9	17.7	12.9	10.4	9.7	7.9	18.5	23.0	18.9	19.0	20.9	24.4	17.4	5.6	22.4	3.2	5.7	7.8	3.9	9.2	4.7	8.0	5.9	6.5	15.4	8.8	5.1	9.5	3.8	6.4	8.0	9.3	6.3	2.9	6.8	24.4	6.9	14.5	16.8	9.3	2.4	4.6	7.6	6.2	5.1	5.1	3.2	8.0	6.7	5.0	2.2	9.9	23.9	4.7	10.0	9.3	7.3	23.9	10.2	6.4	12.0	8.3	15.3	11.3	5.5	4.9	11.8	18.3	3.0	11.1	13.6	3.7	8.5	9.4	5.6	6.6	4.7	8.5	5.9	10.6	5.8	8.8	18.9	18.4	13.2	11.7	19.0	13.3	18.5	13.3	13.6	21.2	12.9	14.1	13.7	6.7	20.9	12.1	23.0	24.4	17.4	19.5	18.3	11.2	19.6	19.1	17.3	18.3	15.0	15.8	10.4	6.0	17.8	35.0	31.0	20.3	31.6	5.0	30.6	29.4	22.7	43.6	45.2	79.4	114.4	52.5	21.7	29.2	79.0	46.7	58.5	79.5	31.0	23.1	32.4	74.4	78.6	25.4	23.7	36.2	33.0	25.4	30.8	35.9	30.4	78.5	44.3	37.2	56.5	73.7	40.0	99.0	41.4	19.4	23.9	62.1	38.8	24.7	74.9	44.1	54.1	29.0
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464437	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 621.9;Late spermatids: 1487.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	22.6	20.7	17.8	16.9	17.3	24.0	23.8	9.5	16.0	13.2	19.9	9.3	13.7	14.3	13.3	23.0	23.0	10.4	16.6	43.2	15.0	15.2	30.6	61.7	16.6	23.3	17.5	10.6	13.8	23.3	14.3	14.3	23.7	18.3	15.0	18.2	13.8	24.0	14.7	89.5	14.1	18.4	15.7	12.3	17.3	18.8	65.5	10.6	20.3	19.1	41.3	19.3	16.0	12.9	24.5	40.7	7.0	28.7	20.3	28.1	28.6	40.5	22.6	24.7	30.1	24.6	35.7	61.5	22.7	32.6	56.3	51.8	39.9	43.8	37.6	37.1	29.8	33.9	35.8	36.0	57.3	50.8	24.4	45.7	38.4	29.3	43.6	46.1	47.5	27.2	32.9	51.2	50.1	40.6	21.8	45.9	28.3	41.5	29.7	34.7	27.9	45.7	50.9	44.4	34.8	39.9	35.4	43.5	55.0	49.7	34.2	36.7	20.3	31.4	40.2	58.2	38.5	24.8	32.7	21.6	31.7	33.7	39.1	47.8	29.9	41.0	52.5	36.1	32.3	44.2	4.9	26.7	7.0	22.0	28.7	27.2	24.5	25.2	25.0	40.7	21.6	23.9	23.2	1.8	20.3	18.9	27.7	28.1	28.6	17.8	17.3	9.5	16.0	15.0	15.2	17.5	10.6	18.3	10.6	35.7	41.7	43.3	52.5	58.2	23.2	120.0	53.5	38.8	28.4	68.0	13.7	219.1	273.5	113.2	621.9	59.7	89.2	116.8	140.3	210.6	61.7	96.5	41.5	122.3	137.3	12.7	63.4	52.8	79.0	1487.0	58.1	81.5	54.0	95.6	78.7	16.2	134.3	66.6	70.0	248.1	19.2	64.7	69.1	202.9	79.7	70.3	235.5	61.8	99.8	87.6
MRS2	MRS2L	ENSG00000124532	"MRS2, magnesium transporter"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA					"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.3	18.6	13.0	16.3	16.1	6.2	18.4	27.4	17.8	11.8	14.5	10.9	15.2	15.7	11.5	15.9	14.5	10.3	12.8	34.1	15.6	13.7	24.4	17.7	11.4	14.0	14.9	15.1	13.8	24.1	16.3	18.9	19.1	14.4	14.1	16.6	16.3	16.9	22.3	47.7	14.0	15.0	12.2	12.1	15.4	15.4	7.9	11.4	11.1	17.4	20.9	14.9	13.9	11.6	11.5	19.4	5.4	15.2	11.2	12.4	9.6	13.2	7.6	9.7	17.2	6.2	5.8	20.8	6.2	7.5	8.0	7.2	30.1	6.2	7.9	25.3	5.4	12.1	8.3	9.6	11.9	8.6	9.6	16.9	12.8	6.6	34.4	9.1	14.1	11.3	9.0	9.6	7.9	6.4	9.2	8.3	10.2	17.7	0.0	8.8	10.3	13.3	13.6	25.3	7.6	7.1	0.1	1.7	17.5	35.0	13.7	14.9	9.1	10.3	32.1	16.9	29.4	16.2	10.1	3.7	3.4	5.3	7.1	11.7	14.4	23.7	10.8	4.3	17.2	14.2	2.3	13.1	5.4	9.5	15.2	12.4	11.5	10.2	10.4	19.4	8.2	11.5	10.6	1.5	11.2	13.5	11.4	8.7	9.6	13.0	16.1	27.4	17.8	15.6	13.7	14.9	15.1	14.4	11.4	32.8	18.3	12.7	11.4	6.4	31.0	50.4	17.8	10.7	11.4	19.2	37.3	38.2	44.7	19.2	0.2	9.5	10.6	0.0	16.5	18.6	12.4	12.6	11.5	12.5	19.8	47.7	9.2	16.5	15.1	0.0	11.2	13.9	6.8	15.4	15.0	21.1	14.0	17.5	15.6	32.6	41.5	19.4	8.9	5.6	10.4	9.8	21.2	12.9	23.3	12.3
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 392.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 130137.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 821.0"	"Low region specificity"	"Detected in all"							HPA053928	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41.0	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26.0	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53.0	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40.0	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821.0	271.8	49.3	113.1	134.0	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257.0	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81.0	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148.0	93.0	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89.0	87.6	67.6	53.0											1179.2	1324.7	15760.8	7514.4	3912.5	0.0	130137.0	15452.1	2295.3	2103.1	12148.5	0.0	0.0	2064.1	2636.7	917.0	2449.9	17720.8	23127.3	3538.6	0.0	2017.3	5309.0	2067.8	31565.1	0.0	0.0	4902.7	11944.3	15339.0	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0.0	3353.9	12846.0	5441.2	13683.6	0.0	6208.8	3859.5	7259.5	5529.7	4316.1	0.0	9799.9	18174.2	10097.1
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.3	10.3	10.8	7.1	7.6	6.4	9.0	6.1	6.0	9.5	7.9	17.7	7.9	18.2	15.9	3.9	9.2	9.7	18.2	11.9	13.3	11.9	9.8	12.8	8.0	15.0	6.3	13.7	4.8	4.5	7.7	8.4	15.0	8.6	8.1	15.4	19.3	5.0	10.6	8.6	14.2	22.2	11.8	30.0	12.5	14.9	17.7	24.6	12.7	10.4	12.9	8.1	9.1	11.7	15.7	12.2	11.0	5.5	4.9	13.0	15.3	14.8	10.3	8.4	14.1	40.1	2.5	12.4	8.8	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3	17.9	17.1	9.0	12.7	11.9	5.3	8.3	2.5	10.7	7.9	5.2	2.0	17.3	24.9	8.2	11.0	6.3	5.0	0.0	6.5	20.2	10.4	14.0	8.1	16.3	10.6	0.0	11.5	2.5	6.5	3.9	7.2	6.1	16.9	1.0	7.7	5.7	6.1	13.3	4.6	22.1	8.7	6.5	8.3	7.4	18.1	12.0	12.8	5.1	13.7	7.5
NDUFS5	CI-15k	ENSG00000168653	"NADH:ubiquinone oxidoreductase subunit S5"	O43920	1	39026318-39034636	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 1936.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042582	Supported					NA	NA					"HPA042582: AB_2678062"	"unprognostic (1.49e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.97e-3)"	"unprognostic (8.96e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.08e-2)"	56.0	62.1	98.7	34.3	84.4	44.5	55.4	48.6	83.7	36.6	62.0	33.7	49.0	42.8	49.4	114.5	59.2	40.9	40.3	166.0	76.3	69.5	61.5	71.3	30.3	35.4	71.6	65.5	49.1	45.8	36.8	46.3	33.0	49.3	44.8	66.9	35.7	72.6	62.9	150.9	36.9	38.2	64.4	46.9	25.1	44.6	22.4	31.9	30.2	47.2	85.8	43.9	55.3	35.1	38.7	64.7	28.4	53.2	36.4	74.4	59.0	42.8	74.8	56.6	68.3	62.4	66.5	74.8	51.2	42.0	50.7	51.6	89.6	57.9	48.1	70.5	54.7	25.2	30.0	72.3	70.0	56.4	52.8	85.1	47.4	134.8	148.5	43.4	95.6	36.5	66.3	80.3	53.6	48.1	50.5	86.1	50.5	75.7	43.9	24.2	95.5	45.4	123.6	98.3	64.9	77.5	61.5	81.1	76.5	99.9	139.1	79.2	73.1	60.0	75.9	66.1	128.0	51.0	77.5	53.2	41.0	48.5	42.0	86.0	35.4	69.2	68.2	45.1	106.9	55.1	26.1	50.8	28.4	46.1	53.2	52.9	38.7	71.9	53.5	51.7	30.0	74.4	63.5	9.7	36.4	48.9	64.7	66.1	59.0	98.7	84.4	48.6	83.7	76.3	69.5	71.6	65.5	49.3	31.9	154.9	172.8	250.2	316.5	409.4	120.7	1936.4	387.3	269.0	202.4	523.4	35.3	556.6	1158.9	487.9	110.4	342.3	536.4	46.7	470.4	522.0	402.8	334.4	205.5	539.4	482.2	93.8	391.7	255.9	289.3	92.4	326.0	334.5	433.6	373.3	534.7	142.1	537.4	534.4	397.4	1154.8	128.4	278.1	523.5	118.9	99.2	402.4	439.3	231.2	642.6	409.2
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.3	12.5	11.5	10.9	17.2	19.4	11.6	14.5	14.5	16.5	16.5	11.4	6.3	23.8	9.3	16.7	11.1	8.7	20.5	15.7	15.5	17.4	10.3	12.5	30.6	12.7	21.0	22.2	13.9	18.1	26.3	14.0	35.5	14.8	10.0	13.6	19.0	20.8	17.2	10.8	14.3	20.9	18.7	11.3	14.2	15.4	12.6	13.0	11.1	14.7	16.0	11.2	14.5	15.7	8.3	14.2	9.1	22.2	12.5	13.5	11.3	9.7	15.7	11.2	10.1	23.7	14.8	11.3	7.7	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0	56.6	43.9	35.8	19.9	7.4	27.8	34.3	28.1	53.5	48.9	26.2	51.1	10.2	6.6	13.9	65.8	11.3	19.0	23.3	11.5	10.2	12.0	21.1	17.4	26.0	12.8	20.6	8.7	16.5	16.7	13.3	17.0	11.5	3.3	13.6	22.8	15.1	11.3	17.6	21.5	6.4	32.6	12.9	11.2	12.1	13.1	9.8	15.1	13.1	16.7	16.1
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 41.5;NB-4: 22.8;U-2197: 15.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA060405, HPA074724"			Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA060405: AB_2684277, HPA074724: "	"unprognostic (9.66e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.9	0.9	0.1	0.3	0.3	1.7	0.0	2.7	4.3	8.8	8.6	0.0	8.6	10.1	2.1	4.5	3.5	3.3	1.1	0.3	1.0	0.4	0.3	41.5	8.8	1.0	3.1	1.4	2.5	3.3	0.1	7.1	0.8	2.8	3.4	1.4	0.0	2.0	1.8	0.1	2.2	22.8	0.0	0.1	0.9	10.8	3.1	4.2	1.0	0.4	0.3	0.3	5.6	0.5	1.2	0.0	0.6	5.5	4.3	4.2	1.5	15.4	2.2	4.1	2.1	10.3	7.5	3.1	0.8	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3	0.0	15.7	22.9	0.8	6.1	0.4	3.1	0.0	2.7	5.7	5.2	0.0	0.0	0.0	5.5	0.4	10.5	19.1	0.0	7.2	0.1	2.8	1.7	9.2	3.9	4.4	0.0	8.1	9.8	17.0	0.0	0.9	7.3	0.0	6.4	10.5	0.3	6.9	10.5	0.4	0.6	1.3	0.0	5.7	0.0	0.0	8.7	0.1	30.5	9.0	3.8
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.9	19.2	19.0	23.6	14.2	12.8	45.0	26.0	14.0	20.1	18.8	42.3	24.4	41.8	21.7	15.7	25.1	25.1	37.6	32.0	35.5	16.3	34.5	50.4	28.8	41.6	21.1	49.8	24.3	16.5	19.1	28.0	64.3	10.9	18.0	24.9	55.0	31.9	25.1	28.7	45.4	55.1	47.4	30.1	33.3	38.4	28.7	55.1	23.7	32.7	29.3	21.7	24.1	34.7	29.9	31.8	23.7	39.4	15.5	25.7	30.2	22.9	44.4	26.0	47.4	59.8	19.0	35.5	30.5	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8	101.3	103.5	73.0	102.7	76.2	27.1	68.8	38.2	96.4	150.2	38.4	39.3	67.7	24.9	45.7	11.5	57.0	15.0	23.3	58.3	76.0	49.7	70.7	131.9	44.1	43.1	23.8	33.8	29.4	17.4	7.9	40.0	46.4	23.6	73.1	32.3	17.7	45.7	10.5	28.0	32.1	43.5	25.8	81.9	59.1	54.7	65.4	56.9	61.8	56.1	83.8
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 10.1;U-266/70: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA					"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.5	2.2	2.4	1.6	0.7	0.2	0.3	0.5	0.0	0.2	4.0	2.1	0.0	0.7	0.0	0.2	0.1	0.0	3.4	2.2	2.6	0.0	0.3	2.1	0.7	5.2	1.7	1.8	0.3	1.4	0.7	0.1	10.1	2.2	0.0	0.0	1.0	3.3	2.9	2.2	1.1	3.1	2.5	0.3	7.1	1.2	0.0	4.4	6.8	1.2	0.2	3.1	2.7	1.2	1.0	0.0	1.1	1.3	0.3	0.9	11.1	1.4	0.6	0.6	0.5	2.8	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0	0.0	0.3	0.0	1.7	1.4	5.8	7.2	0.0	0.0	1.2	8.7	2.0	0.5	14.9	0.2	0.8	0.8	0.0	23.3	0.5	0.9	1.0	1.2	0.0	1.0	1.2	15.9	1.2	0.6	0.3	3.6	0.6	0.5	0.0	0.0	0.6	3.5	0.0	0.0	1.1	1.7	1.5	0.0	0.9	0.9	4.1	0.4	0.5	0.9	0.2	0.4
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"		11	17208153-17349980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"salivary gland: 160.3"	"Cell type enhanced"	"Detected in all"	8	"Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 188.9"	"Low region specificity"	"Detected in many"							"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000		"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	10.2	13.9	9.5	7.5	13.1	66.4	17.9	13.5	7.5	18.3	7.8	3.8	79.5	6.6	11.4	59.6	29.7	13.7	7.3	25.0	7.5	10.9	10.8	51.1	12.5	13.5	8.5	7.6	15.4	92.8	58.9	69.7	35.8	10.3	13.4	8.3	5.8	160.3	104.9	7.2	4.2	6.8	11.3	9.4	9.8	11.4	18.7	6.1	86.1	22.7	17.7	10.4	12.1	11.0	3.7	71.7	28.8	7.6	45.2	49.5	20.1	12.2	5.1	5.7	17.2	12.9	17.8	6.9	27.4	40.0	12.3	21.8	5.0	2.8	18.9	6.9	26.0	11.5	5.3	3.6	6.9	19.3	13.0	8.0	13.9	6.4	8.7	37.3	188.9	25.6	7.7	9.2	8.8	21.6	30.7	15.0	71.0	12.0	38.3	12.1	10.8	66.5	68.3	1.3	20.0	5.4	24.6	13.9	1.5	5.5	3.9	6.8	3.8	12.0	12.1	6.1	8.7	9.9	51.4	13.4	13.1	12.1	39.5	11.5	7.5	4.1	10.4	15.1	66.8	11.1	28.8	7.6	27.6	17.1	5.0	22.3	3.7	16.3	31.5	6.9	2.4	46.0	49.5	7.0	45.2	4.0	71.7	7.0	20.1	9.5	13.1	13.5	7.5	7.5	10.9	8.5	7.6	10.3	6.1	41.7	59.0	14.1	53.1	24.5	64.5	145.2	50.9	702.6	152.4	40.1	51.1	105.9	23.2	65.4	595.9	97.2	5.4	23.3	116.0	281.9	179.4	156.8	63.8	119.0	65.3	33.4	40.7	105.0	27.2	377.7	138.7	39.7	65.8	11.8	82.2	101.2	103.6	8.6	107.5	16.5	80.2	45.3	51.5	125.6	53.1	26.3	968.6	104.6	35.5	54.9
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	8.5	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	1.6	7.5	4.1	2.8	1.4	1.3	24.0	0.2	0.0	5.9	19.5	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	1.9	8.9	10.7	17.6	6.3	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8	11.9	22.0	13.7	80.0	34.6	11.8	47.7	35.7	34.8	5.7	33.2	17.7	39.7	149.2	84.7	2.5	43.4	95.9	0.0	26.5	19.7	19.5	39.7	39.1	21.8	112.1	33.4	35.8	22.7	24.1	8.2	10.6	28.5	43.9	36.9	61.8	28.1	58.1	126.7	3.5	138.7	12.3	0.0	9.5	10.0	28.9	16.7	31.9	15.2	80.1	65.1
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 131.7;Late spermatids: 308.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	10.0	10.8	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.6	19.8	12.2	17.1	11.4	6.4	21.7	8.7	23.1	13.4	29.7	15.3	15.3	16.1	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.6	14.9	4.1	10.7	10.3	14.5	12.7	13.9	11.7	13.4	13.9	28.6	15.8	33.4	16.5	13.3	12.1	16.9	12.3	14.9	10.4	11.2	13.1	12.7	13.0	8.5	8.1	5.7	14.4	10.2	11.6	13.5	8.5	18.4	18.2	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7	8.9	5.0	11.1	14.4	23.1	10.8	4.1	10.2	8.1	14.8	15.7	17.7	18.4	10.0	10.8	131.7	9.3	3.1	23.3	11.1	17.4	12.4	7.0	8.1	11.9	7.4	6.4	3.5	11.6	6.2	308.3	8.9	3.7	20.3	4.6	6.6	10.8	9.6	7.0	7.8	10.1	17.1	12.9	13.2	34.7	19.4	24.0	7.9	8.9	7.4	9.7
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	15.9	18.2	7.0	22.9	12.2	13.7	27.7	18.7	13.9	10.3	11.4	16.2	12.5	9.6	16.6	9.5	9.1	10.3	11.8	14.3	11.3	16.1	20.0	10.4	6.1	21.9	14.0	12.1	26.5	44.8	26.5	13.4	16.0	16.1	12.8	9.7	18.3	15.3	10.3	9.5	14.8	9.0	21.3	10.1	12.8	8.1	19.1	9.0	19.0	10.1	6.9	10.4	9.7	4.1	8.6	4.4	11.8	10.6	6.2	4.6	7.5	8.5	9.5	7.5	11.6	11.1	18.0	12.4	7.9	8.1	8.0	16.7	17.5	5.4	14.8	6.1	7.3	19.5	6.9	6.6	7.8	4.7	7.1	5.0	10.9	9.5	10.7	8.3	6.3	8.4	13.5	9.4	15.2	8.5	8.6	5.6	18.9	11.0	9.8	8.0	5.9	8.2	13.1	29.4	2.9	6.7	6.4	14.8	16.0	7.7	6.8	10.6	9.4	20.3	14.4	17.5	17.7	7.2	7.9	11.3	7.1	7.8	11.5	13.4	8.1	8.4	6.3	4.5	10.2	1.5	10.5	2.7	3.8	10.0	5.5	4.1	4.8	5.0	8.6	3.1	6.0	4.6	4.4	10.6	11.8	5.4	6.2	4.6	18.2	22.9	27.7	18.7	14.3	11.3	21.9	14.0	16.0	19.1	26.8	28.6	0.0	0.0	0.0	0.0	0.0	0.0	28.1	54.6	24.4	0.0	20.7	8.3	18.4	0.0	0.0	0.0	0.0	22.2	19.9	0.0	0.0	11.6	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	11.8	0.0	0.0	21.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 3.0;granulocytes: 1.1;monocytes: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA016583: AB_1848720, HPA061823: AB_2684619"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	13.1	1.4	6.0	1.5	2.0	6.7	7.4	1.2	3.4	2.2	11.3	5.0	4.4	12.3	1.4	5.1	11.3	1.1	5.1	0.0	14.8	3.1	8.0	2.2	4.9	4.2	5.0	15.0	0.6	2.1	5.1	0.2	1.9	5.5	13.3	6.4	1.0	1.0	13.6	14.3	35.2	6.2	4.5	15.6	6.5	2.3	7.1	2.5	3.4	5.4	0.8	2.8	3.8	5.5	0.1	8.7	1.9	6.5	7.8	3.5	9.2	5.6	3.8	2.5	1.8	5.2	8.8	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1											26.8	16.0	20.4	7.7	20.0	1.9	3.7	22.9	8.1	15.9	1.8	3.9	2.0	1.7	10.9	2.7	38.3	8.6	23.3	17.0	12.5	10.4	5.4	6.9	14.3	32.8	0.0	2.4	32.5	19.7	9.7	12.4	33.8	20.3	19.8	7.1	4.5	23.1	7.0	8.9	9.0	6.5	0.0	8.2	1.2	3.2	32.6	6.5	41.5	16.4	7.5
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 84.9;Spermatogonia: 102.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.8	1.4	4.1	8.9	7.0	14.2	1.1	3.8	6.1	1.3	2.8	1.2	1.4	2.7	1.5	1.9	6.7	0.9	1.2	2.3	4.4	3.5	0.8	1.6	1.5	10.6	3.1	4.5	0.9	0.6	0.3	1.2	5.2	2.4	0.8	3.1	0.5	1.4	0.6	0.4	1.9	2.7	1.7	2.9	4.1	1.5	23.1	1.4	12.8	0.9	4.2	10.7	2.6	2.0	4.1	3.4	1.0	2.6	2.8	4.1	2.5	10.9	10.1	16.2	12.6	2.0	2.5	12.0	19.6	7.3	21.7	11.4	14.2	6.7	12.7	10.3	3.7	11.0	11.2	20.8	5.4	18.4	6.5	16.8	10.5	5.4	14.3	2.5	17.2	11.1	0.7	1.0	11.8	6.2	3.5	7.1	11.1	12.7	6.5	13.1	9.6	23.1	21.6	17.9	7.6	27.9	27.9	29.8	12.9	5.3	3.8	19.4	11.5	10.0	11.1	6.8	13.5	5.9	13.7	4.3	20.0	13.6	12.6	18.4	5.0	6.7	44.4	8.5	11.3	15.4	0.0	1.1	1.0	3.5	2.6	1.4	2.7	2.0	2.0	2.2	4.1	2.9	1.4	0.5	2.8	2.5	3.4	4.1	2.5	4.1	7.0	3.8	6.1	4.4	3.5	3.1	4.5	2.4	1.4	3.0	16.4	15.2	2.4	6.0	6.1	3.3	2.5	17.4	9.1	5.2	3.9	22.0	1.7	2.6	9.4	3.0	2.1	0.0	0.6	30.9	9.9	1.7	1.1	8.3	13.2	11.1	1.7	0.0	3.3	6.2	2.6	6.1	32.1	0.0	5.6	2.5	1.6	0.0	3.2	0.7	8.4	0.0	2.2	84.9	102.2	5.3	9.2	4.4	10.3	1.7
ORMDL1		ENSG00000128699	"ORMDL sphingolipid biosynthesis regulator 1"	Q9P0S3	2	189770323-189784371	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.45e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.70e-3)"	"prognostic favorable (3.04e-5)"	"unprognostic (5.90e-3)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.84e-9)"	"unprognostic (2.62e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.49e-5)"	24.9	31.1	23.1	27.3	29.6	28.5	36.8	29.4	30.8	24.7	23.1	24.1	56.0	24.2	28.9	63.8	21.8	25.7	28.5	17.9	22.6	25.1	26.5	30.3	31.5	40.4	30.6	24.1	25.7	39.9	25.1	50.6	37.5	29.9	29.7	30.5	30.4	55.2	41.2	18.3	47.0	38.1	25.6	25.1	63.1	28.1	37.3	24.7	26.3	31.1	21.7	40.3	24.6	23.9	28.7	36.8	29.0	35.2	21.0	37.7	26.2	13.2	10.4	27.6	21.4	37.6	42.7	30.4	25.8	28.1	33.7	33.7	20.4	21.8	22.8	19.5	20.8	18.8	20.7	19.2	17.2	36.6	26.1	24.1	32.4	36.6	25.5	47.8	28.0	27.1	47.7	21.6	28.2	32.3	39.3	24.1	26.3	21.7	35.4	32.6	13.8	26.1	52.4	29.8	15.7	47.5	17.7	23.7	32.4	39.0	20.4	18.1	20.8	14.4	13.8	34.7	32.7	15.7	31.0	22.1	29.8	22.3	21.5	28.5	32.4	26.9	23.9	32.4	30.5	16.3	25.7	25.0	29.0	28.7	30.5	28.6	28.7	33.3	31.1	20.5	24.5	37.7	34.6	10.0	21.0	35.2	36.8	33.8	26.2	23.1	29.6	29.4	30.8	22.6	25.1	30.6	24.1	29.9	24.7	74.5	42.8	77.9	46.4	50.0	133.7	29.1	35.7	62.9	48.9	34.9	164.9	178.2	28.2	47.2	32.5	57.1	35.5	46.7	58.9	59.1	53.0	65.1	43.9	30.6	77.0	62.0	40.7	40.5	102.6	15.7	68.7	72.5	37.1	81.2	33.3	99.7	53.1	47.6	45.6	41.1	186.8	51.8	49.5	126.1	133.3	53.1	182.4	89.2	41.3	44.2
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	6.6	17.0	8.6	6.5	12.1	2.6	11.1	12.9	10.9	7.3	5.6	14.8	2.9	5.0	11.8	9.1	7.0	8.1	4.8	13.0	8.4	7.3	13.0	11.6	5.8	11.2	18.9	9.3	13.8	6.1	7.5	9.8	6.1	11.6	6.9	6.1	9.0	9.7	6.1	16.6	9.2	6.5	8.1	13.4	9.6	5.8	9.4	15.4	10.6	8.2	7.3	9.2	8.0	5.8	9.3	6.0	2.1	2.6	6.6	11.5	3.0	5.6	3.1	13.9	10.6	11.0	6.1	8.3	8.8	6.2	12.5	13.5	3.7	5.9	3.8	9.9	3.7	7.0	8.3	12.4	10.4	14.3	9.7	9.5	12.3	7.7	4.8	5.8	6.9	6.4	6.7	8.9	9.4	4.7	8.6	9.3	9.7	4.4	6.0	8.2	3.2	5.4	8.0	6.7	7.7	14.5	5.9	11.2	6.5	8.1	3.2	8.5	9.4	5.9	10.8	19.2	18.1	8.4	7.6	3.9	8.2	7.2	11.9	5.4	6.1	5.1	6.1	10.8	8.9	8.9	0.2	2.6	2.1	7.3	2.4	10.5	7.4	7.7	8.4	3.5	9.3	11.5	10.2	0.4	6.6	2.1	6.0	5.9	3.0	8.6	12.1	12.9	10.9	8.4	7.3	18.9	9.3	11.6	15.4	6.0	2.2	1.3	2.3	1.6	8.0	8.1	2.5	8.1	1.2	0.0	11.8	8.6	6.6	2.4	0.6	2.3	0.9	0.0	2.0	6.1	3.8	1.2	3.5	3.0	3.8	9.5	0.0	4.3	1.0	0.0	10.3	2.3	1.7	0.0	1.1	12.4	1.5	0.0	7.8	8.4	10.0	25.8	3.1	10.7	12.6	1.8	1.8	5.0	2.3	0.5
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 102.9;Muller glia cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.7	8.4	3.9	16.9	3.4	3.4	19.0	5.3	7.6	11.1	6.2	12.5	2.4	0.1	1.6	2.9	7.3	27.7	7.7	12.7	4.4	2.6	13.2	2.6	32.0	28.9	6.7	0.5	2.6	9.5	17.2	5.8	9.3	8.9	4.9	4.5	5.6	0.2	4.5	33.3	0.3	12.4	4.8	13.6	16.9	10.3	14.7	2.7	4.6	16.0	0.1	13.3	8.3	5.9	7.7	8.6	41.9	2.2	2.3	19.3	19.4	2.4	14.4	2.9	1.3	1.5	6.3	5.9	9.9	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5	0.0	7.2	0.0	23.5	31.9	0.2	102.9	25.5	1.4	7.9	5.2	0.0	27.6	8.3	35.7	0.0	5.9	0.0	0.0	13.1	53.0	16.3	28.4	0.0	29.9	5.0	0.0	0.0	9.2	1.8	0.0	15.0	1.9	16.9	0.0	0.0	62.8	30.4	0.0	11.7	18.2	2.3	32.3	27.0	0.2	10.2	26.1	15.3	0.0	0.2	20.9
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	15.0	17.2	19.9	28.7	22.2	15.6	15.5	25.3	22.1	14.1	12.9	31.4	33.2	16.2	36.3	30.3	14.1	24.1	28.9	32.7	18.6	14.5	11.1	41.8	15.7	20.1	19.9	14.4	16.0	17.2	25.9	28.1	35.5	15.4	23.0	9.1	22.1	12.4	21.5	9.6	13.9	21.2	18.2	20.9	13.6	15.6	22.5	17.8	21.5	23.5	22.2	29.4	29.2	22.1	9.6	17.6	24.6	12.4	36.8	25.8	17.1	12.6	17.9	3.9	6.0	21.8	10.4	27.7	21.6	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3	26.8	33.3	41.0	38.7	108.6	36.9	31.1	68.8	17.4	26.1	62.8	45.2	36.3	39.7	52.6	7.3	54.4	31.6	0.0	34.5	77.2	42.9	53.9	18.5	39.2	38.5	44.5	79.3	57.7	59.6	8.9	42.0	55.7	47.2	49.5	37.2	33.5	72.8	46.7	32.2	44.8	33.5	12.9	46.4	45.1	75.6	101.4	45.7	38.5	39.1	38.8
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	34.3	25.8	53.3	33.0	11.4	25.9	45.9	29.8	21.6	42.8	42.2	40.9	40.9	79.6	34.7	19.9	23.3	21.3	84.1	43.3	73.4	15.9	29.6	43.2	39.5	45.3	21.9	76.8	19.3	21.9	31.4	45.4	34.3	23.7	35.0	45.7	74.5	29.7	36.8	22.9	88.1	38.5	61.1	66.2	32.3	71.6	22.8	52.3	40.5	24.1	57.3	34.3	29.3	41.0	18.0	45.5	27.1	24.6	18.8	33.9	44.4	33.3	60.8	21.0	18.0	83.7	35.7	56.3	37.3	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9	20.8	19.3	31.8	57.8	50.4	26.0	20.9	56.0	21.4	31.8	31.4	5.9	117.2	31.5	30.5	45.8	21.6	14.2	46.7	22.8	137.4	35.6	28.6	20.7	68.6	45.7	27.0	23.8	11.6	15.8	6.6	27.6	17.1	16.9	22.6	34.9	13.2	23.3	7.0	21.9	41.1	22.9	0.0	17.9	39.4	47.7	44.2	45.7	16.0	65.0	44.1
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184741-32190186	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	15.3	17.7	14.1	14.9	14.8	8.1	12.3	19.3	16.4	17.0	20.8	16.4	36.2	13.7	23.0	39.1	19.7	21.9	19.1	13.6	15.9	10.7	14.8	14.6	26.4	24.0	13.7	10.0	25.0	12.3	10.8	24.3	30.7	12.9	18.4	15.3	15.0	14.6	29.1	17.2	22.0	17.2	22.3	12.2	29.6	22.4	9.9	17.7	17.1	25.6	14.4	20.6	17.4	18.4	0.2	1.8	0.7	0.2	0.0	0.2	0.1	2.3	2.4	12.3	9.5	13.2	16.7	6.9	2.0	4.7	5.4	5.5	3.3	3.7	10.8	12.4	7.2	0.9	6.8	3.8	14.0	5.4	8.0	15.6	8.8	4.3	2.6	11.4	6.1	9.5	22.0	7.7	4.0	11.7	6.7	9.6	17.7	13.3	5.2	2.1	10.7	6.7	13.1	0.1	1.3	1.5	9.0	2.6	12.5	11.8	4.0	4.6	6.4	1.6	3.4	13.4	8.5	8.7	12.6	2.5	4.1	10.6	1.7	2.1	27.7	18.1	13.8	8.7	5.0	6.9	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.1	1.8	0.0	0.1	14.1	14.8	19.3	16.4	15.9	10.7	13.7	10.0	12.9	17.7	6.0	14.1	14.8	16.4	16.3	17.4	2.4	25.5	2.7	5.7	15.7	7.9	25.3	3.3	14.4	0.6	11.3	9.8	0.0	11.9	23.0	14.3	16.8	15.0	19.2	16.1	25.4	29.2	25.8	34.2	1.8	18.7	18.4	8.5	9.0	15.8	19.8	12.1	14.0	18.4	7.7	4.6	6.5	18.9	0.7	3.4	16.9	39.5	15.0	14.4	15.7
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		2000000	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	105.3	106.7	110.8	85.7	93.4	158.1	180.8	136.5	131.5	84.1	67.2	50.5	75.7	69.2	101.7	84.5	75.3	89.5	71.0	112.1	105.0	53.1	112.6	108.3	83.8	118.8	94.5	88.9	124.5	148.2	98.1	88.7	62.4	93.2	61.7	71.0	65.0	88.3	61.2	96.5	94.4	71.3	90.8	115.4	73.0	86.2	98.7	104.2	106.8	91.2	57.1	93.5	76.8	132.5	20.9	31.5	17.2	18.5	12.4	28.8	13.7	55.5	86.6	84.7	68.1	123.4	95.5	65.0	59.3	81.3	97.3	69.7	100.8	83.8	99.8	58.0	88.8	43.8	54.7	93.3	80.8	93.1	61.7	67.3	100.3	67.7	98.8	124.5	97.8	66.2	109.9	67.8	82.2	132.3	162.7	93.2	64.6	85.6	179.3	86.8	151.3	91.9	110.2	108.2	47.1	60.8	73.9	77.0	116.9	76.9	87.1	83.7	73.5	81.1	73.1	57.9	87.6	102.3	85.3	68.0	50.5	69.2	46.0	60.1	99.8	68.7	92.3	59.2	62.9	54.8	8.3	18.1	13.1	15.9	18.5	26.1	20.9	24.5	20.5	22.5	20.9	28.8	23.6	17.2	12.4	17.0	31.5	27.4	13.7	110.8	93.4	136.5	131.5	105.0	53.1	94.5	88.9	93.2	104.2	107.2	169.7	269.4	252.9	347.0	77.7	65.9	252.3	107.1	114.9	280.9	104.1	303.4	417.8	203.7	54.9	263.7	254.4	140.2	207.3	313.2	278.0	194.7	148.2	266.4	321.3	96.9	198.2	268.2	433.2	53.3	286.2	303.9	221.0	344.5	257.9	86.2	233.7	238.4	215.3	588.4	177.3	187.5	295.1	298.6	154.1	334.2	370.7	264.2	295.7	283.3
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		110000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	12.5	19.1	29.2	15.4	27.8	15.0	15.6	13.2	33.9	12.0	17.7	12.9	13.1	13.8	14.4	22.4	15.1	12.5	11.4	16.2	31.6	24.8	19.1	23.2	10.8	15.7	27.0	31.9	14.5	21.3	15.3	14.6	14.0	20.7	12.5	16.2	8.2	15.8	16.0	43.6	10.8	13.7	13.4	20.7	11.3	12.2	33.1	17.5	10.7	12.2	22.5	18.9	11.8	9.8	6.8	5.0	3.4	7.1	3.9	7.5	4.3	15.0	10.1	7.0	14.5	7.9	6.7	11.5	11.6	5.9	10.1	9.7	9.5	7.5	22.2	14.1	6.5	19.4	11.0	11.5	13.3	15.3	14.9	12.2	19.9	11.2	15.8	8.8	15.2	13.0	6.0	15.3	14.3	10.2	8.0	9.9	13.1	24.2	9.6	10.9	10.3	18.2	16.1	11.7	10.0	8.8	15.7	10.3	22.4	16.4	7.2	16.3	19.7	10.1	26.4	16.7	7.4	15.2	22.0	8.3	7.2	10.7	8.9	19.1	19.3	52.6	24.8	7.0	20.2	10.3	3.2	5.1	3.4	4.1	6.5	4.2	5.9	5.6	7.5	4.9	6.8	3.3	4.6	2.7	3.9	7.1	5.0	5.3	4.3	29.2	27.8	13.2	33.9	31.6	24.8	27.0	31.9	20.7	17.5	23.8	8.3	51.5	39.3	49.5	21.5	17.7	71.4	17.4	17.0	52.4	9.8	107.5	102.8	74.2	74.3	28.8	70.3	0.0	89.2	103.2	41.2	43.0	62.1	64.4	70.1	17.5	48.4	19.0	26.8	30.2	57.2	47.3	67.4	83.0	47.0	38.4	78.6	71.9	46.3	154.1	21.2	38.8	32.0	200.4	54.7	55.8	92.7	37.6	54.6	43.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031991	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047418	Uncertain					NA	NA					"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	6.5	9.1	7.4	6.7	9.9	2.9	9.7	7.7	8.7	7.9	6.7	17.1	8.8	7.8	7.3	11.7	8.0	7.3	7.7	6.2	7.6	6.7	7.7	14.9	6.6	7.1	17.3	5.2	8.8	18.3	14.9	10.4	6.2	12.6	11.3	7.9	10.2	10.5	9.1	3.0	9.8	8.4	5.8	21.8	8.0	9.1	9.6	12.5	14.9	11.0	3.1	7.5	7.8	6.1	6.2	10.4	8.3	14.6	9.5	10.6	7.7	5.0	4.6	5.7	8.2	7.5	6.3	1.9	7.7	4.9	5.1	4.8	2.5	9.5	3.6	6.3	5.0	4.4	10.4	6.2	6.2	6.6	7.6	6.6	8.3	6.0	3.7	4.6	10.6	6.5	5.6	4.1	6.1	4.8	4.5	4.3	8.0	4.4	6.8	5.9	8.5	6.8	5.7	5.9	9.5	6.6	2.2	5.8	15.7	5.6	7.0	8.0	12.4	8.4	9.9	6.0	5.7	18.7	12.7	6.0	6.8	6.0	10.1	4.7	12.4	13.6	0.2	6.2	5.5	7.5	8.3	14.6	5.6	8.1	11.4	8.4	5.8	8.3	6.4	8.8	6.2	10.6	8.3	2.6	9.5	14.2	10.4	8.5	7.7	7.4	9.9	7.7	8.7	7.6	6.7	17.3	5.2	12.6	12.5	11.9	16.6	6.1	4.5	3.8	14.8	3.7	20.4	13.4	17.0	15.7	9.8	6.5	1.7	11.1	4.3	8.4	7.5	0.0	15.9	3.1	6.7	5.8	4.7	19.2	6.4	15.9	12.1	12.9	12.7	2.3	7.8	5.8	8.5	3.6	13.9	38.7	10.4	3.5	8.5	5.5	11.7	19.4	4.4	24.7	8.3	4.0	1.5	4.8	11.1	3.0
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 74.0;Syncytiotrophoblasts: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 51.0;HUVEC TERT2: 117.2;SK-MEL-30: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	12.9	7.8	11.4	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.3	0.0	25.7	2.0	51.0	16.5	9.0	3.6	0.7	0.0	1.9	1.4	14.6	10.5	5.9	0.7	5.2	1.4	12.5	7.2	2.5	3.3	117.2	0.0	1.0	3.3	1.6	4.9	0.5	0.6	8.3	10.4	8.2	0.0	1.5	6.4	3.8	22.9	3.0	8.3	6.2	3.5	44.1	14.0	7.3	4.4	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.2	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4	0.0	2.6	1.9	20.5	7.7	2.5	5.1	10.2	24.1	4.5	1.8	0.0	74.0	8.3	3.8	0.4	25.9	4.0	0.0	2.2	8.6	8.9	8.4	0.0	21.3	18.4	19.1	10.9	17.2	6.4	0.2	34.8	2.9	38.8	20.8	2.4	26.6	4.6	1.4	26.9	7.7	4.5	12.9	8.6	0.5	2.4	11.0	71.6	0.9	3.3	43.0
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.8	16.5	20.9	21.1	14.2	18.1	15.8	26.2	15.0	20.1	19.7	5.8	13.4	25.2	21.9	20.0	14.0	11.2	20.7	20.7	22.2	33.1	8.7	15.6	27.2	11.1	14.5	12.5	21.4	16.1	12.5	24.5	17.9	15.2	20.0	18.9	9.5	25.6	21.6	11.6	24.2	12.2	30.3	14.4	14.4	17.3	13.1	14.9	15.6	16.7	13.4	23.0	14.0	16.6	8.2	21.4	11.5	9.7	24.2	0.0	24.9	13.0	21.2	8.4	18.3	26.2	14.2	17.9	10.4	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9	14.9	9.1	11.2	9.4	9.7	8.3	21.0	2.5	12.0	13.6	8.7	0.0	21.0	8.3	14.9	21.7	15.3	9.5	0.0	14.0	21.7	10.4	9.6	40.3	9.0	18.5	4.8	9.2	12.9	13.3	3.6	8.1	9.9	1.7	10.8	7.3	8.5	12.8	8.7	7.8	7.9	6.1	19.4	17.8	24.7	22.0	8.3	41.2	13.8	11.4	10.2
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.5	11.1	6.6	13.5	13.0	12.7	9.1	15.8	19.9	8.1	10.6	5.1	8.5	0.4	13.5	16.3	11.7	6.2	5.4	11.5	6.9	3.5	3.5	9.8	4.7	14.8	22.1	2.8	11.8	9.9	12.0	11.2	14.8	14.3	13.1	13.1	0.4	25.5	9.8	11.4	6.3	4.7	10.0	22.5	3.8	6.9	4.9	51.3	20.2	7.2	5.2	8.0	6.5	10.1	9.2	6.1	21.6	5.5	7.8	5.7	5.0	9.6	4.1	15.8	10.4	1.6	15.8	7.5	9.8	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4	8.9	44.0	74.7	61.1	0.0	5.3	0.0	38.2	101.7	39.8	71.5	15.7	39.2	36.5	59.1	22.7	13.5	17.2	0.0	78.1	37.8	35.3	138.3	29.1	20.7	32.8	58.8	43.3	16.5	9.1	6.2	16.4	24.8	0.0	10.0	73.6	37.6	56.5	36.8	8.9	20.3	3.5	12.9	0.0	24.7	4.3	0.0	73.7	17.0	51.4	46.1
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924734-154936991	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA					"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	21.0	28.3	31.3	15.9	34.0	7.2	19.4	13.9	31.7	17.0	18.9	25.3	10.2	26.4	12.1	14.7	30.1	20.2	15.7	24.7	23.9	23.9	26.9	39.3	16.2	18.7	29.6	29.3	18.8	22.2	26.8	26.1	13.8	22.4	17.0	12.0	22.2	18.8	15.9	39.8	26.1	25.2	16.7	23.9	20.5	21.8	15.9	22.8	9.9	17.8	25.3	18.9	12.2	22.8	29.1	22.9	20.4	47.3	13.4	30.4	17.7	11.7	16.6	10.7	16.8	9.9	7.1	11.4	9.5	6.4	8.7	8.3	6.7	23.3	16.7	18.2	10.7	9.5	11.5	14.5	14.1	4.0	23.4	6.6	7.6	22.4	6.2	9.2	11.6	7.0	8.4	13.1	15.8	11.2	4.4	8.7	15.1	8.1	51.9	9.0	23.5	9.1	11.2	9.7	27.1	21.3	13.9	7.0	38.5	14.6	8.6	9.0	21.5	10.2	17.8	11.6	8.4	34.0	20.6	7.4	8.5	7.0	20.1	14.1	42.2	33.7	29.5	14.1	18.7	10.9	4.6	19.8	20.4	17.5	46.9	27.9	29.1	24.0	17.8	22.1	23.9	15.7	15.7	1.7	13.4	47.3	22.9	30.4	17.7	31.3	34.0	13.9	31.7	23.9	23.9	29.6	29.3	22.4	22.8	53.6	29.1	50.4	97.4	62.0	37.2	44.8	76.5	12.0	20.5	50.6	7.9	202.5	225.5	58.9	6.4	26.7	90.5	0.0	62.5	77.8	60.1	55.3	21.9	125.4	120.4	35.0	63.8	33.7	65.6	10.4	39.4	42.6	62.4	49.5	62.3	77.7	52.4	54.7	44.9	190.8	21.7	32.3	55.9	42.4	43.2	79.2	190.4	59.5	69.9	62.7
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 38.3;Late spermatids: 28.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049817	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896"	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	4.0	3.0	4.7	3.4	5.6	6.6	4.5	6.0	5.3	4.7	4.6			2.4	5.8	5.2	3.8	2.8	2.1	3.8	4.7	3.5	4.4	2.2	3.6	3.1	3.5		5.8	4.7	2.0	3.1	1.7		4.5	3.7		4.3	5.1	14.2	5.3	3.0	7.0	4.0	2.5	3.9	9.5			3.9		3.6	4.0	3.9	4.2	3.5	5.7	3.3	3.0	4.8	1.1	1.9	8.1	13.0	16.7	8.6	3.4	1.9	2.9	4.5	2.1	2.7	4.7	3.6	1.2	0.8	2.6	4.6	1.1	3.0	1.3	2.0	4.9	4.6	5.4	4.4	2.7	2.0	2.4	3.6	2.9	5.4	7.2	2.5	1.0	1.3	2.1	2.9	9.4	9.2	2.5	4.2	10.0	5.7	3.0	4.0	1.8	9.5	2.0	1.5	3.0	6.8	12.3	2.5	11.8	4.2	14.4	4.5	3.1	5.0	6.6	0.9	16.4	6.7	2.4	2.1	8.7	1.3	9.7	9.2	1.4	3.3	5.7	2.4	1.5	3.5	2.5	3.9	4.0	3.3	4.2	4.8	2.7	3.8	3.0	1.6	3.5	3.4	1.1											3.0	2.6	3.0	6.4	6.3	4.1	6.0	2.5	4.0	0.0	5.2	11.8	5.7	0.0	1.1	38.3	3.0	4.5	0.0	1.9	3.1	6.0	4.2	5.7	1.7	2.6	3.2	12.5	1.8	4.1	28.3	5.8	3.0	10.1	0.0	2.7	4.6	1.6	4.0	7.4	3.5	5.2	12.9	3.2	22.1	4.1	6.0	8.7	2.2	5.6	8.4
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381194-27409687	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.3"	"Cell type enhanced"	"Detected in all"	17	"Early spermatids: 1236.5;Late spermatids: 2467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	12.7	17.0	9.9	19.9	9.2	19.4	30.2	10.9	19.3	17.9	14.6	9.1	16.9	12.1	26.8	12.5	19.4	19.2	17.7	13.6	8.8	7.6	12.6	18.6	14.7	20.2	9.4	8.0	13.4	18.6	13.8	13.2	11.4	8.7	10.2	16.4	9.1	16.4	18.7	24.1	10.9	12.2	14.9	6.7	14.7	14.1	93.3	8.4	25.8	14.1	19.1	22.5	25.2	17.3	20.2	40.3	24.5	29.1	22.7	38.3	19.0	50.9	42.1	30.9	23.7	19.7	16.1	28.5	31.8	20.9	38.2	30.7	64.8	27.0	60.2	23.4	22.5	32.5	27.9	51.9	35.7	34.4	25.1	42.2	58.6	30.7	68.4	17.8	57.8	24.8	17.4	20.7	38.9	31.4	18.2	36.5	29.9	49.0	18.7	28.9	45.6	42.9	62.8	44.9	35.4	30.4	44.4	64.8	31.6	25.8	35.6	41.6	47.1	28.5	31.6	22.8	25.6	17.5	19.0	29.3	28.6	34.6	25.0	48.2	40.8	45.7	95.2	22.4	47.4	21.4	22.1	17.8	24.5	26.9	22.3	26.5	20.2	28.7	27.9	28.5	18.0	21.7	22.4	9.1	22.7	29.1	40.3	38.3	19.0	9.9	9.2	10.9	19.3	8.8	7.6	9.4	8.0	8.7	8.4	59.6	43.5	61.1	65.0	72.0	42.0	33.6	50.9	61.6	66.0	66.3	27.5	71.4	28.2	97.8	1236.5	66.3	54.6	23.3	120.2	139.9	42.7	66.0	58.8	37.8	76.1	46.1	77.4	35.6	49.4	2467.5	65.0	65.1	23.6	147.9	59.6	64.9	122.3	42.1	66.8	48.3	34.6	45.3	45.8	594.3	323.3	70.4	44.4	79.7	83.2	121.2
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 109.7;Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.8;NK-cell: 10.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.8;NK-cells: 10.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.5;RH-30: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	2.9	11.7	11.0	1.9	23.5	0.8	8.1	10.9	19.7	5.2	8.7	7.4	7.7	3.0	5.4	9.2	3.2	9.6	4.4	8.2	11.5	9.7	8.2	1.1	6.4	0.9	8.1	13.7	5.0	14.3	16.5	15.5	4.5	12.7	4.2	6.8	5.7	14.2	5.3	6.7	1.1	3.0	5.1	9.1	3.2	6.2	10.0	11.2	0.0	10.9	1.3	1.0	4.2	1.4	1.3	0.3	5.8	0.1	10.9	0.2	0.2	0.0	9.4	6.0	6.7	0.0	0.0	4.8	0.4	0.1	0.9	0.7	5.2	3.1	0.0	8.0	0.4	0.6	0.0	10.5	0.0	1.2	0.0	4.0	9.6	3.8	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	4.9	4.3	1.7	0.0	10.5	0.0	9.8	7.8	6.4	6.6	0.0	0.8	1.3	3.9	2.0	0.0	0.0	0.1	3.9	0.1	3.4	6.4	9.2	0.0	0.1	0.0	0.7	5.8	0.0	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.9	0.1	0.3	0.0	0.2	11.0	23.5	10.9	18.3	11.5	9.7	8.1	13.7	12.7	11.2	38.7	49.4	0.0	0.8	0.3	51.3	109.7	7.6	33.5	26.1	45.4	53.0	16.9	3.3	20.0	13.6	2.2	8.8	0.0	6.1	2.0	1.4	8.0	5.7	1.3	1.5	1.6	37.3	8.0	0.0	12.2	2.3	0.4	6.8	0.0	13.4	56.5	7.0	10.5	0.7	6.2	85.0	0.0	3.1	18.2	10.2	0.6	27.7	0.0	16.4	1.0
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.4	6.3	12.6	14.6	7.2	12.8	10.5	19.1	18.7	21.3	28.6	10.0	7.4	14.1	10.6	23.8	14.5	10.5	11.3	10.9	26.4	15.4	9.2	16.7	8.6	16.7	2.9	16.1	10.6	4.8	4.1	23.5	8.2	5.2	9.6	15.2	15.8	37.6	17.7	9.7	16.9	12.8	8.0	13.2	6.3	12.9	17.5	11.3	7.7	8.0	9.3	7.1	12.4	5.9	7.7	14.6	12.6	13.9	6.6	21.7	21.4	39.7	16.1	5.1	9.8	16.4	9.9	17.0	11.6	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7											0.0	2.4	5.1	5.5	3.5	5.0	0.9	2.5	2.7	3.4	3.5	11.8	13.3	3.3	3.7	7.2	2.9	3.5	23.3	4.5	19.3	5.2	5.5	11.5	3.8	7.9	6.4	1.2	4.9	4.8	2.8	6.1	5.1	0.0	5.4	6.1	4.9	3.9	5.3	6.3	1.4	4.5	19.4	5.2	10.6	12.1	2.6	4.8	12.8	7.5	5.0
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084099-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001176	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001176: AB_2171026"	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	11.9	8.6	15.3	13.3	19.1	12.8	12.4	34.0	21.4	10.5	11.9	11.2	12.6	9.1	14.3	11.6	8.3	13.4	6.4	8.7	12.5	11.5	13.1	10.6	9.1	11.2	14.5	14.4	15.2	9.4	12.9	22.3	9.7	11.4	13.9	8.1	7.0	9.5	13.5	14.2	9.5	11.0	12.2	14.2	10.6	10.1	10.2	15.6	9.5	10.8	6.7	10.4	9.8	13.8	8.7	7.6	7.7	7.4	6.5	11.0	4.9	11.8	9.0	14.8	7.7	9.8	6.7	9.7	11.8	6.6	10.6	10.8	6.2	9.9	9.3	8.4	7.0	7.5	8.7	15.6	10.0	16.2	12.5	8.9	12.6	10.5	9.3	8.0	16.8	6.1	4.4	7.1	6.5	8.2	6.5	8.3	9.8	13.6	11.6	13.4	12.6	16.0	12.2	10.0	11.3	9.4	15.9	14.5	10.5	8.7	12.0	12.4	3.8	9.0	11.3	12.9	9.2	7.0	11.3	10.5	7.0	10.4	7.7	12.7	9.4	16.4	19.2	5.0	11.7	7.4	7.7	4.3	6.6	8.3	7.0	10.8	8.7	7.6	8.2	7.6	8.2	10.0	11.0	3.0	6.5	7.4	3.2	8.7	4.9	15.3	19.1	34.0	21.4	12.5	11.5	14.5	14.4	11.4	15.6	23.8	22.7	8.3	14.7	24.3	18.8	13.7	10.2	6.7	17.0	7.0	13.7	10.3	8.3	7.2	1.2	12.1	8.0	0.0	8.2	9.1	12.7	12.1	15.1	6.6	6.6	15.9	9.2	10.4	5.1	3.3	13.8	10.2	13.5	7.2	8.6	9.4	7.0	5.8	13.8	4.4	22.7	6.5	11.3	10.6	11.8	22.1	10.1	10.2	7.9	8.9
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	3.5	0.6	12.6	1.0	0.0	2.7	4.5	6.7	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	0.0	8.8	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.4	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7	8.9	22.1	16.0	6.3	5.0	9.0	2.4	7.6	14.7	13.6	3.5	13.7	12.1	6.6	4.0	0.6	5.0	7.9	0.0	8.1	6.2	9.1	4.6	11.5	3.9	7.0	6.4	7.5	9.2	6.2	1.8	9.5	7.7	10.1	10.0	7.6	8.0	4.9	5.3	9.6	8.2	18.5	6.5	7.2	8.1	5.9	5.0	8.2	10.2	6.5	3.4
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.9;RPMI-8226: 10.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	3.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	3.4	4.6	0.0	0.7	0.0	0.0	1.5	2.5	3.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	0.5	0.0	19.9	0.0	4.0	0.5	0.0	1.6	2.3	1.9	0.0	1.2	0.4	0.0	0.7	1.9	0.5	0.0	0.0	10.7	2.3	3.4	0.0	0.0	1.3	3.0	0.0	4.6	1.9	0.8	0.0	0.0	0.8	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	8.9	7.7	0.8	9.8	5.7	0.0	0.4	7.6	2.7	3.4	14.0	0.0	36.3	1.7	6.8	0.5	0.3	16.0	0.0	15.6	21.7	0.4	6.6	5.7	0.0	3.4	0.0	4.1	0.0	0.3	0.0	0.6	0.0	5.0	0.0	17.5	1.0	10.5	19.8	0.0	0.2	0.0	0.0	0.7	1.0	5.3	5.6	26.5	0.0	14.5	7.4
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome subunit alpha 2"	P25787	7	42916857-42932223	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 569.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008188	Uncertain					NA	NA		80000000			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	24.7	32.2	25.3	24.6	29.5	29.7	29.4	19.6	22.0	19.2	25.6	13.4	26.0	29.8	22.6	26.2	31.1	19.4	20.5	35.8	22.3	16.6	33.3	90.9	23.2	27.4	27.2	17.6	20.8	28.8	12.0	18.8	33.7	29.2	24.5	26.0	10.1	21.7	19.6	57.2	22.4	33.1	22.0	21.4	26.6	27.8	18.6	23.5	42.2	29.9	44.6	29.9	22.8	20.2	46.2	54.1	81.7	47.4	36.7	56.7	75.0	32.1	34.6	40.6	49.1	21.7	24.4	30.3	28.5	33.4	46.1	49.4	51.5	53.0	59.9	50.9	25.2	72.2	45.1	41.9	39.5	53.2	43.2	33.3	30.5	46.9	54.3	23.2	51.7	33.1	22.4	28.9	35.5	21.2	33.0	43.3	36.9	61.4	36.8	36.8	37.8	46.1	101.8	80.4	53.2	43.0	45.1	39.5	58.8	44.3	44.5	33.0	33.6	31.0	71.3	31.1	57.6	51.8	60.6	30.9	27.4	49.9	29.2	56.1	48.0	72.7	98.0	46.5	65.8	77.2	59.0	45.7	81.7	35.2	45.2	40.4	46.2	43.4	40.5	48.5	40.7	39.0	41.3	23.3	36.7	47.4	54.1	56.7	75.0	25.3	29.5	19.6	22.0	22.3	16.6	27.2	17.6	29.2	23.5	83.4	79.1	145.3	58.9	0.1	28.0	0.0	124.9	107.1	122.8	90.7	21.6	258.4	144.2	278.9	15.8	73.3	147.1	70.0	330.5	246.8	63.2	74.2	161.7	195.1	170.9	27.0	148.7	112.3	163.6	12.0	73.4	114.0	0.0	569.9	160.7	54.7	284.0	133.3	79.5	175.7	38.7	129.4	0.0	98.4	110.0	0.0	233.4	138.4	230.0	89.8
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Late spermatids: 395.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003049	Approved		Supported	Nucleoplasm		NA	NA		19000000	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	33.8	42.7	26.7	31.4	38.8	37.1	38.7	24.2	35.0	28.0	35.8	19.4	24.5	32.2	31.0	30.2	37.9	24.7	20.3	54.2	30.5	27.6	47.3	49.0	37.3	36.4	30.1	36.8	31.1	36.7	14.2	35.8	61.2	31.8	22.5	38.6	18.1	27.3	25.5	94.6	31.8	39.5	27.3	25.2	35.7	28.9	67.5	26.5	86.2	26.0	37.2	38.1	28.8	24.5	37.9	68.5	41.4	65.1	49.9	54.8	104.8	59.7	44.2	33.1	33.6	27.3	29.2	66.2	31.3	38.3	47.4	43.1	41.1	43.3	40.0	60.3	30.4	28.5	42.8	38.6	35.7	56.8	40.2	21.1	31.4	32.2	122.9	31.0	65.3	29.4	22.2	29.7	33.1	42.2	23.6	40.0	68.7	33.5	28.0	38.2	63.3	99.9	55.8	31.6	49.2	50.4	148.9	33.6	32.0	40.5	76.8	35.2	29.8	34.9	51.5	32.9	29.2	61.6	43.3	33.3	30.5	30.2	31.0	34.6	29.9	65.4	73.1	24.8	41.4	34.4	32.8	65.1	41.4	46.3	59.4	46.2	37.9	44.8	47.1	66.8	29.9	35.9	43.0	23.5	49.9	56.6	68.5	54.8	104.8	26.7	38.8	24.2	35.0	30.5	27.6	30.1	36.8	31.8	26.5	41.7	28.9	14.5	10.6	29.7	14.3	1.2	15.3	83.0	59.1	14.0	23.6	27.2	18.3	26.4	121.5	28.7	25.7	23.3	31.8	22.0	14.4	12.4	53.1	20.3	20.7	23.8	17.2	30.7	36.5	395.6	21.0	54.6	23.6	27.1	17.6	8.7	26.5	21.0	16.3	18.9	17.8	12.9	22.1	22.9	17.9	29.0	34.6	29.4	22.2	15.3
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		8200000	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.5	48.1	34.4	32.6	46.4	40.1	34.0	32.2	38.4	56.9	48.4	40.5	36.0	28.0	30.1	43.8	39.5	30.8	54.9	40.2	55.0	17.2	37.9	17.8	35.1	142.5	36.6	21.6	21.4	44.7	37.7	42.2	35.2	37.8	58.8	24.7	26.7	16.0	46.5	66.5	12.3	29.6	38.2	43.6	78.0	16.6	26.0	18.7	44.2	32.7	43.9	34.2	22.7	46.1	31.0	47.0	22.2	28.1	31.6	27.9	28.4	25.8	31.6	13.8	27.3	21.0	21.8	17.4	34.5	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3	71.5	50.9	58.0	134.8	124.6	57.4	134.8	129.9	149.9	80.8	90.7	27.5	350.9	233.8	261.5	57.3	106.7	63.2	0.0	201.1	383.6	136.2	130.9	30.1	134.4	190.5	66.7	148.5	90.9	54.9	77.1	109.9	70.7	109.6	199.2	94.1	137.0	244.2	80.7	114.9	331.7	53.8	97.0	134.4	207.4	76.8	137.3	359.7	49.8	123.0	163.4
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366627	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		44000	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	16.4	18.0	16.0	12.3	16.0	11.8	14.1	19.5	26.7	11.7	11.8	8.8	11.5	9.4	12.5	13.3	16.4	9.9	11.4	14.9	17.0	19.7	17.1	31.4	10.8	11.3	23.6	15.3	12.6	17.6	15.7	12.9	13.7	32.5	12.8	13.8	8.1	12.5	11.0	42.3	11.6	10.8	15.7	13.4	12.0	12.4	15.5	11.3	12.7	12.2	18.9	16.7	17.2	19.6	8.8	10.8	12.1	18.1	11.4	14.0	8.9	28.4	17.4	13.8	15.1	10.6	12.9	18.9	20.3	13.0	22.6	20.1	18.0	12.7	16.4	13.1	16.5	17.8	16.9	23.9	20.8	34.0	7.9	17.8	19.1	14.5	18.5	13.8	19.8	11.8	14.2	13.9	21.4	16.9	10.1	22.2	12.7	25.4	9.8	21.2	19.5	18.1	19.2	16.6	13.7	23.1	9.3	35.5	14.7	16.8	23.8	13.2	19.1	15.0	29.4	19.6	17.0	21.0	16.8	22.8	24.1	16.2	18.0	36.6	10.0	15.3	13.9	28.4	21.0	13.8	12.1	10.6	8.8	9.9	17.4	14.0	8.6	13.0	11.1	10.8	8.8	11.7	12.3	7.6	11.4	18.1	7.0	12.1	8.9	16.0	16.0	19.5	26.7	17.0	19.7	23.6	15.3	32.5	11.3	44.7	50.4	33.7	90.9	99.7	41.1	95.7	28.1	60.2	102.4	43.6	23.6	81.6	59.7	68.1	139.8	67.3	22.6	23.3	68.5	68.6	54.6	70.8	48.6	75.5	49.5	87.4	31.6	41.1	43.5	155.9	42.8	55.9	45.5	62.3	25.6	57.8	66.4	21.0	41.4	62.2	40.5	25.8	111.2	105.1	101.1	82.8	102.9	48.5	28.3	110.7
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 93.0"	"Low region specificity"	"Detected in all"							"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	37.3	31.0	24.1	25.2	25.2	42.0	37.4	26.2	27.4	30.5	30.3	24.7	20.6	25.6	34.8	39.6	43.4	27.8	39.2	28.5	23.5	23.4	38.7	46.8	30.9	41.8	24.0	18.9	35.7	44.8	9.9	26.4	35.4	23.0	32.5	35.2	24.8	31.9	28.5	29.0	32.2	34.6	38.1	27.0	35.1	31.0	71.6	20.6	49.0	40.3	37.1	41.3	38.1	29.9	28.8	31.2	33.0	40.9	27.6	41.5	33.2	18.0	11.6	13.5	17.5	25.3	37.0	18.0	17.3	28.4	32.6	36.9	19.7	20.3	20.9	14.2	21.0	23.4	11.5	21.9	23.8	28.5	10.8	10.4	11.4	10.5	23.9	24.2	38.7	17.8	29.6	18.9	19.2	26.3	18.8	22.8	16.2	17.0	26.8	25.3	18.0	24.4	53.6	10.6	93.0	13.7	16.7	20.4	29.9	29.3	25.4	16.6	12.7	17.0	20.1	16.3	14.1	17.5	32.5	14.6	36.3	46.6	30.5	20.2	22.4	31.0	24.6	21.3	20.1	14.5	29.0	35.8	33.0	27.5	36.3	32.7	28.8	36.1	31.6	31.2	26.1	33.1	31.0	12.0	27.6	40.9	25.8	41.5	33.2	24.1	25.2	26.2	27.4	23.5	23.4	24.0	18.9	23.0	20.6	47.6	38.4	56.2	83.4	80.8	24.2	29.0	58.6	49.5	38.7	78.5	21.6	169.1	131.0	97.4	378.7	70.5	65.0	0.0	96.8	115.7	101.3	74.8	60.0	52.1	131.4	23.8	65.8	80.4	130.8	85.9	124.3	107.7	69.2	107.4	75.8	51.3	90.0	80.1	91.2	141.7	16.9	84.1	96.6	169.3	251.7	78.7	155.8	80.3	91.4	103.6
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	81.4	71.0	57.7	34.3	42.5	38.6	87.9	53.4	40.8	68.8	51.4	60.1	85.9	90.3	81.1	45.5	46.3	52.5	108.0	69.7	87.2	66.3	71.9	70.5	44.9	69.5	31.1	83.7	51.2	27.9	51.0	51.9	63.1	65.5	70.7	58.1	113.0	86.5	67.1	50.8	83.1	79.6	98.5	71.9	83.0	72.7	54.4	121.2	60.5	63.8	74.8	43.7	54.5	78.6	46.2	79.6	90.5	70.3	42.3	41.3	48.1	49.5	73.7	36.5	100.4	72.6	45.0	69.1	74.3	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1	166.7	121.6	178.4	623.1	343.3	128.5	151.7	150.3	313.2	146.7	179.7	72.6	370.5	316.7	252.0	38.5	189.7	176.9	116.8	186.9	545.4	268.2	456.4	232.8	165.2	311.0	106.5	250.8	168.1	180.7	81.6	221.2	245.7	268.2	312.0	185.6	201.5	190.6	194.6	200.5	268.7	99.7	142.3	307.9	546.1	341.1	330.1	473.4	233.5	241.8	443.4
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase, non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	16.7	12.5	12.6	27.0	14.3	33.7	19.9	32.6	19.2	14.7	15.0	7.8	17.8	12.9	12.2	14.9	17.0	13.7	15.7	12.8	13.1	6.8	13.6	20.5	21.6	30.3	15.3	10.3	22.1	28.2	10.4	27.2	13.3	13.8	14.4	17.1	7.9	26.3	16.0	13.1	16.0	15.3	11.8	24.7	24.2	13.1	9.4	15.9	61.3	14.7	11.7	28.9	16.5	15.8	29.1	32.8	19.9	28.0	31.7	29.2	19.6	12.0	7.4	8.6	2.8	9.9	17.8	8.4	8.1	18.0	17.4	15.6	16.0	17.5	19.0	13.7	8.3	19.5	7.3	14.0	22.2	22.9	7.3	8.4	13.4	6.4	16.6	13.6	31.5	12.8	14.9	21.1	15.8	31.4	10.7	8.8	20.8	13.0	25.9	13.9	13.8	31.4	26.0	10.3	49.8	8.6	10.6	13.6	21.5	14.6	19.4	15.5	8.0	16.4	9.7	14.0	9.6	8.1	18.1	6.7	22.1	21.3	16.4	17.4	8.3	8.3	27.5	10.4	17.3	9.2	11.5	28.0	19.9	21.0	24.6	28.2	29.1	24.8	23.1	32.8	20.3	18.3	20.0	10.2	31.7	22.8	28.0	29.2	19.6	12.6	14.3	32.6	19.2	13.1	6.8	15.3	10.3	13.8	15.9	32.8	62.4	68.6	84.1	53.1	42.4	13.2	38.2	33.5	60.3	14.0	98.2	46.3	11.6	47.9	16.6	28.1	29.6	23.3	59.5	44.8	31.3	89.2	55.4	27.0	47.0	14.3	31.0	16.5	81.8	19.2	27.0	82.9	21.9	111.8	30.9	14.8	39.1	38.6	24.1	17.3	84.6	19.4	21.1	15.4	50.3	43.8	67.9	68.2	36.2	140.6
QRICH1	FLJ20259	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	28.9	27.6	20.4	23.6	26.8	43.1	27.8	38.9	35.0	26.2	23.3	27.0	21.2	21.0	30.7	22.0	28.4	26.7	23.7	21.5	20.9	16.7	20.3	22.1	26.0	30.3	17.8	22.1	30.5	23.3	30.7	27.3	32.1	23.6	22.6	21.4	28.4	26.4	26.0	32.3	34.1	30.0	24.6	15.9	35.2	25.8	53.9	21.8	40.3	25.9	20.2	37.1	28.1	23.6	15.5	16.0	15.9	26.0	15.8	20.1	11.1	18.6	17.9	35.6	16.4	23.4	22.5	22.2	21.1	27.7	35.4	32.3	19.5	23.7	29.9	13.6	27.5	28.6	14.9	32.6	29.5	30.8	25.6	19.6	29.3	24.8	16.1	21.1	25.5	33.8	25.5	22.5	35.4	22.7	21.6	27.4	27.6	19.8	27.4	24.0	13.8	37.1	17.5	29.1	19.6	22.5	18.6	18.6	24.7	22.1	29.1	13.6	27.4	24.0	22.4	17.4	29.4	20.0	28.9	23.8	23.2	26.4	20.5	30.1	24.7	28.7	36.2	21.2	24.6	26.5	14.0	13.2	15.9	16.8	16.5	19.9	15.4	16.2	18.6	16.0	15.5	17.5	20.1	9.9	15.8	26.0	11.4	16.6	11.1	20.4	26.8	38.9	35.0	20.9	16.7	17.8	22.1	23.6	21.8	8.9	13.9	26.2	11.9	19.7	13.5	17.6	17.8	12.0	17.0	19.2	21.6	22.0	1.7	13.7	8.6	15.8	13.1	0.0	11.9	22.9	14.2	14.3	16.1	18.7	17.0	11.1	24.9	18.4	24.3	7.9	20.8	21.5	11.8	17.2	21.2	10.6	16.0	7.0	29.0	9.7	17.1	6.5	17.0	40.7	25.1	19.7	30.8	18.4	16.9	13.5
RABIF	"mss4, RASGRF3"	ENSG00000183155	"RAB interacting factor"	P47224	1	202878957-202889135	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027715, HPA054936"	Approved		Approved	"Microtubules,Cytokinetic bridge"		NA	NA			"Microtubules, Cytokinetic bridge"		"HPA027715: AB_10602151, HPA054936: AB_2732590"	"unprognostic (4.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.62e-3)"	"prognostic favorable (5.64e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.23e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.47e-1)"	7.1	7.0	13.4	10.3	13.8	14.0	7.9	11.5	17.9	8.9	10.4	10.9	3.1	9.9	6.3	8.2	13.8	6.2	8.4	6.7	12.7	15.4	11.2	10.9	8.9	11.7	13.4	10.4	4.0	5.7	6.0	9.2	11.2	14.5	8.6	11.7	6.6	7.9	6.8	7.4	10.6	12.0	9.3	18.2	10.2	7.0	30.2	10.6	8.9	6.3	8.8	15.8	9.4	7.5	15.7	17.7	31.1	21.0	14.9	18.7	15.6	12.4	13.5	9.6	11.0	15.2	11.7	10.6	13.9	7.7	14.4	13.5	9.3	10.9	10.3	6.9	11.0	9.9	11.8	7.6	8.8	10.9	12.2	14.1	8.5	11.1	9.7	12.3	11.6	14.8	9.7	12.7	18.1	4.7	7.2	18.9	13.4	13.4	11.4	14.0	20.8	12.9	12.6	7.8	9.8	16.7	9.3	13.0	14.1	14.7	13.0	13.7	12.0	12.0	21.2	10.7	12.5	13.7	8.5	14.5	10.1	9.3	4.6	12.2	6.0	13.2	11.0	9.9	10.8	9.3	24.1	20.0	27.6	18.3	21.0	13.3	15.7	17.4	17.2	17.7	15.5	15.9	16.7	31.1	14.9	18.8	16.9	18.7	15.6	13.4	13.8	11.5	17.9	12.7	15.4	13.4	10.4	14.5	10.6	0.0	15.7	22.8	29.0	48.2	4.6	9.3	7.6	9.4	7.9	12.2	2.0	43.7	13.3	34.0	555.0	24.8	30.4	0.0	46.5	41.5	19.7	25.2	12.7	28.9	36.9	1.6	22.4	16.0	37.6	2502.1	26.2	34.4	50.6	48.7	12.4	10.8	58.5	31.6	28.3	47.7	5.7	12.9	27.6	68.8	55.8	45.4	66.0	26.1	13.4	37.3
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Pancreatic endocrine cells: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	20.1	4.6	11.4	9.9	21.8	18.2	7.9	17.7	25.6	16.1	17.9	11.5	9.9	10.4	6.7	13.7	15.1	21.0	16.1	11.5	27.9	9.9	7.6	8.1	7.6	8.4	35.4	14.0	11.5	14.3	14.1	28.7	40.9	20.2	78.1	10.2	16.2	6.9	16.3	6.5	9.8	16.7	32.1	22.1	9.2	12.3	10.3	9.0	16.4	9.4	20.5	19.9	10.9	17.5	12.0	21.5	16.4	15.4	25.0	9.5	8.5	12.0	12.6	12.3	9.5	12.7	10.7	14.6	17.3	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9	77.4	36.8	45.3	32.8	80.0	10.9	33.0	45.9	29.4	21.6	22.7	5.9	45.4	18.3	162.0	51.6	66.4	59.6	23.3	107.3	77.4	54.6	33.5	31.1	26.2	97.6	11.1	45.8	69.3	24.5	12.3	44.3	67.7	28.7	146.1	46.5	37.7	277.8	66.0	65.4	28.4	15.8	32.3	24.7	52.6	55.6	95.7	51.8	25.5	51.1	47.7
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Cell line enhanced"	"Detected in all"		"OE19: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	18.4	12.4	11.1	12.5	12.8	20.1	14.7	22.3	12.1	11.4	12.3	13.8	18.3	23.5	16.3	20.4	16.3	10.6	15.3	16.7	14.4	23.3	14.8	12.4	11.5	10.2	10.4	36.4	14.4	14.0	16.8	16.0	16.0	15.4	19.3	20.7	17.7	21.7	18.1	14.6	21.8	16.0	8.6	74.7	12.7	29.5	19.8	17.2	15.8	25.7	14.9	12.2	19.3	16.9	9.9	17.8	10.5	16.9	23.0	34.1	26.2	23.6	26.5	13.4	13.3	25.4	14.8	17.3	12.8	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1	53.6	33.1	41.7	69.2	138.9	39.0	58.4	94.3	28.1	45.5	455.4	27.5	88.3	104.5	97.1	10.8	89.6	83.8	93.5	79.0	356.6	77.0	126.4	39.3	76.9	61.7	49.3	71.2	62.0	61.6	4.2	67.3	70.3	55.6	119.0	76.9	41.2	124.5	79.5	82.0	81.7	31.3	64.7	79.6	48.8	70.5	212.0	37.3	67.5	84.5	98.4
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.9;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	12.4	12.7	15.1	14.0	13.6	30.1	24.8	13.1	24.0	14.5	14.4	9.8	9.8	8.3	13.2	14.3	40.8	9.7	15.5	12.2	15.0	16.0	11.8	16.0	17.9	10.5	18.0	14.3	12.4	11.9	14.7	10.6	15.7	13.7	13.9	11.4	8.3	14.4	11.4	31.8	16.9	9.1	14.7	12.4	9.5	11.0	60.1	12.6	20.9	10.7	20.0	18.0	14.4	21.0	2.0	2.3	3.8	2.0	2.7	8.1	1.2	16.4	7.2	17.5	17.6	23.7	22.1	18.5	20.2	22.8	21.2	22.4	11.0	9.7	14.6	33.0	23.5	16.3	9.0	13.4	11.7	29.3	24.4	12.5	14.7	14.3	20.3	32.9	22.8	11.0	22.2	15.2	25.0	20.8	17.2	17.1	25.8	31.0	11.7	23.5	16.5	26.1	19.1	7.7	15.8	10.2	20.9	13.7	20.7	16.8	19.0	22.0	15.5	16.3	30.2	29.9	34.8	16.1	19.5	16.9	19.3	13.7	15.8	20.7	28.2	34.3	19.8	8.9	14.6	35.7	0.8	1.3	3.8	1.9	1.8	3.8	2.0	4.0	2.0	1.4	1.7	3.8	2.6	1.8	2.7	2.0	2.3	8.1	1.2	15.1	13.6	13.1	24.0	15.0	16.0	18.0	14.3	13.7	12.6	17.9	26.2	5.2	7.4	22.0	22.2	34.0	10.2	14.7	19.4	17.4	13.7	13.9	1.7	7.7	73.9	29.8	11.6	0.0	9.3	7.6	18.5	14.9	9.3	15.6	15.1	6.4	12.7	19.0	23.5	76.0	14.7	15.7	16.9	11.8	16.6	18.6	13.3	3.5	23.3	9.1	16.1	6.5	13.7	65.4	35.1	22.8	23.8	15.3	9.9	10.2
RAP2B		ENSG00000181467	"RAP2B, member of RAS oncogene family"	P61225	3	153162270-153170620	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 171.5;Suprabasal keratinocytes: 170.6;Urothelial cells: 286.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		2400000				"unprognostic (2.44e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	13.4	5.3	8.2	9.9	8.1	21.9	10.2	2.1	10.4	12.0	8.8	5.4	2.5	4.8	7.3	8.6	26.5	5.8	11.2	6.6	9.5	6.0	5.8	7.7	13.1	22.8	4.6	5.9	8.9	7.8	3.1	3.1	14.5	3.8	8.1	6.7	11.1	9.7	4.7	4.2	8.6	6.7	6.5	6.8	16.6	14.6	4.2	3.7	16.2	4.6	9.9	14.8	10.1	12.4	4.9	9.2	15.5	19.8	9.7	14.7	7.7	18.6	6.9	3.4	4.9	7.4	6.7	9.3	4.8	7.2	3.3	3.7	3.6	11.0	1.3	5.4	4.4	5.4	18.8	2.6	8.7	3.9	7.5	5.0	7.6	3.6	6.6	3.8	7.0	12.0	7.2	7.5	4.9	9.3	5.8	7.9	3.6	4.3	16.0	6.2	7.4	6.5	10.1	7.0	3.9	10.7	5.7	9.2	16.9	5.1	18.2	0.0	1.8	5.0	4.6	14.7	6.3	3.4	3.7	15.8	5.1	8.0	5.5	12.0	10.4	1.7	3.4	6.8	7.9	5.2	15.5	13.1	5.0	14.7	19.8	11.2	4.9	12.8	12.8	9.2	3.1	7.4	11.4	5.1	9.7	18.3	6.6	9.0	7.7	8.2	8.1	2.1	10.4	9.5	6.0	4.6	5.9	3.8	3.7	11.9	16.8	24.9	111.7	171.5	3.9	3.9	20.4	9.4	17.0	15.7	2.0	13.9	3.3	22.9	0.4	14.3	61.1	0.0	18.9	45.9	40.4	85.7	26.5	11.9	112.5	3.2	46.5	20.9	130.9	1.3	17.8	75.3	33.7	102.8	31.8	6.8	46.0	17.5	13.8	8.6	6.2	0.0	16.2	1.8	5.5	170.6	12.7	40.2	11.0	286.3
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	24.1	27.9	41.6	22.2	35.3	37.6	32.9	28.0	35.7	23.0	22.7	27.4	15.8	18.4	19.4	43.7	27.6	21.2	16.6	39.2	38.3	37.4	34.2	28.3	23.6	28.1	40.4	22.3	18.5	15.6	12.3	19.5	54.1	32.4	20.3	23.9	22.1	21.3	20.8	46.5	21.8	23.0	23.2	45.2	26.4	21.4	16.4	24.8	31.7	31.1	37.4	34.4	19.5	19.4	33.4	60.7	32.2	41.5	23.9	38.5	62.6	31.4	18.0	34.0	16.9	24.2	29.0	19.2	25.4	23.3	38.3	33.9	29.1	15.2	27.6	17.2	24.9	15.4	18.0	32.3	29.0	40.5	32.1	51.5	17.1	26.4	35.5	20.8	41.7	22.2	24.0	23.5	27.7	20.1	21.9	32.4	16.9	20.2	28.1	33.7	38.6	25.0	48.1	18.7	62.3	19.0	32.9	23.6	34.7	43.7	20.4	16.1	10.4	22.3	22.4	22.7	19.9	19.3	28.7	21.5	23.3	24.1	19.5	24.1	23.9	21.9	40.9	29.3	21.3	25.9	32.2	37.2	29.9	24.7	37.0	23.1	33.4	30.9	26.0	37.6	29.4	27.0	29.2	12.6	23.9	41.5	60.7	38.5	62.6	41.6	35.3	28.0	35.7	38.3	37.4	40.4	22.3	32.4	24.8	214.4	129.3	179.4	176.3	267.3	89.0	482.7	183.4	214.2	152.4	212.9	23.6	426.2	431.0	299.7	34.9	245.1	200.1	537.3	290.2	543.9	259.5	193.3	126.0	227.4	379.6	84.2	155.8	166.3	230.6	64.7	172.0	279.5	323.9	596.9	175.3	142.8	316.2	192.9	166.6	432.2	119.9	116.4	233.8	222.2	235.9	324.0	565.2	152.3	178.9	211.6
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 97.8;Spermatocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.9	11.3	6.8	6.8	1.0	1.9	8.4	7.0	2.9	10.5	12.1	8.9	5.7	16.0	10.5	1.6	5.9	8.9	5.6	6.9	5.8	8.7	15.1	7.7	12.0	6.8	0.8	7.0	7.1	1.0	1.7	8.8	3.2	2.0	4.0	13.1	10.6	4.8	5.0	25.7	12.9	7.0	6.8	5.6	19.7	13.9	9.9	11.5	2.6	5.9	14.2	8.3	7.5	2.8	3.2	3.1	7.4	4.4	3.8	12.5	6.3	17.7	11.5	11.6	12.8	12.7	7.4	11.3	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4	0.0	1.6	10.4	15.3	12.5	15.9	2.4	10.2	4.0	1.2	0.0	3.9	40.3	0.0	3.9	12.7	4.9	4.6	0.0	5.4	97.8	9.3	6.6	3.5	3.4	41.5	7.9	8.1	10.4	10.3	15.1	7.8	11.9	11.8	6.4	7.7	10.1	1.9	7.0	4.6	0.8	11.2	6.5	11.3	51.9	45.0	11.5	19.0	12.5	19.0	7.3
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870483	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 101.9"	"Low region specificity"	"Detected in all"							"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	17.2	14.6	8.9	28.1	9.5	36.0	21.5	6.0	9.3	14.3	15.7	5.3	6.6	8.4	12.2	12.3	33.6	15.3	11.8	11.3	7.4	8.5	11.4	64.3	18.8	31.4	10.1	5.7	18.6	71.6	1.9	12.1	10.5	10.7	14.7	15.7	6.4	15.7	14.0	17.7	19.4	13.7	12.2	11.5	37.5	17.4	9.7	8.9	17.9	15.2	32.5	27.8	18.9	15.9	24.1	24.2	1.9	7.6	13.1	13.8	3.5	15.8	17.9	5.8	67.6	17.3	101.9	17.8	16.1	37.2	13.1	8.5	7.6	3.7	49.0	3.7	15.0	41.1	4.1	14.4	41.1	7.3	2.9	2.6	4.4	2.2	17.1	70.0	9.0	6.5	74.0	84.0	4.1	44.6	20.5	44.5	27.2	3.1	3.1	71.8	20.1	65.7	5.1	90.9	6.1	3.2	88.2	2.1	7.5	32.5	35.3	0.9	4.9	1.6	8.1	7.0	3.3	11.3	8.0	20.6	2.5	19.3	5.0	22.4	5.0	3.5	7.8	45.9	5.5	52.1	1.0	4.8	1.9	6.8	5.7	13.8	24.1	10.0	9.0	5.1	17.9	6.7	7.4	1.0	13.1	7.6	24.2	6.3	3.5	8.9	9.5	6.0	8.1	7.4	8.5	10.1	5.7	10.7	8.9	8.9	36.6	274.9	201.6	175.5	13.0	14.5	53.5	57.6	92.1	19.2	3.9	84.0	56.3	132.5	30.8	89.5	76.2	23.3	199.7	252.2	105.2	161.6	105.0	90.9	170.2	7.9	138.8	87.8	140.5	29.1	129.2	89.6	74.2	57.7	130.6	34.1	350.4	115.2	83.8	69.0	18.4	45.3	94.8	47.6	26.2	216.6	82.3	126.9	150.6	274.6
RPL39L	RPL39L1	ENSG00000163923	"Ribosomal protein L39 like"	Q96EH5	3	187120948-187180908	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 23.7;testis: 90.1"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 387.1;Late spermatids: 163.8;Spermatocytes: 729.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA047105	Approved					NA	NA					"HPA047105: AB_2679933"	"unprognostic (1.01e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.05e-4)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (6.94e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.02e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.60e-1)"	2.5	1.0	4.1	4.6	4.7	3.4	5.8	2.3	5.0	4.6	3.6	2.2	0.9	1.2	3.8	2.3	2.9	3.4	2.2	5.2	3.3	3.2	1.9	1.5	1.9	5.2	2.9	2.7	1.7	1.7	2.4	2.3	2.5	2.8	3.3	1.7	1.8	2.6	3.4	0.6	3.5	1.8	4.0	2.9	2.6	2.5	90.1	2.0	9.2	1.2	2.6	6.1	3.0	3.4	18.2	6.5	2.3	5.7	8.0	23.7	13.5	44.3	15.6	5.5	8.7	2.6	3.9	5.1	13.9	10.1	12.7	13.8	1.0	7.8	18.8	38.8	7.9	24.8	15.3	11.3	2.6	19.5	32.5	2.1	0.2	12.7	0.1	4.9	3.9	5.0	3.1	2.0	10.5	9.0	9.7	12.9	23.5	9.9	22.5	4.7	15.0	0.2	15.7	34.8	15.6	25.9	16.5	7.7	14.0	4.1	1.0	13.5	14.2	10.9	29.9	32.0	13.2	29.4	13.3	5.8	0.1	14.5	11.9	13.9	29.7	31.6	35.8	7.7	16.6	29.0	2.3	5.7	1.3	13.7	5.3	7.0	18.2	14.3	12.2	5.7	12.9	10.2	14.5	0.8	8.0	3.7	6.5	23.7	13.5	4.1	4.7	2.3	5.0	3.3	3.2	2.9	2.7	2.8	2.0	3.0	10.3	39.5	29.2	22.1	3.0	43.1	20.4	4.0	3.4	3.5	0.0	14.1	6.6	11.3	387.1	9.3	0.9	0.0	2.2	80.7	21.7	27.0	6.9	7.3	32.1	6.4	0.0	33.2	26.4	163.8	20.1	13.8	21.9	0.0	3.3	10.4	7.3	0.0	11.0	1.8	1.8	6.5	26.2	729.2	137.8	18.4	12.5	13.8	6.0	19.0
RTL8A	"CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6"	ENSG00000203950	"Retrotransposon Gag like 8A"	Q9BWD3	X	135050932-135052196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 92.9;Ductal cells: 62.7;Pancreatic endocrine cells: 65.5;Proximal tubular cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.1"															NA	NA						"unprognostic (2.10e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (2.16e-2)"	"unprognostic (4.48e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.57e-2)"	26.6	22.1	24.1	13.3	33.5	9.0	26.6	32.7	35.2	24.3	21.1	27.7	14.6	20.1	27.6	17.6	34.1	25.9	20.8	31.8	22.5	26.7	27.6	15.7	21.8	12.9	23.2	21.2	42.7	22.0	15.2	28.6	20.7	24.4	28.6	12.4	21.9	31.5	36.2	17.6	36.8	18.5	27.5	24.5	18.5	23.8	11.5	19.3	8.0	27.2	19.2	14.9	27.5	23.1	4.1	9.0	16.5	19.6	2.6	6.3	5.3	15.5	17.8	8.7	19.1	9.3	8.0	14.9	7.1	5.4	14.1	15.4	18.5	6.1	0.0	17.4	8.7	15.5	9.7	4.5	10.1	4.5	5.2	20.2	3.6	17.9	0.0	22.7	1.0	4.4	15.3	17.0	14.4	6.4	5.4	10.3	2.9	4.9	0.0	6.4	54.1	1.0	9.5	4.8	3.7	20.2	3.3	10.2	0.0	2.7	8.0	17.6	23.6	8.0	4.8	15.0	3.4	5.5	2.5	12.2	10.7	10.3	21.8	14.5	2.5	3.9	0.0	6.3	4.3	8.4	16.5	13.1	13.2	5.0	17.3	4.0	3.0	5.0	6.0	9.0	4.1	5.8	6.3	3.2	2.6	19.6	7.5	3.3	5.3	24.1	33.5	32.7	35.2	22.5	26.7	23.2	21.2	24.4	19.3	56.6	13.7	0.0	0.0	0.0	0.0	0.0	0.0	26.8	47.8	59.3	0.0	55.2	92.9	62.7	0.0	0.0	0.0	0.0	55.7	53.1	0.0	0.0	10.5	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	25.2	0.0	0.0	65.5	0.0	0.0	83.6	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193379-83198932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	5.0	10.1	8.5	3.4	10.4	1.0	5.4	11.8	14.6	5.6	4.0	5.9	11.6	4.2	5.7	15.9	3.1	6.5	7.6	7.2	9.4	11.0	7.5	8.1	4.8	3.9	6.5	11.7	7.0	13.4	7.4	9.8	4.2	11.6	19.2	4.3	3.7	16.4	11.3	4.1	3.4	4.0	5.5	4.8	4.1	5.3	14.5	3.9	1.7	10.4	3.1	4.4	5.2	2.8	3.7	6.8	0.7	3.9	0.8	4.6	2.1	2.2	2.0	4.7	8.9	5.7	4.2	3.3	5.0	10.7	3.8	4.6	2.9	1.2	1.7	4.1	6.1	8.7	2.2	3.9	3.0	5.9	2.0	4.0	2.0	3.0	6.4	8.8	0.5	1.6	5.4	5.0	4.8	10.0	12.5	7.0	4.8	3.1	3.0	4.6	3.1	0.7	1.5	1.6	2.0	2.0	2.5	9.7	1.0	7.9	2.5	1.7	5.8	3.0	4.9	4.5	7.1	3.0	3.0	7.4	2.7	1.7	3.7	2.2	6.7	2.7	1.0	3.1	0.8	3.1	0.5	1.8	0.0	2.4	1.6	3.9	3.7	3.6	3.6	2.0	2.2	4.6	4.5	0.7	0.8	3.9	6.8	4.0	2.1	8.5	10.4	11.8	14.6	9.4	11.0	6.5	11.7	11.6	3.9	0.0	7.9	5.2	3.2	3.3	5.6	5.0	5.1	4.0	0.0	1.8	0.0	6.8	5.0	7.7	27.1	2.9	2.6	0.0	8.0	2.7	5.8	7.9	0.0	4.4	4.3	1.6	5.2	4.3	1.3	11.7	8.3	2.3	8.5	3.6	4.7	8.4	6.2	3.4	5.6	9.3	4.1	6.5	5.0	20.7	7.2	2.0	4.8	2.5	2.6	2.1
SCNM1	MGC3180	ENSG00000163156	"Sodium channel modifier 1"	Q9BWG6	1	151156664-151170297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052439, HPA054324"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052439: AB_2681834, HPA054324: AB_2682451"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (2.17e-13)"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.71e-2)"	20.5	15.5	22.2	21.1	21.1	32.9	16.2	17.0	20.0	15.3	16.8	21.0	8.0	16.3	18.4	15.0	19.4	16.5	15.5	16.5	19.8	17.1	19.5	19.8	16.1	34.0	22.9	14.9	16.8	13.5	10.3	12.1	23.6	20.2	17.3	14.7	20.3	16.2	15.2	47.9	21.7	20.5	18.0	22.3	41.8	14.6	14.4	19.4	40.9	16.1	20.1	27.2	21.6	15.6	28.2	61.4	50.9	45.3	28.8	30.1	37.8	13.1	9.2	10.3	12.1	14.5	10.9	17.4	10.4	12.1	25.4	19.9	20.1	12.9	21.0	17.0	11.2	6.6	17.8	12.0	9.6	12.4	13.2	13.3	18.1	13.2	12.8	21.0	24.0	17.8	11.4	18.7	17.8	16.0	11.9	15.3	14.7	14.4	16.1	12.4	32.4	17.0	37.3	26.2	20.5	14.4	23.3	12.4	26.0	13.6	8.8	12.8	20.6	11.8	19.2	23.3	13.4	17.8	77.1	11.2	12.2	11.4	12.6	22.1	20.9	28.4	32.8	12.7	25.5	15.6	50.9	45.3	45.6	20.4	33.7	19.3	28.2	24.8	23.0	60.2	24.7	22.9	19.9	45.7	28.8	21.0	61.4	30.1	37.8	22.2	21.1	17.0	20.0	19.8	17.1	22.9	14.9	20.2	19.4	3.0	17.5	25.9	17.5	23.7	17.9	26.6	12.7	24.1	21.6	27.9	17.7	31.2	46.4	32.0	24.9	23.7	24.2	46.7	27.7	28.6	28.9	12.3	39.3	11.0	62.2	7.9	13.8	18.4	58.4	19.2	28.7	54.1	20.3	52.3	15.5	22.0	32.8	28.1	20.1	28.3	14.5	32.3	33.0	22.8	13.5	15.9	23.0	46.7	16.8	19.6
SEC22B	"ERS-24, sec22b, SEC22L1"	ENSG00000265808	"SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)"	O75396	1	120150898-120176515	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB079017		Approved				NA	NA		980000			"CAB079017: "	"unprognostic (2.21e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (4.58e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (5.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.15e-1)"	11.9	12.0	7.4	8.9	8.3	6.2	10.3	7.6	10.2	12.3	8.5	8.2	15.5	10.0	11.1	18.3	7.3	7.0	10.1	7.7	6.3		10.7	23.6	8.8	9.2	7.6	9.1	10.1	19.6	11.1	25.6	24.8	8.8	11.8	11.2	9.8	19.4	13.4	8.2	6.7	12.4	9.2	7.2	8.9	10.2	7.1	8.3	10.9	11.4	6.3	9.4	11.1	7.8	12.4	16.1	25.1	16.6	14.5	17.8	10.7	9.9	3.3	6.4	9.9	37.0	26.2	8.4	23.5	19.5	16.6	30.8	5.4	4.3	6.3	11.6	14.8	10.1	4.1	6.0	6.3	22.9	8.0	5.6	7.1	18.7	9.3	21.2	9.6	8.7	25.4	8.2	21.4	11.6	29.1	10.2	8.3	4.6	13.6	22.4	19.3	8.9	5.2	9.2	7.0	8.8	8.4	14.9	7.0	12.7	7.6	6.6	7.1	8.4	12.2	12.4	9.7	6.4	11.2	13.9	22.9	10.9	39.7	15.3	9.4	6.4	9.8	35.3	8.6	25.2	17.4	16.6	14.1	13.3	14.9	17.8	12.4	15.0	13.6	10.0	11.0	15.3	17.0	25.1	14.5	13.1	16.1	11.7	10.7											26.8	35.7	29.7	22.2	0.0	30.0	15.7	43.3	18.7	27.3	40.1	31.4	56.3	94.5	35.1	4.1	27.0	42.5	46.7	34.0	57.8	20.6	54.1	50.7	64.8	44.2	11.1	40.8	36.8	48.0	4.2	46.6	36.7	0.0	32.5	67.3	56.4	32.0	24.6	45.3	46.1	137.0	51.8	24.3	20.0	13.5	0.0	91.4	42.0	36.3	29.4
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	27.5	49.3	34.8	35.6	49.9	36.2	30.4	17.0	52.5	23.6	30.6	14.8	23.3	38.5	22.1	38.1	36.3	26.9	28.7	32.7	29.7	31.9	33.8	49.5	26.4	40.1	29.3	40.0	28.4	41.5	9.7	30.7	28.9	22.2	32.8	16.2	22.8	48.2	26.0	52.7	21.1	37.8	15.5	19.5	49.3	36.8	30.8	18.7	44.4	43.2	25.4	35.5	21.6	23.3	61.7	83.7	39.6	71.7	29.9	53.1	71.6	32.3	23.7	25.6	14.7	3.9	12.5	4.7	13.1	11.1	11.2	6.6	6.4	16.4	15.6	36.6	7.2	10.4	14.4	11.9	15.9	7.5	22.7	25.7	20.7	15.1	15.6	23.0	30.5	40.6	13.2	13.5	13.2	12.4	16.8	19.5	22.5	19.7	14.8	13.3	31.1	26.3	46.9	45.4	10.5	31.1	33.6	24.7	29.7	10.7	15.1	13.8	28.1	11.5	10.8	33.6	15.8	29.7	22.9	19.4	12.7	28.0	25.0	18.9	74.4	53.4	10.3	27.4	24.3	30.1	39.6	71.7	34.5	29.9	71.0	28.2	59.7	39.7	31.3	71.2	61.7	53.1	37.6	5.4	29.9	65.4	83.7	29.4	71.6	34.8	49.9	17.0	52.5	29.7	31.9	29.3	40.0	22.2	18.7	154.9	129.2	0.0	0.0	0.0	0.0	0.0	0.0	262.3	136.5	143.1	0.0	264.9	376.4	215.3	0.0	0.0	0.0	0.0	273.6	236.1	0.0	0.0	123.2	0.0	352.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	178.5	0.0	0.0	265.5	0.0	0.0	359.8	0.0	0.0	0.0	0.0	0.0	0.0	123.1	0.0	0.0	0.0
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 96.1"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 96.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	25.1	34.7	16.3	19.6	17.1	18.0	38.3	11.4	15.6	22.8	33.7	20.7	51.6	33.2	21.6	33.7	24.8	20.5	21.9	35.0	15.6	14.6	30.9	58.2	27.0	24.5	24.6	13.4	19.3	80.9	14.6	27.5	38.2	21.2	23.5	37.8	16.5	58.0	42.1	28.3	20.6	41.5	21.8	26.8	27.5	26.8	44.4	18.7	9.7	34.0	22.5	26.4	21.0	30.9	10.0	96.1	17.5	14.8	14.3	17.2	9.6	9.4	15.1	13.6	12.0	29.8	21.2	11.3	28.9	22.2	20.2	20.4	17.9	23.0	7.2	10.8	25.6	34.0	27.0	14.7	13.0	13.2	13.0	19.6	12.1	13.5	18.5	47.3	9.1	14.1	18.4	37.3	13.5	40.2	15.9	15.0	9.6	12.1	81.9	21.6	15.2	6.6	14.2	10.3	36.4	9.8	8.5	11.1	15.7	20.3	22.7	7.6	19.3	20.1	19.0	40.2	18.7	14.2	20.7	15.9	19.1	12.5	25.6	21.9	59.5	49.7	10.4	20.8	10.9	22.9	17.5	10.8	12.3	16.0	12.9	15.4	10.0	12.4	17.2	9.3	7.0	9.4	14.0	3.7	14.3	14.8	96.1	10.9	9.6	16.3	17.1	11.4	15.6	15.6	14.6	24.6	13.4	21.2	18.7	110.2	99.5	0.0	0.0	0.0	0.0	0.0	0.0	104.4	118.3	146.5	0.0	113.3	26.6	173.0	0.0	0.0	0.0	0.0	166.1	174.9	0.0	0.0	27.9	0.0	109.2	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	160.5	0.0	0.0	185.9	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	254.0	0.0	0.0	0.0
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Group enriched"	"Detected in many"	6	"B-cells: 178.5;Kupffer cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		8100000000	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.8	0.3	0.0	0.0	0.0	0.0	1.2	18.6	0.0	0.9	0.0	0.8	12.8	0.1	0.0	0.2	0.2	4.9	0.1	0.3	3.9	0.2	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	24.1	0.0	11.2	1.3	7.0	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3	8.9	20.2	178.5	0.3	0.3	0.0	0.3	2.5	2.7	3.4	10.4	0.0	9.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.6	0.8	0.0	9.3	0.4	5.6	0.0	0.0	1.8	97.5	0.0	0.6	7.5	1.7	0.0	0.0	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	23.8	20.3	0.0	0.5
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1, 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	44.1	58.5	33.3	38.6	48.7	23.1	29.0	25.0	36.3	29.6	48.4	16.8	44.0	41.5	33.5	44.1	45.4	24.0	29.5	69.9	34.8	27.9	34.7	91.6	24.3	28.2	31.7	31.8	45.7	43.6	14.8	51.2	63.5	32.2	32.2	27.8	22.0	43.4	34.5	109.5	34.2	39.0	42.1	43.8	25.0	40.0	52.5	28.8	28.8	28.7	61.8	28.0	31.5	34.0	50.6	94.9	36.7	65.7	42.0	79.0	48.9	63.4	37.5	52.3	54.3	22.4	19.5	28.2	51.9	25.5	21.9	27.4	33.9	52.8	41.9	129.0	25.2	67.7	32.9	43.7	35.0	31.1	48.7	33.0	50.2	55.2	52.6	20.5	74.2	37.6	24.8	27.5	32.7	33.5	34.3	29.2	50.4	65.0	51.8	22.2	80.4	83.8	105.3	70.7	64.4	34.3	32.6	67.4	49.5	31.0	63.2	43.1	54.5	96.9	81.4	52.8	83.8	23.2	56.6	60.0	43.2	75.2	79.8	64.7	32.6	87.4	121.2	47.2	65.6	59.4	36.7	61.3	15.8	45.5	65.7	43.2	50.6	59.3	53.1	86.3	45.3	46.9	47.2	4.1	42.0	55.4	94.9	79.0	48.9	33.3	48.7	25.0	36.3	34.8	27.9	31.7	31.8	32.2	28.8	160.8	197.7	0.0	0.0	0.0	0.0	0.0	0.0	274.4	190.0	232.1	0.0	543.9	349.8	309.5	0.0	0.0	0.0	0.0	464.8	599.1	0.0	0.0	94.2	0.0	339.5	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	421.2	0.0	0.0	446.5	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	729.5	0.0	0.0	0.0
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 821.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		5100000	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	31.6	38.8	21.1	23.5	34.8	17.3	29.6	13.4	20.8	31.8	44.6	35.2	38.1	54.9	30.3	30.3	36.0	35.9	42.4	58.7	21.1	21.3	32.4	20.1	36.2	45.3	33.7	20.4	45.3	85.3	26.5	23.7	38.5	28.5	37.8	30.9	32.6	23.4	32.6	51.0	12.0	85.5	36.6	32.4	41.4	29.9	55.5	28.9	5.9	32.6	34.2	23.7	31.7	24.5	8.4	30.8	34.2	31.3	23.6	18.6	24.0	30.4	20.0	6.6	27.3	17.9	40.0	20.4	28.5	34.6	22.6	26.4	7.0	22.1	0.2	32.9	32.2	25.8	46.3	18.3	29.0	21.2	40.0	8.3	17.9	23.9	11.8	31.4	0.3	10.9	23.0	20.3	21.5	5.6	39.6	53.5	0.2	23.2	0.5	40.2	21.6	0.2	0.3	3.9	34.7	38.5	2.0	12.3	25.6	28.5	7.4	0.4	16.9	23.4	3.5	31.6	25.6	15.4	14.6	38.2	23.1	8.5	51.3	19.2	0.6	0.1	0.6	17.8	18.0	23.7	13.9	31.3	34.2	16.8	30.4	8.3	8.4	9.5	11.1	30.8	6.9	11.3	18.6	2.8	23.6	24.6	3.1	1.3	24.0	21.1	34.8	13.4	20.8	21.1	21.3	33.7	20.4	28.5	28.9	47.6	66.6	38.9	56.1	18.2	24.1	116.6	30.6	123.1	58.0	71.5	19.6	135.2	84.6	164.5	478.1	107.4	297.6	0.0	298.9	268.0	77.3	94.3	101.6	31.0	159.4	28.6	70.0	185.4	162.5	821.7	77.1	104.2	60.8	173.1	110.7	143.7	252.9	244.7	79.9	156.8	48.0	77.6	110.5	190.3	30.0	23.1	135.0	42.4	162.8	77.4
SERPING1	"C1-INH, C1IN, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57614853	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 693.2"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 749.1;Hepatocytes: 2308.4;Leydig cells: 680.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	143	"dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0"	"Group enriched"	"Detected in some"	6	"ASC diff: 148.4;ASC TERT1: 76.8;HSkMC: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		38000000000			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	88.8	16.3	3.6	18.2	5.4	1.6	75.0	3.8	6.3	62.7	37.8	7.3	16.7	6.2	63.4	58.8	58.3	63.4	61.6	55.5	3.4	3.0	53.4	693.2	73.8	22.4	5.7	4.1	116.4	38.1	8.0	18.4	33.1	14.9	70.3	11.9	82.6	20.7	33.2	36.5	23.1	20.3	38.7	17.3	42.7	30.3	39.2	3.6	1.8	41.5	24.4	16.8	68.7	122.2	0.0	28.5	32.1	11.0	0.1	0.0	2.8	0.0	0.0	5.6	0.0	148.4	76.8	1.0	9.4	6.7	2.0	3.6	0.3	0.0	0.0	11.3	4.8	0.0	0.0	0.0	0.6	1.2	0.0	0.0	4.6	0.0	0.2	19.6	0.2	0.9	127.4	1.9	0.7	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.0	0.0	0.7	0.5	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.1	5.1	0.1	0.4	0.0	0.3	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	0.1	0.0	11.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	32.1	0.1	4.4	28.5	0.0	2.8	3.6	5.4	3.8	6.3	3.4	3.0	5.7	4.1	14.9	3.6	110.2	95.0	7.0	53.1	67.3	0.6	19.8	749.1	34.8	102.4	150.1	0.0	17.1	36.5	333.2	3.5	154.2	0.0	0.0	39.3	87.1	278.1	25.0	7.0	2308.4	40.1	0.0	0.0	231.4	85.9	8.5	680.9	41.3	86.0	12.6	0.0	52.7	58.0	0.0	215.0	42.4	4.4	265.1	282.5	2.4	3.0	51.9	21.1	39.9	0.0	30.8
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36184319	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 75.1;RH-30: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	6.5	6.9	7.8	8.0	7.5	12.9	6.5	11.5	9.0	7.5	7.7	10.3	3.7	10.2	9.9	6.3	13.5	8.1	4.9	4.1	7.3	5.1	4.2	14.0	5.8	9.4	8.8	7.4	7.7	6.1	3.9	12.5	49.1	6.5	7.2	9.5	6.1	6.3	5.4	3.4	7.6	7.7	6.4	7.4	9.4	5.3	3.9	7.4	19.5	5.0	7.5	11.7	7.9	8.4	6.5	16.0	14.7	7.9	7.7	8.5	5.0	7.6	3.8	16.2	18.0	3.9	6.4	75.1	9.9	7.5	25.4	19.2	21.0	6.0	11.0	2.7	8.0	4.6	8.0	18.0	12.5	27.3	4.9	10.4	6.4	14.1	9.9	1.9	14.2	2.9	5.8	3.3	4.6	3.2	2.6	7.0	9.9	11.0	2.5	9.1	3.7	16.5	8.2	14.7	7.5	5.8	16.3	94.3	7.0	1.8	8.0	13.9	16.6	31.0	6.8	4.3	12.4	6.8	8.0	3.2	9.5	11.0	3.5	6.8	3.2	3.0	13.6	4.3	17.5	6.8	10.3	7.9	14.7	5.4	7.2	8.5	5.6	5.7	5.8	16.0	6.5	7.9	6.0	1.5	7.7	4.1	4.3	5.3	5.0	7.8	7.5	11.5	9.0	7.3	5.1	8.8	7.4	6.5	7.4	20.8	9.9	6.7	3.2	3.3	7.4	1.1	2.5	6.7	0.0	1.8	9.8	117.2	1.7	2.4	0.4	3.6	2.3	0.0	2.6	184.7	4.7	0.7	2.3	8.6	29.3	0.0	2.9	1.3	9.2	0.0	3.7	2.6	1.7	7.2	3.6	2.3	2.6	3.5	6.0	1.1	6.8	0.0	2.3	0.7	4.0	3.4	70.1	6.4	7.4	0.9
SLAIN1	"C13orf32, FLJ30046"	ENSG00000139737	"SLAIN motif family member 1"	Q8ND83	13	77697854-77764242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 89.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 44.5;Muller glia cells: 87.9"	"Cancer enhanced"	"Detected in many"		"glioma: 25.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 2.2;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 20.8;HL-60: 27.6;MOLT-4: 31.7;REH: 22.1;SCLC-21H: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.76e-5)"	"unprognostic (1.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.20e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.80e-3)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-2)"	1.4	6.0	27.6	3.0	41.5	8.7	4.1	14.2	73.1	3.6	1.7	74.8	0.3	1.9	4.4	7.4	2.6	10.2	2.4	3.7	39.1	20.7	5.1	4.5	6.0	5.8	56.7	19.6	4.8	6.5	7.5	2.7	2.4	38.3	4.5	2.0	1.3	5.6	3.8	1.9	1.3	1.6	3.2	89.3	4.6	6.6	17.6	51.9	4.1	6.5	0.0	6.0	2.5	1.0	0.7	2.2	0.0	0.2	0.8	4.7	1.0	0.1	1.2	15.3	0.3	0.0	0.0	2.6	0.1	0.0	0.0	0.0	1.4	3.1	11.6	0.8	0.0	0.0	0.1	14.4	0.0	0.0	14.5	20.8	9.9	2.8	0.2	0.4	27.6	0.7	0.0	0.0	0.0	0.0	1.7	0.5	16.5	0.3	15.6	0.0	0.3	31.7	2.8	5.8	10.2	4.6	22.1	1.3	0.0	7.1	1.2	21.9	11.1	0.0	4.2	2.8	5.3	0.0	12.6	0.1	0.2	0.6	0.1	4.0	15.1	6.8	14.0	1.7	3.3	0.9	0.0	0.1	0.0	2.1	0.2	3.0	0.7	2.5	2.3	0.2	0.6	2.7	4.2	0.0	0.8	0.2	2.2	4.7	1.0	27.6	41.5	14.2	26.2	39.1	20.7	56.7	19.6	38.3	51.9	11.9	9.6	3.4	2.7	0.7	8.2	3.6	10.2	0.0	3.4	3.5	15.7	1.4	1.7	2.0	44.5	1.5	0.0	0.0	2.3	0.1	1.9	4.1	0.0	4.9	0.2	3.2	8.6	3.1	0.8	12.1	1.4	0.7	6.8	0.0	0.5	87.9	2.7	0.0	0.7	3.3	3.0	0.0	2.3	3.6	2.0	1.1	0.3	5.1	0.0	3.0
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.9;lymphoid tissue: 45.0"	"Cell type enriched"	"Detected in many"	5	"monocytes: 204.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 80.7"					"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		620000	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"	5.5	1.0	0.7	28.6	0.7	2.3	3.4	0.6	0.7	4.1	11.9	0.2	0.4	11.1	1.9	1.3	6.7	1.6	6.2	1.0	0.7	0.7	2.4	3.1	10.2	24.6	0.8	0.4	2.5	2.2	0.0	0.9	1.3	0.6	1.8	10.2	2.9	15.1	4.8	0.9	2.0	15.8	0.8	1.2	45.0	11.0	1.5	0.4	5.9	2.1	4.2	38.7	11.5	2.6	3.7	27.4	1.1	14.9	17.3	32.9	8.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	2.2	0.0	0.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	80.7	6.8	0.0	2.2	0.0	0.0	0.0	1.6	0.3	32.9	11.0	25.4	3.7	3.5	22.4	7.2	0.6	1.1	13.6	1.1	17.3	14.9	27.4	0.0	8.7	0.7	0.7	0.6	0.7	0.7	0.7	0.8	0.4	0.6	0.4	8.9	8.9	20.2	1.4	0.7	0.0	0.8	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	23.3	2.3	0.1	1.1	1.8	8.1	0.0	8.9	0.0	0.0	0.6	6.0	0.0	0.0	12.8	18.6	204.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	39.5	0.0	3.0
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.4;SK-BR-3: 38.8"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.2	26.4	2.5	12.6	0.9	0.7	5.0	6.0	2.0	7.8	5.9	16.0	6.1	6.4	4.7	1.4	3.8	9.2	3.6	6.3	1.4	4.7	20.4	5.2	16.1	50.4	1.1	11.7	6.4	0.5	3.3	5.5	1.1	1.5	4.5	9.1	8.7	8.1	2.6	26.8	17.1	12.4	2.6	6.0	19.9	13.0	5.4	20.2	6.9	12.9	16.7	11.3	5.7	38.8	1.3	0.7	16.6	6.5	1.9	6.0	19.8	8.7	11.0	5.0	2.5	3.7	2.6	12.4	5.2	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5	0.0	2.1	0.0	5.5	0.0	2.9	3.3	17.8	13.4	5.7	14.0	0.0	11.3	21.6	15.4	23.8	0.5	9.3	0.0	20.3	4.7	0.9	3.9	0.0	37.7	6.8	0.0	4.7	3.1	0.3	65.6	2.0	0.3	0.0	1.0	15.4	1.5	9.6	24.6	1.8	75.1	3.8	0.0	0.2	8.4	2.3	0.0	3.5	1.5	28.8	4.3
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.8	6.2	4.8	1.3	1.7	1.7	7.6	5.3	1.7	4.0	1.5	5.8	3.1	10.0	26.5	9.4	2.2	3.3	6.5	7.4	5.9	0.7	2.2	13.1	3.4	20.6	5.8	2.1	4.1	28.6	4.9	22.1	2.6	21.6	3.2	3.0	8.2	9.1	1.2	0.8	0.5	1.2	8.1	3.9	0.9	2.0	3.6	1.0	6.6	2.5	0.5	3.3	0.9	11.7	1.4	1.5	12.4	31.4	2.3	6.5	3.4	6.0	6.9	3.1	3.2	3.9	3.2	46.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0	0.0	5.9	3.7	7.0	4.0	4.0	3.6	2.5	1.4	3.4	0.0	2.0	2.2	0.0	3.6	2.1	1.6	1.1	0.0	21.4	0.5	1.0	37.7	4.6	0.4	0.5	1.6	25.9	3.7	0.0	0.4	2.3	9.0	5.0	90.2	5.4	48.4	27.4	1.1	2.1	0.0	1.9	0.0	1.0	0.7	0.7	2.8	0.9	0.0	1.3	11.1
SMIM10L1		ENSG00000256537	"Small integral membrane protein 10 like 1"		12	11171222-11176016	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (2.27e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.80e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (8.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.70e-4)"	6.2	13.6	6.5	5.1	10.4	5.4	6.7	4.2	14.4	5.1	5.8	5.2	5.3	5.7	5.1	9.4	4.4	4.1	6.3	13.2	7.9		7.6	10.6	4.6	6.0	8.0	7.4	3.9	5.1	5.4	9.2	5.3	8.4	7.7	5.2	3.8	12.5	7.5	20.6	2.9	5.4	8.2	6.0	5.5	5.8	3.5	9.0	6.3	7.0	5.9	4.3	4.6	7.0	7.8	9.6	18.1	10.2	12.4	11.5	8.8	7.2	4.4	12.0	5.2	9.8	7.2	10.5	10.9	6.5	7.2	5.6	9.3	6.5	6.0	4.8	6.1	9.2	4.8	7.1	5.4	9.2	20.8	8.2	11.0	6.4	8.9	6.7	15.3	3.6	6.3	4.8	7.3	7.4	8.6	5.8	10.3	7.9	5.5	8.1	7.0	10.6	12.8	19.3	4.0	5.7	9.0	14.3	6.4	8.9	8.4	6.4	7.0	8.8	5.4	15.2	20.4	2.9	10.5	6.9	12.9	18.2	5.5	10.8	4.8	9.8	14.9	9.4	9.0	11.6	18.1	10.2	11.1	9.8	8.1	10.3	6.5	10.2	10.1	8.1	7.8	11.5	9.3	1.3	12.4	7.4	9.6	10.3	8.8											14.9	27.2	2.2	14.7	0.0	25.3	80.7	38.2	30.8	33.0	7.0	23.6	48.7	44.7	42.1	3.7	38.6	15.0	0.0	44.3	16.5	28.8	18.3	15.1	31.1	38.2	25.4	11.7	28.8	16.5	6.9	24.5	21.5	0.0	41.5	23.6	20.4	43.8	14.0	30.4	53.6	32.5	32.3	32.3	9.8	16.6	0.0	15.0	30.5	20.4	8.7
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"		9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in many"	6	"blood: 102.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 54.9;Distal tubular cells: 101.2;Proximal tubular cells: 50.5"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 102.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 102.4"	"Low cell line specificity"	"Detected in all"																	NA	NA						"prognostic favorable (4.18e-5)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favorable (8.39e-4)"	"prognostic favorable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	4.0	6.9	5.0	4.3	12.2	7.9	5.6	4.8	11.0	4.0	4.0	2.4	4.4	4.8	2.2	7.8	2.3	4.0	2.1	8.6	5.1		6.2	3.9	5.6	8.8	5.7	5.8	3.7	11.5	3.7	5.5	2.1	8.9	4.4	1.6	4.0	5.9	4.6	13.8	2.1	3.9	4.5	11.4	6.6	5.1	16.2	6.1	4.5	2.8	4.7	4.1	2.6	0.0	18.4	8.4	102.4	7.6	13.3	22.0	9.9	7.1	4.1	7.5	6.7	3.3	10.0	4.1	3.8	5.6	2.9	5.9	1.0	2.0	5.5	5.5	5.4	5.3	2.9	5.1	3.3	4.2	10.7	11.4	27.2	12.4	9.1	7.6	6.7	4.7	7.3	5.3	2.8	6.7	8.4	6.6	18.1	3.8	14.0	5.2	5.5	11.8	27.5	9.2	7.3	7.8	6.2	3.5	9.8	6.8	3.8	5.6	6.9	9.0	3.5	4.6	9.5	2.8	5.9	3.8	2.1	5.6	2.7	3.7	15.7	12.0	19.5	12.5	4.1	1.8	13.6	7.3	47.4	12.7	7.2	16.9	17.6	18.3	14.7	6.1	18.4	22.0	19.0	102.4	13.3	7.6	8.4	18.3	9.9											26.8	29.6	0.0	0.0	0.0	0.0	0.0	0.0	54.9	17.0	27.9	0.0	21.4	101.2	16.2	0.0	0.0	0.0	0.0	28.2	10.1	0.0	0.0	23.3	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	10.8	0.0	0.0	21.1	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0
SMU1	"BWD, FLJ10805, fSAP57, SMU-1"	ENSG00000122692	"SMU1, DNA replication regulator and spliceosomal factor"	Q2TAY7	9	33041764-33076659	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019708	Supported		Approved	Vesicles		NA	NA		16000	Vesicles		"HPA019708: AB_1857300"	"unprognostic (2.20e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.98e-3)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.67e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.96e-2)"	25.0	20.0	21.7	17.0	22.2	23.3	20.7	29.6	24.5	22.2	18.0	28.3	17.4	14.5	28.3	21.2	18.1	20.6	15.0	17.1	21.3	21.2	19.5	21.9	17.0	19.7	22.1	18.1	26.3	18.7	30.3	26.6	18.2	24.2	21.1	19.1	20.2	20.5	21.0	22.9	21.9	19.6	23.6	23.5	21.0	16.9	16.0	19.5	31.1	24.1	16.5	24.6	20.8	17.7	14.4	21.2	20.7	17.5	12.9	16.5	10.4	16.0	12.7	15.3	13.3	16.7	12.8	12.0	12.6	11.4	17.3	17.2	12.9	6.8	20.4	9.3	15.6	9.4	9.9	19.6	15.1	19.3	23.3	9.4	15.3	22.0	15.0	14.5	26.4	14.5	13.3	17.3	15.9	11.4	13.0	14.4	14.3	14.1	13.1	14.4	7.4	20.6	28.3	21.1	12.1	13.6	17.7	12.7	11.0	13.1	12.1	13.1	11.4	17.0	12.3	7.9	12.5	11.9	9.7	15.4	11.1	12.4	16.1	14.6	5.9	10.8	24.1	12.4	12.5	7.9	20.7	14.9	11.6	14.1	16.0	15.0	14.4	16.0	13.2	16.6	13.7	16.3	16.5	8.7	12.9	17.5	21.2	13.2	10.4	21.7	22.2	29.6	24.5	21.3	21.2	22.1	18.1	24.2	19.5	23.8	28.9	28.1	39.6	47.7	26.6	25.4	28.1	54.9	39.8	19.2	35.3	29.5	18.3	29.2	19.4	33.7	15.9	0.0	21.2	30.4	26.9	27.7	37.1	26.6	27.4	22.3	27.0	23.4	26.4	4.7	30.0	32.1	21.9	31.5	18.7	36.8	23.2	18.4	24.4	25.3	37.1	19.4	32.4	27.7	31.8	50.3	48.3	29.4	20.4	33.1
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	9.5	15.2	17.3	7.0	16.4	4.9	15.5	13.2	16.1	9.8	11.1	11.7	13.5	9.2	9.5	24.1	19.2	14.2	9.2	10.7	15.0	7.8	13.8	23.5	7.8	17.0	11.5	15.0	10.3	23.6	8.3	11.5	14.9	14.4	11.9	10.5	14.2	16.2	10.9	13.6	16.4	16.2	9.2	10.4	11.2	15.2	12.1	14.1	12.6	12.4	6.1	13.1	10.0	9.8	24.2	23.8	38.0	25.0	13.0	20.8	17.0	13.1	24.3	9.6	9.9	17.8	13.9	16.2	10.2	13.4	16.1	14.7	24.3	29.5	7.9	26.2	14.7	15.1	17.3	6.7	26.9	10.4	8.2	14.1	11.8	19.4	17.3	21.3	7.9	14.7	15.9	42.0	18.9	18.8	17.6	12.9	14.1	19.6	17.3	17.6	25.4	9.8	15.4	11.9	22.6	22.0	7.2	9.8	14.2	19.9	19.4	14.3	17.0	11.7	20.2	17.9	20.3	31.5	14.9	6.2	10.8	12.0	9.7	11.6	16.2	12.7	5.3	15.7	6.2	16.3	38.0	25.0	28.7	15.8	19.7	15.7	24.2	15.6	17.0	21.1	18.8	14.1	14.1	24.5	13.0	15.8	23.8	20.8	17.0	17.3	16.4	13.2	16.1	15.0	7.8	11.5	15.0	14.4	14.1	6.0	13.6	25.1	12.2	6.6	9.3	17.5	17.8	29.4	11.4	24.4	7.9	73.8	51.4	31.2	3.9	10.8	34.2	0.0	34.9	84.6	11.8	15.7	2.3	42.7	39.7	6.4	11.1	16.5	16.8	8.1	17.3	14.0	5.0	41.5	23.4	10.0	39.3	24.6	16.6	49.7	9.3	32.3	9.6	25.1	29.2	9.2	83.6	15.0	23.3	16.5
SNRPA1	Lea1	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	11.9	13.3	12.4	26.1	19.6	35.2	17.7	9.7	17.2	9.9	18.0	10.2	10.4	14.6	14.3	21.1	24.6	12.4	11.8	17.3	17.9	9.8	16.1	19.7	14.1	29.2	11.2	12.2	10.8	16.3	9.1	10.7	29.3	14.1	10.3	19.3	11.3	17.2	9.1	13.4	12.1	22.5	11.7	9.4	26.4	15.9	24.3	7.0	33.4	11.6	18.1	30.0	12.3	12.2	21.7	23.5	8.4	18.2	18.3	26.9	15.3	31.5	22.1	21.4	10.8	6.0	5.0	21.0	29.5	13.6	26.5	20.2	47.2	28.3	35.2	16.9	19.9	20.8	18.9	31.9	21.0	28.5	17.8	49.3	27.6	36.0	24.9	4.6	31.6	19.8	4.0	15.8	16.9	21.3	5.9	17.0	27.3	38.4	33.2	16.2	35.1	31.8	33.6	27.3	42.5	18.8	31.8	23.1	35.5	19.3	83.2	16.7	17.6	18.0	20.6	22.2	23.4	19.8	25.0	12.3	14.2	26.9	16.5	29.3	27.5	81.2	68.5	11.5	29.9	16.7	1.4	15.0	8.4	24.6	18.2	24.1	21.7	25.4	24.2	23.5	19.1	21.2	26.3	2.9	18.3	16.6	22.3	26.9	15.3	12.4	19.6	9.7	17.2	17.9	9.8	11.2	12.2	14.1	7.0	17.9	53.6	59.5	65.8	58.3	35.1	25.2	15.3	45.5	37.5	34.9	11.8	110.2	58.0	79.4	34.5	35.0	39.1	93.5	94.8	120.7	56.9	51.6	62.5	29.7	59.4	35.0	25.9	25.8	23.7	11.4	32.2	36.6	40.5	102.8	40.2	29.4	78.7	40.3	26.9	68.5	28.5	12.9	49.2	116.7	62.4	44.3	93.9	69.8	47.8	83.9
SNRPD1	"HsT2456, Sm-D1, SNRPD"	ENSG00000167088	"Small nuclear ribonucleoprotein D1 polypeptide"	P62314	18	21612267-21633524	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040516	Supported					NA	NA		490000			"HPA040516: AB_10673236"	"unprognostic (1.83e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (7.90e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.83e-1)"	25.7	27.9	30.3	39.6	28.5	59.7	24.9	26.5	33.3	20.6	35.6	21.3	16.3	32.5	25.8	21.8	42.8	22.0	20.4	20.1	24.7	28.7	28.9	31.4	21.9	50.5	26.8	25.8	30.2	21.9	11.2	34.9	28.0	34.0	21.7	35.9	14.5	22.3	17.2	47.1	24.1	33.9	22.9	26.7	34.5	27.6	27.6	25.7	50.1	20.8	44.1	53.2	24.2	26.0	46.0	51.8	10.7	41.5	29.5	42.5	31.3	34.8	18.1	58.0	27.9	8.7	7.3	25.8	39.0	12.5	26.6	26.2	33.8	18.0	47.5	32.2	15.1	36.7	33.3	35.1	24.1	29.3	29.7	25.5	39.4	27.3	41.2	11.7	96.4	35.7	7.9	12.9	24.3	23.1	18.5	14.1	46.3	39.1	26.9	16.8	26.3	60.0	68.4	44.5	68.1	29.8	48.3	42.1	50.4	18.6	26.3	36.0	37.3	32.2	25.2	28.6	26.7	17.6	56.4	22.9	27.0	53.1	22.5	64.8	48.5	43.4	94.6	19.8	58.1	30.7	9.9	31.0	10.7	30.2	37.0	32.8	46.0	38.3	36.5	51.8	41.6	40.0	35.3	2.4	29.5	41.5	50.4	42.5	31.3	30.3	28.5	26.5	33.3	24.7	28.7	26.8	25.8	34.0	25.7	74.5	70.7	129.6	184.7	179.8	58.8	52.5	91.7	92.3	127.4	94.2	11.8	341.3	182.4	160.8	11.3	131.9	72.5	163.5	167.6	430.8	137.7	117.6	99.2	94.4	209.7	44.5	117.9	92.7	99.3	20.1	100.7	131.1	108.0	161.5	140.4	72.8	190.4	101.7	83.4	166.0	37.5	97.0	115.4	266.8	286.5	194.0	219.0	115.0	212.0	191.6
SNRPE	Sm-E	ENSG00000182004	"Small nuclear ribonucleoprotein polypeptide E"	P62304	1	203861603-203870550	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA		75000				"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.87e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-3)"	21.0	30.2	19.3	27.6	19.3	41.0	39.4	17.2	18.5	25.5	28.0	14.5	23.6	20.2	33.5	33.0	25.5	22.9	18.8	18.9	16.6	17.6	24.3	27.1	16.6	39.1	18.8	21.4	41.0	39.9	11.8	20.9	23.5	21.7	23.6	23.6	15.8	39.9	23.2	22.7	18.5	19.6	24.1	16.2	23.7	22.1	26.7	16.6	52.2	22.8	38.1	30.2	27.0	21.6	19.1	29.7	9.2	15.9	24.6	21.8	15.8	50.5	30.7	60.9	31.0	14.0	26.5	40.6	35.5	22.6	34.2	32.6	36.9	39.4	53.2	32.5	21.8	33.2	35.0	50.5	40.6	42.9	29.9	44.3	33.8	44.0	41.8	21.9	67.7	33.0	23.1	12.5	36.8	35.2	29.7	31.2	53.9	64.8	31.4	29.5	52.0	69.0	71.6	79.2	33.5	32.1	46.1	55.6	58.7	41.5	31.0	32.7	46.4	25.2	54.7	61.3	58.1	40.4	54.3	19.8	25.2	42.3	25.7	66.1	25.3	37.9	99.7	24.8	38.5	29.5	7.3	14.9	9.2	15.1	15.9	21.8	19.1	19.2	17.5	22.8	16.9	21.1	20.9	5.6	24.6	15.7	29.7	17.8	15.8	19.3	19.3	17.2	18.5	16.6	17.6	18.8	21.4	21.7	16.6	119.1	108.0	190.6	209.9	216.8	43.6	66.7	211.5	124.5	146.7	122.1	13.7	416.8	359.8	339.4	15.6	193.0	78.8	46.7	408.0	479.9	195.3	185.2	108.7	227.4	265.7	54.0	156.8	120.9	164.1	28.0	219.5	164.8	163.6	256.1	231.7	98.2	365.8	98.2	154.2	312.4	37.9	97.0	165.8	194.0	231.8	223.7	188.2	136.4	293.3	242.6
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 114.2;Spermatogonia: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	8.2	10.6	19.9	12.4	5.6	9.4	25.7	18.0	13.5	12.1	4.0	7.7	11.2	19.0	8.3	9.1	6.7	11.0	7.5	11.7	8.9	9.1	5.1	8.0	14.2	9.0	11.0	9.0	12.1	30.6	24.8	8.6	15.6	10.1	11.5	9.8	19.2	9.2	9.7	15.8	10.5	11.6	6.1	11.1	12.2	24.2	4.5	8.8	13.6	5.4	19.1	13.7	13.8	7.8	10.2	1.9	1.8	1.6	2.3	1.5	7.0	15.7	13.5	15.9	7.9	12.5	4.4	8.2	11.6	14.1	11.5	14.5	15.9	17.4	19.2	7.3	9.1	8.4	11.6	15.6	18.3	13.1	6.7	15.6	12.0	11.3	14.4	4.1	9.4	10.6	7.8	22.2	21.0	46.2	32.9	7.8	8.3	16.1	14.5	12.2	8.4	6.2	14.1	11.3	16.0	12.9	22.7	20.8	13.1	8.9	15.3	13.8	17.3	11.7	19.8	8.8	20.2	4.8	29.8	6.2	15.2	5.6	5.2	21.4	24.1	14.2	8.2	7.2	8.9	1.9	1.8	0.6	2.3	0.5	2.3	7.8	1.9	1.5	5.0	4.9	1.7	1.5	1.3	1.6	0.3	10.2	1.4	1.5	10.6	12.4	25.7	18.0	11.7	8.9	9.0	11.0	15.6	4.5	17.9	20.3	22.0	45.5	51.5	37.0	8.1	20.4	6.7	14.8	34.9	21.6	8.5	5.0	23.2	64.2	40.9	8.4	23.3	24.4	9.8	35.6	26.6	10.4	4.2	7.0	39.7	35.2	25.2	7.5	27.6	29.4	17.9	18.6	19.0	17.3	21.1	32.7	7.0	31.5	9.3	4.7	51.8	25.5	114.2	132.8	52.8	4.5	14.9	27.3	22.4
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121546	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	8.9	11.8	14.6	11.1	19.4	5.6	16.1	17.0	24.3	13.0	13.9	8.5	9.9	6.4	12.3	16.2	8.5	9.8	12.0	11.5	14.4	17.3	11.1	8.4	9.3	13.1	15.7	15.8	12.2	9.6	11.6	14.3	9.1	14.4	15.9	16.6	8.2	10.6	15.3	12.0	12.1	9.0	18.2	15.1	12.4	11.1	6.3	13.4	8.8	12.5	6.6	11.9	10.9	14.2	10.8	9.4	1.2	6.1	11.3	13.1	8.3	11.6	8.8	10.5	8.0	10.9	12.3	7.1	7.9	5.1	10.3	6.8	11.4	9.8	2.5	13.3	7.2	9.0	1.8	12.2	4.0	10.7	4.6	14.6	7.1	25.9	14.9	8.9	6.0	5.5	10.2	7.7	6.6	6.9	10.1	8.0	6.5	8.6	8.3	10.7	16.7	8.7	10.9	10.3	3.3	9.9	8.5	13.8	10.7	10.9	5.5	7.2	7.4	13.8	3.4	6.8	16.8	7.6	4.2	8.1	8.7	8.4	14.9	4.7	8.3	5.7	7.3	6.8	11.7	4.8	1.2	5.3	0.6	9.0	6.1	13.0	10.8	11.4	12.3	6.5	8.5	13.1	10.5	0.3	11.3	5.5	9.4	13.1	8.3	14.6	19.4	17.0	24.3	14.4	17.3	15.7	15.8	14.4	13.4	17.9	5.3	4.7	6.7	4.7	10.0	8.4	0.0	1.4	1.2	10.4	0.0	6.7	13.3	5.2	0.0	10.5	5.5	0.0	4.6	4.8	9.3	5.0	10.5	2.9	4.4	11.1	11.1	5.5	2.5	0.0	11.2	2.6	8.5	1.8	7.8	5.2	2.9	10.5	17.7	8.5	5.4	25.8	8.6	0.0	0.4	7.9	2.5	10.1	10.5	4.8
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	45.3	27.4	37.4	42.1	38.3	69.5	43.5	42.6	39.1	36.4	41.7	32.9	34.0	25.5	37.2	31.8	42.9	40.8	27.4	37.5	33.0	28.1	34.3	36.9	32.3	51.8	35.8	27.0	53.9	31.3	22.4	47.2	37.4	38.1	40.1	46.6	30.1	30.2	33.0	29.2	36.2	35.8	43.1	31.9	36.4	35.2	27.2	36.7	67.5	35.9	46.7	67.0	49.6	38.6	28.0	73.9	12.9	38.0	37.6	37.6	53.9	52.3	35.0	61.8	47.2	23.9	18.8	38.2	37.5	31.5	63.3	48.8	41.1	37.7	88.1	27.1	41.0	41.4	41.6	81.1	59.7	67.7	41.1	49.9	52.9	27.8	46.2	29.2	70.9	44.8	16.6	20.3	41.2	46.1	20.2	48.0	53.7	63.7	37.4	45.9	40.9	87.1	67.2	65.1	61.6	36.8	77.8	59.2	52.8	44.8	43.7	47.8	45.2	41.7	41.0	56.7	46.2	41.5	76.3	31.3	32.4	47.3	32.4	56.3	36.9	54.6	120.8	27.8	66.1	44.9	12.9	38.0	11.5	32.9	36.2	37.1	28.0	31.1	34.5	73.9	24.0	31.4	32.3	3.7	37.6	24.4	43.7	37.6	53.9	37.4	38.3	42.6	39.1	33.0	28.1	35.8	27.0	38.1	36.7	187.6	233.6	318.3	350.5	417.2	149.0	207.3	150.3	167.3	258.2	118.7	51.1	416.8	308.4	279.1	130.6	291.5	222.5	70.0	281.9	659.0	372.0	205.6	389.0	176.1	317.5	93.8	319.4	203.1	270.2	235.9	196.2	343.3	317.2	322.0	216.3	322.7	247.9	247.6	161.9	198.3	123.9	200.5	442.5	331.9	315.7	389.7	439.9	330.0	297.7	236.4
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738321-141787922	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002866	Supported		Supported	Mitochondria		NA	NA		250000	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	41.1	52.5	45.4	40.9	52.6	41.7	51.6	26.8	44.3	41.7	42.4	33.9	38.7	36.9	45.2	58.9	61.0	37.1	36.8	57.8	38.6	38.6	55.2	83.4	31.0	56.0	42.7	41.0	45.2	49.6	40.7	44.4	47.2	44.4	38.8	44.8	34.1	41.2	39.0	62.9	42.4	40.8	45.5	36.7	50.7	44.6	38.3	33.3	62.9	45.6	67.4	54.7	42.8	38.6	42.6	41.2	31.3	35.9	36.3	48.7	40.8	39.6	46.0	41.1	51.7	18.3	29.8	37.8	28.6	27.6	36.6	41.2	48.5	45.5	62.0	40.6	24.0	60.0	29.9	47.6	50.0	52.1	29.8	49.7	30.4	34.6	42.8	36.2	89.1	24.2	28.0	34.1	38.3	54.0	26.0	44.6	39.0	76.6	26.3	50.0	58.2	63.1	116.4	90.6	64.7	57.6	36.6	37.4	80.7	47.9	39.1	37.0	50.9	33.5	44.5	44.4	32.2	30.1	39.3	32.1	26.1	25.2	40.2	75.9	47.4	62.7	111.0	53.5	80.3	56.9	31.3	29.1	26.6	30.1	35.5	44.0	42.6	48.7	40.2	36.8	37.0	45.1	48.1	7.5	36.3	35.9	41.2	46.4	40.8	45.4	52.6	26.8	44.3	38.6	38.6	42.7	41.0	44.4	33.3	95.3	94.9	115.3	144.9	103.0	51.8	257.7	158.0	105.7	114.9	143.1	39.3	266.1	296.8	270.0	118.1	112.7	85.6	46.7	306.8	254.8	138.8	122.4	145.8	187.5	221.5	41.3	92.5	95.8	119.0	35.7	127.1	153.1	99.5	206.4	126.8	92.4	270.9	108.7	116.3	344.0	71.9	97.0	135.8	228.3	170.8	113.2	218.9	139.5	153.1	201.9
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523518-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 151.6;Late spermatids: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA042324: AB_10794273, HPA075418: AB_2686749"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (8.34e-5)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.16e-4)"	"prognostic favorable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	7.7	9.3	5.7	5.5	9.0	8.6	8.2	12.1	7.9	8.1	6.9	10.0	7.2	5.5	10.0	7.8	6.1	7.9	6.0	8.6	5.6	5.9	6.3	7.6	5.7	5.3	6.1	5.1	9.4	11.6	5.2	12.8	6.4	6.3	7.3	8.0	9.4	7.0	9.0	10.2	8.9	6.2	7.9	6.4	5.2	5.8	49.0	7.0	4.6	11.8	4.6	5.6	6.8	7.7	4.2	3.5	0.3	2.1	6.9	5.2	1.9	4.8	1.5	8.7	6.1	11.9	11.8	2.1	6.3	4.8	2.7	4.0	2.8	4.8	2.1	2.6	2.5	8.1	3.4	10.2	8.1	4.1	3.1	6.0	5.9	7.6	1.8	6.8	5.0	6.4	2.2	2.0	3.1	6.4	6.4	8.7	7.4	3.4	6.9	11.0	1.9	2.6	2.0	3.9	2.3	5.3	4.2	4.6	0.8	5.5	6.0	6.4	3.9	3.4	4.7	4.4	1.6	3.6	3.0	8.3	6.2	6.1	8.0	6.0	1.8	1.3	2.1	5.6	8.0	13.5	0.1	1.8	0.2	2.4	2.1	3.9	4.2	3.6	1.8	1.7	1.8	5.2	2.8	0.3	6.9	1.6	3.5	2.4	1.9	5.7	9.0	12.1	7.9	5.6	5.9	6.1	5.1	6.3	7.0	20.8	8.1	4.5	14.2	15.0	16.4	6.1	20.4	12.0	13.6	8.7	5.9	11.0	8.3	7.6	151.6	11.9	5.1	0.0	7.4	5.7	9.2	11.9	8.1	6.8	7.5	23.8	5.2	4.9	7.8	193.4	16.7	7.5	20.3	4.6	9.5	19.1	6.4	3.5	15.2	5.7	22.0	19.4	7.6	33.6	11.3	15.9	5.1	8.7	9.7	9.3
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.9	9.6	4.5	7.5	19.9	26.9	14.6	13.7	41.9	90.5	101.9	15.2	10.4	3.7	8.7	29.3	30.1	7.6	5.1	10.9	18.0	30.7	4.2	16.6	7.6	8.9	13.8	8.5	10.4	17.8	7.0	16.7	5.9	9.9	10.8	6.5	9.0	22.0	16.6	7.3	6.4	10.8	6.3	5.8	15.8	5.4	12.4	4.5	11.9	11.2	6.3	6.1	16.1	6.2	41.9	6.7	6.4	10.6	9.5	18.0	10.6	15.5	8.8	37.4	54.8	3.5	13.7	7.3	8.3	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4	68.5	26.4	26.1	13.6	19.7	12.8	39.2	48.4	49.5	50.0	50.6	23.6	11.6	6.6	40.3	8.8	23.9	22.2	0.0	32.6	47.9	29.1	25.0	50.7	45.1	91.4	3.2	20.2	25.8	63.7	2.6	20.1	70.4	16.9	25.2	23.9	14.3	30.0	22.8	28.0	36.2	16.5	38.8	21.7	18.5	24.5	27.4	7.0	25.4	27.4	24.1
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"	"Low cell line specificity"	"Detected in all"											HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	15.2	7.1	17.3	16.1	20.6	29.3	10.5	16.9	16.5	14.1	14.7	4.4	16.9	13.9	15.1	25.5	13.7	6.3	16.6	21.3	19.2	17.4	13.7	21.9	8.2	10.7	20.3	22.2	14.2	18.0	24.4	16.8	15.7	21.3	11.6	18.2	23.5	12.6	30.9	18.9	31.6	25.6	34.0	21.2	18.2	16.0	18.5	23.0	39.2	8.0	21.9	21.1	22.5	15.7	15.7	17.5	6.3	24.6	18.9	13.8	11.2	24.4	23.5	14.6	21.0	27.0	42.5	23.2	24.9	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0	38.7	43.1	0.0	0.0	0.0	0.0	0.0	0.0	62.9	51.2	92.5	0.0	209.3	167.5	157.0	0.0	0.0	0.0	0.0	84.6	217.6	0.0	0.0	52.3	0.0	164.1	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	256.1	0.0	0.0	115.5	0.0	0.0	171.0	0.0	0.0	0.0	0.0	0.0	0.0	230.3	0.0	0.0	0.0
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.7	17.1	62.4	33.1	34.8	37.2	27.9	35.9	45.4	44.8	59.5	36.8	43.0	23.1	33.4	41.4	41.9	24.7	51.1	49.9	70.5	21.6	39.2	42.7	33.6	43.2	25.2	48.1	40.7	28.6	48.3	35.1	26.8	42.2	41.7	46.2	39.3	37.6	47.9	28.7	60.5	80.0	75.0	34.8	36.4	39.2	35.0	40.7	54.3	28.1	43.4	47.4	29.3	28.5	48.0	70.7	25.6	46.1	29.2	33.1	33.4	30.3	31.7	32.8	64.7	58.6	36.9	34.3	29.0	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1	104.2	49.5	141.2	176.9	375.0	93.7	54.1	96.8	83.0	78.5	179.7	60.9	228.3	407.8	216.2	44.0	153.6	150.3	46.7	152.2	246.7	239.6	215.1	91.1	181.0	182.5	82.6	136.7	118.4	134.8	20.6	120.3	156.9	200.8	294.0	123.6	118.9	175.8	178.5	120.2	378.6	73.5	109.9	205.0	172.2	119.7	371.1	175.4	191.9	139.7	207.2
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 115.4;Late spermatids: 129.6;T-cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	6.0	11.2	7.4	6.7	7.1	2.8	6.1	20.3	9.2	9.4	9.6	7.9	11.5	5.1	10.0	11.4	4.7	11.7	6.6	4.4	6.1	4.6	8.5	4.2	6.9	3.9	6.3	7.7	11.7	10.2	11.4	15.4	7.1	8.3	10.4	5.4	7.7	7.6	8.1	3.0	3.8	4.3	7.1	10.1	3.7	5.3	14.8	8.8	6.0	9.5	2.6	4.7	6.6	6.5	1.2	3.3	0.3	0.4	5.0	17.1	5.4	3.7	3.6	11.8	3.2	2.2	8.5	2.1	1.8	2.7	8.7	7.6	5.0	2.1	2.2	2.7	1.8	3.1	0.6	9.4	8.1	9.5	2.2	4.2	1.7	2.2	13.1	5.5	2.2	1.0	5.9	7.2	6.7	10.0	16.0	3.6	5.4	3.6	3.2	6.2	1.9	4.3	6.8	4.4	10.6	1.8	5.4	2.7	1.1	11.9	4.6	4.4	2.8	0.6	0.3	5.3	10.3	2.4	3.1	1.8	2.4	0.1	2.7	4.9	4.3	1.1	9.6	4.3	6.3	2.0	0.3	0.4	0.0	8.5	0.4	13.9	1.1	12.4	10.9	1.3	1.2	17.1	13.4	0.3	5.0	0.4	3.3	5.4	5.4	7.4	7.1	20.3	9.2	6.1	4.6	6.3	7.7	8.3	8.8	3.0	4.5	5.6	13.2	1.5	7.1	2.8	2.5	9.4	6.8	7.0	5.9	9.3	10.0	6.5	115.4	5.8	0.8	0.0	2.8	10.3	4.2	6.5	3.5	2.6	8.1	3.2	8.1	7.4	1.6	129.6	7.2	3.5	5.0	14.4	2.8	2.2	4.1	2.8	4.9	7.7	14.2	12.9	7.2	21.3	17.9	1.1	6.9	33.1	3.3	8.8
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719632-16765336	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	17.6	31.3	13.1	12.9	12.3	26.2	16.5	10.2	14.0	17.1	23.8	12.2	16.1	20.6	17.0	13.7	18.5	14.4	20.7	25.7	13.5	13.7	28.7	51.4	17.6	11.4	15.8	11.0	19.9	14.3	22.8	15.9	18.9	18.4	16.2	16.1	10.7	15.9	21.3	22.5	12.6	33.0	12.3	17.3	13.7	16.9	10.1	11.2	15.3	16.2	13.3	15.1	17.9	13.5	12.6	11.1	17.8	15.0	13.8	15.2	9.1	15.9	13.5	9.8	18.3	13.3	15.2	4.5	12.8	9.2	10.7	10.7	12.6	13.3	12.5	18.8	12.5	21.9	9.6	11.9	16.7	14.4	8.1	23.8	5.0	14.6	12.0	9.5	8.5	7.8	10.3	7.9	18.5	15.8	12.5	14.7	3.9	10.7	7.1	14.4	18.8	4.5	9.2	11.4	8.9	14.9	5.0	12.4	12.6	15.9	10.6	10.0	12.3	23.8	17.0	12.6	13.3	22.6	7.7	11.6	13.8	7.3	28.0	10.3	7.7	6.6	14.6	13.6	4.3	11.2	9.2	10.5	12.7	15.2	11.3	12.3	12.6	13.0	13.9	11.1	10.8	13.1	13.6	17.8	13.8	15.0	9.2	14.4	9.1	13.1	12.3	10.2	14.0	13.5	13.7	15.8	11.0	18.4	11.2	59.6	59.3	59.9	76.6	56.9	18.5	68.5	81.5	190.1	93.3	75.0	21.6	57.3	94.5	102.2	188.0	47.2	124.9	23.3	115.1	64.1	49.1	85.9	200.3	200.6	44.7	22.3	101.7	67.5	63.9	250.6	39.1	90.0	64.1	53.3	93.6	45.0	138.4	150.8	51.2	108.8	19.3	58.2	83.4	13.3	21.5	45.9	125.9	62.3	95.4	91.2
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		77000	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	32.2	24.2	40.4	23.5	26.6	31.7	25.6	47.9	39.5	43.5	43.2	39.6	21.3	76.3	34.9	46.1	34.6	31.3	59.1	47.5	76.3	26.2	27.1	68.0	29.2	27.2	22.5	83.0	29.3	25.9	27.4	49.7	51.2	23.5	45.8	22.9	68.1	36.0	50.2	35.5	38.8	35.4	38.7	31.2	25.8	58.3	64.6	32.4	35.6	51.8	38.1	30.9	33.3	28.2	19.6	25.2	24.4	51.7	42.0	29.5	24.1	30.9	57.2	22.5	44.4	50.3	27.0	50.2	41.0	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1	107.2	97.5	44.7	111.8	131.7	43.4	77.5	48.4	87.0	134.2	43.6	15.7	88.7	46.4	116.0	77.9	92.0	42.3	0.0	85.9	107.5	80.8	88.9	59.0	74.1	86.4	58.8	54.4	52.8	60.2	17.6	68.1	69.2	50.6	61.3	65.0	37.9	106.5	45.6	60.5	62.1	40.3	19.4	102.9	77.7	58.0	123.8	98.7	52.5	77.4	123.7
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877778-34888089	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	20.6	25.5	22.2	26.8	28.1	43.1	27.2	30.1	29.8	23.0	23.2	17.5	26.7	21.1	23.6	24.2	23.5	22.7	22.0	33.3	21.5	17.9	20.7	28.7	23.2	28.6	24.8	22.1	27.9	25.4	16.7	18.8	30.6	26.7	23.8	25.3	20.4	20.3	31.0	39.3	31.2	24.2	26.8	23.4	31.1	22.6	32.7	29.0	29.4	23.3	24.6	28.7	22.8	22.6	14.9	20.1	26.5	23.6	13.2	16.7	12.8	14.7	6.5	21.3	37.5	13.3	14.2	18.8	11.9	10.0	20.5	19.8	14.9	9.5	20.3	15.9	11.3	9.9	9.4	26.1	11.0	16.7	12.2	21.0	22.7	13.4	25.0	18.8	28.7	16.0	15.9	18.0	13.8	11.3	12.5	24.9	22.7	35.8	15.7	9.8	26.9	18.3	24.0	19.0	31.0	11.1	20.0	18.9	15.9	15.1	9.6	25.7	23.2	14.0	15.4	26.8	19.1	24.9	36.1	14.3	14.2	18.7	8.2	14.4	14.2	35.0	29.1	5.3	34.4	20.5	26.5	23.6	19.3	12.6	21.0	12.1	11.6	13.4	13.5	20.1	14.9	15.7	14.0	14.6	13.2	16.8	17.7	16.7	12.8	22.2	28.1	30.1	29.8	21.5	17.9	24.8	22.1	26.7	29.0	26.8	15.0	26.1	25.7	40.9	27.7	20.1	17.8	9.4	27.3	40.1	11.8	61.7	54.7	36.9	4.5	33.1	30.6	46.7	54.7	56.3	29.1	24.0	21.9	52.1	38.6	30.2	37.9	55.9	51.2	5.7	31.4	34.5	23.6	33.3	34.7	36.0	41.8	49.1	35.0	24.2	31.6	32.3	23.1	88.2	45.3	51.1	64.2	35.9	39.2	25.5
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA		110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.8	1.5	3.4	7.0	9.5	0.1	3.0	6.0	4.0	1.1	6.5	5.5	1.2	2.5	0.4	10.2	1.6	6.7	1.4	2.3	4.4	0.0	2.4	1.3	2.1	1.9	1.2	0.0	1.7	2.2	0.4	5.7	0.8	1.7	1.1	13.3	0.0	0.6	2.0	5.9	1.2	4.0	9.0	0.5	0.0	0.3	1.6	4.3	5.8	0.3	3.9	12.0	0.9	2.6	1.0	6.4	0.0	7.6	10.6	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9	23.8	29.5	66.8	38.2	66.3	4.1	5.3	35.7	8.1	17.0	5.2	0.0	3.2	5.0	68.6	0.4	41.7	52.4	0.0	65.7	73.1	29.1	47.1	26.5	9.7	45.6	14.3	16.1	26.4	22.4	0.0	12.0	40.0	21.9	144.3	54.7	32.1	71.9	35.1	9.9	5.0	3.0	6.5	44.0	0.9	0.7	66.9	4.0	91.4	30.7	39.7
TBC1D7	"dJ257A7.3, FLJ32666"	ENSG00000145979	"TBC1 domain family member 7"	Q9P0N9	6	13266542-13328583	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034748	Approved					NA	NA					"HPA034748: AB_10671232"	"unprognostic (9.53e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-3)"	"unprognostic (5.54e-2)"	"unprognostic (9.30e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.78e-2)"	8.8	11.8	14.9	13.2	14.3	21.9	13.7	17.5	19.3	10.7	14.7	12.9	10.0	14.2	8.7	20.9	15.8	6.4	10.4	30.4	14.7	13.6	21.2	16.1	13.2	12.3	14.5	13.5	7.6	10.6	7.5	14.1	14.1	14.1	12.9	16.8	17.7	11.6	10.1	13.5	12.4	10.5	10.1	12.8	11.4	9.2	12.4	11.9	19.4	7.8	14.7	14.8	10.7	10.2	8.7	23.0	23.5	12.0	11.1	7.6	5.6	6.6	6.6	9.5	9.7	7.4	4.3	6.6	2.9	3.4	6.4	7.2	13.3	6.0	4.6	20.0	4.9	14.9	5.4	6.4	7.5	5.8	7.2	7.6	12.8	4.5	11.6	17.3	8.2	19.6	5.8	10.7	7.9	5.1	6.4	10.6	14.9	14.3	6.2	8.0	10.8	10.5	19.9	6.4	8.3	6.4	15.7	4.1	19.6	14.2	9.1	18.5	8.2	7.4	14.6	80.5	19.9	14.1	4.9	7.6	6.6	8.2	3.6	4.1	14.8	42.9	21.9	6.2	8.7	13.3	12.5	12.0	14.0	6.7	10.2	4.3	8.7	5.7	5.9	23.0	7.9	5.3	6.4	23.5	11.1	7.2	22.6	7.6	5.6	14.9	14.3	17.5	19.3	14.7	13.6	14.5	13.5	14.1	11.9	11.9	15.2	14.0	8.2	6.6	6.1	22.7	10.2	6.7	6.8	15.7	3.9	36.1	28.2	14.9	6.9	7.9	9.5	23.3	12.6	18.5	8.0	10.1	9.2	13.2	21.5	9.5	8.6	9.2	15.1	3.8	4.0	20.6	10.1	18.0	18.8	6.5	17.8	17.3	4.9	39.8	8.2	12.9	7.2	12.8	33.5	7.9	39.2	8.7	15.7	11.3
TCAF1	"FAM115A, KIAA0738"	ENSG00000198420	"TRPM8 channel associated factor 1"	Q9Y4C2	7	143851375-143902198	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 187.1;Syncytiotrophoblasts: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011732	Approved					NA	NA					"HPA011732: AB_2668526"	"unprognostic (1.57e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.95e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-1)"	15.9	31.2	17.6	7.2	46.8	2.5	12.9	23.6	29.4	17.5	10.9	12.4	4.1	7.1	19.6	9.5	9.1	13.8	11.5	13.6	18.4	23.3	9.1	16.7	11.0	5.4	14.5	17.7	25.0	11.2	18.3	27.0	46.2	25.0	22.1	12.1	8.8	8.6	12.4	10.2	9.9	9.0	18.1	11.3	6.4	12.4	5.4	16.5	9.7	15.9	5.6	5.3	8.8	8.4	2.9	4.4	1.4	4.4	6.8	8.3	3.4	14.8	9.2	29.7	30.7	19.5	19.0	18.2	17.5	20.8	14.0	18.8	19.3	10.7	0.0	8.3	20.3	18.1	9.7	11.3	11.5	15.5	8.2	8.4	8.1	5.2	17.1	13.4	0.0	5.5	19.6	10.4	16.5	6.1	22.3	17.4	10.4	13.4	1.4	27.1	22.3	13.1	5.0	9.1	16.5	5.8	8.2	20.0	1.9	11.1	12.0	8.5	50.9	18.0	11.2	8.2	22.1	16.9	1.2	15.7	14.8	9.6	13.9	10.4	4.6	5.8	0.1	27.3	2.4	20.3	0.6	2.2	1.4	8.3	2.8	5.7	2.8	4.9	5.3	4.4	2.9	4.4	5.5	0.8	6.8	4.4	2.4	3.3	3.4	17.6	46.8	23.6	26.1	18.4	23.3	14.5	17.7	25.0	16.5	41.7	36.2	1.4	13.2	0.0	45.0	38.9	28.1	14.7	27.3	3.5	23.6	187.1	0.0	30.7	1.7	31.5	14.4	0.0	30.7	32.2	41.1	26.7	7.0	68.4	28.6	28.6	18.7	28.8	6.2	0.7	49.2	9.9	0.0	10.8	36.9	28.5	48.8	14.0	53.0	6.8	24.7	12.9	15.0	14.4	11.1	0.0	436.2	7.5	30.3	16.4
TCEAL3	"MGC15737, WEX8"	ENSG00000196507	"Transcription elongation factor A like 3"	Q969E4	X	103607451-103629690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 240.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045564, HPA058982"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (2.55e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.05e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (7.19e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.64e-1)"	14.8	36.9	36.8	11.0	34.2	9.9	18.3	30.2	47.4	35.0	15.5	24.9	33.7	9.3	42.8	24.9	17.8	27.4	17.9	21.0	33.7	40.7	16.0	5.1	12.5	7.3	43.4	29.1	49.8	22.6	28.3	35.2	13.5	40.3	45.5	7.9	11.9	21.9	55.4	9.7	8.0	8.9	48.3	44.0	18.5	14.5	15.2	23.6	0.8	17.7	4.0	6.4	44.3	23.0	9.6	9.7	4.5	6.9	14.7	12.2	5.3	24.3	2.6	6.6	5.4	23.1	11.8	0.2	36.6	17.3	16.5	22.1	0.0	2.4	0.0	4.5	26.2	29.5	9.6	4.7	14.2	12.1	0.0	1.2	1.8	10.4	0.0	22.2	0.0	8.1	15.2	4.4	11.7	16.7	23.5	11.2	8.5	0.0	7.1	22.4	20.3	1.1	0.1	2.9	0.0	7.0	8.5	4.2	0.1	7.8	4.8	10.2	8.3	1.6	2.1	8.4	3.4	10.0	5.6	14.6	8.7	4.5	17.7	11.2	7.6	3.5	0.0	21.5	0.0	19.0	4.5	6.9	3.8	11.1	3.5	12.2	7.3	9.7	8.8	7.6	9.6	9.7	11.8	1.1	14.7	0.3	9.7	12.2	5.3	36.8	34.2	30.2	31.1	33.7	40.7	43.4	29.1	40.3	23.6	14.9	45.8	12.7	75.4	23.0	50.9	40.8	28.1	71.0	45.5	71.5	17.7	2.8	121.0	35.9	2.5	42.8	1.5	0.0	34.1	1.9	50.3	86.9	94.6	3.4	51.9	17.5	41.8	54.6	26.4	9.3	145.6	40.9	15.1	39.7	22.5	116.7	22.7	8.6	240.8	25.8	28.7	25.8	47.6	2.1	1.5	14.8	2.3	16.0	4.4	34.1
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 434.9;Paneth cells: 431.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.2	18.6	25.1	25.7	12.6	15.8	20.4	15.2	20.4	19.4	10.1	21.4	27.9	16.6	35.4	13.1	19.6	18.0	20.8	27.4	20.6	20.0	15.0	31.5	16.0	30.7	19.4	17.1	17.0	15.8	14.4	18.1	24.5	20.8	17.9	9.2	22.7	12.7	23.8	19.6	14.4	20.5	12.2	20.8	17.0	23.0	26.1	25.3	20.4	11.7	12.9	32.8	25.8	17.2	15.1	17.8	18.2	14.8	12.4	11.0	23.1	13.3	39.1	29.2	10.2	40.5	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7	6.0	14.7	22.2	25.0	12.6	10.6	16.2	30.6	26.8	20.5	21.0	5.9	16.0	41.4	30.3	141.5	21.2	434.9	0.0	31.2	20.7	17.0	29.4	23.1	27.3	64.5	6.4	50.6	22.7	22.6	63.7	16.7	28.7	11.8	84.8	117.3	17.2	19.7	431.3	21.9	159.2	13.9	32.3	20.6	8.9	20.2	14.4	37.1	27.7	86.0	22.3
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 12.7;granulocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in many"		"HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.1	2.3	0.0	1.8	1.5	1.7	0.0	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.6	0.8	0.1	0.0	1.7	16.7	0.0	0.2	1.4	0.0	1.1	0.0	0.5	5.8	0.4	3.3	0.8	1.0	3.8	0.3	1.1	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.3	0.4	0.9	0.6	3.4	0.0	0.0	0.0	2.3	0.0	16.7	11.9	2.1	0.0	2.4	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6	6.0	5.0	0.8	1.5	2.3	0.5	1.6	12.7	0.0	4.5	0.0	0.0	1.3	0.0	1.3	3.9	0.6	2.2	0.0	0.9	0.1	0.9	1.1	18.5	3.2	4.0	0.0	2.9	0.0	4.5	1.7	0.0	2.8	1.7	0.0	1.4	5.0	0.9	0.0	0.4	1.8	2.4	6.5	0.7	0.7	1.1	2.6	0.7	2.5	2.0	1.3
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647786-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	22.5	45.0	51.0	17.9	71.8	35.3	18.2	70.1	64.9	20.9	12.6	30.5	12.5	12.5	21.7	28.3	13.6	17.4	17.2	30.0	44.2	68.4	21.5	19.6	17.2	28.4	47.5	53.5	30.9	16.7	37.6	41.8	12.6	48.3	23.4	13.0	18.9	15.5	22.3	18.5	15.1	12.7	18.5	39.4	22.3	14.0	24.3	32.5	20.5	26.2	10.5	27.6	16.2	15.6	20.4	8.9	40.5	12.4	17.1	23.9	7.2	6.5	6.2	14.0	10.8	15.9	16.7	4.4	19.9	17.2	17.0	12.7	6.8	7.2	33.5	26.7	13.4	8.4	9.5	13.8	5.7	14.5	12.5	20.0	17.0	9.6	15.5	20.8	22.9	24.4	14.1	16.2	13.6	21.2	18.8	11.4	22.2	19.9	14.2	19.4	19.3	27.6	29.3	7.0	8.5	14.4	31.4	9.0	27.5	12.6	6.0	34.0	20.5	25.9	6.1	15.8	5.3	14.0	22.6	12.4	16.3	8.6	14.0	15.2	59.4	51.6	47.1	17.1	15.7	15.4	20.2	9.1	40.5	13.1	8.0	16.3	16.9	20.1	21.6	8.9	20.4	23.9	15.4	14.6	17.1	12.4	8.7	18.6	7.2	51.0	71.8	70.1	58.6	44.2	68.4	47.5	53.5	48.3	32.5	44.7	58.4	95.8	104.6	173.7	401.9	88.0	58.6	66.9	62.6	89.0	88.4	58.2	114.4	66.6	5.3	93.4	31.5	373.8	44.4	27.1	105.9	83.9	122.3	51.2	54.5	267.0	93.8	76.7	65.2	15.0	107.0	85.4	114.7	101.0	37.4	289.1	40.5	40.2	122.7	55.7	146.1	135.8	124.6	277.5	103.3	169.9	102.3	207.5	28.1	86.4
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385022-58399221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 617.4;Late spermatids: 619.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	19.3	21.2	11.1	21.0	12.1	28.5	15.3	15.4	13.9	16.8	21.0	7.7	12.5	17.6	20.7	12.1	17.4	15.3	11.0	15.9	10.2	11.2	22.4	31.4	11.5	21.5	12.5	10.7	18.4	14.3	12.3	23.9	22.2	12.9	17.2	14.7	9.2	16.3	10.6	21.7	10.2	18.7	16.1	10.8	21.0	14.5	40.2	11.6	35.4	22.2	14.8	18.4	16.6	11.8	13.1	14.1	7.2	9.5	14.3	13.1	6.8	21.5	12.3	13.9	14.4	4.1	5.1	15.9	9.8	9.8	12.3	13.8	43.3	23.2	43.0	14.4	4.5	9.3	16.9	25.4	13.8	19.6	18.3	22.6	16.3	9.4	16.1	6.4	41.2	13.4	5.1	6.4	15.0	13.8	5.9	10.6	12.9	38.4	19.9	8.6	11.8	32.6	16.2	26.3	9.9	12.9	26.0	30.0	19.3	7.6	14.6	18.6	12.8	19.6	27.4	24.1	11.9	29.7	12.3	8.1	9.2	29.4	10.5	26.3	20.2	30.8	54.2	11.8	31.8	6.9	1.0	9.5	3.7	8.5	9.0	11.0	12.2	10.3	8.9	11.5	13.1	13.1	10.4	7.2	14.3	7.2	14.1	8.5	6.8	11.1	12.1	15.4	13.9	10.2	11.2	12.5	10.7	12.9	11.6	50.6	24.7	36.3	36.6	44.5	22.3	31.1	43.3	37.5	61.4	19.2	15.7	83.2	74.6	32.4	617.4	32.7	10.6	23.3	38.6	59.4	34.2	33.1	27.8	54.6	37.5	36.5	14.9	23.9	17.8	619.6	38.3	33.8	21.9	26.2	34.1	37.2	30.5	21.0	29.0	61.4	19.4	25.8	30.9	42.9	56.9	47.8	43.8	30.2	47.6	24.4
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	11.9	9.1	11.8	12.5	14.5	10.7	7.7	19.0	12.5	10.5	10.7	12.3	10.9	10.4	15.5	8.1	13.4	8.2	7.7	8.5	10.9	9.9	11.6	16.5	7.1	17.6	18.1	7.6	9.9	8.1	11.1	23.3	9.6	11.5	8.4	8.7	8.9	10.4	7.6	12.1	9.1	9.4	10.8	14.2	12.8	9.6	26.3	17.7	16.2	9.2	7.8	17.8	14.6	7.8	11.7	11.0	9.1	9.7	9.7	14.2	6.4	12.7	6.9	16.1	13.5	10.2	7.4	20.0	7.0	7.0	15.3	16.0	14.2	8.3	18.2	5.9	9.8	23.0	8.4	20.8	11.7	18.9	5.8	9.0	11.0	9.1	9.5	8.1	25.0	10.2	4.9	7.2	16.3	10.6	6.6	16.3	16.0	24.9	8.7	13.2	9.6	18.2	14.2	15.9	16.5	10.2	25.6	15.5	16.6	8.4	12.5	10.9	8.2	19.7	10.2	11.7	19.2	6.9	17.8	8.2	13.7	14.7	10.9	23.2	7.1	12.2	26.7	11.6	17.3	11.7	9.1	6.7	5.7	9.5	9.7	14.2	11.7	11.6	12.0	11.0	9.5	13.6	13.3	0.7	9.7	7.8	6.5	11.4	6.4	11.8	14.5	19.0	12.5	10.9	9.9	18.1	7.6	11.5	17.7	17.9	9.4	6.2	13.1	11.4	30.6	7.8	2.5	9.4	18.2	10.4	19.6	20.5	13.3	14.2	47.4	13.4	4.5	0.0	7.0	13.3	10.4	10.2	26.5	10.5	13.7	27.0	9.1	7.4	6.3	5.6	17.8	13.1	3.3	10.8	7.1	13.8	10.7	8.7	15.9	6.8	25.5	6.5	11.3	57.7	26.8	8.0	15.7	17.9	13.2	10.8
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972449-46003734	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	5.7	4.6	1.2	6.8	3.8	6.0	13.6	4.1	8.6	2.6	4.2	1.5	5.8	6.1	2.9	7.3	4.2	2.4	3.2	11.5	5.3		6.6	8.3	4.8	9.9	1.6	2.5	2.2	2.8	3.0	3.4	8.1	5.5	3.4	4.1	2.6	7.5	5.2	16.2	2.4	3.5	3.6	2.2	2.5	2.8	17.2	1.4	4.5	4.5	4.0	4.4	3.3	1.7	29.5	39.7	18.5	45.3	26.7	29.8	39.6	40.7	43.0	28.6	28.8	23.8	22.3	27.9	33.7	40.5	41.1	43.7	54.2	32.5	36.5	28.0	35.4	29.5	35.2	43.6	36.0	40.8	27.0	43.0	23.3	32.3	58.2	38.4	43.2	26.1	26.7	32.2	35.1	50.0	17.1	37.9	31.9	41.1	20.6	36.0	40.8	38.5	60.1	34.5	30.2	13.4	29.9	27.6	26.7	46.1	28.6	33.6	30.9	18.7	41.7	33.7	23.1	44.1	25.9	27.8	19.9	34.7	25.4	47.9	22.1	36.4	51.3	37.0	62.6	16.5	15.7	35.6	18.5	28.0	45.3	28.7	29.5	27.1	29.8	39.7	27.9	24.6	27.2	8.2	26.7	39.3	32.8	29.6	39.6											8.9	17.4	24.2	12.4	19.5	13.0	86.5	30.6	28.1	19.4	12.2	7.9	39.3	38.1	39.5	62.9	13.7	15.7	23.3	26.2	38.0	14.2	16.2	26.6	23.3	30.2	0.0	9.8	17.8	17.5	15.7	16.4	18.4	21.9	33.3	15.8	22.1	29.8	14.0	11.0	47.3	9.2	6.5	16.5	85.7	48.5	18.9	29.7	13.8	23.3	16.0
TIMM9	TIM9A	ENSG00000100575	"Translocase of inner mitochondrial membrane 9"	Q9Y5J7	14	58408494-58427614	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002932	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA002932: AB_1080287"	"prognostic favorable (8.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (9.89e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.41e-1)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.77e-2)"	22.2	20.8	23.0	14.6	33.9	14.6	25.0	18.7	25.2	18.2	22.5	16.4	19.5	19.7	20.3	29.7	23.3	18.8	19.7	18.7	20.8	19.1	23.7	21.4	14.5	25.9	20.2	20.6	31.8	42.8	11.9	18.9	17.5	22.1	19.5	15.0	15.4	29.1	20.3	33.5	17.8	13.9	25.9	20.9	18.5	20.2	21.4	22.3	20.1	25.2	24.8	19.3	26.6	17.9	17.6	14.3	4.0	10.6	16.5	19.2	7.6	25.2	21.6	17.2	16.5	19.8	36.0	23.5	24.6	13.0	18.6	16.4	21.9	27.3	33.8	26.5	14.3	17.0	17.7	22.7	23.8	27.2	22.7	12.9	17.6	14.6	24.9	49.7	28.2	16.9	28.5	30.4	18.1	36.9	30.2	19.1	17.4	28.3	21.0	18.7	42.8	26.2	35.2	14.7	37.9	38.1	22.2	26.1	21.3	24.7	22.5	22.0	13.2	15.6	40.5	42.8	20.8	28.8	16.6	19.0	23.6	32.4	15.6	26.6	14.4	14.3	31.0	18.5	27.5	27.6	4.0	9.0	2.2	9.4	10.1	17.4	17.6	15.0	13.9	13.1	14.4	19.2	17.7	0.9	16.5	10.6	14.3	15.1	7.6	23.0	33.9	18.7	25.2	20.8	19.1	20.2	20.6	22.1	22.3	29.8	18.3	54.9	38.9	31.4	13.2	16.9	22.9	17.4	21.6	14.0	21.6	67.7	61.3	33.7	21.8	22.4	19.6	0.0	46.4	80.4	30.9	38.4	35.8	26.1	53.0	4.8	24.2	33.7	38.6	24.7	68.7	33.3	32.1	26.2	36.7	19.3	38.9	24.6	48.4	88.0	21.4	19.4	36.3	66.9	15.8	34.6	61.4	30.6	54.6	36.6
TMEM14B	MGC1223	ENSG00000137210	"Transmembrane protein 14B"	Q9NUH8	6	10747759-10852753	"Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (5.45e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (5.45e-1)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	30.0	47.6	31.7	17.5	33.3	63.8	31.8	24.4	38.4	23.0	24.6	25.9	24.7	21.7	23.0	30.2	24.1	31.1	21.5	53.0	27.3	26.8	42.8	58.3	18.5	25.8	28.7	21.8	25.4	34.9	16.9	20.2	27.2	31.8	28.1	25.4	37.9	44.6	20.0	54.1	18.7	35.7	20.5	25.7	27.3	26.7	15.3	20.2	36.5	53.7	34.8	31.6	19.1	18.4	48.0	64.6	57.7	43.2	40.8	54.7	53.0	72.3	32.0	14.6	21.8	16.4	21.2	22.8	15.2	26.9	32.8	39.0	31.6	34.7	26.4	38.3	18.0	76.5	16.4	13.0	26.3	51.4	16.9	19.4	21.5	27.7	45.5	24.5	32.3	20.8	17.2	15.3	35.2	35.1	18.7	18.1	23.9	53.1	10.9	26.4	28.4	28.3	39.5	22.5	38.1	25.0	23.5	21.0	61.2	38.9	19.7	25.6	18.9	19.3	38.4	47.6	29.4	27.6	27.9	18.3	25.4	30.5	16.9	52.1	25.7	54.6	34.0	20.4	18.1	38.0	50.0	43.2	57.7	35.6	39.8	48.5	48.0	49.2	40.2	51.7	44.9	54.7	45.4	24.1	40.8	42.3	64.6	51.5	53.0	31.7	33.3	24.4	38.4	27.3	26.8	28.7	21.8	31.8	20.2	74.5	54.4	90.3	74.6	72.8	83.2	130.8	147.7	235.5	76.2	83.7	56.9	155.7	310.0	144.5	13.8	83.9	81.4	210.2	192.6	152.4	109.4	140.9	80.8	138.6	178.9	101.7	77.4	58.3	98.5	36.4	89.2	113.2	114.7	329.2	133.8	116.3	188.8	87.7	70.7	244.0	134.7	25.8	77.3	40.8	119.3	88.1	88.6	88.8	159.5	94.9
TMEM258	C11orf10	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	15.3	23.1	18.9	16.5	22.5	23.9	31.0	16.2	25.2	28.2	21.6	19.7	34.6	17.7	21.2	81.8	18.1	26.7	22.4	36.6	19.5	15.8	19.0	32.0	33.2	35.9	24.7	19.0	32.2	117.2	6.8	29.1	19.8	18.8	20.0	24.5	13.3	54.0	31.0	22.2	14.0	16.1	18.4	20.1	19.7	21.2	19.9	19.4	17.3	25.3	24.8	22.9	15.7	19.1	53.3	107.7	87.4	51.7	31.0	51.4	50.2	24.4	42.4	36.9	29.3	57.5	56.0	20.5	19.7	32.3	19.5	22.7	36.5	44.2	17.4	37.4	46.2	38.2	26.5	32.0	37.8	25.8	25.5	28.5	14.6	46.5	56.1	54.3	30.5	17.0	47.4	58.3	24.1	63.6	49.7	36.0	39.7	36.0	66.9	31.7	81.3	21.4	53.3	45.9	57.0	29.1	24.0	24.8	111.2	40.5	40.2	29.1	30.6	17.6	37.5	34.6	35.1	41.6	61.1	17.8	22.4	20.2	28.7	14.0	43.6	34.3	28.7	31.6	18.7	23.2	87.4	51.7	59.1	40.6	43.7	49.7	53.3	48.3	45.1	42.6	42.3	41.6	41.1	39.8	31.0	42.2	107.7	51.4	50.2	18.9	22.5	16.2	25.2	19.5	15.8	24.7	19.0	18.8	19.4	95.3	210.6	191.2	192.8	203.3	34.4	466.4	425.4	301.2	234.3	301.8	17.7	370.2	250.4	433.9	186.9	238.5	290.8	23.3	568.5	499.5	345.7	260.4	219.6	452.5	405.4	35.0	298.8	324.7	368.7	111.6	310.7	338.3	539.9	431.0	448.2	326.7	464.8	390.9	201.5	405.8	52.5	168.1	247.3	313.1	426.1	243.9	424.8	226.6	405.7	222.4
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 845.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17.0	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4.0	1.1	23.6	13.1	8.0	5.6	5.4	2.4	9.6	12.4	5.9	3.0	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4	6.0	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8.0	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16.0	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592642	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048712	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	33.2	37.8	34.5	31.2	39.7	28.3	44.1	24.3	38.5	26.7	34.7	13.1	28.3	37.5	28.7	32.7	36.9	25.4	31.1	39.6	30.9	34.7	44.3	45.3	24.4	37.4	37.6	26.3	27.4	83.8	12.7	28.8	19.6	32.3	25.2	31.2	17.3	49.6	36.2	51.5	24.1	34.8	34.1	23.9	38.9	31.2	33.0	27.2	24.5	36.3	46.1	37.8	26.7	35.3	59.1	43.1	14.0	33.9	40.2	54.9	50.5	55.1	64.4	38.2	34.2	43.9	43.2	21.1	42.1	27.0	41.1	44.0	68.5	22.9	37.8	34.6	39.9	41.9	19.2	33.9	50.2	42.9	53.1	53.6	33.2	89.6	98.1	36.1	54.4	22.0	37.2	27.6	45.2	44.8	19.5	46.8	42.5	80.8	42.5	41.7	44.2	45.8	47.9	66.5	46.6	40.8	38.9	31.9	55.6	47.0	34.6	33.1	30.4	21.6	29.5	30.7	33.9	20.6	63.8	31.7	28.5	61.0	44.8	64.9	16.2	46.8	63.1	34.9	47.1	43.8	12.3	32.2	14.0	43.0	33.9	52.7	59.1	53.1	47.7	39.0	49.1	54.9	50.5	3.7	40.2	28.5	43.1	42.1	50.5	34.5	39.7	24.3	38.5	30.9	34.7	37.6	26.3	32.3	27.2	26.8	30.2	43.6	35.9	99.7	4.4	20.1	58.6	49.5	53.4	43.6	11.8	22.0	68.0	47.4	168.9	45.6	41.0	0.0	110.0	44.6	34.2	29.9	44.0	129.9	59.4	1.6	17.4	52.2	57.8	127.0	32.5	43.7	59.1	81.2	44.0	6.7	88.5	35.1	29.4	80.6	6.2	0.0	32.3	51.5	22.8	128.0	21.1	47.8	53.1	48.7
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Cell line enhanced"	"Detected in all"		"HEL: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.2	7.6	10.5	9.2	12.9	11.7	6.7	10.5	9.9	8.7	10.2	4.7	4.2	13.4	6.1	10.5	7.7	5.5	12.4	11.9	12.3	11.1	6.8	45.2	13.3	5.9	8.0	12.8	12.5	9.4	13.4	12.6	8.9	10.9	10.6	10.2	7.8	7.0	14.2	4.4	11.4	23.6	14.0	6.1	7.8	11.8	9.4	6.0	11.7	8.7	5.2	8.4	10.5	5.7	6.8	12.4	5.8	7.3	11.1	9.6	9.8	5.0	7.7	4.9	7.8	14.5	8.9	7.4	4.3	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0	50.6	20.6	26.5	37.9	41.9	48.4	16.8	28.1	18.7	38.7	24.4	35.3	25.9	16.6	21.0	148.7	37.9	22.0	0.0	16.2	14.5	27.8	32.6	40.5	20.2	15.7	52.4	44.0	22.1	16.6	13.0	30.8	27.2	18.6	27.9	18.4	48.5	18.7	22.9	30.8	19.1	38.4	19.4	37.1	51.9	49.7	41.7	42.4	34.1	19.0	41.6
TPGS2	"C18orf10, DKFZP586M1523, HsT3006"	ENSG00000134779	"Tubulin polyglutamylase complex subunit 2"	Q68CL5	18	36777647-36829216	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 400.9;Late spermatids: 769.5;Spermatocytes: 273.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040596, HPA040617"	Uncertain					NA	NA					"HPA040596: AB_10796458, HPA040617: AB_10794037"	"unprognostic (6.51e-3)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.93e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.03e-2)"	"unprognostic (5.28e-2)"	16.3	21.1	27.6	10.4	31.1	22.3	20.9	15.2	38.3	18.3	14.9	26.0	7.2	10.2	14.8	13.1	22.2	21.8	16.7	21.9	23.9	36.0	18.5	10.1	18.4	13.7	43.8	19.9	27.4	15.3	15.9	8.4	13.3	42.1	13.9	16.1	21.8	12.4	14.3	5.5	17.5	12.8	18.6	35.7	9.5	12.2	72.2	14.0	37.0	19.7	10.3	23.7	22.3	15.2	13.1	13.3	57.4	16.6	14.3	27.0	15.2	29.7	23.5	45.7	39.8	22.9	25.1	19.2	32.9	45.0	46.5	56.4	11.3	21.5	29.3	23.0	65.7	29.4	29.7	37.6	46.2	55.0	38.2	12.8	20.5	43.0	30.5	23.6	26.3	18.4	33.4	24.1	41.3	21.4	44.8	55.2	30.7	29.5	21.8	60.9	17.7	41.7	15.5	27.6	13.2	15.4	31.3	42.3	35.6	51.2	29.2	32.2	35.3	49.4	12.9	14.4	41.8	24.7	25.5	30.8	47.0	17.4	6.6	26.2	27.8	26.2	34.7	37.7	21.5	26.1	57.4	13.4	25.6	14.2	14.7	14.0	13.1	16.6	14.6	13.3	9.5	12.6	14.3	4.1	14.3	16.6	10.6	27.0	15.2	27.6	31.1	15.2	38.3	23.9	36.0	43.8	19.9	42.1	14.0	41.7	25.9	27.4	33.2	25.6	18.1	14.8	53.5	60.2	46.6	24.4	7.9	68.2	61.3	109.7	400.9	22.4	15.8	70.0	68.2	126.5	48.1	17.0	18.5	17.4	70.3	7.9	19.0	32.5	26.5	769.5	33.9	27.0	30.4	69.5	19.0	19.7	79.7	24.6	46.3	33.5	21.0	32.3	28.3	273.9	121.6	34.9	26.2	29.8	42.2	32.1
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	66.5	33.2	42.5	27.9	36.0	47.1	42.9	57.2	52.9	75.9	57.3	61.8	62.4	50.1	46.6	64.5	30.5	61.7	42.1	60.2	81.0	34.7	22.9	61.7	32.4	41.6	28.6	90.2	82.0	35.5	33.0	66.9	51.5	34.2	116.7	36.9	46.3	53.9	93.7	39.9	70.2	93.1	95.7	113.6	72.2	60.2	29.5	71.0	54.8	50.8	29.9	56.1	43.5	57.9	56.7	59.2	80.8	107.9	87.2	66.5	48.1	63.7	89.6	45.9	75.4	67.0	60.1	68.0	105.0	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4	577.7	334.3	245.8	179.3	132.8	84.5	62.7	104.4	335.9	395.8	92.5	29.5	101.3	89.5	278.9	51.0	357.1	327.9	0.0	302.5	278.2	125.9	137.0	499.8	99.0	485.9	287.6	135.3	175.6	320.5	131.0	43.1	444.6	145.1	764.7	164.6	45.8	384.6	230.6	28.0	130.8	59.1	19.4	73.4	34.9	54.6	125.3	85.2	233.3	208.9	254.0
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155074	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 48.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA					"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.3	13.2	11.5	6.6	10.2	4.9	5.6	13.1	14.3	4.6	18.2	4.1	6.2	18.4	6.5	10.1	8.9	4.1	7.6	6.5	9.0	8.0	40.2	36.2	6.5	6.2	9.3	7.5	3.8	9.4	12.9	11.6	3.3	8.5	6.2	19.4	6.9	12.9	7.2	7.0	5.7	29.4	6.2	7.2	9.4	6.6	4.1	7.5	5.4	48.2	6.3	5.3	6.4	5.6	1.6	16.9	3.7	23.8	5.4	8.3	8.3	11.9	3.6	4.1	10.0	6.7	13.1	10.0	13.9	15.5	11.9	18.6	8.4	3.0	1.5	10.4	18.3	9.2	6.0	5.7	10.0	19.9	7.9	8.2	9.9	6.2	12.3	7.4	4.5	8.9	7.5	10.8	13.3	8.5	7.8	16.5	6.8	19.5	2.9	8.6	5.5	4.6	6.2	6.7	16.6	10.5	5.8	10.0	6.7	13.8	12.3	6.6	5.1	9.1	16.2	17.8	10.6	11.7	4.5	7.0	27.4	5.3	14.3	19.7	4.1	18.5	3.9	9.8	6.2	27.4	3.4	12.0	3.7	6.5	23.8	8.3	1.5	5.3	6.2	16.9	1.6	4.8	6.5	1.2	5.4	19.6	3.7	8.2	8.3	11.5	10.2	13.1	14.3	9.0	8.0	9.3	7.5	8.5	7.5	14.9	13.3	18.0	32.1	37.9	15.1	15.4	22.9	4.0	6.8	33.2	21.6	17.3	97.8	34.1	1.2	11.7	80.0	0.0	32.7	21.7	11.7	34.2	23.0	79.7	40.7	6.4	23.1	12.3	34.5	1.5	3.7	56.7	23.6	19.8	31.8	22.9	51.4	78.6	9.6	230.3	16.8	0.0	14.7	0.4	8.1	30.2	14.6	23.5	36.6	71.2
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.8	13.1	33.0	16.8	9.6	7.6	18.2	25.8	16.7	28.5	22.6	21.1	16.8	30.8	31.1	13.2	19.7	20.8	36.1	25.1	33.6	25.9	22.9	28.8	11.9	28.0	12.8	30.5	23.3	7.3	12.5	16.8	16.3	9.2	21.8	15.4	27.5	19.7	21.8	16.7	75.5	44.3	49.2	31.1	20.5	45.9	26.6	35.9	27.7	13.9	24.5	24.4	17.0	24.0	30.4	17.7	24.2	33.9	12.4	19.3	25.3	16.1	38.8	36.3	88.4	57.5	19.9	35.5	30.4	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1	59.6	114.4	168.3	155.0	229.4	101.5	57.6	104.4	62.9	102.4	66.3	184.6	157.7	61.3	105.4	125.7	154.8	106.8	233.6	94.8	196.4	163.4	151.8	191.8	78.1	151.9	68.3	218.4	179.9	244.9	31.1	118.2	213.7	128.2	216.4	142.0	89.2	85.0	121.0	110.3	42.8	196.4	103.5	173.1	132.6	147.0	227.8	179.8	202.0	165.8	133.4
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	"P0DI81, P0DI82"	X	13712244-13734635	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.5	6.4	15.6	9.5	13.7	9.5	9.4	24.1	16.1	10.5	9.4	10.1	8.8	8.2	16.4	8.7	8.5	9.4	7.6	6.4	14.4	14.2	10.1	10.1	7.8	16.1	10.4	13.0	11.7	11.2	8.9	19.5	7.2	11.5	8.9	9.1	10.2	8.1	8.3	4.9	10.3	8.8	16.0	11.5	11.1	10.7	4.3	11.1	4.3	8.8	4.2	16.4	8.1	9.4	11.2	10.7	13.7	6.6	18.5	16.1	9.0	6.8	5.3	8.2	20.9	6.3	4.8	3.3	6.4	5.5	5.1	5.5	4.5	8.5	11.6	10.3	5.3	6.7	9.0	10.8	9.2	7.0	11.7	16.2	8.6	12.5	3.6	4.8	11.8	16.6	6.3	5.2	10.9	14.9	10.3	4.5	8.5	10.8	20.0	5.2	11.3	11.6	15.6	7.9	5.7	9.5	11.4	10.8	11.3	8.0	5.1	8.7	11.6	11.8	9.5	8.2	13.0	11.8	7.9	5.9	5.2	4.6	9.2	4.0	10.3	10.1	14.5	4.8	8.4	5.2	13.7	4.9	8.6	16.1	6.6	16.0	11.2	12.8	15.8	4.3	11.1	10.8	15.5	10.0	18.5	5.4	10.7	15.3	9.0	15.6	13.7	24.1	16.1	14.4	14.2	10.4	13.0	11.5	11.1	8.9	6.2	22.8	8.2	13.5	14.5	9.8	20.4	4.0	11.4	8.7	11.8	12.7	18.3	9.2	12.6	7.7	9.1	0.0	11.8	15.8	11.6	9.3	9.2	11.3	10.0	19.1	11.6	11.1	9.5	3.8	11.8	9.5	8.5	9.0	14.7	8.3	15.9	17.6	10.6	20.2	13.6	6.5	11.4	4.5	3.3	15.4	15.0	27.7	13.4	10.5
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"B-cells: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.4	13.9	3.6	4.5	9.0	8.8	14.6	1.6	3.8	7.9	7.4	5.5	8.5	5.6	2.7	4.4	5.2	8.0	1.8	3.6	3.3	1.4	13.8	4.2	7.4	13.9	3.3	5.4	1.9	7.3	7.6	3.9	2.3	4.4	10.4	1.7	4.0	4.8	1.4	0.0	2.7	6.2	4.3	8.2	10.4	7.1	0.1	0.1	3.4	7.1	12.0	0.5	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.3	5.2	9.7	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9	23.8	43.9	100.5	47.4	13.3	0.6	3.5	22.9	17.4	29.6	43.6	0.0	19.8	14.9	19.1	0.9	42.0	39.9	0.0	13.0	17.5	17.0	35.9	34.6	14.8	28.8	0.0	17.4	27.0	84.3	2.2	18.4	61.3	10.1	49.5	29.9	0.3	17.8	40.3	17.7	62.8	0.7	6.5	18.9	0.2	0.2	8.2	17.7	36.2	23.3	78.5
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892643-919357	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.4;testis: 52.9"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 109.7;Early spermatids: 114.7;Late spermatids: 165.0;Spermatocytes: 66.2;Spermatogonia: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.5	0.9	1.7	8.6	1.2	3.4	1.7	0.6	1.6	1.6	2.7	0.4	1.4	2.4	1.6	1.9	5.3	4.9	2.4	1.2	1.4	1.7	1.3	0.8	1.5	4.7	0.6	0.6	2.1	1.0	0.0	1.9	2.8	1.0	1.0	4.5	0.4	1.3	1.0	0.6	1.4	2.5	2.5	0.7	3.8	1.4	52.9	0.3	16.4	0.5	8.8	6.3	1.1	1.8	2.7	2.3	0.0	0.3	3.3	4.8	0.9	19.5	22.6	14.7	20.8	1.3	3.3	15.4	20.6	10.3	32.8	30.8	21.2	13.5	17.6	14.8	12.1	28.5	14.3	31.1	14.7	41.0	26.3	24.2	12.3	42.5	15.4	0.3	19.9	7.3	1.4	1.0	27.3	11.9	3.4	16.0	14.2	18.0	15.6	22.3	13.3	19.3	16.5	16.1	11.5	19.7	11.6	27.3	32.8	8.7	10.5	14.6	15.0	31.3	11.3	6.0	13.3	21.8	9.3	8.1	17.5	21.7	14.2	22.9	9.2	20.0	19.1	10.3	22.8	19.0	0.0	0.1	0.0	1.0	0.1	0.5	2.7	1.4	1.9	0.3	2.1	0.6	0.2	0.0	3.3	0.3	2.3	4.8	0.9	1.7	1.2	0.6	1.6	1.4	1.7	0.6	0.6	1.0	0.3	0.0	1.4	3.7	3.5	3.1	0.6	0.2	0.0	109.7	4.5	0.0	0.0	3.6	0.0	3.1	114.7	1.4	0.8	0.0	1.6	20.1	1.9	2.1	5.7	0.2	6.2	3.2	4.1	3.1	1.5	165.0	2.0	3.2	0.0	1.8	2.4	0.8	1.8	1.5	2.1	1.0	0.7	6.5	0.3	66.2	77.5	1.3	2.9	4.3	2.8	2.0
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.7	7.6	9.9	12.2	8.3	7.9	28.2	10.9	19.6	16.5	16.3	7.1	9.9	14.8	12.0	12.2	10.1	10.5	10.7	9.2	16.9	21.7	6.8	6.7	5.7	9.4	15.3	26.4	9.4	5.4	17.9	7.2	15.1	6.7	9.2	25.6	14.9	41.5	14.6	11.0	26.3	13.4	21.2	27.1	8.6	16.7	16.5	31.3	10.5	7.6	10.3	15.2	14.3	11.4	27.6	10.9	14.4	16.6	4.7	11.0	24.8	7.5	17.4	56.5	38.6	22.6	10.5	14.8	23.9	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2	44.7	7.2	17.1	10.6	9.8	8.6	28.6	10.2	6.7	14.8	12.2	3.9	38.5	46.4	27.7	1.2	12.0	3.3	0.0	36.4	40.6	19.8	10.9	31.2	33.9	27.3	3.2	6.4	17.8	13.1	1.7	20.1	20.1	32.1	24.4	7.9	13.0	30.5	3.5	18.4	51.8	12.1	12.9	20.6	40.8	50.7	11.5	18.9	35.9	10.2	9.5
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753535-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 24.7;plasmacytoid DC: 51.3"	"Group enriched"	"Detected in many"	41	"B-cells: 24.7;dendritic cells: 51.3"	"Cell line enhanced"	"Detected in many"		"OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	20.8	24.2	17.7	7.6	24.9	6.2	25.6	10.7	33.0	18.6	23.6	3.0	21.0	25.2	5.9	12.3	8.8	5.7	16.0	6.8	14.5	21.7	3.3	22.2	53.4	14.8	12.0	15.9	2.1	55.2	4.6	48.0	19.0	14.0	15.1	29.1	8.5	49.1	19.2	4.1	4.7	27.8	5.9	3.6	12.9	31.3	3.1	3.4	3.6	13.0	7.1	18.5	12.1	10.6	24.7	51.3	0.9	0.0	0.8	0.0	1.2	7.1	5.9	7.6	8.0	0.9	0.0	2.1	15.4	2.5	0.4	0.7	20.8	11.1	0.2	3.9	5.5	1.9	11.1	8.7	12.9	3.4	0.2	9.4	3.0	2.4	2.2	2.1	0.2	0.6	0.9	5.6	0.8	0.9	4.4	4.7	3.2	10.0	0.0	0.4	20.4	0.4	0.4	5.3	74.3	7.2	8.2	0.0	7.4	24.0	13.6	34.3	5.2	2.8	49.6	0.7	11.3	92.8	0.8	0.4	0.2	2.7	0.2	5.0	4.5	0.1	0.1	7.1	0.1	10.8	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	24.7	0.0	0.0	0.9	0.8	0.0	51.3	0.0	1.2	17.7	24.9	10.7	33.0	14.5	21.7	12.0	15.9	14.0	3.4	461.6	65.1	58.0	67.1	37.8	65.4	15.8	38.2	25.4	58.0	27.9	7.9	258.0	6.6	62.2	1.0	52.8	83.8	46.7	178.4	88.6	42.3	128.5	9.2	25.9	34.7	14.3	103.4	9.8	15.8	1.8	0.6	4.3	30.4	105.6	362.8	2.3	99.4	94.7	0.7	0.7	7.4	32.3	10.8	0.7	16.8	34.6	168.2	8.7	117.0	107.7
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	16.4	12.0	6.0	18.0	5.1	4.9	11.2	13.6	13.4	9.7	7.3	14.6	17.5	7.2	13.4	9.6	4.0	11.8	9.1	18.5	4.4	18.6	13.2	10.6	21.2	16.9	10.4	7.1	12.2	6.1	9.6	6.5	23.3	7.9	15.7	12.9	11.8	10.5	7.3	49.8	9.2	10.8	8.2	47.2	16.4	10.6	4.6	22.1	19.6	16.5	12.4	9.7	9.3	18.4	13.7	4.5	23.4	10.4	13.1	6.4	25.6	7.6	13.1	7.9	5.6	5.3	9.9	16.3	9.6	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6	14.9	27.3	38.0	42.2	74.1	12.6	12.5	61.1	18.7	12.5	8.7	5.9	73.8	46.4	110.8	79.5	30.8	86.0	46.7	170.3	125.9	25.3	69.4	25.3	62.7	61.4	12.7	59.5	26.4	25.1	197.6	38.0	25.2	28.7	33.3	168.9	16.3	123.1	69.1	32.2	68.8	9.3	12.9	27.2	56.2	48.1	108.3	73.3	42.9	88.1	73.3
TTC8	"BBS8, RP51"	ENSG00000165533	"Tetratricopeptide repeat domain 8"	Q8TAM2	14	88824153-88881078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.47e-2)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.77e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.80e-2)"	5.8	27.0	10.9	4.5	16.9	6.7	13.4	10.0	18.5	11.0	8.5	8.3	13.8	4.8	15.5	24.4	9.1	18.2	11.6	8.3	10.7	13.5	10.1	12.3	6.4	2.9	7.2	11.9	49.9	9.1	13.6	43.4	5.0	13.5	16.5	7.4	21.1	10.1	14.6	2.2	5.9	4.8	12.0	5.6	5.4	5.8	38.1	6.1	1.5	25.0	6.8	4.7	11.8	6.9	1.9	2.5	13.6	1.9	2.1	0.8	0.7	8.1	12.2	7.9	7.0	14.6	20.4	6.1	9.9	15.8	14.5	9.1	3.6	15.7	3.5	9.9	14.7	8.8	12.0	8.2	8.9	14.6	3.2	2.9	2.2	4.4	4.3	11.9	4.3	0.6	12.5	10.6	9.6	8.7	14.4	8.0	4.8	7.8	4.3	11.0	15.4	5.2	3.9	4.0	4.7	10.7	1.5	9.8	2.0	12.6	13.6	8.4	49.4	15.1	9.0	9.0	5.2	21.3	3.2	4.6	10.2	5.6	9.1	6.8	0.8	3.1	1.7	15.3	1.3	4.0	13.6	0.8	5.1	0.6	1.1	0.8	0.5	0.8	0.6	2.5	1.9	0.4	0.6	0.8	2.1	1.9	1.1	0.0	0.7	10.9	16.9	10.0	18.5	10.7	13.5	7.2	11.9	13.5	6.1	3.0	7.0	0.5	6.8	7.8	13.3	4.4	10.2	26.8	11.4	8.7	37.3	8.4	11.6	12.1	5.1	4.5	2.6	0.0	5.5	7.8	8.8	4.9	0.0	5.4	5.7	19.1	10.4	3.7	2.4	5.4	18.1	5.5	6.8	0.0	6.8	10.5	7.5	0.0	23.7	12.3	39.2	19.4	7.6	11.6	6.3	5.6	1.5	0.0	6.2	2.6
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.6	33.3	34.3	29.0	42.5	23.7	29.7	30.6	38.4	32.6	21.8	24.6	27.1	26.5	32.3	27.8	31.0	31.5	26.9	39.8	27.6	14.4	37.1	20.6	40.8	34.0	54.0	24.2	32.2	27.9	36.1	33.2	40.6	30.8	20.8	27.1	45.5	38.8	23.9	31.2	35.3	24.1	17.3	26.5	25.5	22.5	47.0	44.8	38.9	27.7	25.3	16.9	23.7	28.1	27.7	25.9	29.0	24.4	40.4	21.3	14.0	28.9	44.2	47.3	42.3	26.3	41.4	29.5	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1	53.6	38.7	77.2	102.3	119.4	77.4	92.0	48.4	57.6	61.4	27.9	131.6	212.5	92.9	122.4	165.3	62.6	79.4	46.7	112.7	104.6	91.2	91.6	51.9	68.4	133.8	54.0	72.8	56.4	76.0	218.7	71.9	78.2	62.4	131.7	97.3	59.0	117.2	83.1	78.8	104.9	82.7	64.7	97.8	196.1	99.4	110.2	299.9	68.2	101.2	105.2
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	13.0	23.8	11.8	13.9	12.8	17.0	11.6	15.1	14.5	11.6	11.9	12.8	9.4	10.0	18.6	10.8	16.8	10.7	10.5	11.5	10.4	8.6	12.7	9.5	11.6	11.0	8.4	10.7	15.2	13.5	13.4	18.2	18.3	11.5	12.7	14.4	12.3	17.6	11.7	38.1	18.4	9.7	12.2	10.6	10.4	12.0	27.5	11.5	24.7	15.4	21.0	19.2	11.6	13.6	4.7	6.8	4.7	10.5	7.5	8.2	3.3	18.2	16.9	12.2	15.4	12.1	10.7	14.7	14.7	9.2	15.2	14.8	22.8	9.7	21.3	4.7	12.2	11.7	10.7	20.5	16.1	17.0	15.6	10.0	11.8	21.5	24.9	9.9	26.7	19.1	9.9	13.7	19.3	13.5	8.0	12.2	13.1	16.2	17.6	13.7	12.2	19.8	45.4	13.0	10.3	13.3	15.4	7.6	13.5	14.7	13.8	12.6	8.7	17.4	14.2	4.3	12.8	12.6	12.0	14.3	9.1	12.3	10.7	16.3	6.8	14.2	22.9	10.0	10.3	22.5	2.6	4.3	4.7	3.9	5.2	8.2	4.7	4.8	5.4	5.0	2.5	4.3	5.8	2.6	7.5	10.5	6.8	5.3	3.3	11.8	12.8	15.1	14.5	10.4	8.6	8.4	10.7	11.5	11.5	50.6	20.2	9.0	24.4	25.0	26.2	52.5	10.2	21.4	35.2	12.2	56.9	37.2	3.3	18.9	83.6	26.8	12.7	23.3	17.1	31.0	14.7	20.0	13.9	11.6	14.4	15.9	24.1	12.9	14.3	60.5	28.1	14.3	25.3	17.2	25.5	15.1	23.5	28.1	23.0	14.0	28.1	25.8	15.5	69.4	62.7	27.1	61.0	10.2	24.8	20.2
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Group enriched"	"Detected in some"	16	"Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RT4: 13.8"	"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	3.0	1.9	0.0	0.0	0.1	0.0	0.0	22.9	16.0	15.9	0.0	0.0	0.0	1.7	316.2	0.0	0.0	3.3	0.0	231.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	265.1	3.1	0.0	685.5	6.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352848	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 501.0;Late spermatids: 1092.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 63.8;Karpas-707: 55.2;U-266/70: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA					"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	18.7	17.3	14.6	47.1	15.4	52.7	28.2	19.1	13.6	18.8	25.9	11.3	24.4	28.0	19.5	18.4	19.2	18.0	19.9	17.1	14.4	14.7	18.7	33.5	20.4	52.0	17.0	9.5	17.2	46.1	11.5	13.6	27.5	13.0	22.9	26.3	10.7	42.1	33.2	12.5	11.3	36.3	17.9	18.9	45.8	24.4	17.7	14.4	42.5	17.6	16.4	47.7	21.7	21.4	20.7	23.7	15.9	17.8	6.4	6.4	6.1	8.3	2.9	8.1	10.3	8.5	11.1	0.0	13.3	11.8	8.2	9.1	4.7	5.2	63.8	7.4	13.7	6.9	3.4	5.3	7.7	13.5	8.9	8.2	11.6	3.8	7.7	22.6	14.5	7.6	8.4	7.7	6.9	11.8	11.1	18.4	7.6	9.3	55.2	9.6	5.1	6.0	11.2	2.8	5.9	4.2	23.9	10.5	30.5	10.3	5.9	4.1	8.3	5.6	12.4	12.3	12.3	4.9	32.3	12.3	4.6	4.4	8.1	10.2	62.1	30.8	17.5	9.1	10.5	7.6	10.3	6.6	12.3	3.4	11.1	4.0	20.7	4.6	4.2	6.5	13.4	4.3	3.9	15.9	6.4	17.8	23.7	6.4	6.1	14.6	15.4	19.1	13.6	14.4	14.7	17.0	9.5	13.0	14.4	14.9	33.4	95.3	52.5	22.0	31.9	8.1	30.6	22.7	18.2	19.2	27.5	69.3	43.1	55.4	501.0	59.9	55.1	0.0	88.1	72.0	50.7	96.3	24.3	37.6	70.2	22.3	74.2	98.8	102.2	1092.2	50.6	55.8	69.2	46.9	54.1	14.7	86.7	70.2	44.9	36.1	13.7	32.3	55.6	20.7	19.6	30.4	108.2	36.2	57.4	100.2
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 110.3"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.9	14.4	21.1	16.5	23.1	20.7	12.2	21.1	24.1	27.1	25.8	16.4	12.1	23.6	10.6	27.9	20.5	21.4	28.1	22.9	27.1	23.5	30.4	27.3	14.1	19.5	15.4	39.0	19.7	18.2	20.0	19.7	14.3	19.6	30.4	14.7	110.3	12.7	29.3	18.4	20.2	28.2	15.5	28.0	15.2	16.6	31.8	6.4	25.4	20.1	19.0	14.1	16.8	21.2	19.4	20.3	13.2	21.6	21.8	19.3	24.8	16.2	21.4	12.4	20.0	21.6	26.1	18.1	18.2	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6	101.3	71.0	116.9	138.6	111.5	51.2	50.6	107.0	125.8	95.5	68.0	15.7	283.0	167.5	270.4	53.8	105.0	174.1	140.2	335.7	335.1	102.8	131.4	126.9	137.0	262.0	65.2	120.8	104.3	125.9	41.0	80.8	163.0	119.8	326.4	95.3	76.6	339.4	136.8	97.6	204.5	41.2	103.5	83.5	134.5	117.6	113.3	311.1	142.4	115.8	190.0
UBE2Q2	DKFZp762C143	ENSG00000140367	"Ubiquitin conjugating enzyme E2 Q2"	Q8WVN8	15	75843285-75901078	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.28e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.92e-2)"	17.8	19.8	15.6	18.8	10.9	22.2	41.1	11.6	14.4	20.0	25.2	12.4	12.9	6.0	17.6	15.5	24.7	11.8	22.7	25.1	15.0	16.0	16.5	6.3	21.0	25.9	19.8	10.3	17.2	13.8	7.7	12.6	34.8	12.0	22.3	13.5	13.0	20.1	15.0	26.4	11.0	11.1	42.9	23.1	15.1	14.7	13.5	11.6	27.6	21.4	22.3	11.2	40.2	35.7	6.1	4.2	18.0	6.9	10.6	9.6	4.8	9.6	14.8	13.8	9.8	19.3	25.5	20.7	21.4	24.2	14.2	16.2	7.7	13.3	9.6	15.9	30.7	12.7	7.9	24.7	14.1	17.5	9.8	10.0	12.0	9.0	10.4	21.3	12.5	7.0	17.7	16.4	10.0	14.8	21.2	19.6	17.4	4.5	14.5	30.1	7.4	10.2	11.6	9.7	1.5	10.7	12.2	21.6	3.8	22.6	15.4	12.0	9.4	18.4	17.3	23.3	20.6	11.1	17.2	25.9	17.7	16.2	11.8	7.5	15.8	27.7	7.6	7.1	19.3	10.7	18.0	4.7	15.5	7.2	5.3	9.0	6.1	9.6	7.6	4.2	4.8	7.7	6.4	0.7	10.6	6.9	1.5	6.1	4.8	15.6	10.9	11.6	14.4	15.0	16.0	19.8	10.3	12.0	11.6	3.0	9.2	13.9	24.8	44.8	18.2	27.1	17.8	2.7	17.0	22.7	127.6	47.1	19.9	22.6	48.2	37.3	1.6	23.3	14.7	102.2	32.0	46.6	19.7	3.8	22.3	6.4	17.9	28.3	25.4	26.7	22.5	34.8	35.4	26.2	21.3	14.6	20.4	10.5	27.3	24.5	151.5	25.8	46.7	48.6	74.1	40.7	92.0	27.7	17.9	30.6
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1400000	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	27.1	22.3	19.0	19.3	18.8	18.8	34.0	35.7	19.5	36.3	34.0	29.0	14.5	40.3	27.3	29.2	34.9	15.3	37.4	27.2	41.4	11.4	18.5	22.7	15.0	22.7	18.9	55.7	21.8	15.0	21.1	37.1	21.3	16.8	27.9	19.9	31.2	29.9	35.8	22.0	31.1	15.2	18.5	16.3	26.2	25.9	24.9	29.3	26.8	23.6	22.2	18.6	37.0	17.9	15.2	21.6	17.5	15.1	31.5	42.7	32.3	39.2	50.5	19.8	35.9	40.0	24.6	23.3	26.5	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5	20.8	33.1	28.2	36.7	52.1	52.7	40.0	22.9	42.8	51.2	41.8	29.5	80.1	38.1	58.5	41.3	39.3	15.4	23.3	46.8	58.4	42.1	56.1	33.5	39.4	45.0	109.7	21.2	28.3	30.4	14.7	29.4	39.1	33.7	54.1	19.4	35.6	58.1	19.5	43.2	43.1	50.1	0.0	45.7	26.2	61.2	45.8	113.4	38.8	27.3	39.1
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.8	5.4	1.6	2.7	1.4	0.0	0.9	0.4	1.0	1.3	1.7	0.7	0.0	6.4	1.2	1.1	0.3	1.4	0.6	1.6	1.7	0.1	1.4	0.3	0.0	1.1	3.3	0.3	5.5	0.1	0.6	0.0	0.4	0.3	4.1	4.1	4.1	0.9	3.5	3.2	1.7	6.7	0.0	0.3	4.6	1.0	2.1	1.3	0.2	0.0	1.1	1.5	0.2	5.0	10.2	1.3	1.7	0.2	2.1	2.9	0.5	0.1	6.5	2.6	1.3	1.4	1.8	1.4	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1											3.0	5.6	0.0	1.7	0.8	24.4	5.0	0.0	17.4	3.4	3.5	5.9	3.4	8.3	1.0	0.3	5.8	0.0	0.0	0.0	2.1	4.3	1.1	1.1	0.8	6.1	6.4	3.5	4.9	3.9	0.8	3.7	2.5	5.0	0.0	0.3	29.9	0.3	0.0	7.8	12.2	15.2	0.0	3.9	3.6	6.7	0.4	2.3	1.7	0.2	0.4
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4, small subunit processome component"	Q969X6	16	69131291-69231130	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Proximal tubular cells: 76.7;Spermatogonia: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 88.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: AB_2678542"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavorable (9.05e-5)"	"prognostic unfavorable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favorable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	20.0	11.8	11.8	13.0	21.9	19.5	16.0	10.9	24.3	11.0	13.3	11.9	6.2	8.2	18.5	11.0	16.4	15.9	10.1	12.9	12.3	11.3	21.0	17.9	11.4	14.4	10.4	12.1	18.3	23.8	15.0	10.1	11.8	15.0	14.3	14.5	14.0	18.0	12.3	40.1	13.6	9.2	17.7	11.8	13.8	13.1	30.4	10.6	14.0	20.9	11.7	17.8	17.7	11.3	16.3	13.1	1.8	12.7	16.8	20.9	15.4	16.4	20.3	11.9	17.3	10.2	9.1	19.4	18.8	12.5	33.0	24.4	39.2	14.0	36.3	15.5	11.6	13.8	21.5	25.7	20.9	35.9	7.3	15.9	17.3	13.1	19.6	12.6	20.7	11.2	8.9	11.0	29.3	27.3	8.9	14.5	19.8	36.3	4.4	18.2	19.7	22.2	10.0	28.9	15.9	14.2	36.0	18.7	32.7	13.2	17.1	20.9	14.7	39.0	9.1	9.8	14.6	16.6	10.7	10.0	17.2	17.3	15.7	25.2	12.9	25.5	88.7	12.0	15.8	18.2	1.5	9.5	1.8	14.6	12.7	20.9	16.3	16.7	14.7	13.1	11.0	19.6	17.7	0.8	16.8	9.1	11.1	15.8	15.4	11.8	21.9	10.9	24.3	12.3	11.3	10.4	12.1	15.0	10.6	6.0	10.7	11.1	25.0	0.0	4.5	0.0	7.6	10.7	18.2	5.2	7.9	16.1	8.3	18.4	14.3	9.0	1.6	23.3	22.0	16.7	10.8	10.3	2.3	8.3	14.8	6.4	0.0	11.6	7.5	4.7	14.7	7.8	0.0	6.4	6.9	5.3	18.5	3.5	13.8	76.7	5.0	6.5	0.0	24.5	51.1	0.0	10.8	5.0	11.0	20.2
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093303-106194339	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		10000			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	12.3	11.7	15.2	17.3	19.9	20.7	20.1	23.0	20.5	14.1	13.3	11.9	27.6	9.5	16.1	22.3	15.6	19.2	16.2	20.0	17.0	18.2	40.2	16.1	28.8	20.7	15.1	11.6	16.3	17.0	18.6	13.4	37.9	19.6	16.2	15.6	14.7	11.6	17.6	18.0	11.5	9.9	13.8	22.9	19.7	17.9	19.4	10.6	15.0	26.2	14.1	19.1	21.6	15.3	11.6	7.5	11.2	9.8	11.9	34.1	15.1	16.5	12.5	13.2	10.0	23.6	17.6	28.6	18.3	17.2	13.0	16.2	24.5	28.3	3.0	22.8	18.9	29.2	8.4	5.7	15.0	14.2	15.9	10.0	9.1	5.6	27.5	9.3	7.4	10.1	11.4	16.6	13.2	8.9	15.1	13.6	5.8	5.3	7.3	26.8	11.8	8.2	15.9	15.5	16.0	16.8	15.3	10.0	8.5	83.9	15.6	4.4	4.9	13.1	11.8	10.8	18.6	4.4	23.6	12.2	14.6	15.3	11.8	11.3	9.0	12.4	4.1	14.5	16.6	26.7	3.9	9.8	11.2	8.8	8.0	9.5	4.9	19.6	14.3	7.5	11.6	25.4	17.6	2.0	11.9	5.3	5.4	34.1	15.1	15.2	19.9	23.0	20.5	17.0	18.2	15.1	11.6	19.6	10.6	83.4	72.6	12.3	22.3	14.9	9.1	15.3	22.9	29.4	61.4	82.0	3.9	59.1	43.1	42.5	42.6	18.9	11.0	23.3	21.9	60.0	31.9	15.7	28.9	12.9	29.5	7.9	6.3	8.6	19.8	11.4	14.1	25.4	13.5	80.2	14.3	10.0	25.7	10.5	12.0	16.7	6.8	19.4	20.8	11.9	59.8	11.5	20.6	30.5	19.9	15.5
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29, retromer complex component"	Q9UBQ0	12	110491097-110502117	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	39.2	34.9	35.6	28.5	38.5	44.4	32.6	23.0	46.6	30.3	38.0	24.4	29.5	33.6	31.5	50.4	51.2	29.0	27.5	35.9	31.5	30.9	62.2	51.2	31.3	33.1	32.8	27.8	27.6	31.4	18.3	31.4	34.5	46.6	41.6	43.5	27.3	34.1	40.6	64.0	25.2	36.2	47.3	28.9	43.1	34.9	17.0	23.8	29.8	38.3	32.9	38.0	51.5	27.4	40.5	67.4	52.7	79.9	41.7	46.0	72.1	31.7	31.3	29.8	21.2	33.5	33.3	23.6	30.3	31.7	30.6	27.7	31.3	27.9	29.6	31.9	29.9	28.8	30.4	39.3	28.0	32.1	35.0	31.5	36.1	39.5	25.7	29.2	43.0	31.7	21.9	24.0	25.9	28.7	37.6	53.4	37.2	34.4	27.7	54.8	16.0	33.6	61.2	17.0	28.4	40.3	22.5	30.5	41.4	50.9	47.5	32.1	17.0	34.3	30.5	37.9	26.9	41.5	33.3	30.0	26.6	17.5	36.7	35.3	18.9	26.4	34.7	31.0	41.2	28.3	43.9	57.6	52.7	31.9	73.2	35.1	40.5	40.7	37.3	67.4	31.4	37.4	36.8	38.5	41.7	79.9	45.3	46.0	72.1	35.6	38.5	23.0	46.6	31.5	30.9	32.8	27.8	46.6	23.8	71.5	94.8	96.1	135.1	127.5	39.4	250.4	84.1	64.3	80.8	96.0	25.5	160.1	245.4	200.0	41.5	113.7	129.2	93.5	157.1	168.3	132.5	122.3	149.1	158.7	359.0	39.7	79.9	84.7	157.7	66.8	85.4	222.9	168.7	333.6	105.3	60.6	179.9	147.3	99.3	306.8	85.6	155.2	150.4	117.3	94.5	151.2	149.5	101.5	149.3	145.2
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 118.8;SK-MEL-30: 143.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		53000000	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	11.1	10.6	7.0	40.7	10.1	14.4	11.2	14.4	27.9	31.0	39.2	6.9	10.0	12.1	13.5	34.3	7.6	19.0	20.2	16.4	20.0	19.2	5.8	7.8	8.1	8.5	118.8	22.2	12.8	16.3	23.6	18.0	37.5	9.4	27.8	8.2	24.4	32.1	13.2	21.3	7.6	10.4	7.0	11.4	19.3	6.4	11.0	7.7	15.1	9.8	18.7	10.9	8.6	7.5	143.4	9.4	19.1	28.2	18.4	3.3	7.5	33.9	7.5	62.6	31.8	22.5	37.4	17.3	30.2	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4	23.8	39.7	41.6	6.7	12.9	9.0	12.1	7.6	30.8	29.6	21.0	19.6	14.6	13.3	29.0	112.5	76.4	8.5	0.0	56.4	9.8	20.5	12.1	29.0	14.9	40.6	7.9	14.3	87.8	44.2	82.6	10.6	72.8	8.5	71.3	14.1	9.3	34.3	7.2	12.7	15.3	15.8	19.4	21.7	69.3	20.9	10.7	13.8	10.2	10.1	11.4
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.7	18.2	17.4	14.3	10.5	6.1	24.2	15.7	8.4	24.1	15.9	26.7	7.8	35.4	15.4	13.3	15.6	15.1	31.4	30.1	29.2	14.0	24.6	21.1	21.3	38.4	11.8	21.6	36.1	7.5	21.6	23.6	15.2	6.4	16.0	15.8	28.1	9.4	23.2	26.2	27.7	11.3	34.2	19.5	30.5	27.7	27.4	13.5	21.4	36.8	14.4	10.5	13.8	17.4	12.5	23.3	14.0	14.9	11.6	13.4	26.9	25.9	33.3	7.8	9.8	31.8	16.9	24.3	39.1	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3	11.9	10.7	30.3	21.0	18.4	11.9	21.5	12.7	37.5	9.1	17.4	23.6	49.7	21.6	29.8	2.7	9.8	7.4	0.0	11.8	45.7	9.9	13.5	15.1	13.4	41.0	7.9	15.1	8.0	19.6	2.7	6.9	17.8	5.0	10.8	16.5	8.4	20.0	7.0	8.5	24.4	9.2	12.9	13.1	12.3	22.6	16.2	38.1	17.5	21.3	22.3
WDR83OS	"C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668071-12671356	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	43.7	59.8	39.3	29.4	39.4	48.7	64.6	25.3	42.7	51.2	52.0	37.1	53.0	29.7	43.3	84.9	60.6	68.2	66.6	53.2	35.1	35.9	54.2	70.2	49.5	47.7	38.6	29.1	69.6	104.0	33.0	45.8	64.6	27.4	60.0	45.4	35.4	69.7	55.7	56.3	46.7	53.3	51.3	42.2	40.9	41.2	43.3	30.1	30.7	84.8	60.3	49.0	45.1	61.8	87.0	94.2	99.3	101.3	84.2	77.9	107.6	29.6	28.6	36.1	40.7	47.1	38.9	15.6	22.0	28.2	25.9	22.5	24.7	25.9	11.8	51.5	50.3	23.4	23.7	32.8	33.9	22.2	27.8	48.0	15.4	28.3	39.8	36.6	26.8	24.9	39.5	43.9	28.0	33.3	49.8	33.7	25.5	27.3	30.7	33.0	95.1	20.1	64.9	30.2	39.0	83.6	17.1	18.1	47.0	31.7	33.6	29.4	46.1	24.3	26.1	30.5	24.8	32.0	47.8	23.6	46.8	13.1	51.2	32.1	55.4	62.6	18.5	40.3	46.4	30.2	98.0	101.3	96.1	70.3	92.3	65.9	87.0	67.4	71.9	94.2	79.1	62.0	68.8	99.3	84.2	95.4	64.6	77.9	107.6	39.3	39.4	25.3	42.7	35.1	35.9	38.6	29.1	27.4	30.1	74.5	37.5	152.6	167.3	152.5	39.0	119.0	183.4	42.8	61.4	324.5	25.5	375.2	339.8	234.8	5.0	170.5	280.3	46.7	221.1	281.1	204.6	188.6	147.4	250.1	254.1	47.7	187.6	164.5	230.9	14.5	157.9	197.6	281.7	241.7	209.3	164.9	220.3	245.4	136.2	435.1	44.1	97.0	189.6	99.3	110.7	193.5	338.8	153.0	222.7	198.5
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	1.9	2.9	70.0	0.0	38.8	54.2	40.6	9.7	23.9	13.5	18.8	4.2	4.6	0.0	9.8	2.7	12.6	20.3	15.7	15.9	11.5	0.1	11.7	0.0	8.4	0.0	33.9	0.0	0.1	38.7	10.7	33.1	10.9	13.7	31.7	3.7	0.0	0.1	19.9	0.3	0.0	0.2	3.1	4.2	4.7	0.0	14.7	0.0	2.3	10.5	3.9	8.2	8.9	0.4	11.6	66.2	1.9	0.2	36.7	13.0	10.4	20.8	13.1	4.7	0.1	0.0	29.9	0.3	23.7	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3	44.7	28.8	2.4	56.2	37.7	7.2	27.1	35.7	115.1	44.3	26.2	131.6	119.4	8.3	69.5	13.0	20.8	38.0	0.0	52.3	3.0	31.4	26.5	5.7	10.2	20.8	12.7	9.2	34.4	10.2	7.0	30.2	10.7	18.6	12.6	24.7	7.3	63.3	28.8	51.9	30.0	160.2	38.8	20.8	0.5	0.7	26.2	46.1	1.8	33.6	39.6
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	27.2	18.5	22.9	29.4	26.1	26.5	34.4	30.4	20.8	28.2	25.5	53.9	22.1	37.2	27.9	21.5	36.2	19.9	42.1	37.1	40.0	33.8	32.2	53.4	28.6	59.6	35.3	54.3	32.8	21.6	41.2	30.6	43.6	24.9	30.2	23.2	51.0	29.2	29.4	24.5	34.6	38.8	43.2	36.0	46.9	27.7	31.0	34.6	35.7	33.3	27.7	20.4	19.2	26.3	43.9	36.0	18.5	39.6	25.9	31.9	27.6	19.5	36.2	25.5	42.7	53.2	28.3	38.6	27.8	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7	68.5	78.9	141.2	127.1	188.5	73.2	87.6	66.2	78.9	102.4	109.9	56.9	114.7	217.2	91.2	123.7	87.8	121.8	46.7	90.4	141.8	94.0	129.7	109.7	114.6	109.7	54.0	97.5	65.7	86.1	224.0	72.8	100.6	60.8	118.2	99.1	80.5	96.4	97.7	82.0	189.8	120.6	32.3	103.2	184.4	186.8	182.8	148.5	83.7	117.5	153.1
ZCRB1	"MADP-1, MADP1, RBM36, SNRNP31, ZCCHC19"	ENSG00000139168	"Zinc finger CCHC-type and RNA binding motif containing 1"	Q8TBF4	12	42312078-42326118	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 690.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (5.33e-7)"	"unprognostic (4.31e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.11e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (1.39e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.32e-3)"	"unprognostic (9.44e-2)"	20.0	26.0	42.6	14.1	40.7	19.7	21.0	23.0	32.0	15.0	19.0	19.5	18.4	16.5	18.3	35.4	22.0	18.8	18.8	27.8	39.4	34.7	25.0	26.4	13.2	19.0	49.6	23.2	21.3	27.6	14.5	24.2	15.6	33.3	21.3	15.2	11.4	20.5	18.4	54.9	16.2	17.0	29.5	62.3	15.8	22.1	41.0	39.0	19.1	23.0	24.5	17.8	25.3	13.5	31.3	31.1	29.8	19.8	23.8	38.0	15.9	20.6	14.9	16.2	21.8	15.2	20.7	17.5	17.2	16.4	11.4	10.9	11.8	24.0	12.8	36.6	15.5	18.5	12.8	9.7	15.5	18.8	35.7	18.8	20.0	13.2	12.0	20.0	22.1	18.3	14.8	18.0	11.9	21.5	31.4	14.9	32.8	18.6	26.9	17.6	12.1	31.2	28.0	18.7	50.4	17.6	17.5	31.7	27.1	21.0	10.8	17.5	17.2	23.6	16.3	22.9	19.8	39.0	19.2	17.3	18.9	24.0	18.6	16.5	27.2	25.7	49.7	28.4	79.3	9.0	29.8	15.1	28.5	17.4	18.6	22.4	31.3	24.1	20.9	24.8	27.8	21.1	23.7	11.0	23.8	19.8	31.1	38.0	15.9	42.6	40.7	23.0	32.0	39.4	34.7	49.6	23.2	33.3	39.0	56.6	58.7	78.3	67.2	40.3	35.6	140.6	81.5	141.8	72.8	54.1	23.6	124.2	184.1	116.5	690.7	66.0	43.4	23.3	175.3	117.1	78.1	70.9	51.0	92.3	97.2	36.5	46.7	56.4	69.2	82.7	104.4	74.0	67.4	120.8	73.6	71.7	129.2	42.1	94.0	166.9	43.4	71.1	78.3	386.8	136.4	36.0	72.9	62.5	76.4	65.6
ZNF101	"DKFZp570I0164, HZF12"	ENSG00000181896	"Zinc finger protein 101"	Q8IZC7	19	19668796-19683509	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.4;lymphoid tissue: 37.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 27.4"	"Cell line enhanced"	"Detected in all"		"U-698: 41.1"									"HPA023449, HPA055486"	Uncertain					NA	NA					"HPA023449: AB_2671211, HPA055486: AB_2682831"	"unprognostic (5.05e-2)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.15e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (1.11e-4)"	"unprognostic (3.15e-2)"	"unprognostic (7.02e-2)"	"prognostic favorable (4.37e-4)"	4.0	2.5	2.8	21.6	2.7	9.7	5.6	2.7	2.9	2.7	3.7	2.2	2.3	2.5	3.2	2.3	8.1	2.0	4.4	2.2	3.2	2.4	4.0	3.0	4.0	36.0	2.8	1.9	2.7	3.6	1.5	2.5	4.2	2.2	2.5	3.8	3.9	7.0	3.1	1.5	4.2	8.1	1.6	3.1	11.0	3.5	11.3	2.1	37.9	4.5	4.3	22.1	5.4	3.1	6.8	4.8	5.4	3.3	4.8	27.4	7.7	3.0	2.8	3.5	4.2	1.4	2.4	6.3	3.6	2.0	2.8	4.9	3.5	3.8	17.5	3.9	1.9	3.0	2.8	6.1	3.7	5.7	2.5	3.2	5.6	2.7	5.7	1.1	10.1	9.5	1.8	2.1	5.1	3.8	1.7	3.4	13.3	3.9	9.9	3.3	3.6	12.8	3.3	9.3	3.0	4.3	5.1	4.6	7.4	2.9	5.1	1.8	2.0	3.3	2.8	1.2	4.8	3.7	6.0	2.5	4.0	1.6	6.0	3.5	4.6	9.1	41.1	2.3	5.5	3.7	5.4	2.0	3.4	6.5	2.7	11.5	6.8	15.5	10.2	3.0	6.4	22.2	16.1	3.0	4.8	3.3	4.8	27.4	7.7	2.8	2.7	2.7	2.9	3.2	2.4	2.8	1.9	2.2	2.1	11.9	5.0	16.1	1.9	2.3	6.4	2.4	2.5	6.7	4.5	8.7	5.9	4.9	3.3	3.6	9.5	6.8	3.6	0.0	5.6	4.2	2.3	2.5	5.8	2.4	5.9	1.6	2.9	4.9	7.3	7.1	2.6	6.1	3.3	5.4	2.3	2.5	4.6	3.5	1.4	2.4	10.7	0.0	1.9	8.6	9.8	1.9	1.7	17.5	2.6	3.1
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560353-9584533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: AB_2682651"	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favorable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.75e-5)"	13.8	8.9	10.4	11.0	12.3	21.0	14.0	16.1	11.8	10.6	8.9	6.2	12.5	6.7	9.4	10.0	16.5	12.4	7.6	10.3	10.3	5.0	9.2	13.2	14.6	13.0	13.6	6.3	13.8	12.5	22.3	20.2	8.3	11.0	11.8	10.6	5.3	14.1	13.7	9.4	18.6	12.3	12.3	14.8	12.4	11.1	6.2	13.0	12.2	11.3	10.4	12.1	15.8	12.7	6.0	4.6	2.9	4.5	7.1	6.8	1.8	7.7	5.0	6.0	12.5	2.8	3.3	9.3	2.7	2.4	4.0	5.0	8.7	3.4	8.8	7.7	2.1	2.2	7.7	12.2	7.1	5.7	4.2	19.8	27.5	12.3	7.7	3.5	13.6	13.8	4.5	6.3	4.0	10.5	3.6	2.9	9.7	9.8	15.0	2.9	6.5	10.1	31.3	14.8	3.1	8.7	6.5	8.2	6.1	3.9	33.0	10.7	5.4	5.3	5.2	3.1	12.5	4.3	4.4	4.2	12.8	7.2	4.4	6.9	16.0	8.7	10.4	3.5	8.0	4.4	2.9	3.6	2.1	5.5	4.4	6.8	4.0	4.9	5.1	4.1	6.0	6.1	6.8	2.8	7.1	4.5	4.6	4.3	1.8	10.4	12.3	16.1	11.8	10.3	5.0	13.6	6.3	11.0	13.0	6.0	8.0	14.1	29.6	20.0	6.5	9.7	7.6	10.7	17.0	8.7	11.8	10.7	6.6	9.0	1.1	7.1	3.3	23.3	4.7	9.4	7.3	18.2	14.0	9.6	4.6	6.4	13.1	9.2	8.9	0.4	5.8	9.2	8.5	1.8	9.2	2.5	9.4	3.5	7.8	4.2	7.0	6.5	6.6	5.4	11.3	27.7	8.8	13.8	12.3	32.8
ZNF165	"CT53, ZSCAN7"	ENSG00000197279	"Zinc finger protein 165"	P49910	6	28080975-28089563	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 113.2;Intestinal endocrine cells: 51.6;Syncytiotrophoblasts: 66.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.7;GAMG: 14.0"					"Low region specificity"	"Detected in all"			HPA007247			Approved	"Nuclear speckles,Microtubules"		NA	NA			"Nuclear speckles, Microtubules"		"HPA007247: AB_2797217"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (9.82e-5)"	0.4	0.8	1.2	2.1	1.7	0.7	2.2	1.3	2.4	1.5	2.6	0.9	7.9	2.0	1.1	6.3	2.5	1.8	0.6	0.8	1.7	1.1	3.5	2.7	2.6	0.9	0.8	0.3	0.7	5.4	3.1	7.7	6.2	4.0	1.2	3.6	0.6	2.5	1.3	0.4	1.0	3.4	0.4	0.5	1.0	2.2	23.9	0.5	1.2	3.1	1.4	2.5	1.2	1.2	8.6	4.2	1.6	0.6	0.2	1.7	0.5	10.5	0.7	0.7	0.5	0.3	0.5	18.7	0.4	0.5	0.8	0.7	7.3	7.9	1.0	3.1	0.2	14.0	4.1	1.7	5.2	0.6	0.2	2.9	0.3	1.2	7.9	0.3	1.8	1.4	0.3	2.9	0.6	7.8	0.5	0.2	0.6	1.8	0.3	0.5	3.0	0.3	2.0	1.5	9.6	0.9	1.3	0.6	6.1	4.3	5.2	7.8	0.6	0.8	9.3	0.7	2.1	4.3	0.3	0.1	0.5	0.8	0.3	0.7	2.6	7.0	2.7	0.3	2.0	0.3	0.0	0.3	1.6	0.7	0.6	1.5	6.0	0.9	0.5	1.2	8.6	1.7	1.3	1.1	0.2	0.2	4.2	0.4	0.5	1.2	1.7	1.3	2.4	1.7	1.1	0.8	0.3	4.0	0.5	6.0	9.5	11.5	12.9	7.6	0.8	0.5	2.5	17.4	6.8	3.5	0.0	6.9	3.3	13.6	113.2	0.9	23.8	0.0	10.7	7.5	0.6	4.0	0.0	0.0	1.3	0.0	51.6	0.0	0.6	7.2	0.9	1.5	5.0	2.8	4.7	1.2	17.1	10.5	2.1	1.4	2.4	0.0	1.3	12.3	2.7	10.3	66.6	1.3	5.6	36.9
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	5.8	5.3	9.9	6.0	12.5	11.3	8.5	10.8	23.4	10.2	6.7	8.6	3.4	5.1	8.5	6.6	6.4	7.1	6.2	4.7	11.8	6.0	10.7	5.2	6.1	8.7	11.5	14.1	9.9	6.0	11.7	9.2	4.5	8.7	7.0	7.1	3.4	7.0	7.1	6.4	8.7	6.0	6.9	10.9	7.4	6.5	13.3	9.9	14.1	8.9	3.7	9.7	7.7	6.8	7.7	4.2	8.1	3.8	7.2	12.0	4.1	4.2	1.3	7.4	13.3	5.3	4.0	2.4	4.1	5.6	4.9	7.5	2.4	2.5	7.7	7.1	2.7	3.3	2.6	6.5	2.6	7.1	7.4	4.0	9.2	4.8	3.3	2.8	10.9	6.6	2.9	4.1	3.5	3.7	5.8	5.2	11.9	7.0	14.3	8.0	2.1	17.5	9.3	4.3	2.3	3.0	23.1	10.3	11.4	3.4	3.9	12.6	6.1	4.7	4.1	6.1	3.8	4.7	9.5	3.5	7.5	4.9	3.3	4.7	6.6	11.0	14.5	1.6	12.8	7.3	2.2	2.8	8.1	8.9	3.8	12.0	7.7	9.4	8.5	4.2	6.6	7.1	9.0	1.5	7.2	2.9	2.6	10.5	4.1	9.9	12.5	10.8	23.4	11.8	6.0	11.5	14.1	8.7	9.9	6.0	7.2	4.5	3.0	3.7	2.1	3.3	2.5	8.1	7.9	1.8	2.0	3.5	6.6	2.0	23.7	4.2	1.3	0.0	2.6	2.5	3.1	3.8	4.7	1.6	2.5	9.5	6.8	3.1	3.5	9.2	3.1	3.1	1.7	1.8	5.0	2.7	2.2	2.8	3.5	3.1	4.1	0.0	5.6	11.2	5.7	3.9	2.4	6.9	3.7	4.2
ZNF253	"BMZF-1, FLJ90391, ZNF411"	ENSG00000256771	"Zinc finger protein 253"	O75346	19	19865886-19894674	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (3.03e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.39e-5)"	"unprognostic (4.75e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.26e-3)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (4.88e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.54e-3)"	6.2	9.4	9.9	6.7	15.0	3.9	13.1	33.9	15.7	10.3	7.7	11.5	7.8	6.7	8.5	7.9	5.5	10.3	5.8	7.5	10.4	8.4	11.6	8.1	6.3	12.9	14.1	12.3	20.9	9.6	12.3	19.6	6.9	16.7	9.8	9.0	7.1	8.7	9.2	10.1	5.8	8.7	5.4	13.4	11.6	8.7	6.6	17.6	16.7	23.1	7.1	13.1	9.9	8.6	9.7	4.4	11.2	2.0	6.5	16.2	4.5	0.0	0.0	12.7	10.1	1.7	1.7	5.8	1.7	0.8	3.5	3.9	1.6	3.1	9.3	6.8	1.6	3.0	1.9	0.1	0.4	5.3	1.0	3.8	0.7	0.8	2.9	2.3	0.1	0.2	2.6	2.2	2.4	0.3	5.3	0.1	0.3	5.4	4.8	5.1	4.2	14.9	3.2	13.5	0.0	1.6	14.2	7.8	6.8	4.6	6.9	8.0	7.8	7.6	1.9	2.0	10.3	4.3	11.3	0.1	4.6	0.1	3.8	2.4	6.6	5.7	14.9	0.2	0.4	2.2	11.2	1.5	3.7	6.0	2.0	7.8	9.6	8.1	7.9	3.4	9.7	16.2	10.6	1.3	6.5	1.7	4.4	5.9	4.5	9.9	15.0	33.9	15.7	10.4	8.4	14.1	12.3	16.7	17.6	8.9	2.2	11.5	1.2	0.3	12.2	4.5	5.1	10.7	5.7	5.2	5.9	4.5	14.9	4.4	7.8	3.8	1.6	0.0	2.6	2.6	2.5	1.5	2.3	1.8	2.3	12.7	7.5	1.8	1.6	0.4	4.6	2.2	1.7	0.0	2.2	9.6	2.3	3.5	4.2	5.4	25.3	0.0	1.1	5.9	5.5	0.4	4.1	9.6	4.6	1.3
ZNF257	BMZF-4	ENSG00000197134	"Zinc finger protein 257"	Q9Y2Q1	19	22052452-22091480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 8.3;Spermatocytes: 11.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 6.2;NTERA-2: 13.6;RH-30: 7.2"															NA	NA						"unprognostic (8.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.99e-3)"	"unprognostic (9.40e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.62e-4)"	3.6	1.6	2.9	7.8	2.9	9.1	3.4	2.8	5.7	3.8	2.2	2.2	1.1	1.2	4.0	4.1	2.3	3.7	1.4	2.8	3.1	2.4	3.3	1.4	2.0	10.8	3.1	2.9	6.4	5.5	3.9	3.1	5.1	3.9	3.5	1.7	2.2	2.1	2.1	1.1	2.1	2.8	2.9	4.2	6.4	3.0	8.8	3.3	9.3	6.2	1.0	6.0	3.8	4.6	5.2	1.6	5.0	1.2	2.7	3.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	1.3	2.9	0.7	4.3	3.7	0.0	0.7	0.0	1.7	0.1	6.2	0.0	0.0	0.0	4.5	0.0	0.1	3.9	0.2	0.1	0.1	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	3.7	3.6	13.6	0.0	1.6	0.1	7.2	3.0	0.7	1.5	0.0	1.9	0.0	0.0	1.1	1.8	0.0	3.2	0.0	0.0	0.2	0.4	0.1	0.2	2.8	4.9	0.1	0.0	0.2	5.0	0.9	2.9	1.6	1.2	1.7	5.2	2.8	2.3	0.6	4.9	3.2	1.9	4.2	2.7	1.1	1.6	1.4	0.8	2.9	2.9	2.8	5.7	3.1	2.4	3.1	2.9	3.9	3.3	0.0	0.0	5.9	1.4	1.1	1.3	1.6	0.0	2.7	2.3	7.0	0.0	3.1	8.3	1.5	4.0	1.8	0.0	0.0	1.6	4.7	1.5	0.8	2.3	0.0	1.0	4.8	0.0	5.5	0.3	1.7	1.4	1.9	0.0	1.0	0.5	0.8	0.8	0.0	1.4	0.0	0.4	0.0	1.0	11.3	6.1	1.5	2.9	2.2	0.0	1.3
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.3	3.4	7.1	18.8	12.4	10.1	29.4	5.0	6.7	7.0	7.5	5.0	7.3	5.8	6.6	4.5	12.9	8.6	2.6	21.3	10.8	7.7	8.1	1.7	4.2	0.6	9.4	0.0	4.9	7.9	13.7	6.1	12.5	9.0	6.6	7.9	1.4	0.0	10.1	8.7	8.7	5.8	6.2	4.0	8.8	6.5	1.2	3.6	6.5	4.4	7.8	8.5	6.3	7.2	9.7	9.8	5.9	8.5	5.1	7.9	5.2	4.5	4.2	1.9	4.0	3.6	0.2	1.3	9.9	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4	11.9	6.1	3.2	10.0	4.4	8.9	5.5	0.0	12.0	10.3	7.0	13.7	10.6	11.6	9.8	9.2	8.0	2.1	0.0	6.6	10.6	6.1	5.3	5.8	0.8	8.0	6.4	4.6	6.2	8.2	3.2	6.4	7.8	10.1	3.6	2.2	7.4	6.7	0.0	9.9	13.5	9.7	6.5	9.2	22.3	9.8	4.8	10.2	10.9	4.3	6.9
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403904	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Ciliated cells: 17.4;Early spermatids: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050886	Uncertain					NA	NA					"HPA050886: AB_2681262"	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	4.1	4.3	9.9	1.7	11.8	0.5	6.4	7.0	15.1	7.5	3.3	3.3	3.3	1.6	6.4	6.3	3.6	7.9	2.5	2.4	8.1	4.9	5.6	0.7	3.6	3.4	3.5	9.9	10.1	4.7	6.8	4.6	2.7	6.5	5.5	3.3	3.4	3.9	7.2	1.0	3.4	2.4	5.7	4.3	4.2	3.0	8.8	4.6	2.0	7.9	0.4	3.1	4.4	3.5	3.7	1.2	0.3	0.1	0.8	3.1	0.7	5.0	0.8	3.1	10.7	1.3	1.8	6.3	1.3	1.0	1.8	4.2	2.8	1.1	0.0	4.6	1.2	3.7	1.7	6.1	4.7	3.0	0.0	3.7	1.9	0.2	1.0	2.1	5.4	2.7	5.4	6.1	0.3	4.8	3.7	0.2	8.5	8.2	0.0	0.3	1.0	6.4	7.8	3.8	0.7	3.4	0.0	0.0	1.4	1.2	2.0	1.2	5.0	0.0	7.1	0.6	5.2	1.2	4.7	0.6	5.9	1.9	0.3	3.8	3.4	8.0	0.0	0.3	0.5	6.3	0.3	0.1	0.0	0.9	0.1	2.0	3.7	1.5	0.8	0.0	3.6	3.1	1.9	0.2	0.8	0.0	1.2	0.2	0.7	9.9	11.8	7.0	15.1	8.1	4.9	3.5	9.9	6.5	4.6	0.0	1.4	0.0	0.4	0.8	2.3	0.8	0.0	17.4	4.5	1.8	0.0	1.8	0.0	1.1	42.5	1.5	0.0	0.0	1.2	1.0	1.5	0.3	0.0	0.0	0.9	3.2	1.7	1.8	0.0	2.5	1.7	0.6	0.0	0.0	0.0	3.3	1.0	0.0	2.5	1.0	0.7	0.0	0.9	3.9	2.5	0.3	0.2	0.0	0.9	0.3
ZNF429		ENSG00000197013	"Zinc finger protein 429"	Q86V71	19	21496682-21556270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004139			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004139: AB_2667147"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.96e-8)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.48e-1)"	6.3	14.3	12.0	4.8	13.1	4.3	11.2	15.3	14.2	10.2	6.7	12.3	10.3	5.4	7.5	12.4	6.2	10.8	5.6	4.9	9.6	7.6	11.3	11.1	6.4	9.0	12.6	8.6	14.3	14.3	17.7	24.1	7.4	12.3	8.7	8.9	8.4	9.3	8.2	5.2	11.0	6.2	5.7	9.1	10.6	8.4	11.3	12.9	7.5	16.6	5.1	7.5	7.8	7.5	7.2	2.7	10.4	2.4	9.2	9.5	2.8	0.3	0.9	5.2	6.1	3.6	3.7	4.7	2.7	2.0	3.8	5.8	0.6	3.3	4.4	7.6	1.8	3.3	1.4	3.0	1.2	7.5	1.3	3.6	0.8	0.7	1.6	1.9	4.6	1.8	3.3	1.8	2.3	0.7	3.5	0.2	7.0	7.2	0.9	5.9	3.2	11.0	2.9	5.3	0.1	1.7	5.0	2.9	1.8	4.2	5.2	8.6	3.5	0.2	0.2	1.8	10.8	6.1	2.9	0.6	0.5	1.1	4.3	2.0	0.7	3.6	5.9	0.3	0.4	1.7	10.0	1.8	8.4	4.9	2.2	5.3	7.2	6.8	6.5	1.6	6.4	9.5	8.6	10.4	9.2	2.4	2.7	4.1	2.8	12.0	13.1	15.3	14.2	9.6	7.6	12.6	8.6	12.3	12.9	26.8	9.9	1.5	5.8	2.5	13.6	4.8	5.1	17.4	14.8	7.0	5.9	7.7	18.3	6.3	27.6	5.0	4.0	0.0	4.4	6.1	5.8	5.1	3.5	5.4	3.0	3.2	6.4	6.7	2.1	3.9	10.6	4.3	5.0	1.8	5.6	10.0	5.0	6.2	5.6	10.6	7.6	19.4	5.1	14.2	16.8	1.8	5.7	10.2	5.8	3.1
ZNF43	"HTF6, KOX27, ZNF39L1"	ENSG00000198521	"Zinc finger protein 43"	P17038	19	21804949-21852125	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.5;MOLT-4: 22.9"									HPA050271	Uncertain					NA	NA					"HPA050271: AB_2681070"	"unprognostic (9.25e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.47e-3)"	"unprognostic (4.45e-3)"	"prognostic favorable (3.16e-5)"	"unprognostic (2.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.43e-3)"	12.2	11.1	8.7	10.0	11.8	14.8	12.9	15.7	10.8	13.8	7.3	6.6	9.1	5.4	10.6	14.1	7.2	11.3	6.2	7.3	9.0	8.8	11.5	2.4	8.1	12.2	13.2	9.4	18.5	8.0	12.3	15.8	7.9	14.6	11.7	8.9	6.4	8.8	8.8	6.6	10.6	8.3	7.4	16.7	15.7	7.6	15.9	12.5	26.0	13.1	6.2	11.0	10.7	8.5	14.4	5.9	17.2	3.3	5.8	13.9	2.4	0.2	2.1	16.5	12.2	1.6	4.0	6.5	4.0	1.8	5.5	7.6	0.2	2.2	3.6	4.4	2.4	4.8	0.3	0.2	0.4	9.2	0.4	3.9	0.1	0.7	1.7	0.9	0.1	4.5	3.3	0.6	5.5	0.2	1.4	1.1	13.8	0.2	0.7	4.0	2.4	22.9	5.3	10.9	0.3	3.3	13.4	6.6	3.8	3.5	11.0	10.1	7.9	0.1	0.0	1.3	8.0	6.0	3.3	0.2	0.4	0.5	3.5	4.1	0.9	6.2	6.3	0.2	0.5	0.5	17.2	3.3	4.1	6.6	3.3	6.3	12.3	8.7	7.1	3.0	14.4	13.9	9.4	3.4	5.8	2.7	5.9	5.4	2.4	8.7	11.8	15.7	10.8	9.0	8.8	13.2	9.4	14.6	12.5	11.9	10.0	11.1	7.8	1.8	16.1	9.7	7.6	9.4	15.9	3.5	9.8	8.1	14.9	9.6	27.1	9.8	2.0	23.3	8.4	6.5	4.9	7.8	15.1	0.2	4.0	7.9	10.9	12.9	2.7	6.2	13.0	4.3	1.7	3.6	4.8	10.4	6.4	3.5	8.9	5.6	8.6	6.5	2.8	20.4	17.2	1.8	4.9	13.8	6.6	4.0
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	9.3	11.1	17.7	8.4	16.2	2.7	14.1	39.5	16.1	13.6	10.4	17.2	11.4	5.1	18.8	18.8	5.9	17.3	8.2	11.9	14.2	8.2	11.2	7.5	10.4	11.8	17.6	15.5	24.0	7.6	22.1	29.2	9.8	16.2	13.6	9.3	11.2	8.3	11.4	3.3	8.7	9.8	16.3	16.2	14.9	8.8	13.7	19.8	10.7	14.0	3.4	10.3	10.2	11.3	12.5	5.3	18.9	4.3	14.2	15.8	6.2	8.7	4.7	9.3	11.3	5.5	5.0	2.4	5.3	11.0	8.0	6.8	2.3	1.0	7.1	6.3	7.7	10.9	3.1	5.6	5.0	10.2	11.4	7.5	9.6	7.8	3.1	9.8	8.4	10.6	10.5	9.1	9.0	11.2	6.8	6.7	10.7	7.0	25.2	5.0	0.0	11.4	26.6	15.1	1.5	7.8	5.6	11.3	9.6	4.9	12.3	10.5	8.8	10.4	1.7	12.5	14.2	7.5	6.4	5.6	14.7	3.3	12.0	8.0	2.0	0.0	6.9	2.6	5.3	9.2	18.9	3.4	7.5	9.1	3.2	12.0	11.9	9.6	9.6	5.3	12.5	15.8	12.7	1.9	14.2	4.3	4.4	8.4	6.2	17.7	16.2	39.5	16.1	14.2	8.2	17.6	15.5	16.2	19.8	3.0	3.5	6.2	5.8	3.4	26.6	7.1	10.2	6.7	3.4	3.5	25.5	5.9	1.7	5.9	7.0	10.5	1.7	0.0	2.7	3.8	8.9	4.1	2.3	2.1	4.2	25.4	2.9	12.3	3.8	1.8	11.8	5.7	3.3	5.4	3.7	25.1	2.8	2.9	12.7	2.4	27.1	6.5	11.3	15.7	34.5	2.6	2.4	10.1	3.8	2.2
ZNF561	MGC45408	ENSG00000171469	"Zinc finger protein 561"	Q8N587	19	9604680-9621399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (6.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.63e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (9.21e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.27e-3)"	"unprognostic (2.85e-3)"	11.7	11.7	7.5	9.1	8.8	7.7	14.6	11.2	8.2	14.5	11.5	10.4	21.9	6.6	18.6	14.9	21.5	16.3	11.1	9.1	7.0	6.4	11.3	10.7	10.8	13.4	9.6	6.2	18.1	16.9	13.1	18.3	8.8	7.4	19.2	11.4	9.6	13.3	15.9	10.3	15.7	10.6	22.2	8.5	10.4	11.6	7.7	11.7	16.4	20.6	11.7	12.2	26.1	14.3	7.2	6.6	9.3	8.5	2.7	10.9	5.7	7.6	3.0	17.0	13.3	14.8	17.6	15.3	10.0	13.4	12.5	14.2	5.6	3.4	6.8	7.4	9.9	7.3	4.3	11.4	19.2	13.1	9.5	12.1	8.6	6.4	9.7	8.6	11.3	8.7	11.3	30.3	9.3	12.2	20.0	15.7	5.0	9.9	9.2	15.6	3.6	4.8	11.9	14.1	6.4	9.6	5.7	8.5	7.4	11.4	28.1	10.9	11.0	0.2	6.2	7.8	17.3	7.9	7.5	4.9	13.6	4.7	9.6	9.7	11.2	15.7	9.4	6.7	2.9	9.1	5.0	8.5	9.3	8.5	8.2	10.9	4.8	6.6	7.6	6.6	7.2	9.6	7.2	5.5	2.7	4.2	5.9	6.3	5.7	7.5	8.8	11.2	8.2	7.0	6.4	9.6	6.2	7.4	11.7	0.0	6.5	5.1	21.6	12.2	9.2	9.0	7.6	28.1	9.1	14.0	5.9	6.9	3.3	10.1	5.2	7.1	6.9	0.0	5.7	6.5	5.6	10.8	7.0	6.4	9.6	9.5	10.9	10.4	10.3	5.2	10.6	7.0	3.3	5.4	6.7	6.0	7.4	7.0	12.4	6.8	11.0	6.5	5.6	7.2	9.8	19.6	5.4	7.5	6.8	25.5
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336245-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.7"									"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055771: AB_2682914, HPA078134: AB_2732372"	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	2.3	4.8	7.9	2.1	11.9	0.8	5.5	11.0	9.7	5.5	3.0	6.9	3.3	1.5	5.1	11.7	2.1	7.4	4.3	4.2	7.6	7.7	5.9	1.0	3.3	2.6	7.5	7.2	14.3	2.9	7.5	6.8	4.5	10.0	7.6	2.9	5.7	2.2	4.1	1.9	1.6	1.8	4.4	8.5	4.1	2.7	18.1	7.3	3.6	7.7	0.2	2.1	3.6	2.4	3.6	1.5	4.0	0.5	2.5	4.8	1.6	0.2	0.0	6.0	4.9	4.0	3.4	4.6	1.8	3.3	1.1	3.3	0.0	0.4	0.4	3.7	0.8	7.4	0.2	0.0	0.0	2.8	0.1	2.9	0.1	0.3	0.2	4.8	0.0	1.5	4.6	0.1	1.2	0.2	2.9	3.4	3.3	0.3	0.2	5.4	1.2	3.1	0.9	5.7	0.0	0.4	2.2	4.5	0.6	2.1	4.3	7.5	4.3	0.1	0.4	1.8	8.9	3.6	2.6	2.7	0.3	2.0	0.1	2.3	0.2	11.7	0.0	0.0	0.1	2.3	4.0	0.5	1.1	2.9	0.1	4.4	2.5	2.4	2.3	1.4	3.6	4.8	2.0	1.4	2.5	0.1	1.5	3.2	1.6	7.9	11.9	11.0	9.7	7.6	7.7	7.5	7.2	10.0	7.3	0.0	0.3	0.0	0.8	0.0	2.9	2.6	2.5	2.7	3.4	3.5	3.9	1.2	5.0	1.6	28.1	1.1	0.0	0.0	0.0	1.4	0.8	0.9	2.3	0.0	0.5	0.0	0.0	0.6	0.8	7.0	0.9	0.0	1.7	0.0	0.0	3.8	0.2	0.0	1.1	0.6	2.4	6.5	0.4	5.0	2.3	0.3	0.6	0.0	0.4	0.3
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favorable (3.91e-4)"	"prognostic favorable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	10.6	28.6	11.9	11.1	10.8	6.4	10.4	11.3	17.1	14.6	9.2	11.8	7.3	10.1	15.3	10.9	7.8	12.5	13.0	11.4	13.1	8.7	10.9	10.4	13.9	12.4	9.5	17.9	25.6	16.0	17.2	12.2	15.2	13.6	11.0	9.1	11.8	9.7	11.5	22.5	6.2	9.3	19.2	12.6	14.8	10.1	12.1	9.5	14.6	15.6	8.1	13.6	12.7	12.5	1.2	4.7	9.7	5.0	6.4	4.3	2.9	3.1	4.0	8.1	13.8	7.3	2.0	5.8	7.1	5.1	3.8	2.5	9.1	8.0	5.4	10.5	6.7	7.1	4.8	2.9	4.9	1.3	13.8	5.1	9.7	7.3	2.2	7.6	11.5	13.6	3.1	7.2	2.8	6.0	6.5	3.6	8.0	9.3	5.6	3.6	3.5	4.5	4.0	1.7	3.1	2.2	3.0	8.1	4.2	6.3	14.3	3.3	5.0	8.7	3.7	5.1	7.1	8.8	11.7	1.5	4.2	7.1	4.6	3.5	6.6	5.9	4.4	2.7	12.3	4.4	1.9	4.1	8.6	4.3	3.9	2.6	0.7	2.5	4.0	4.7	1.2	2.3	4.0	9.7	6.4	5.0	1.9	1.3	2.9	11.9	10.8	11.3	17.1	13.1	8.7	9.5	17.9	13.6	9.5	6.0	17.3	7.4	12.9	2.7	12.1	7.7	12.7	6.7	6.8	7.0	9.8	1.1	6.6	7.1	1.3	9.6	3.9	0.0	8.8	0.7	6.7	4.7	3.5	6.4	6.8	17.5	5.2	18.4	16.2	1.9	14.4	13.6	0.0	2.8	1.8	15.3	6.8	0.0	22.6	3.7	16.8	19.4	9.8	5.9	5.3	1.9	0.5	12.8	2.4	5.4
ZNF708	"KOX8, ZNF15, ZNF15L1"	ENSG00000182141	"Zinc finger protein 708"	P17019	19	21291160-21329425	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.0"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (4.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (2.96e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.94e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.22e-3)"	4.4	6.5	11.2	9.2	44.3	7.5	10.0	14.2	24.0	9.2	5.4	14.5	3.0	5.9	6.6	6.9	4.3	6.6	5.5	6.2	11.5	8.9	4.9	3.5	6.5	12.1	46.0	9.8	18.4	8.3	5.5	9.3	5.3	25.7	9.0	5.6	4.8	7.8	5.7	3.7	4.6	6.1	3.7	32.1	7.4	8.3	6.3	35.7	8.6	10.8	2.9	9.5	5.9	5.2	6.3	3.1	11.2	2.7	6.1	8.4	3.3	1.7	1.2	10.9	6.0	3.2	2.9	9.7	3.2	1.4	2.0	3.7	3.2	2.6	0.1	4.7	2.3	2.0	1.7	3.7	2.1	3.4	1.4	5.9	8.7	4.2	2.3	1.4	7.7	2.4	2.4	2.3	1.3	2.1	3.2	2.9	4.5	6.0	0.6	3.6	2.3	6.5	6.0	15.1	0.4	3.6	8.1	5.5	4.2	1.3	11.3	8.6	5.1	2.9	0.1	2.6	6.4	4.1	5.4	4.4	2.9	1.8	3.9	3.4	5.3	4.7	11.0	0.2	3.1	2.2	10.8	2.7	5.7	5.3	2.6	7.7	5.4	6.9	7.9	3.1	6.3	8.4	7.6	11.2	6.1	2.3	2.9	4.6	3.3	11.2	44.3	14.2	24.0	11.5	8.9	46.0	9.8	25.7	35.7	29.8	6.7	9.8	5.4	1.1	11.7	2.8	2.5	8.1	3.4	8.7	9.8	2.7	5.0	6.6	0.7	4.5	2.1	0.0	4.6	2.1	3.7	4.0	11.5	1.5	2.3	15.9	6.9	6.7	1.6	0.8	7.8	5.9	3.3	1.0	2.9	12.0	4.8	0.0	6.3	1.6	15.4	6.5	4.2	6.2	4.1	0.5	2.9	14.9	2.3	2.8
ZNF714		ENSG00000160352	"Zinc finger protein 714"		19	21082159-21125270	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 25.6"															NA	NA						"unprognostic (2.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (1.21e-1)"	"unprognostic (6.88e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.86e-2)"	2.4	5.5	6.4	5.4	15.0	7.7	4.1	17.1	10.2	3.0	2.7	2.7	5.7	3.3	4.2	4.5	9.4	3.4	2.2	2.2	6.4	6.8	2.3	1.4	2.7	5.7	4.5	7.3	21.6	4.9	1.2	4.9	3.5	11.5	3.2	5.0	2.7	3.6	2.4	3.2	9.5	4.2	2.3	5.2	3.2	3.6	4.8	4.2	20.0	18.1	2.8	5.3	3.1	3.6	5.5	11.9	6.6	3.7	4.4	7.2	2.1	9.7	2.0	15.0	7.1	0.9	2.1	12.4	5.6	3.3	12.0	11.2	4.5	7.8	4.1	8.3	3.0	4.5	2.4	0.0	4.6	17.8	3.3	10.3	0.8	6.7	4.5	1.2	5.6	4.6	1.3	0.9	8.3	3.5	2.9	4.0	21.4	10.6	5.4	7.0	2.2	25.6	4.1	14.5	2.1	3.3	9.2	1.0	4.1	3.3	6.2	13.1	8.2	9.0	0.1	2.7	12.2	0.3	0.6	1.9	5.7	0.2	5.0	3.6	4.4	11.7	0.8	0.3	1.5	1.9	5.4	3.1	6.6	3.8	3.7	3.9	3.4	4.1	5.5	4.8	5.5	7.2	6.4	3.1	4.4	2.6	11.9	5.3	2.1	6.4	15.0	17.1	10.2	6.4	6.8	4.5	7.3	11.5	4.2	41.7	7.8	4.5	4.0	3.7	20.6	4.3	5.1	2.7	6.8	5.2	15.7	7.7	1.7	3.7	1.1	4.1	4.2	0.0	3.4	12.7	5.5	6.1	1.1	0.0	4.2	15.9	6.4	4.3	2.2	0.6	4.9	5.9	3.3	0.0	3.9	7.4	2.5	0.0	3.5	1.1	14.5	6.5	2.7	20.1	6.1	3.4	3.9	6.1	5.6	5.9
ZNF738		ENSG00000172687	"Zinc finger protein 738"	Q8NE65	19	21358930-21379302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.3"									HPA059135	Uncertain					NA	NA					"HPA059135: AB_2683918"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.27e-3)"	"prognostic favorable (2.27e-4)"	"unprognostic (2.10e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.39e-5)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.20e-2)"	5.1	4.6	8.1	7.8	21.5	17.5	5.8	25.1	12.5	6.3	4.7	13.6	3.4	4.8	9.4	6.7	5.9	6.3	4.8	4.3	9.3	10.1	4.4	1.4	5.3	9.8	18.6	9.9	14.8	4.7	3.9	4.5	10.6	14.7	6.3	6.4	7.3	6.0	5.2	3.0	6.7	5.5	6.5	13.2	6.9	5.2	7.5	16.0	14.8	6.3	3.0	9.5	5.8	6.2	8.8	5.4	10.0	7.9	7.6	7.2	3.2	1.5	0.9	23.9	9.0	2.9	2.3	16.9	5.8	2.3	11.0	11.4	2.0	7.5	5.1	6.1	2.1	6.7	4.2	8.3	2.7	15.1	6.5	6.4	4.1	1.7	1.6	1.6	1.5	1.4	2.0	1.6	6.3	3.5	4.2	4.8	13.9	0.2	0.2	6.6	1.6	19.0	7.8	25.3	0.1	4.3	19.9	9.7	3.2	2.7	3.6	11.3	5.5	2.2	0.2	3.2	18.2	2.8	14.3	3.2	1.4	1.6	7.4	5.2	0.5	7.9	13.5	0.3	0.5	2.8	7.2	6.2	7.8	3.9	6.4	3.5	7.2	4.8	4.6	5.3	8.8	4.8	4.7	10.0	7.6	7.9	5.4	7.2	3.2	8.1	21.5	25.1	12.5	9.3	10.1	18.6	9.9	14.7	16.0	8.9	0.6	3.2	4.8	3.1	8.6	1.4	5.1	2.7	1.2	14.0	13.7	20.6	6.6	5.5	1.7	6.8	0.8	0.0	6.6	22.2	6.1	3.6	2.3	0.0	9.8	0.0	4.1	5.5	8.3	1.7	4.9	5.6	5.0	0.0	2.9	3.5	5.4	0.0	3.9	0.7	13.1	32.3	5.3	12.7	20.0	1.6	13.0	5.1	3.4	4.7
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.8	9.8	7.8	4.5	9.0	14.5	8.6	8.6	9.4	3.8	11.3	8.7	5.7	21.6	17.0	13.9	9.4	7.2	11.4	7.0	8.3	10.8	5.5	11.2	10.6	6.0	8.8	14.9	10.2	15.3	8.8	14.6	11.7	8.2	6.6	5.4	5.9	11.3	7.0	13.3	8.7	9.3	21.2	7.8	7.0	9.0	17.3	4.7	13.5	22.7	6.7	6.9	6.0	4.7	8.2	15.5	10.7	13.5	6.0	11.0	18.0	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4	14.9	8.1	9.5	6.7	5.0	27.5	18.5	7.6	6.7	7.9	8.7	47.1	20.4	18.3	10.5	17.1	10.1	10.5	0.0	13.4	11.0	8.5	5.8	12.7	7.4	9.8	28.6	11.6	6.2	7.8	12.0	10.3	5.8	5.0	6.4	12.5	10.3	7.1	9.7	5.6	10.5	30.2	19.4	8.6	20.9	10.0	5.5	19.0	8.6	9.0	5.8
ZNF83	"FLJ11015, HPF1, ZNF816B"	ENSG00000167766	"Zinc finger protein 83"	P51522	19	52594060-52690496	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA025970	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025970: AB_1859463"	"unprognostic (6.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (9.20e-4)"	"prognostic favorable (9.06e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (6.92e-6)"	13.1	19.0	14.5	16.2	66.8	14.6	22.3	42.6	20.2	21.6	16.4	11.7	41.4	8.4	23.3	54.0	11.4	27.2	16.0	11.1	17.2	11.5	26.0	4.0	12.9	18.5	25.7	12.5	34.5	11.8	22.3	29.4	44.2	21.9	25.5	14.0	11.0	11.8	32.6	5.8	16.2	12.3	21.0	20.4	19.0	14.7	9.8	24.4	16.9	24.3	8.1	15.9	15.9	34.3	9.9	4.3	8.5	4.9	12.8	9.3	3.7	8.7	0.4	12.5	9.0	11.3	22.9	7.0	13.6	9.4	8.2	11.2	3.4	7.6	9.1	7.1	9.2	6.1	3.9	7.5	9.0	11.5	1.3	8.7	7.7	7.8	4.3	9.3	5.4	10.8	18.4	11.4	6.9	34.4	29.1	9.2	10.3	8.4	7.5	13.5	5.9	7.6	9.4	3.5	1.5	8.6	7.7	10.7	6.1	21.0	17.6	7.3	5.9	8.7	8.6	3.4	21.1	9.1	5.7	12.5	8.3	5.1	4.2	13.9	0.8	8.0	12.6	0.4	5.8	6.6	4.4	3.6	8.5	7.6	3.9	7.8	6.9	8.9	9.3	4.3	9.9	7.6	8.7	3.3	12.8	4.9	2.9	4.3	3.7	14.5	66.8	42.6	20.2	17.2	11.5	25.7	12.5	21.9	24.4	32.8	21.2	4.2	45.7	9.2	27.1	12.9	7.6	28.1	33.0	38.4	33.4	40.1	16.6	16.3	20.0	24.8	7.0	0.0	6.1	16.9	23.5	72.4	34.8	1.3	11.8	46.1	10.4	16.0	4.9	11.1	39.4	15.8	28.7	9.0	14.0	14.3	8.5	17.5	32.5	17.0	38.2	6.5	16.6	13.0	14.7	8.4	53.5	19.2	6.5	63.1
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 69.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044760	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favorable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	5.2	8.4	4.3	7.0	7.0	7.7	8.4	24.7	7.1	5.3	3.4	3.3	7.8	1.0	5.5	3.4	4.8	4.3	3.4	4.9	4.3	3.6	4.9	1.9	3.4	7.8	3.9	5.4	8.9	13.1	6.3	3.5	6.5	5.2	4.7	4.6	3.4	5.1	6.8	1.7	5.4	4.0	4.9	6.3	6.9	7.8	22.8	5.0	15.4	11.7	4.4	8.7	4.7	4.5	8.5	3.2	4.4	3.9	7.6	4.6	2.3	0.8	0.4	9.7	8.3	3.8	3.4	7.6	7.1	2.5	9.6	9.9	0.0	4.3	8.7	8.2	1.7	3.9	0.8	0.1	5.4	10.6	0.3	4.4	2.4	0.9	0.6	0.7	0.1	1.8	1.5	1.8	4.6	6.5	1.7	2.9	9.4	0.1	3.6	5.5	2.9	13.6	5.4	7.2	0.0	8.0	7.6	14.8	4.1	3.4	8.2	6.3	4.8	0.1	0.3	1.3	9.1	4.2	7.1	2.0	4.6	1.3	12.3	7.6	4.6	11.1	9.7	0.2	0.1	3.9	0.8	1.2	4.4	3.4	3.9	2.8	8.5	3.8	2.6	2.7	6.8	4.6	3.8	4.0	7.6	2.5	3.2	4.3	2.3	4.3	7.0	24.7	7.1	4.3	3.6	3.9	5.4	5.2	5.0	3.0	1.7	9.5	2.8	0.7	4.5	3.1	0.0	4.0	2.3	5.2	0.0	7.6	1.7	5.2	69.1	6.9	0.1	0.0	5.4	11.6	3.1	2.0	11.5	0.0	7.1	3.2	0.0	3.7	0.6	10.5	2.8	5.9	5.0	7.2	2.4	3.2	4.1	2.3	3.5	1.7	1.9	19.4	1.4	16.9	13.6	1.3	6.3	5.2	1.5	1.8
ZNF93	"FLJ12488, HPF34, TF34, ZNF505"	ENSG00000184635	"Zinc finger protein 93"	P35789	19	19900913-19963464	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.4"															NA	NA						"unprognostic (1.49e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.80e-5)"	"prognostic favorable (9.31e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-6)"	"unprognostic (7.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (6.06e-2)"	7.9	3.2	3.4	7.2	5.5	4.4	6.7	10.9	3.9	7.4	4.3	1.5	8.0	1.7	8.5	9.5	4.6	4.6	5.3	3.1	3.0	3.7	6.7	2.8	4.9	14.0	4.3	0.7	11.9	7.0	3.8	8.0	5.1	3.7	6.3	4.5	2.3	5.4	9.7	2.8	6.4	4.4	9.3	5.4	9.5	4.2	6.8	4.0	17.4	17.0	5.4	8.0	10.1	3.9	7.5	4.0	11.0	4.9	6.2	6.3	2.4	0.0	0.0	12.7	13.8	1.1	0.9	11.4	4.7	2.1	11.1	13.2	2.9	2.3	3.9	4.3	2.2	9.3	0.4	0.0	0.2	12.5	0.1	0.5	0.1	0.3	0.2	0.8	0.1	0.2	1.7	0.8	10.4	0.8	2.0	0.2	0.1	2.0	0.4	10.3	1.1	15.2	6.7	22.4	0.0	3.3	13.9	11.3	4.3	2.4	7.4	7.6	4.6	0.2	1.0	2.1	16.1	3.9	8.4	0.2	10.9	0.5	10.3	6.9	1.6	7.4	8.1	0.1	1.8	3.5	5.4	4.2	11.0	1.9	4.7	2.5	6.4	3.8	3.2	4.0	7.5	5.2	2.8	9.2	6.2	4.9	3.6	6.3	2.4	3.4	5.5	10.9	3.9	3.0	3.7	4.3	0.7	3.7	4.0	3.0	1.3	7.3	4.9	0.9	1.5	3.1	5.1	5.3	3.4	1.8	2.0	4.2	6.6	5.0	2.1	2.4	0.5	0.0	5.5	13.1	2.5	2.3	6.9	0.0	7.1	3.2	0.0	0.6	3.2	1.1	1.1	5.6	1.7	8.2	1.7	2.1	4.7	0.0	2.8	1.3	2.8	0.0	2.3	8.4	7.9	2.4	4.2	0.8	2.0	3.2
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 10.0;Early spermatids: 20.0;Late spermatids: 14.4;Muller glia cells: 5.8;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HMC-1: 4.4;NTERA-2: 4.5;T-47d: 6.5"									HPA007938	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	0.9	6.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4	0.0	0.0	0.0	0.3	0.0	2.8	0.6	0.0	0.0	0.0	1.8	2.0	0.0	10.0	0.8	20.0	0.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	14.4	0.9	0.0	1.7	0.0	0.0	5.8	0.4	0.0	0.0	0.0	2.1	0.0	0.3	17.0	3.1	0.0	0.0	0.0	0.0	0.4
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124560-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	5.3	6.7	7.6	7.8	8.9	3.5	9.3	26.4	7.7	5.4	9.0	5.5	12.7	11.0	6.0	9.6	6.1	5.4	6.3	3.7	6.9	5.4	9.5	6.9	6.2	11.3	8.0	5.9	4.6	8.3	11.2	11.9	2.8	7.8	7.5	12.0	4.3	10.4	9.9	5.1	8.8	13.0	6.2	10.1	13.4	9.1	3.2	9.3	11.7	7.5	4.2	11.2	7.2	5.4	10.0	11.0	30.5	6.3	9.9	10.7	4.8	0.0	7.2	9.3	6.8	2.6	0.6	7.6	2.5	5.3	6.6	7.1	5.0	4.7	7.1	6.7	2.3	4.6	5.6	6.4	3.6	6.2	10.2	8.9	7.4	5.8	6.9	4.1	5.4	6.3	0.8	6.1	5.5	3.0	7.0	12.0	0.2	1.0	6.1	1.7	7.9	0.0	8.6	1.9	6.0	4.4	8.8	7.1	9.8	7.7	10.2	12.6	13.9	1.2	7.7	8.7	6.3	10.1	2.6	3.7	2.5	5.7	3.7	6.4	3.1	9.8	1.9	1.1	2.7	1.3	30.5	4.9	5.4	8.1	6.3	10.7	10.0	7.2	6.2	5.0	8.1	8.8	7.1	8.9	9.9	6.1	11.0	7.7	4.8	7.6	8.9	26.4	7.7	6.9	5.4	8.0	5.9	7.8	9.3	6.0	1.6	1.4	0.6	1.5	3.8	1.4	5.1	9.4	4.5	7.0	3.9	2.0	5.0	10.1	2.5	3.5	5.6	0.0	11.1	1.0	0.7	0.9	2.3	1.8	1.8	1.6	1.7	3.1	4.6	0.9	0.6	4.0	1.7	5.4	4.7	3.1	8.2	6.8	3.2	5.8	5.5	0.0	1.1	0.7	5.1	1.1	1.5	8.2	7.7	0.6
